10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-14-036458.txt : 20140205 0001193125-14-036458.hdr.sgml : 20140205 20140205131743 ACCESSION NUMBER: 0001193125-14-036458 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20131231 FILED AS OF DATE: 20140205 DATE AS OF CHANGE: 20140205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 14575421 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 10-Q 1 d630893d10q.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2013

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 0-26642

MYRIAD GENETICS, INC.

(Exact name of registrant as specified in its charter)


Delaware		87-0494517
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

320 Wakara Way, Salt Lake City, UT		84108
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (801) 584-3600

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “accelerated filer,” “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Check one:

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of January 31, 2014 the registrant had 72,974,449 shares of $0.01 par value common stock outstanding.

MYRIAD GENETICS, INC.

INDEX TO FORM 10-Q


		Page
PART I - Financial Information

Item 1.	Financial Statements

	Condensed Consolidated Balance Sheets (Unaudited) as of December 31, 2013 and June 30, 2013	3

	Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) for the three and six months ended December 31, 2013 and 2012	4

	Condensed Consolidated Statements of Cash Flows (Unaudited) for the six months ended December 31, 2013 and 2012	5

	Notes to Condensed Consolidated Financial Statements (Unaudited)	6

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	14

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22

Item 4.	Controls and Procedures	22

PART II - Other Information

Item 1.	Legal Proceedings	23

Item 1A.	Risk Factors	23

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	24

Item 3.	Defaults Upon Senior Securities	24

Item 4.	Mine Safety Disclosures	24

Item 5.	Other Information	24

Item 6.	Exhibits	24

Signatures		26

MYRIAD GENETICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)


(In thousands, except per share amounts)	December 31, 2013		June 30, 2013
Assets
Current assets:
Cash and cash equivalents	$	71,599	$	104,073
Marketable investment securities		281,996		268,243
Prepaid expenses		4,237		5,963
Trade accounts receivable, less allowance for doubtful accounts of $9,200 at Dec. 31, 2013 and $7,500 at Jun. 30, 2013		84,137		94,333
Deferred taxes		9,074		8,007
Other receivables		3,463		3,373

Total current assets		454,506		483,992

Equipment and leasehold improvements:
Equipment		73,570		65,903
Leasehold improvements		18,390		18,294

		91,960		84,197
Less accumulated depreciation		60,647		56,595

Net equipment and leasehold improvements		31,313		27,602

Long-term marketable investment securities		135,187		158,748
Long-term deferred taxes		29,983		28,632
Note receivable		23,000		21,667
Other assets		13,000		13,000
Intangibles, net		12,842		13,330
Goodwill		56,850		56,850

Total assets	$	756,681	$	803,821

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	17,596	$	18,132
Accrued liabilities		45,844		44,334
Deferred revenue		3,952		2,043

Total current liabilities		67,392		64,509

Unrecognized tax benefits		13,318		10,718

Total liabilities		80,710		75,227

Stockholders’ equity:
Preferred stock, $0.01 par value, authorized 5,000 shares, issued and outstanding no shares		—		—
Common stock, $0.01 par value, authorized 150,000 shares at Dec. 31, 2013 and Jun. 30, 2013, issued and outstanding 73,974 at Dec. 31, 2013 and 80,577 at Jun. 30, 2013		740		806
Additional paid-in capital		663,122		697,346
Accumulated other comprehensive income (loss)		506		(424	)
Retained earnings		11,603		30,866

Total stockholders’ equity		675,971		728,594

	$	756,681	$	803,821

See accompanying notes to condensed consolidated financial statements (unaudited).

MYRIAD GENETICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (UNAUDITED)


	Three Months Ended December 31,						Six Months Ended December 31,
(In thousands, except per share amounts)	2013			2012			2013			2012
Molecular diagnostic testing	$	196,158		$	140,651		$	389,144		$	267,919
Companion diagnostic services		7,902			8,489			17,383			14,658

Total revenue		204,060			149,140			406,527			282,577
Costs and expenses:
Cost of molecular diagnostic testing		22,755			15,566			44,194			29,498
Cost of companion diagnostic services		3,376			4,318			7,418			7,713
Research and development expense		17,090			14,107			33,893			25,507
Selling, general, and administrative expense		77,840			59,563			155,119			115,691

Total costs and expenses		121,061			93,554			240,624			178,409

Operating income		82,999			55,586			165,903			104,168
Other income (expense):
Interest income		1,330			1,385			2,691			2,753
Other		(185	)		14			(623	)		(114	)

Total other income		1,145			1,399			2,068			2,639
Income before income taxes		84,144			56,985			167,971			106,807
Income tax provision		33,784			21,949			62,146			41,635

Net income	$	50,360		$	35,036		$	105,825		$	65,172

Earnings per share:
Basic	$	0.67		$	0.43		$	1.37		$	0.80
Diluted	$	0.66		$	0.42		$	1.33		$	0.78
Weighted average shares outstanding
Basic		75,070			81,692			77,323			81,632
Diluted		76,825			84,240			79,312			84,091
Net income	$	50,360		$	35,036		$	105,825		$	65,172
Comprehensive income:
Unrealized gain (loss) on available-for-sale securities, net of tax		253			(70	)		538			13
Change in foreign currency translation adjustment, net of tax		(112	)		(280	)		392			(72	)

Comprehensive income	$	50,501		$	34,686		$	106,755		$	65,113

See accompanying notes to condensed consolidated financial statements (unaudited).

MYRIAD GENETICS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)


	Six Months Ended December 31,
(In thousands)	2013			2012
Cash flows from operating activities:
Net income	$	105,825		$	65,172
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		4,811			4,455
Loss on disposition of assets		40			4
Share-based compensation expense		13,792			13,704
Bad debt expense		21,793			14,729
Impairment of intangible asset		—			1,490
Accreted interest on note receivable		(1,333	)		(1,333	)
Unrecognized tax benefits		2,600			130
Excess tax benefit from share-based compensation		(592	)		(3,623	)
Deferred income taxes		(1,826	)		5,899
Changes in operating assets and liabilities:
Prepaid expenses		1,807			501
Trade accounts receivable		(11,597	)		(29,851	)
Other receivables		(172	)		1,672
Accounts payable		(536	)		3,434
Accrued liabilities		1,510			(3,580	)
Deferred revenue		1,909			667

Net cash provided by operating activities		138,031			73,470

Cash flows from investing activities:
Capital expenditures for equipment and leasehold improvements		(8,098	)		(7,008	)
Purchases of marketable investment securities		(102,661	)		(239,264	)
Proceeds from maturities and sales of marketable investment securities		113,424			207,230

Net cash provided by (used in) investing activities		2,665			(39,042	)

Cash flows from financing activities:
Net proceeds from common stock issued under share-based compensation plans		6,362			23,903
Excess tax benefit from share-based compensation		592			3,623
Repurchase and retirement of common stock		(180,124	)		(79,883	)

Net cash used in financing activities		(173,170	)		(52,357	)

Net decrease in cash and cash equivalents		(32,474	)		(17,929	)
Cash and cash equivalents at beginning of period		104,073			86,352

Cash and cash equivalents at end of period	$	71,599		$	68,423

See accompanying notes to condensed consolidated financial statements (unaudited).

MYRIAD GENETICS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(1)	Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the “Company”) in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2013, included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2013. Operating results for the three and six months ended December 31, 2013 may not necessarily be indicative of results to be expected for any other interim period or for the full year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Certain reclassifications have been made to prior period amounts to conform to the current period presentation.

(2)	Marketable Investment Securities

The Company has classified its marketable investment securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders’ equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at December 31, 2013 and June 30, 2013 were as follows:


(In thousands)	Amortized cost		Gross unrealized holding gains		Gross unrealized holding losses			Estimated fair value
At December 31, 2013:
Cash and cash equivalents:
Cash	$	53,924	$	—	$	—		$	53,924
Cash equivalents		17,675		—		—			17,675

Total cash and cash equivalents		71,599		—		—			71,599

Available-for-sale securities:
Corporate bonds and notes		84,259		60		(1	)		84,318
Municipal bonds		268,341		300		(99	)		268,542
Federal agency issues		64,293		30		—			64,323

Total available-for-sale securities		416,893		390		(100	)		417,183

Total cash, cash equivalents and available-for-sale securities	$	488,492	$	390	$	(100	)	$	488,782


(In thousands)	Amortized cost		Gross unrealized holding gains		Gross unrealized holding losses			Estimated fair value
At June 30, 2013:
Cash and cash equivalents:
Cash	$	40,412	$	—	$	—		$	40,412
Cash equivalents		63,653		8		—			63,661

Total cash and cash equivalents		104,065		8		—			104,073

Available-for-sale securities:
Corporate bonds and notes		71,626		13		(15	)		71,624
Municipal bonds		251,513		109		(537	)		251,085
Federal agency issues		104,293		24		(35	)		104,282

Total available-for-sale securities		427,432		146		(587	)		426,991

Total cash, cash equivalents and available-for-sale securities	$	531,497	$	154	$	(587	)	$	531,064

Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at December 31, 2013:


(In thousands)	Amortized cost		Estimated fair value
Cash	$	53,924	$	53,924
Cash equivalents		17,675		17,675
Available-for-sale:
Due within one year		281,882		281,996
Due after one year through five years		135,011		135,187
Due after five years		—		—

	$	488,492	$	488,782

(3)	Share-Based Compensation

The Company maintains a share-based compensation plan, the 2010 Employee, Director and Consultant Equity Incentive Plan, as amended (the “2010 Plan”), that has been approved by the Company’s shareholders. The 2010 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of stock options, restricted and unrestricted stock awards and other stock-based awards to employees, consultants and directors. On December 5, 2013, the shareholders approved an amendment to the 2010 Plan to set the number of shares available for grant to 3,500,000. At December 31, 2013, 3,733,317 shares were available for issuance, which includes 233,317 shares carried over between December 6 and 31, 2013, from the Company’s 2003 Employee, Director and Consultant Option Plan (the “2003 Plan) and the 2010 Plan that were cancelled or expired without the issuance of shares of common stock by the Company. In addition, as of December 31, 2013, the Company may grant up to 6,999,352 additional shares under the 2010 Plan if options previously granted under 2003 Plan are cancelled or expire without the issuance of shares of common stock by the Company.

The number of shares, terms, and vesting period of awards under the 2010 Plan are determined by the Compensation Committee of the Board of Directors for each equity award. Options under the plan granted prior to December 5, 2012 generally vest ratably over four years and expire ten years from the grant date. Options granted after December 5, 2012 generally vest ratably over four years and expire eight years from the grant date. The exercise price of options granted is equivalent to the fair market value of the stock on the grant date.

The Company also has an Employee Stock Purchase Plan that was approved by shareholders in 2012 (the “2012 Purchase Plan”), under which 2,000,000 shares of common stock have been authorized. Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period. As of December 31, 2013, approximately 144,000 shares of common stock have been issued under the 2012 Purchase Plan and approximately 1,856,000 were available for issuance.

A summary of the stock option activity under the Company’s plans for the six months ended December 31, 2013 is as follows:


	Number of shares		Weighted average exercise price
Options outstanding at June 30, 2013		14,434,970	$	21.75
Options granted		3,304,553		26.48
Less:
Options exercised		310,866		14.23
Options canceled or expired		354,729		24.33

Options outstanding at December 31, 2013		17,073,928	$	22.75

As of December 31, 2013, options to purchase 9,218,423 shares were vested and exercisable at a weighted average price of $21.39. As of December 31, 2013, there was $52,276,000 of total unrecognized share-based compensation expense related to share-based awards granted under the Company’s plans that will be recognized over a weighted-average period of 2.57 years.

Share-based compensation expense recognized and included in the condensed consolidated statements of income was allocated as follows:


	Three months ended December 31,				Six months ended December 31,
(In thousands)	2013		2012		2013		2012
Cost of molecular diagnostic testing	$	209	$	271	$	432	$	560
Cost of companion diagnostic services		74		47		137		104
Research and development expense		846		869		1,627		1,678
Selling, general, and administrative expense		5,728		5,918		11,596		11,362

Total share-based compensation expense	$	6,857	$	7,105	$	13,792	$	13,704

(4)	Stockholders’ Equity

Share Repurchase Program

In November 2013, the Company completed its fifth share repurchase program, which authorized the repurchase of up to $200 million of the Company’s common stock. In November 2013, the Company’s Board of Directors authorized a sixth share repurchase program of $300 million of the Company’s outstanding common stock. The Company plans to repurchase its common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company’s management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors. As of December 31, 2013, approximately $273.3 million remained available for repurchases under the sixth program. The Company uses the par value method of accounting for its stock repurchases. As a result of the stock repurchases, the Company reduced common stock and additional paid-in capital and recorded charges to retained earnings. The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to retained earnings for the repurchases for the three and six months ended December 31, 2013 and 2012 were as follows:


	Three months ended December 31,				Six months ended December 31,
(In thousands)	2013		2012		2013		2012
Shares purchased and retired		3,185		1,231		6,991		3,067
Common stock and additional paid-in-capital reductions	$	25,096	$	9,372	$	55,036	$	23,122
Charges to retained earnings	$	52,713	$	24,311	$	125,088	$	56,760

(5)	Earnings Per Share

Basic earnings per share is computed based on the weighted-average number of shares of the Company’s common stock outstanding. Diluted earnings per share is computed based on the weighted-average number of shares of the Company’s common stock, including the dilutive effect of common stock equivalents outstanding.

The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:


	Three months ended December 31,				Six months ended December 31,
(In thousands)	2013		2012		2013		2012
Denominator:
Weighted-average shares outstanding used to compute basic earnings per share		75,070		81,692		77,323		81,632
Effect of dilutive stock options		1,755		2,548		1,989		2,459

Weighted-average shares outstanding and dilutive securities used to compute dilutive earnings per share		76,825		84,240		79,312		84,091

Certain outstanding stock options were excluded from the computation of diluted earnings per share for the three and six months ended December 31, 2013 and 2012 because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:


	Three months ended December 31,				Six months ended December 31,
(In thousands)	2013		2012		2013		2012
Anti-dilutive options excluded from EPS computation		8,500		5,605		7,136		4,585

(6)	Segment and Related Information

The Company’s business units have been aggregated into three reportable segments: (i) research, (ii) molecular diagnostics and (iii) companion diagnostics. The research segment is focused on the discovery of genes, biomarkers and proteins related to major common diseases and includes corporate services such as finance, human resources, legal, and information technology. The molecular diagnostics segment provides testing that is designed to assess an individual’s risk for developing disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression and disease recurrence. The companion diagnostics segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries. The Company evaluates segment performance based on results from operations before interest income and expense and other income and expense.

Segment revenue and operating income (loss) were as follows during the periods presented:


(In thousands)	Research			Molecular diagnostics		Companion diagnostics			Total
Three months ended December 31, 2013:
Revenue	$	—		$	196,158	$	7,902		$	204,060
Depreciation and amortization		482			1,467		489			2,438
Segment operating income (loss)		(16,286	)		98,233		1,052			82,999
Three months ended December 31, 2012:
Revenue	$	—		$	140,651	$	8,489		$	149,140
Depreciation and amortization		578			1,232		401			2,211
Segment operating income (loss)		(16,334	)		72,970		(1,050	)		55,586
Six months ended December 31, 2013:
Revenue	$	—		$	389,144	$	17,383		$	406,527
Depreciation and amortization		992			2,830		989			4,811
Segment operating income (loss)		(32,967	)		195,981		2,889			165,903
Six months ended December 31, 2012:
Revenue	$	—		$	267,919	$	14,658		$	282,577
Depreciation and amortization		1,210			2,424		821			4,455
Segment operating income (loss)		(30,765	)		138,030		(3,097	)		104,168


	Three months ended December 31,					Six months ended December 31,
(In thousands)	2013			2012		2013			2012
Total operating income for reportable segments	$	82,999		$	55,586	$	165,903		$	104,168
Interest income		1,330			1,385		2,691			2,753
Other		(185	)		14		(623	)		(114	)
Income tax provision		33,784			21,949		62,146			41,635

Net income	$	50,360		$	35,036	$	105,825		$	65,172

(7)	Fair Value Measurements

The fair value of the Company’s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:


Level 1 —		quoted prices in active markets for identical assets and liabilities.
Level 2 —		observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Some of the Company’s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.
Level 3 —		unobservable inputs.

The substantial majority of the Company’s financial instruments are valued using quoted prices in active markets or based on other observable inputs. For Level 2 securities, the Company uses a third party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information. The Company reviews, tests and validates this information. The following table sets forth the fair value of the financial assets that the Company re-measured on a regular basis:


(In thousands)	Level 1		Level 2		Level 3		Total
at December 31, 2013:

Money market funds (a)	$	9,351	$	—	$	—	$	9,351
Corporate bonds and notes		—		89,318		—		89,318
Municipal bonds		—		270,554		—		270,554
Federal agency issues		—		65,635		—		65,635

Total	$	9,351	$	425,507	$	—	$	434,858


(In thousands)	Level 1		Level 2		Level 3		Total
at June 30, 2013:

Money market funds (a)	$	12,691	$	—	$	—	$	12,691
Corporate bonds and notes		—		71,624		—		71,624
Municipal bonds		—		302,055		—		302,055
Federal agency issues		—		104,282		—		104,282

Total	$	12,691	$	477,961	$	—	$	490,652

(a)

Money market funds are primarily comprised of exchange traded funds and accrued interest

(8)	Income Taxes

In order to determine the Company’s quarterly provision for income taxes, the Company used an estimated annual effective tax rate that is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

Income tax expense for the three months ended December 31, 2013 was $33,784,000, or approximately 40% of pre-tax income, compared to $21,949,000, for the three months ended December 31, 2012, or approximately 39% of pre-tax income. Income tax expense for the six months ended December 31, 2013 was $62,146,000, or approximately 37% of pre-tax income, compared to $41,635,000, or approximately 39% of pre-tax income. Income tax expense for the three and six months ended December 31, 2013 is based on the Company’s estimated annual effective tax rate for the full fiscal year ending June 30, 2014, adjusted by discrete items recognized during the period. For the six months ended December 31, 2013, the Company’s recognized effective tax rate differs from the U.S. federal statutory rate of 35% primarily due to the effect of state income taxes, a deduction for the write-off of stock in a wholly-owned subsidiary recently divested, as well as timing differences related to the recognition of the tax effect of equity compensation expense from incentive stock options and the deduction realized if those options are disqualified upon exercise and sale.

The Company files U.S., U.K., France and state income tax returns in jurisdictions with various statutes of limitations. Annual and interim tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued. The Company’s U.S. federal tax return, U.K. and France income tax returns and all other state tax returns are not currently under examination.

(9)	Goodwill and Intangible Assets

Goodwill

At December 31, 2013, the Company had recorded goodwill of $56,850,000 related to the acquisition of Myriad RBM, Inc. on May 31, 2011 (formerly Rules-Based Medicine, Inc.). There were no events or circumstances that indicated that impairment exists; therefore, the Company recorded no impairment of goodwill for the three and six months ended December 31, 2013.

Intangible Assets

Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and tradenames as well as non-amortizable intangible assets of in-process technologies and research and development. Certain of these intangible assets were recorded as part of the Company’s purchase of Rules-Based Medicine, Inc. on May 31, 2011. The following summarizes the amounts reported as intangible assets:


(In thousands)	Gross Carrying Amount		Accumlated Amortization			Net
December 31, 2013:
Purchased licenses and technologies	$	4,500	$	(2,800	)	$	1,700
Customer relationships		4,650		(1,208	)		3,442
Trademarks		3,000		(100	)		2,900

Total amortizable intangible assets		12,150		(4,108	)		8,042

In-process research and development		4,800		—			4,800

Total non-amortizable intangible assets		4,800		—			4,800

Total intangible assets	$	16,950	$	(4,108	)	$	12,842


(In thousands)	Gross Carrying Amount		Accumlated Amortization			Net
June 30, 2013:
Purchased licenses and technologies	$	4,500	$	(2,644	)	$	1,856
Customer relationships		4,650		(976	)		3,674
Trademarks		3,000		—			3,000

Total amortizable intangible assets		12,150		(3,620	)		8,530

In-process research and development		4,800		—			4,800

Total non-amortizable intangible assets		4,800		—			4,800

Total intangible assets	$	16,950	$	(3,620	)	$	13,330

The Company recorded amortization during the respective periods for these intangible assets as follows:


	Three months ended December 31,				Six months ended December 31,
(In thousands)	2013		2012		2013		2012
Amortization on intangible assets	$	244	$	231	$	488	$	506

(10)	Term Loan and Option Agreement

On September 8, 2011, the Company issued a $25,000,000 term loan to Crescendo Bioscience, Inc. (“Crescendo”) of South San Francisco, CA under a Loan and Security Agreement (“Loan Agreement”) and also secured an exclusive three-year option to acquire Crescendo pursuant to a definitive merger agreement (the “Option Agreement”). The stated interest rate on the term loan is 7%. The fair value of the Option Agreement of $8,000,000 was determined utilizing valuation models at the time of the issuance, including the market and income based approaches, which utilize various inputs including projected income, volatility, risk free rates and projected terms. The Company periodically evaluates the Option Agreement for impairment. No impairment indicators were noted at December 31, 2013.

The residual $17,000,000 value of the term loan has been classified as a note receivable at its accreted value of $23,000,000 on the condensed consolidated balance sheet as of December 31, 2013. The Company recorded interest income related to accretion of the note receivable and the stated interest rate for the three and six months ended December 31, 2013 of $1,104,000 and $2,208,000, respectively, in the condensed consolidated statement of income. The Company is utilizing the effective interest method to accrete the discount portion of the note receivable through interest income over the three-year term of the Company’s option to acquire Crescendo under the Option Agreement. The note receivable is evaluated for collectability each reporting period. If the Company determines that the note receivable and any accrued interest is not collectible, such amount will be written off in the period that determination is made. No amounts related to the note receivable or accrued interest were written off during the three or six months ended December 31, 2013.

On November 14, 2013, the Company received notice from Crescendo that Crescendo had achieved the minimum revenue milestone under the Option Agreement. If the Company exercises its option to acquire Crescendo, it expects to finance the purchase price out of the Company’s cash, cash equivalents and marketable investment securities available on hand.

(11)	Cost Basis Investment

As of December 31, 2013, the Company had a $5,000,000 investment in RainDance Technologies, Inc. which has been recorded under the cost method as an “Other Asset” on the Company’s condensed consolidated balance sheet. There were no events or circumstances that indicated that impairment exists; therefore, the Company recorded no impairment in the investment for the three or six months ended December 31, 2013.

(12)	Commitments and Contingencies

The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of December 31, 2013, the management of the Company believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company’s consolidated financial position, operating results, or cash flows.

(13)	Subsequent Event

On February 2, 2014, the Company amended and restated the Option Agreement with Crescendo by entering into an amended definitive agreement and plan of merger (the “Merger Agreement”) to purchase Crescendo for $270 million in cash, subject to adjustments for Crescendo’s cash, indebtedness, working capital and other amounts to be determined in accordance with the Merger Agreement. The Company plans to utilize its existing cash and marketable investment securities to pay the purchase price to acquire Crescendo. The Company currently anticipates that the merger will be completed by the end of fiscal year 2014, subject to regulatory clearance and the satisfaction of customary closing conditions and the other terms and conditions of the Merger Agreement.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

We are a leading molecular diagnostic company dedicated to making a difference in patients’ lives through the discovery and commercialization of novel, transformative tests across major diseases. We believe in improving healthcare for patients by providing physicians with important information to answer critical questions and solve unmet medical needs. Through our proprietary technologies, we believe we are positioned to identify important disease genes, the proteins they produce, and the biological pathways in which they are involved to better understand the underlying molecular basis for the cause of human disease. We believe that identifying these biomarkers (the genes, their expression levels and the proteins they produce) will enable us to develop novel molecular diagnostic tests.

Our goal is to provide physicians with critical information that may guide the healthcare management of their patients to prevent disease, diagnose the disease at an earlier stage, determine the most appropriate therapy, or assess the aggressiveness of their disease. Our proprietary technologies, including DNA, RNA and protein analysis, help us to understand the genetic basis of human disease and the role that genes and their related proteins may play in the onset and progression of disease. We use this information to guide the development of new molecular diagnostic tests that are designed to assess an individual’s risk for developing disease later in life (predictive medicine), identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment (personalized medicine), assess a patient’s risk of disease progression and disease recurrence (prognostic medicine) or accurately diagnose disease (diagnostic medicine).

Our business strategy for future growth is focused on three key initiatives. First, we are working to grow and expand our existing products and markets. Second, we are developing our business internationally and have recently established operations in Europe and Canada. Finally, we are launching and intend to continue to launch new potentially transformative products across a diverse set of disease indications, complementing our current businesses in oncology, women’s health, urology and dermatology.

On February 2, 2014, we entered into a definitive agreement and plan of merger (the “Merger Agreement”) to purchase Crescendo Bioscience, Inc. (“Crescendo”) for $270 million in cash, subject to adjustment for Crescendo’s cash, indebtedness, working capital and other amounts to be determined in accordance with the Merger Agreement. We currently anticipate that the merger will be completed by the end of our fiscal year 2014, subject to regulatory clearance and the satisfaction of customary closing conditions and the other terms and conditions of the Merger Agreement. We believe that this acquisition represents an attractive opportunity because (i) it facilitates our entry into the high growth autoimmune market, (ii) it diversifies our product revenues and (iii) it enhances our strength in protein-based diagnostics.

Products and Services

We offer twelve commercial molecular diagnostic tests, including seven predictive medicine tests, two personalized medicine tests, and two prognostic medicine tests and one diagnostic medicine test. We market these tests in the United States through our own sales force of approximately 400 people. We have also established commercial laboratory operations in Munich, Germany and international headquarters in Zurich, Switzerland. We currently market our BRACAnalysis^®, COLARIS^®, COLARIS AP^®, and Prolaris^® products through our own sales force in Europe and Canada and have entered into distributor agreements with organizations in select Latin American, Middle Eastern, Asian and African countries.

Our twelve commercial molecular diagnostic tests include:

•

Myriad myRisk^TM Hereditary Cancer, our predictive medicine test for hereditary cancers;

•

Myriad myPlan^TM Lung Cancer, our prognostic medicine test for predicting the aggressiveness of lung cancer;

•

Myriad myPath^TM Melanoma, our diagnostic medicine test for the difficult cases of melanoma;

•

BRACAnalysis^®, our predictive medicine test for hereditary breast and ovarian cancer;

•

COLARIS^®, our predictive medicine test for hereditary colorectal and uterine cancer;

•

COLARIS AP^®, our predictive medicine test for hereditary colorectal cancer;

•

MELARIS^®, our predictive medicine test for hereditary melanoma;

•

PANEXIA™, our predictive medicine test for pancreatic cancer;

•

PREZEON^®, our personalized medicine test to assess PTEN status for disease progression and drug response;

•

Prolaris^®, our prognostic medicine test for prostate cancer;

•

Theraguide^® 5-FU, our personalized medicine test for chemotherapy toxicity to 5-FU; and

•

BART^TM, our predictive medicine test for detecting large genomic rearrangements involved in hereditary breast and ovarian cancer.

On September 3, 2013, we launched Myriad myRisk^TM Hereditary Cancer to physician thought leaders as part of a staged product rollout. We began expanding physician access to Myriad myRisk Hereditary Cancer on January 1, 2014. On October 29, 2013, we launched Myriad myPlan™ Lung Cancer to leading oncologists throughout the United States and on November 12, 2013,we launched Myriad myPath™ Melanoma through an early-access program that will introduce the test to leading dermatopathologists across the country. We intend to expand access to Myriad myPlan Lung Cancer and Myriad myPath Melanoma throughout the remainder of our fiscal year ending June 30, 2014.

Through our wholly owned subsidiary, Myriad RBM, Inc., we provide biomarker discovery and companion diagnostic services to the pharmaceutical, biotechnology, and medical research industries utilizing our multiplexed immunoassay technology. Our technology enables us to efficiently screen large sets of clinical samples from both diseased and non-diseased populations against our extensive menu of protein biomarkers. By analyzing the data generated from these tests, we attempt to discover biomarker patterns that may be used to identify patients who would likely respond to a particular therapy. In addition to the companion diagnostic research revenue received from analyzing these samples, we also use this information to create and validate new biomarkers that can aid us in the development of our own novel molecular diagnostic tests that could aid a physician in making diagnostic and treatment decisions.

Use of Resources

During the three and six months ended December 31, 2013, we devoted our resources to supporting and growing our molecular diagnostic and companion diagnostic businesses, as well as to the research and development of future molecular and companion diagnostic candidates. We have three reportable operating segments—research, molecular diagnostics and companion diagnostics. See Note 6 “Segment and Related Information” in the notes to our condensed consolidated financial statements (unaudited) for information regarding these operating segments.

For the three and six months ended December 31, 2013, we had net income of $50.4 million and $105.8 million and diluted earnings per share of $0.66 and $1.33, compared to net income of $35.0 million and $65.2 million and diluted earnings per share of $0.42 and $0.78 per share in the same period in the prior year. Net income and diluted earnings per share results for the three and six months ended December 31, 2013 included income tax expense of $33.8 million and $62.1 million compared to $21.9 million and $41.6 million for the same period in the prior year.

Share Repurchase Program

Between May 2010 and November 2013, we repurchased $700 million of our outstanding common stock. In November 2013, we announced that our board of directors had authorized us to repurchase an additional $300 million of our outstanding common stock and we have repurchased an additional $26.7 million of our outstanding common stock under this repurchase plan as of December 31, 2013. During the three months ended December 31, 2013, we repurchased $77.8 million of our outstanding common stock under our prior and current programs. In connection with our stock repurchase program our board of directors authorized us to repurchase shares from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by our management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors. See also “Part II, Item 2. Unregistered Sales of Equity Securities and Use of Proceeds – Issuer Purchases of Equity Securities.”

Critical Accounting Policies

Critical accounting policies are those policies which are both important to the presentation of a company’s financial condition and results and require management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. No significant changes to our accounting policies took place during the period. For a further discussion of our critical accounting policies, see our Annual Report on Form 10-K for the fiscal year ended June 30, 2013.

Results of Operations for the Three Months Ended December 31, 2013 and 2012

Revenue

Revenue is comprised of sales of our molecular diagnostic tests and our companion diagnostic services. Total revenue for the three months ended December 31, 2013 was $204.1 million, compared to $149.1 million for the same three months in 2012. This 37% increase in revenue is primarily due to increased molecular diagnostic testing volume for our BRACAnalysis, BART, Colaris and Colaris AP tests and our Myriad Hereditary Cancer test, which we launched during 2013, as disclosed in the table below. We believe that our increased sales, marketing, and education efforts resulted in wider acceptance of our molecular diagnostic tests by the medical community and increased patient testing volumes. The 7% decrease in companion diagnostic service revenue was due to changes and timing of customer projects year over year. There can be no assurance that our revenue will continue to increase or remain at current levels.

Total revenue of our molecular diagnostic tests and companion diagnostic services and revenue by product as a percent of total revenue for the three months ended December 31, 2013 and 2012 were as follows:


	Three months ended December 31,				% Change			% of Total Revenue
(In thousands)	2013		2012		% Change			2013			2012
Molecular diagnostic testing revenue:
BRACAnalysis	$	141,228	$	110,267		28	%		69	%		74	%
BART		24,698		15,781		57	%		12	%		10	%
COLARIS & COLARIS AP		15,554		12,063		29	%		8	%		8	%
Myriad myRisk		11,509		—		N/A			6	%		N/A
Other		3,169		2,540		25	%		1	%		2	%

Total molecular diagnostic testing revenue		196,158		140,651		39	%

Companion diagnostic service revenue		7,902		8,489		(7	%)		4	%		6	%

Total revenue	$	204,060	$	149,140		37	%		100	%		100	%

Our molecular diagnostic sales force is focused on two major markets, oncology and women’s health. Oncology and women’s health revenue was 52% and 48% of total molecular diagnostic testing revenue, respectively, during the three months ended December 31, 2013. Sales of molecular diagnostic tests in each market for the three months ended December 31, 2013 and 2012 were as follows:


	Three months ended December 31,
(In thousands)	2013		2012		% Change
Molecular diagnostic testing revenue:
Oncology	$	101,592	$	90,857		12	%
Women’s health		94,566		49,794		90	%

Total molecular diagnostic testing revenue	$	196,158	$	140,651		39	%

Costs and Expenses

Cost of revenue is comprised primarily of salaries and related personnel costs, laboratory supplies, royalty payments, equipment costs and facilities expense. Cost of molecular diagnostic testing revenue for the three months ended December 31, 2013 was $22.8 million, compared to $15.6 million for the same three months in 2012. This increase of 46% in molecular diagnostic testing cost of revenue is primarily due to the 39% increase in testing revenue and additional costs associated with processing samples from our three newly launched tests at levels which have not yet achieved economies

of scale. Our costs of companion diagnostic services include similar items. Cost of companion diagnostic services for the three months ended December 31, 2013 was $3.4 million, compared to $4.3 million for the same three months in 2012. This 21% decrease in companion diagnostic testing cost of revenue is due to the 7% decrease in companion diagnostic revenue as well as increased efficiencies within the laboratory.

Our gross margins for molecular diagnostics were 88% at December 31, 2013 compared to 89% for the same three months of the prior year. Molecular diagnostic margins were impacted by the change in product mix primarily due to the launch or our three new molecular diagnostic tests. Our cost of revenue may continue to fluctuate from quarter to quarter based on the introduction of new molecular diagnostic tests such as Myriad myRisk Hereditary Cancer which was launched in September 2013, Myriad myPlan Lung Cancer which was launched in October 2013, and Myriad myPath Melanoma, which was launched in November 2013; testing volumes in both molecular diagnostic and companion diagnostic segments; changes in our costs associated with such tests and services and the adoption of new technologies and operating systems in our laboratories. There can be no assurance that gross profit margins will remain at current levels.

Our research and development expenses include costs incurred in maintaining and improving our current molecular diagnostic tests and costs incurred for the discovery, validation and development of our pipeline of molecular and companion diagnostic test candidates. Research and development expenses are comprised primarily of salaries and related personnel costs, laboratory supplies, clinical trial costs, equipment, and facilities costs. Research and development expenses incurred during the three months ended December 31, 2013 were $17.1 million compared to $14.1 million for same three months in 2012. This increase of 21% was primarily due to the following:

•

an increase of approximately $4.2 million in internal development activities and clinical studies to support our existing and future molecular diagnostic testing products; and

•

a decrease of approximately $1.2 million in internal development activities to support our companion diagnostic services business.

We expect that our research and development expenses as a percentage of revenues will be relatively flat over the next several years as we continue to develop our pipeline and expand our offerings of molecular diagnostic tests and companion diagnostic services.

Our sales, general and administrative expenses include costs associated with building our molecular diagnostic and companion diagnostic businesses domestically and internationally. Selling, general and administrative expenses consist primarily of salaries, commissions and related personnel costs for sales, marketing, customer service, billing and collection, executive, legal, finance and accounting, information technology, human resources, and allocated facilities expenses. Selling, general and administrative expenses for the three months ended December 31, 2013 were $77.8 million, compared to $59.6 million for the same three months in 2012. The increase in selling, general and administrative expense of 31% was due primarily to supporting the 37% increase in revenue and include:

•

an increase in sales and marketing expense of approximately $11.4 million due to new marketing initiatives, added sales force headcount and increased sales commissions associated with the increase in revenue;

•

an increase of approximately $2.9 million in bad debt expense;

•

an increase of approximately $2.1 million in general administrative expenses to support our growth;

•

an increase of approximately $1.3 million in international administrative costs to establish administrative and sales and marketing infrastructures;

•

an increase of approximately $1.1 million in legal fees associated with various legal proceedings to enforce our intellectual property; and

•

a decrease of approximately $0.6 million in administrative support for our companion diagnostic services business.

We expect that our selling, general and administrative expenses will continue to fluctuate from quarter to quarter and that such increases may be substantial, depending on the number and scope of any new molecular diagnostic and companion diagnostic launches, our efforts in support of our existing molecular diagnostic tests and companion diagnostic services, our litigation expenses as well as our continued international expansion efforts.

Other Income (Expense)

Interest income was $1.3 million for the three months ended December 31, 2013 compared to $1.4 million for the three months ended December 31, 2012. Interest income consists primarily of interest income recorded from the note receivable from Crescendo Bioscience, Inc.

Income Tax Provision

Income tax expense for the three months ended December 31, 2013 was $33.8 million, for an effective income tax rate of approximately 40%, compared to income tax expense of $21.9 million or a 39% effective income tax rate in the same period in 2012. Our quarterly effective tax rate differs from the U.S. federal statutory rate of 35%, primarily due to a 4% state income tax impact and an approximate 1% impact from exclusion of certain losses incurred from our international operations. Certain significant or unusual items are separately recognized during the period in which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

Results of Operations for the Six Months Ended December 31, 2013 and 2012

Revenue

Total revenue for the six months ended December 31, 2013 was $406.5 million, compared to $282.6 million for the same six months in 2012. This 44% increase in revenue is primarily due to increased molecular diagnostic testing volume for our BRACAnalysis, BART, Colaris and Colaris AP tests and our Myriad myRisk Hereditary Cancer test, which we launched in 2013, and an increase in companion diagnostic services due to increased research collaborations, as disclosed in the table below. We believe that our increased sales, marketing, and education efforts resulted in wider acceptance of our molecular diagnostic tests by the medical community and increased patient testing volumes.

Total revenue of our molecular diagnostic tests and companion diagnostic services and revenue by product as a percent of total revenue for the six months ended December 31, 2013 and 2012 were as follows:


	Six months ended December 31,				% Change			% of Total Revenue
(In thousands)	2013		2012		% Change			2013			2012
Molecular diagnostic testing revenue:
BRACAnalysis	$	290,807	$	215,239		35	%		72	%		76	%
BART		49,470		23,404		111	%		12	%		8	%
COLARIS & COLARIS AP		29,891		24,143		24	%		7	%		9	%
Myriad myRisk		11,950		—		N/A			3	%		N/A
Other		7,026		5,133		37	%		2	%		2	%

Total molecular diagnostic testing revenue		389,144		267,919		45	%

Companion diagnostic service revenue		17,383		14,658		19	%		4	%		5	%

Total revenue	$	406,527	$	282,577		44	%		100	%		100	%

Our molecular diagnostic sales force is focused on two major markets, oncology and women’s health. Oncology and women’s health revenue was 54% and 46% of total molecular diagnostic testing revenue, respectively, during the six months ended December 31, 2013. Sales of molecular diagnostic tests in each market for the six months ended December 31, 2013 and 2012 were as follows:


	Six months ended December 31,				% Change
(In thousands)	2013		2012		% Change
Molecular diagnostic testing revenue:
Oncology	$	209,917	$	174,232		20	%
Women’s health		179,227		93,687		91	%

Total molecular diagnostic testing revenue	$	389,144	$	267,919		45	%

Costs and Expenses

Cost of molecular diagnostic testing revenue for the six months ended December 31, 2013 was $44.2 million, compared to $29.5 million for the same six months in 2012. This increase of 50% in molecular diagnostic testing cost of revenue is primarily due to the 45% increase in testing revenue. Cost of companion diagnostic services for the six months ended December 31, 2013 was $7.4 million, compared to $7.7 million for the same three months in 2012. This 4% decrease in companion diagnostic testing cost of revenue is due to increased efficiencies gained in our companion diagnostic laboratory. Gross margins for molecular diagnostics for the six months ended December 31, 2013 and December 31, 2012 were 89%.

Research and development expenses incurred during the six months ended December 31, 2013 were $33.9 million compared to $25.5 million for same six months in 2012. This increase of 33% was primarily due to the following:

•

an increase of approximately $9.5 million in internal development activities and clinical studies to support our existing and future molecular diagnostic testing products;

•

an increase of $2.0 million due to external research and development activities to develop proprietary technologies; and

•

a decrease of approximately $3.1 million in internal development activities to support our companion diagnostic services business.

Selling, general and administrative expenses for the six months ended December 31, 2013 were $155.1 million, compared to $115.7 million for the same six months in 2012. The increase in selling, general and administrative expense of 34% was due primarily to supporting the 44% increase in revenue and include:

•

an increase in sales and marketing expense of approximately $20.8 million due to new marketing initiatives, added sales force headcount and increased sales commissions associated with the increase in revenue;

•

an increase of approximately $7.2 million in bad debt expense;

•

an increase of approximately $6.0 million in general administrative expenses to support our growth;

•

an increase of approximately $3.3 million in legal fees associated with various legal proceedings to enforce our intellectual property;

•

an increase of approximately $2.7 million in international administrative costs to establish administrative and sales and marketing infrastructure; and

•

a decrease of approximately $0.6 million in administrative fees associated with the companion diagnostic services business.

Other Income (Expense)

Interest income was $2.7 million for the six months ended December 31, 2013 compared to $2.8 million for the six months ended December 31, 2012. Interest income consists primarily of interest income recorded from the note receivable from Crescendo Bioscience, Inc.

Income Tax Provision

Income tax expense for the six months ended December 31, 2013 was $62.1 million, for an effective income tax rate of approximately 37%, compared to income tax expense of $41.6 million or a 39% effective income tax rate in the same

period in 2012. Income tax expense for the six months ended December 31, 2013 is based on our estimated annual effective tax rate for the full fiscal year ending June 30, 2014 adjusted by discrete items recognized during the period. Our annual effective tax rate differs from the U.S. federal statutory rate of 35% primarily due to a 4% blended state income tax rate offset by a 2% impact from certain losses incurred by our international operations and certain discrete items that are required to be separately recognized during the quarter in which they occurred, including a deduction for the write-off of stock in a wholly-owned subsidiary recently divested. Certain significant or unusual items are separately recognized during the period in which they occur and can be a source of variability in the effective tax rates from period to period.

Liquidity and Capital Resources

Cash, cash equivalents, and marketable investment securities were $488.8 million at December 31, 2013 compared to $531.1 million at June 30, 2013, which is a decrease of $42.3 million, or 8%. This decrease in cash, cash equivalents and marketable investment securities was attributable to the purchase of $180.1 million of our common stock under our share repurchase programs offset by cash collections from molecular and companion diagnostic sales.

Net cash provided by operating activities was $138.0 million during the six months ended December 31, 2013, compared to $73.5 million during the same six months in 2012. Our cash from operations was impacted by non-cash charges in the form of share-based compensation and depreciation and amortization, which totaled $13.8 million and $4.8 million, respectively, during the six months ended December 31, 2013.

Net cash provided by investing activities was $2.7 million during the six months ended December 31, 2013 compared to net cash used in investing activities of $39.0 million during the same six months in 2012. Investing activities were comprised of capital expenditures for equipment and facilities of $8.1 million, offset by net proceeds from maturity of marketable investment securities of $10.8 million.

Financing activities used cash of $173.2 million during the six months ended December 31, 2013 and $52.4 million in the same six months in 2012. Cash utilized in financing activities during the six months ended December 31, 2013 was primarily due to the purchase of $180.1 million of our common stock through our share repurchase programs, partially offset by $6.4 million from cash provided primarily by the exercise of stock options.

We believe that our existing capital resources and net cash expected to be generated from sales of our molecular diagnostic tests and companion diagnostic services will be adequate to fund our current and planned operations for the next several years, although no assurance can be given that changes will not occur that would consume available capital resources more quickly than we currently expect and that we may need or want to raise additional funds. Our future capital requirements, cash flows, and results of operations could be affected by and will depend on many factors that are currently unknown to us, including:

•

our anticipated acquisition of Crescendo Biosciences, Inc., including the costs associated with such acquisition and our ability to successfully integrate and achieve the expected benefits of the acquisition;

•

failure to sustain revenue growth or margins in our molecular diagnostic testing and companion diagnostic services businesses;

•

increased competition in our major markets or the introduction of technological innovations or new commercial tests by our competitors;

•

changes in the government regulatory approval process for our tests;

•

timing and amount of repurchases of our common stock;

•

termination of the licenses underlying our molecular diagnostic tests and companion diagnostic services or failure to enter into product or technology licensing or other arrangements favorable to us;

•

delays or other problems with operating our laboratory facilities;

•

costs and expenses incurred in supporting our existing molecular diagnostic tests and companion diagnostic services;

•

progress, results and cost of developing and launching additional molecular diagnostic tests and offering additional companion diagnostic services;

•

potential business development activities, in-licensing agreements and acquisitions;

•

progress, results and costs of our international expansion efforts;

•

costs, timing, outcome, and enforcement of any regulatory review of our existing or future molecular diagnostic tests and companion diagnostic services;

•

costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our issued patents and defending intellectual property-related claims;

•

costs, timing and outcome of any litigation that we are pursuing or against us;

•

changes in intellectual property laws covering our molecular diagnostic tests and companion diagnostic services and patents or enforcement in the United States and foreign countries;

•

changes in the governmental or private insurers reimbursement levels for our tests; and

•

changes in structure of the healthcare system or healthcare payment systems.

Effects of Inflation

We do not believe that inflation has had a material impact on our business, sales, or operating results during the periods presented.

Certain Factors That May Affect Future Results of Operations

The Securities and Exchange Commission encourages companies to disclose forward-looking information so that investors can better understand a company’s future prospects and make informed investment decisions. This Quarterly Report on Form 10-Q contains such “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.

Words such as “may,” “anticipate,” “estimate,” “expects,” “projects,” “intends,” “plans,” “believes” and words and terms of similar substance used in connection with any discussion of future operating or financial performance, identify forward-looking statements. All forward-looking statements are management’s present expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to: the risk that sales and profit margins of our existing molecular diagnostic tests and companion diagnostic services may decline or will not continue to increase at historical rates; risks related to changes in the governmental or private insurers reimbursement levels for our tests; risks related to increased competition and the development of competing test and services; the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and companion diagnostic services in a timely manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and companion diagnostic services, including our ability to successfully generate revenue outside the United States; the risk that licenses to the technology underlying our molecular diagnostic tests and companion diagnostic services tests and any future tests are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems with operating our laboratory testing facilities; risks related to public concern over our genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms, if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire; the risk that we or our licensors may be unable to protect the proprietary technologies underlying our tests; the risk of patent-infringement claims or challenges to the validity of our patents or other intellectual property; risks of new, changing and competitive technologies and regulations in the United States and internationally; and other factors discussed under the heading “Risk Factors” contained in Item 1A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2013, which has been filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K.

In light of these assumptions, risks and uncertainties, the results and events discussed in the forward-looking statements contained in this Quarterly Report or in any document incorporated by reference might not occur. Stockholders are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date of this Quarterly Report. We are not under any obligation, and we expressly disclaim any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise. All subsequent forward-looking statements attributable to us or to any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in our market risk during the three and six months ended December 31, 2013 compared to the disclosures in Part II, Item 7A of our Annual Report on Form 10-K for the fiscal year ended June 30, 2013, which is incorporated by reference herein.

Item 4. Controls and Procedures

(a)

Evaluation of Disclosure Controls and Procedures. Our principal executive officer and principal financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q, have concluded that, based on such evaluation, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

In designing and evaluating our disclosure controls and procedures, our management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and our management necessarily is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

(b)

Changes in Internal Controls. There were no changes in our internal control over financial reporting identified in connection with the evaluation of such internal control that occurred during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - Other Information

Item 1. Legal Proceedings

Background

Following the U.S. Supreme Court decision in June 2013 in Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al., several companies have commenced offering clinical diagnostic and genomic laboratory services, including the testing and analysis of the BRCA1 and BRCA2 genes, that purport to compete with our BRACAnalysis testing and services. We believe that these tests and services infringe various patent claims that we own or have exclusively licensed from the University of Utah Research Foundation, HSC Research and Development Limited Partnership (and affiliate of Hospital For Sick Children), the Trustees of the University of Pennsylvania, and Endorecherche, Inc. (collectively, the “Patent Owners”). Under our license agreements with the Patent Owners, we are responsible for pursuing these patent infringement litigations, defending any counterclaims and paying related costs. Accordingly, we have commenced several lawsuits alleging that these companies infringe various patent claims owned by Myriad and the Patent Owners and have received several complaints or counterclaims from these companies seeking declaratory judgment that they do not infringe various patent claims owned by Myriad and the Patent Owners and that these patent claims are invalid.

There have been no material developments in the legal proceedings involving Ambry Genetics Corporation, Gene by Gene LTD, Counsyl, Inc., Quest Diagnostics Incorporated and Quest Diagnostics Nichols Institute and GeneDX, Inc. disclosed in Part II, Item 1 of our Quarterly Report on Form 10-Q for the fiscal quarter ending September 30, 2013, except as follows:

Invitae Corporation

On November 25, 2013, Myriad and the Patent Owners filed a complaint against Invitae Corporation (“Invitae”) in the United States District Court for the District of Utah, Central Division, alleging that Invitae’s testing services related to the BRCA1 and BRCA2 genes infringe various patent claims owned by Myriad and the Patent Owners, and seeking an injunction against Invitae from selling any product or service that infringes the claims of these patents. On December 9, 2013, Invitae filed a motion to dismiss the complaint for lack of personal jurisdiction. On November 26, 2013, Invitae filed a complaint for declaratory judgment against Myriad Genetics, Inc. in the United States District Court for the Northern District of California, seeking a judgment that Invitae has not infringed, and is not infringing, various patent claims owned by Myriad and the Patent Owners relating to BRCA testing, and a judgment that various patent claims owned by Myriad and the Patent Owners are invalid. No responsive pleading to the complaint has yet been filed. Myriad and the Patent Owners intend to vigorously enforce their patent rights against Invitae.

Laboratory Corporation of America Holdings

On December 3, 2013, Myriad and the Patent Owners filed a Complaint against Laboratory Corporation of America Holdings (“LabCorp”) in the United States District Court for the District of Utah, Central Division, alleging that LabCorp’s testing services infringe various patent claims owned by Myriad and the Patent Owners which relate to the BRCA1 and BRCA2 genes, and seek an injunction against LabCorp from selling any product or service which infringes the claims of the patents asserted. On January 23, 2014, LabCorp filed its answer and affirmative defenses to the Complaint. Myriad and the Patent Owners intend to vigorously enforce their patent rights against LabCorp.

Other than as set forth above, we are not a party to any legal proceedings that we believe will have a material impact on our business, financial position or results of operations.

Item 1A. Risk Factors

There have been no material changes to the risk factors included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities

In November 2013, we completed our stock repurchase authorization for $200 million, which was approved in February 2013. In November 2013, our board of directors authorized a new stock repurchase program for $300 million. We are authorized to complete the repurchase from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company’s management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors.

The details of the activity under our stock repurchase programs during the fiscal quarter ended December 31, 2013 were as follows:

Issuer Purchases of Equity Securities


Period	(a) Total Number of Shares Purchased		(b) Average Price Paid per Share		(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs		(d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
October 1, 2013 to October 31, 2013		1,871,118	$	24.58		1,871,118	$	5,064,869
November 1, 2013 to November 30, 2013		371,228	$	25.74		371,228		295,508,423
December 1, 2013 to December 31, 2013		943,119	$	23.59		943,119		273,255,921
Total		3,185,465				3,185,465	$	273,255,921

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.


10.1$		Myriad Genetics, Inc. 2010 Employee, Director and Consultant Equity Incentive Plan, as amended (previously filed as Exhibit 10.1 to the Current Report on Form 8-K on December 6, 2013 (File No. 000-26642) and incorporated herein by reference).

31.1		Certification of Chief Executive Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Chief Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.

32.1		Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		The following materials from Myriad Genetics, Inc.’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2013, formatted in XBRL (Extensible Business Reporting Language): (i) the unaudited Condensed Consolidated Balance Sheets, (ii) the unaudited Condensed Consolidated Statements of Income and Comprehensive Income, (iii) the unaudited Condensed Consolidated Statements of Cash Flows, and (iv) Notes to Condensed Consolidated Financial Statements.

$	Management contract or compensatory plan or arrangement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	MYRIAD GENETICS, INC.

Date: February 5, 2014	By:	/s/ Peter D. Meldrum
		Peter D. Meldrum
		President and Chief Executive Officer
		(Principal executive officer)

Date: February 5, 2014	By:	/s/ James S. Evans
		James S. Evans
		Chief Financial Officer
		(Principal financial and chief accounting officer)

EX-31.1 2 d630893dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, Peter D. Meldrum, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Myriad Genetics, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 5, 2014


By:		/s/ Peter D. Meldrum
		Peter D. Meldrum
		President and Chief Executive Officer

EX-31.2 3 d630893dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

SARBANES-OXLEY SECTION 302(a) CERTIFICATION

I, James S. Evans, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Myriad Genetics, Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 5, 2014


By:		/s/ James S. Evans
		James S. Evans
		Chief Financial Officer
		(Principal financial and chief accounting officer)

EX-32.1 4 d630893dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

Certification

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Myriad Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the quarter ended December 31, 2013 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: February 5, 2014						Date: February 5, 2014

By: /s/ Peter D. Meldrum						By: /s/ James S. Evans
Peter D. Meldrum						James S. Evans
President and Chief Executive Officer						Chief Financial Officer

EX-101.INS 5 mygn-20131231.xml XBRL INSTANCE DOCUMENT

3500000

72974449

86352000

80577000

21.75

14434970

0.01

150000000

0.01

5000000

80577000

64509000

-424000

10718000

56595000

697346000

18132000

728594000

30866000

2043000

44334000

7500000

75227000

3620000

806000

803821000

158748000

5963000

56850000

18294000

13330000

94333000

4800000

84197000

8007000

65903000

27602000

28632000

803821000

490652000

104073000

8530000

13000000

21667000

3373000

12150000

16950000

268243000

483992000

4800000

63653000

63661000

8000

40412000

104065000

104073000

8000

71626000

71624000

13000 15000

251513000

251085000

109000 537000

427432000

426991000

146000 587000

531497000

531064000

154000 587000

104293000

104282000

24000 35000

4800000

976000

3674000

4650000

2644000

1856000

4500000

3000000

104282000

12691000

71624000

302055000

12691000

477961000

25000000

68423000

2000000

73974000

22.75

17073928

9218423

0.01

150000000

0.01

5000000

21.39

73974000

67392000

506000

13318000

60647000

663122000

17596000

675971000

11603000

3952000

45844000

9200000

80710000

4108000

740000

756681000

135187000

4237000

56850000

281882000

5000000

18390000

12842000

84137000

135187000

4800000

91960000

9074000

73570000

31313000

29983000

756681000

434858000

71599000

8042000

13000000

23000000

3463000

52276000

135011000

12150000

281996000

16950000

281996000

488782000

488492000

454506000

17000000 8000000 4800000

17675000

53924000

71599000

84259000

84318000

60000 1000

268341000

268542000

300000 99000

416893000

417183000

390000 100000

488492000

488782000

390000 100000

64293000

64323000

30000

56850000

3733317

1856000

4800000

1208000

3442000

4650000

2800000

1700000

4500000

100000

2900000

3000000

65635000

9351000

89318000

270554000

9351000

425507000

0.80

0.78

84091000

2459000

0.39

3067000

130000

73470000

4585000

81632000

7008000

13000

2753000

-1672000

239264000

-5899000

-114000

3623000

267919000

1333000

106807000

-72000

29851000

282577000

65113000

104168000

14658000

-501000

-4000

79883000

2639000

65172000

1490000

178409000

-52357000

13704000

14729000

4455000

-17929000

115691000

41635000

667000

-3580000

3434000

29498000

3623000

506000

207230000

-39042000

25507000

7713000

23903000

23122000 56760000

-30765000

1210000

14658000

-3097000

821000

267919000

138030000

2424000

11362000

1678000

560000

104000

MYGN MYRIAD GENETICS INC false Large Accelerated Filer 2014 10-Q 2013-12-31 0000899923 --06-30 Q2

<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(1)</td> <td align="left" valign="top">Basis of Presentation</td> </tr> </table> The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the “Company”) in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2013, included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2013. Operating results for the three and six months ended December 31, 2013 may not necessarily be indicative of results to be expected for any other interim period or for the full year. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Certain reclassifications have been made to prior period amounts to conform to the current period presentation. </div>

1.37

<div> These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="72%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three months ended December 31,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Six months ended December 31,</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Anti-dilutive options excluded from EPS computation </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,500</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,605</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,136</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,585</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> </table> </div>

3304553

1.33

79312000

<div> The Company recorded amortization during the respective periods for these intangible assets as follows:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three months ended December 31,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Six months ended December 31,</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Amortization on intangible assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">244</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">231</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">506</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> </table> </div>

1989000

<div> The following table sets forth the fair value of the financial assets that the Company re-measured on a regular basis:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="69%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Level 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Level 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Level 3</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> at December 31, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Money market funds (a) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,351</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,351</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Corporate bonds and notes </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">89,318</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">89,318</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Municipal bonds </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">270,554</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">270,554</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Federal agency issues </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65,635</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">65,635</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,351</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">425,507</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">434,858</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="68%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Level 1</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Level 2</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Level 3</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> at June 30, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Money market funds (a) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,691</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,691</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Corporate bonds and notes </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,624</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,624</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Municipal bonds </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">302,055</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">302,055</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Federal agency issues </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,282</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,282</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,691</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">477,961</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">490,652</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="4%"> </td> <td valign="top" width="4%" align="left">(a)</td> <td valign="top" align="left">Money market funds are primarily comprised of exchange traded funds and accrued interest</td> </tr> </table> </div>

0.35

26.48

<div> Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at December 31, 2013:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="78%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Amortized cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Estimated fair value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Available-for-sale: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Due within one year </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">281,882</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">281,996</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Due after one year through five years </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">135,011</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">135,187</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Due after five years </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,492</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,782</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="68%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three months ended December 31,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Six months ended December 31,</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Denominator: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Weighted-average shares outstanding used to compute basic earnings per share </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">75,070</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">81,692</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">77,323</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">81,632</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Effect of dilutive stock options </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,755</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,548</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,989</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,459</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Weighted-average shares outstanding and dilutive securities used to compute dilutive earnings per share </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">76,825</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">84,240</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">79,312</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">84,091</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

0.37

<div> Segment revenue and operating income (loss) were as follows during the periods presented:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="65%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Research</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Molecular diagnostics</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Companion diagnostics</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Total</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Three months ended December 31, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Revenue </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">196,158</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,902</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">204,060</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Depreciation and amortization </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">482</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,467</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">489</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,438</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Segment operating income (loss) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(16,286</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">98,233</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,052</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">82,999</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Three months ended December 31, 2012: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Revenue </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">140,651</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,489</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">149,140</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Depreciation and amortization </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">578</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,232</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">401</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,211</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Segment operating income (loss) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(16,334</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">72,970</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,050</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">55,586</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Six months ended December 31, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Revenue </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">389,144</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">17,383</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">406,527</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Depreciation and amortization </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">992</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,830</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">989</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,811</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Segment operating income (loss) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(32,967</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">195,981</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,889</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">165,903</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Six months ended December 31, 2012: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Revenue </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">267,919</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">14,658</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">282,577</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Depreciation and amortization </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,210</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,424</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">821</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,455</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Segment operating income (loss) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(30,765</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">138,030</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,097</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,168</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table>   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="66%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three months ended December 31,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Six months ended December 31,</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total operating income for reportable segments </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">82,999</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">55,586</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">165,903</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">104,168</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Interest income </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,330</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,385</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,691</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,753</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(185</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(623</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(114</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Income tax provision </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,784</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">21,949</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">62,146</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">41,635</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">50,360</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">35,036</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">105,825</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">65,172</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

6991000

2600000

P4Y

<div> A summary of the stock option activity under the Company’s plans for the six months ended December 31, 2013 is as follows:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="75%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Number of shares</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Weighted average exercise price</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Options outstanding at June 30, 2013 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,434,970</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21.75</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Options granted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,304,553</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26.48</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Less: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Options exercised </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">310,866</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14.23</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Options canceled or expired </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">354,729</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24.33</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Options outstanding at December 31, 2013 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,073,928</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">22.75</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> </div>

138031000

<div> The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at December 31, 2013 and June 30, 2013 were as follows:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="62%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Amortized cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Estimated fair value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> At December 31, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash and cash equivalents: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,599</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,599</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Available-for-sale securities: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Corporate bonds and notes </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">84,259</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">84,318</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Municipal bonds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">268,341</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(99</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">268,542</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Federal agency issues </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">64,293</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">64,323</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">416,893</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">390</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">417,183</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash, cash equivalents and available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,492</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">390</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">)</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,782</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="62%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Amortized cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Estimated fair value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> At June 30, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash and cash equivalents: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">40,412</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">40,412</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">63,653</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">63,661</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,065</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,073</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Available-for-sale securities: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Corporate bonds and notes </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,626</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(15</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,624</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Municipal bonds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">251,513</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">109</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(537</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">251,085</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Federal agency issues </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,293</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(35</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,282</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">427,432</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">146</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(587</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">426,991</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash, cash equivalents and available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">531,497</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">154</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(587</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">531,064</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

310866

24.33

7136000

<div> Share-based compensation expense recognized and included in the condensed consolidated statements of income was allocated as follows:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="70%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three months ended December 31,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Six months ended December 31,</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Cost of molecular diagnostic testing </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">209</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">271</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">432</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">560</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cost of companion diagnostic services </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">74</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">47</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">137</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Research and development expense </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">846</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">869</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,627</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,678</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Selling, general, and administrative expense </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,728</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,918</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,596</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,362</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total share-based compensation expense </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,857</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">7,105</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,792</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,704</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td valign="top" width="4%" align="left">(2)</td> <td valign="top" align="left">Marketable Investment Securities</td> </tr> </table> The Company has classified its marketable investment securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders’ equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at December 31, 2013 and June 30, 2013 were as follows:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="62%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Amortized cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Estimated fair value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> At December 31, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash and cash equivalents: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,599</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,599</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Available-for-sale securities: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Corporate bonds and notes </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">84,259</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">60</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">84,318</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Municipal bonds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">268,341</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(99</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">268,542</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Federal agency issues </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">64,293</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">64,323</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">416,893</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">390</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">417,183</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash, cash equivalents and available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,492</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">390</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">)</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,782</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="62%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Amortized cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding gains</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross unrealized holding losses</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Estimated fair value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> At June 30, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash and cash equivalents: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">40,412</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap">$</td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">40,412</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">63,653</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">63,661</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash and cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,065</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,073</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Available-for-sale securities: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Corporate bonds and notes </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,626</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">13</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(15</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">71,624</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Municipal bonds </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">251,513</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">109</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(537</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">251,085</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Federal agency issues </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,293</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(35</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">104,282</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">427,432</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">146</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(587</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">426,991</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total cash, cash equivalents and available-for-sale securities </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">531,497</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">154</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(587</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">531,064</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at December 31, 2013:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="78%"></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="4%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Amortized cost</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Estimated fair value</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Cash </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">53,924</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Cash equivalents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,675</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Available-for-sale: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Due within one year </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">281,882</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">281,996</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Due after one year through five years </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">135,011</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">135,187</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Due after five years </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,492</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">488,782</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

14.23

P2Y6M26D

77323000

<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(8)</td> <td align="left" valign="top">Income Taxes</td> </tr> </table> In order to determine the Company’s quarterly provision for income taxes, the Company used an estimated annual effective tax rate that is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter. Income tax expense for the three months ended December 31, 2013 was $33,784,000, or approximately 40% of pre-tax income, compared to $21,949,000, for the three months ended December 31, 2012, or approximately 39% of pre-tax income. Income tax expense for the six months ended December 31, 2013 was $62,146,000, or approximately 37% of pre-tax income, compared to $41,635,000, or approximately 39% of pre-tax income. Income tax expense for the three and six months ended December 31, 2013 is based on the Company’s estimated annual effective tax rate for the full fiscal year ending June 30, 2014, adjusted by discrete items recognized during the period. For the six months ended December 31, 2013, the Company’s recognized effective tax rate differs from the U.S. federal statutory rate of 35% primarily due to the effect of state income taxes, a deduction for the write-off of stock in a wholly-owned subsidiary recently divested, as well as timing differences related to the recognition of the tax effect of equity compensation expense from incentive stock options and the deduction realized if those options are disqualified upon exercise and sale. The Company files U.S., U.K., France and state income tax returns in jurisdictions with various statutes of limitations. Annual and interim tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued. The Company’s U.S. federal tax return, U.K. and France income tax returns and all other state tax returns are not currently under examination. </div>

354729

0.07

8098000

538000

2691000

172000

102661000

1826000

-623000

592000

389144000

1333000

167971000

392000

11597000

406527000

106755000

165903000

17383000

-1807000

-40000

180124000

2068000

105825000

240624000

-173170000

13792000

21793000

4811000

-32474000

155119000

62146000

1909000

1510000

-536000

44194000

592000

488000

113424000

2665000

33893000

7418000

6362000

<div> The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to retained earnings for the repurchases for the three and six months ended December 31, 2013 and 2012 were as follows:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="92%" align="center"> <tr> <td width="67%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Three months ended December 31,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="6" align="center">Six months ended December 31,</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Shares purchased and retired </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,185</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,231</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,991</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,067</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Common stock and additional paid-in-capital reductions </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">25,096</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,372</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">55,036</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">23,122</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Charges to retained earnings </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">52,713</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,311</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">125,088</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">56,760</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> </table> </div> 55036000 2208000 <div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left">(10)</td> <td align="left" valign="top">Term Loan and Option Agreement</td> </tr> </table> On September 8, 2011, the Company issued a $25,000,000 term loan to Crescendo Bioscience, Inc. (“Crescendo”) of South San Francisco, CA under a Loan and Security Agreement (“Loan Agreement”) and also secured an exclusive three-year option to acquire Crescendo pursuant to a definitive merger agreement (the “Option Agreement”). The stated interest rate on the term loan is 7%. The fair value of the Option Agreement of $8,000,000 was determined utilizing valuation models at the time of the issuance, including the market and income based approaches, which utilize various inputs including projected income, volatility, risk free rates and projected terms. The Company periodically evaluates the Option Agreement for impairment. No impairment indicators were noted at December 31, 2013.   The residual $17,000,000 value of the term loan has been classified as a note receivable at its accreted value of $23,000,000 on the condensed consolidated balance sheet as of December 31, 2013. The Company recorded interest income related to accretion of the note receivable and the stated interest rate for the three and six months ended December 31, 2013 of $1,104,000 and $2,208,000, respectively, in the condensed consolidated statement of income. The Company is utilizing the effective interest method to accrete the discount portion of the note receivable through interest income over the three-year term of the Company’s option to acquire Crescendo under the Option Agreement. The note receivable is evaluated for collectability each reporting period. If the Company determines that the note receivable and any accrued interest is not collectible, such amount will be written off in the period that determination is made. No amounts related to the note receivable or accrued interest were written off during the three or six months ended December 31, 2013. On November 14, 2013, the Company received notice from Crescendo that Crescendo had achieved the minimum revenue milestone under the Option Agreement. If the Company exercises its option to acquire Crescendo, it expects to finance the purchase price out of the Company’s cash, cash equivalents and marketable investment securities available on hand. </div> 125088000 <div> The following summarizes the amounts reported as intangible assets:   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="84%" align="center"> <tr> <td width="70%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Accumlated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> December 31, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Purchased licenses and technologies </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,500</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,800</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Customer relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,650</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,208</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,442</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Trademarks </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(100</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,900</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total amortizable intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,150</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,108</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,042</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total non-amortizable intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total intangible assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,950</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(4,108</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">12,842</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table>   <table style="BORDER-COLLAPSE: collapse; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="84%" align="center"> <tr> <td width="70%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt"> <td valign="bottom">(In thousands)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Gross Carrying Amount</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Accumlated Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1pt solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> June 30, 2013: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Purchased licenses and technologies </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4,500</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(2,644</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,856</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Customer relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,650</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(976</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,674</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Trademarks </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,000</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total amortizable intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,150</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,620</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,530</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt" bgcolor="#CCEEFF"> <td valign="top"> Total non-amortizable intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom" nowrap="nowrap" align="right"> —  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,800</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> <td valign="top"> Total intangible assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">16,950</td> <td valign="bottom" nowrap="nowrap"> </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,620</td> <td valign="bottom" nowrap="nowrap">)</td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">13,330</td> <td valign="bottom" nowrap="nowrap"> </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

-32967000

992000

17383000

2889000

989000

389144000

195981000

2830000

P8Y

P10Y

6999352

11596000

1627000

432000

137000

233317

144000

270000000

200000000

300000000

273300000

0.43

0.42

84240000

2548000

0.39

1231000

5605000

81692000

-70000

1385000

14000

140651000

56985000

-280000

149140000

34686000

55586000

8489000

1399000

35036000

93554000

7105000

2211000

59563000

21949000

15566000

231000

14107000

4318000

9372000 24311000

-16334000

578000

8489000

-1050000

401000

140651000

72970000

1232000

5918000

869000

271000

47000

0.67

0.66

76825000

1755000

0.35

0.40

3185000

8500000

75070000

253000

1330000

-185000

196158000

84144000

-112000

204060000

50501000

82999000

7902000

1145000

50360000

121061000

6857000

2438000

77840000

33784000

22755000

244000

17090000

3376000

25096000 1104000 52713000

-16286000

482000

7902000

1052000

489000

196158000

98233000

1467000

5728000

846000

209000

74000

0000899923 mygn:RulesBasedMedicineIncorporationMember 2013-10-01 2013-12-31 0000899923 mygn:CostOfCompanionDiagnosticServicesMember 2013-10-01 2013-12-31 0000899923 mygn:CostOfMolecularDiagnosticTestingMember 2013-10-01 2013-12-31 0000899923 us-gaap:ResearchAndDevelopmentExpenseMember 2013-10-01 2013-12-31 0000899923 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2013-10-01 2013-12-31 0000899923 mygn:MolecularDiagnosticsMember 2013-10-01 2013-12-31 0000899923 mygn:CompanionDiagnosticsMember 2013-10-01 2013-12-31 0000899923 us-gaap:ResearchMember 2013-10-01 2013-12-31 0000899923 2013-10-01 2013-12-31 0000899923 mygn:CostOfCompanionDiagnosticServicesMember 2012-10-01 2012-12-31 0000899923 mygn:CostOfMolecularDiagnosticTestingMember 2012-10-01 2012-12-31 0000899923 us-gaap:ResearchAndDevelopmentExpenseMember 2012-10-01 2012-12-31 0000899923 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2012-10-01 2012-12-31 0000899923 mygn:MolecularDiagnosticsMember 2012-10-01 2012-12-31 0000899923 mygn:CompanionDiagnosticsMember 2012-10-01 2012-12-31 0000899923 us-gaap:ResearchMember 2012-10-01 2012-12-31 0000899923 2012-10-01 2012-12-31 0000899923 mygn:SixthShareRepurchaseProgramMember 2013-12-01 2013-12-31 0000899923 2011-08-09 2011-09-08 0000899923 mygn:SixthShareRepurchaseProgramMember 2013-11-08 2013-11-30 0000899923 mygn:FifthShareRepurchaseProgramMember 2013-11-08 2013-11-30 0000899923 mygn:CrescendoBioscienceIncMembermygn:OptionAgreementMemberus-gaap:SubsequentEventMember 2014-02-01 2014-02-02 0000899923 mygn:EmployeeStockPurchasePlanTwentyTwelveMember 2013-07-01 2013-12-31 0000899923 mygn:EmployeeDirectorAndConsultantEquityIncentivePlanMember 2013-07-01 2013-12-31 0000899923 mygn:RulesBasedMedicineIncorporationMember 2013-07-01 2013-12-31 0000899923 mygn:CostOfCompanionDiagnosticServicesMember 2013-07-01 2013-12-31 0000899923 mygn:CostOfMolecularDiagnosticTestingMember 2013-07-01 2013-12-31 0000899923 us-gaap:ResearchAndDevelopmentExpenseMember 2013-07-01 2013-12-31 0000899923 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2013-07-01 2013-12-31 0000899923 mygn:EmployeeDirectorAndConsultantEquityIncentivePlanMemberus-gaap:MaximumMember 2013-07-01 2013-12-31 0000899923 mygn:ScenarioTwoMember 2013-07-01 2013-12-31 0000899923 mygn:ScenarioOneMember 2013-07-01 2013-12-31 0000899923 mygn:MolecularDiagnosticsMember 2013-07-01 2013-12-31 0000899923 mygn:CompanionDiagnosticsMember 2013-07-01 2013-12-31 0000899923 us-gaap:ResearchMember 2013-07-01 2013-12-31 0000899923 2013-07-01 2013-12-31 0000899923 mygn:CostOfCompanionDiagnosticServicesMember 2012-07-01 2012-12-31 0000899923 mygn:CostOfMolecularDiagnosticTestingMember 2012-07-01 2012-12-31 0000899923 us-gaap:ResearchAndDevelopmentExpenseMember 2012-07-01 2012-12-31 0000899923 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2012-07-01 2012-12-31 0000899923 mygn:MolecularDiagnosticsMember 2012-07-01 2012-12-31 0000899923 mygn:CompanionDiagnosticsMember 2012-07-01 2012-12-31 0000899923 us-gaap:ResearchMember 2012-07-01 2012-12-31 0000899923 2012-07-01 2012-12-31 0000899923 us-gaap:FairValueInputsLevel2Member 2013-12-31 0000899923 us-gaap:FairValueInputsLevel1Member 2013-12-31 0000899923 us-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel2Member 2013-12-31 0000899923 us-gaap:MunicipalBondsMember 2013-12-31 0000899923 us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member 2013-12-31 0000899923 us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0000899923 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member 2013-12-31 0000899923 us-gaap:MoneyMarketFundsMember 2013-12-31 0000899923 us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member 2013-12-31 0000899923 us-gaap:USTreasuryAndGovernmentMember 2013-12-31 0000899923 mygn:TrademarkMember 2013-12-31 0000899923 mygn:PurchasedLicensesAndTechnologiesMember 2013-12-31 0000899923 us-gaap:CustomerRelationshipsMember 2013-12-31 0000899923 us-gaap:InProcessResearchAndDevelopmentMember 2013-12-31 0000899923 mygn:EmployeeStockPurchasePlanTwentyTwelveMember 2013-12-31 0000899923 mygn:EmployeeDirectorAndConsultantEquityIncentivePlanMember 2013-12-31 0000899923 mygn:RulesBasedMedicineIncorporationMember 2013-12-31 0000899923 mygn:FederalAgencyIssuesMember 2013-12-31 0000899923 mygn:TotalCashCashEquivalentsAndAvailableForSaleMember 2013-12-31 0000899923 mygn:AccumulatedAvailableForSaleSecuritiesMember 2013-12-31 0000899923 us-gaap:MunicipalBondsMember 2013-12-31 0000899923 us-gaap:CorporateDebtSecuritiesMember 2013-12-31 0000899923 us-gaap:CashAndCashEquivalentsMember 2013-12-31 0000899923 us-gaap:CashMember 2013-12-31 0000899923 us-gaap:CashEquivalentsMember 2013-12-31 0000899923 2013-12-31 0000899923 mygn:EmployeeStockPurchasePlanTwentyTwelveMember 2012-12-31 0000899923 2012-12-31 0000899923 2011-09-08 0000899923 us-gaap:FairValueInputsLevel2Member 2013-06-30 0000899923 us-gaap:FairValueInputsLevel1Member 2013-06-30 0000899923 us-gaap:MunicipalBondsMemberus-gaap:FairValueInputsLevel2Member 2013-06-30 0000899923 us-gaap:MunicipalBondsMember 2013-06-30 0000899923 us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member 2013-06-30 0000899923 us-gaap:CorporateDebtSecuritiesMember 2013-06-30 0000899923 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member 2013-06-30 0000899923 us-gaap:MoneyMarketFundsMember 2013-06-30 0000899923 us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Member 2013-06-30 0000899923 us-gaap:USTreasuryAndGovernmentMember 2013-06-30 0000899923 mygn:TrademarkMember 2013-06-30 0000899923 mygn:PurchasedLicensesAndTechnologiesMember 2013-06-30 0000899923 us-gaap:CustomerRelationshipsMember 2013-06-30 0000899923 us-gaap:InProcessResearchAndDevelopmentMember 2013-06-30 0000899923 mygn:FederalAgencyIssuesMember 2013-06-30 0000899923 mygn:TotalCashCashEquivalentsAndAvailableForSaleMember 2013-06-30 0000899923 mygn:AccumulatedAvailableForSaleSecuritiesMember 2013-06-30 0000899923 us-gaap:MunicipalBondsMember 2013-06-30 0000899923 us-gaap:CorporateDebtSecuritiesMember 2013-06-30 0000899923 us-gaap:CashAndCashEquivalentsMember 2013-06-30 0000899923 us-gaap:CashMember 2013-06-30 0000899923 us-gaap:CashEquivalentsMember 2013-06-30 0000899923 2013-06-30 0000899923 2012-06-30 0000899923 2014-01-31 0000899923 mygn:EmployeeDirectorAndConsultantEquityIncentivePlanMember 2013-12-05 shares iso4217:USD iso4217:USD shares pure mygn:Segment utr:Y Money market funds are primarily comprised of exchange traded funds and accrued interest

EX-101.SCH 6 mygn-20131231.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income link:calculationLink link:presentationLink link:definitionLink 106 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 107 - Disclosure - Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Marketable Investment Securities link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Share-Based Compensation link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Earnings Per Share link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Segment and Related Information link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Goodwill and Intangible Assets link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Term Loan and Option Agreement link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Cost Basis Investment link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Subsequent Event link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Marketable Investment Securities (Tables) link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Share-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Stockholders' Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Earnings Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Segment and Related Information (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Goodwill and Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Detail) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Schedule of Maturities of Debt Securities Classified as Cash Equivalents and Available-For-Sale (Detail) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Share-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Schedule of Share-Based Compensation Recognized in Consolidated Statements of Comprehensive Income (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Schedule of Stock Repurchases (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Reconciliation of Denominators of Basic and Diluted Earnings Per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Schedule Of Anti-Dilutive Options Excluded From EPS Computation (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Segment and Related Information - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Schedule of Total Operating Income for Continuing Reportable Segments (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Schedule of Fair Value of Financial Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Goodwill And Other Intangible Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Amortization on Intangible Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Term Loan and Option Agreement - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Cost Basis Investment - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Subsequent Event - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 7 mygn-20131231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 mygn-20131231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 mygn-20131231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts Payable Current Accounts payable Accounts Receivable Net Current Trade accounts receivable, less allowance for doubtful accounts of $9,200 at Dec. 31, 2013 and $7,500 at Jun. 30, 2013 Accrued Liabilities Current Accrued liabilities Accumulated Available For Sale Securities [Member] Accumulated Available For Sale Securities [Member] Total Available For Sale Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Less accumulated depreciation Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated other comprehensive income (loss) Acquired Finite Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Intangible Assets [Line Items] Acquired Intangible Assets [Line Items] Acquired Finite And Infinite-Lived Intangible Assets [Line Items] Acquired Intangible Assets [Table] Acquired Intangible Assets [Table] Acquired Intangible Assets [Table] Additional Paid In Capital Additional paid-in capital Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Allowance For Doubtful Accounts Receivable Current Allowance for doubtful accounts Amendment Flag Amendment Flag Amortization Of Intangible Assets Amortization on intangible assets Amount Charged To Retained Earnings As A Result Of Stock Repurchases. Amount Charged To Retained Earnings As Result Of Stock Repurchases Charges to retained earnings Amount Of Reduction In Common Stock As A Result Of Stock Repurchases Amount Of Reduction In Common Stock As Result Of Stock Repurchases Common stock and additional paid-in-capital reductions Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Anti-dilutive options excluded from EPS computation Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Assets Total assets Assets [Abstract] Assets Assets Current Total current assets Assets Current [Abstract] Current assets: Assets Fair Value Disclosure Total fair value of financial assets Available For Sale Securities Estimated fair value Estimated fair value Available For Sale Securities Amortized Cost Amortized cost Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost Due after five years, Amortized cost Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value Due after five years, Estimated fair value Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Due after one year through five years, Amortized cost Available For Sale Securities Debt Maturities After One Through Five Years Fair Value Due after one year through five years, Estimated fair value Available For Sale Securities Debt Maturities Amortized Cost Total Available For Sale Securities Debt Maturities Single Maturity Date Total Available For Sale Securities Debt Maturities Within One Year Amortized Cost Due within one year, Amortized cost Available For Sale Securities Debt Maturities Within One Year Fair Value Due within one year, Estimated fair value Amount of accumulated pre-tax unrealized gain before deducting pre-tax unrealized losses on investments in available-for-sale securities impacting investments. Available For Sale Securities Gross Unrealized Gain Accumulated In Investments Gross unrealized holding gains Amount of accumulated pre-tax unrealized loss before deducting pre-tax unrealized gain on investments in available-for-sale securities impacting investments. Available For Sale Securities Gross Unrealized Loss Accumulated In Investments Gross unrealized holding losses Basis Of Accounting Basis of Presentation Business Acquisition Acquiree [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business Acquisition [Axis] Cash And Cash Equivalents At Carrying Value Cash and cash equivalents at end of period Cash and cash equivalents at beginning of period Cash and cash equivalents Cash And Cash Equivalents [Member] Total Cash And Cash Equivalents Cash And Cash Equivalents Period Increase Decrease Net decrease in cash and cash equivalents Cash Equivalents [Member] Cash Equivalents Cash [Member] Cash Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments And Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock Par Or Stated Value Per Share Common stock, par value Common Stock Shares Authorized Common stock, authorized Common Stock Shares Issued Common stock, issued Common Stock Shares Outstanding Common stock, outstanding Common Stock Value Common stock, $0.01 par value, authorized 150,000 shares at Dec. 31, 2013 and Jun. 30, 2013, issued and outstanding 73,974 at Dec. 31, 2013 and 80,577 at Jun. 30, 2013 Companion Diagnostics [Member] Companion Diagnostics [Member] Companion Diagnostics Comprehensive Income Net Of Tax Comprehensive income Corporate Debt Securities [Member] Corporate Bonds And Notes Cost Method Investments Investment accounted under cost method Cost Method Investments Description [Text Block] Cost Basis Investment Cost Of Companion Diagnostic Services [Member] Cost Of Companion Diagnostic Services [Member] Cost Of Companion Diagnostic Services Cost Of Molecular Diagnostic Testing [Member] Cost Of Molecular Diagnostic Testing [Member] Cost Of Molecular Diagnostic Testing Cost Of Revenue Cost of molecular diagnostic testing Costs And Expenses Total costs and expenses Crescendo Bioscience, Inc. [Member] Crescendo Bioscience Inc [Member] Crescendo Current Fiscal Year End Date Current Fiscal Year End Date Customer Relationships [Member] Customer Relationships Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument [Table] Schedule of Long-term Debt Instruments [Table] Deferred Revenue Current Deferred revenue Deferred Tax Assets Net Current Deferred taxes Deferred Tax Assets Net Noncurrent Long-term deferred taxes Depreciation And Amortization Depreciation and amortization Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Share-Based Compensation Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Information [Line Items] Document Information [Line Items] Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share [Abstract] Earnings Per Share [Abstract] Earnings Per Share Basic Basic Earnings Per Share Basic And Diluted [Abstract] Earnings per share: Earnings Per Share Diluted Diluted Earnings Per Share [Text Block] Earnings Per Share Effective Income Tax Rate Continuing Operations Approximate rate on pre-tax income Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate U.S. federal statutory rate Effective period of option. Effective Period Of Option Effective period of option, in years Eligible Item Or Group For Fair Value Option [Axis] Eligible Item or Group for Fair Value Option [Axis] Employee Director And Consultant Equity Incentive Plan [Member] Employee Director And Consultant Equity Incentive Plan [Member] The 2010 Plan Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Total unrecognized share-based compensation cost related to share-based awards granted Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 Total unrecognized share-based compensation cost, weighted-average period, years Employee Stock Purchase Plan Twenty Twelve [Member] Employee Stock Purchase Plan Twenty Twelve [Member] 2012 Purchase Plan Entities [Table] Entities [Table] Entity Central Index Key Entity Central Index Key Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity [Domain] Entity [Domain] Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Equity [Abstract] Equity [Abstract] Excess Tax Benefit From Share Based Compensation Financing Activities Excess tax benefit from share-based compensation Excess Tax Benefit From Share Based Compensation Operating Activities Excess tax benefit from share-based compensation Fair Value Assets Measured On Recurring And Nonrecurring Basis Table [Text Block] Schedule of Fair Value of Financial Assets Fair Value By Fair Value Hierarchy Level [Axis] Fair Value, Hierarchy [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Fair Value Inputs Level 1 [Member] Level 1 Fair Value Inputs Level 2 [Member] Level 2 Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value Option Eligible Item Or Group [Domain] Fair Value, Option, Eligible Item or Group [Domain] Fair Value Option Loans Aggregate Principal Amount Outstanding Fair Value Option Loans Aggregate Principal Amount Outstanding Fair value of Option Agreement Fair Value Option Qualitative Disclosures Related To Election [Line Items] Fair Value, Option, Qualitative Disclosures Related to Election [Line Items] Fair Value Option Qualitative Disclosures Related To Election [Table] Fair Value, Option, Qualitative Disclosures Related to Election [Table] Federal Agency Issues [Member] Federal Agency Issues [Member] Federal Agency Issues Fifth Share Repurchase Program [Member] Fifth Share Repurchase Program [Member] Fifth Share Repurchase Program Finite Lived Intangible Assets Accumulated Amortization Accumulated Amortization Finite Lived Intangible Assets Amortization Expense Table [Text Block] Amortization for Intangible Assets Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite Lived Intangible Assets Gross Gross Carrying Amount, amortizable intangible assets Finite Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite Lived Intangible Assets Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite Lived Intangible Assets Net Net, amortizable intangible assets Gain Loss On Disposition Of Assets Loss on disposition of assets Goodwill Goodwill Goodwill Acquired Goodwill And Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill And Intangible Assets Disclosure [Text Block] Goodwill and Intangible Assets Goodwill Impairment Loss Impairment of goodwill Impairment Of Intangible Assets Finitelived Impairment of intangible asset Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Income before income taxes Income related to accretion of the note receivable and the stated interest rate. Income Related To Accretion Of Note Receivable And Stated Interest Rate Interest income related to accretion of the note receivable and the stated interest rate Income Statement [Abstract] Income Statement [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Income Taxes Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Income Tax Expense Benefit Income tax expense Income tax provision Increase Decrease In Accounts Payable Accounts payable Increase Decrease In Accounts Receivable Trade accounts receivable Increase Decrease In Accrued Interest Receivable Net Accreted interest on note receivable Increase Decrease In Accrued Liabilities Accrued liabilities Increase Decrease In Deferred Income Taxes Deferred income taxes Increase Decrease In Deferred Revenue Deferred revenue Increase Decrease In Operating Capital [Abstract] Changes in operating assets and liabilities: Increase Decrease In Other Receivables Other receivables Increase Decrease In Prepaid Expense Prepaid expenses Indefinite Lived Intangible Assets By Major Class [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite Lived Intangible Assets Excluding Goodwill Net, non-amortizable intangible assets Indefinite Lived Intangible Assets Gross (Excluding Goodwill) Indefinite Lived Intangible Assets Gross Excluding Goodwill Gross Carrying Amount, non-amortizable intangible assets Indefinite Lived Intangible Assets Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In Process Research And Development [Member] In-Process Research And Development Intangible Assets Gross Excluding Goodwill Gross Carrying Amount, total intangible assets Intangible Assets Net Excluding Goodwill Intangibles, net Net, total intangible assets Investment Income Interest Interest income Investments All Other Investments [Abstract] Investments, All Other Investments [Abstract] Investments Classified By Contractual Maturity Date Table [Text Block] Schedule of Maturities of Debt Securities Classified as Cash Equivalents and Available-For-Sale Investments Debt And Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block] Marketable Investment Securities Investment Type [Axis] Investment Type [Axis] Investment Type Categorization [Member] Investments [Domain] Leasehold Improvements Gross Leasehold improvements Legal Entity [Axis] Legal Entity [Axis] Liabilities Total liabilities Liabilities And Stockholders Equity Total liabilities and stockholders' equity Liabilities And Stockholders Equity [Abstract] Liabilities and Stockholders' Equity Liabilities Current Total current liabilities Liabilities Current [Abstract] Current liabilities: Machinery And Equipment Gross Equipment Marketable Securities Current Marketable investment securities Marketable Securities Noncurrent Long-term marketable investment securities Maximum [Member] Maximum Molecular Diagnostics [Member] Molecular Diagnostics [Member] Molecular Diagnostics Money Market Funds [Member] Money Market Funds Municipal Bonds [Member] Municipal Bonds Net Cash Provided By Used In Financing Activities Net cash used in financing activities Net Cash Provided By Used In Financing Activities [Abstract] Cash flows from financing activities: Net Cash Provided By Used In Investing Activities Net cash provided by (used in) investing activities Net Cash Provided By Used In Investing Activities [Abstract] Cash flows from investing activities: Net Cash Provided By Used In Operating Activities Net cash provided by operating activities Net Cash Provided By Used In Operating Activities [Abstract] Cash flows from operating activities: Net Income Loss Net income Net income Nonoperating Income Expense Total other income Nonoperating Income Expense [Abstract] Other income (expense): Notes Receivable Net Accreted value of loan agreement Note receivable Number Of Reportable Segments Number of reportable segment Operating Costs And Expenses [Abstract] Costs and expenses: Operating Income Loss Segment operating income (loss) Operating income Total operating income for reportable segments Option Agreement [Member] Option Agreement [Member] Option Agreement Other Assets Other assets Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Change in foreign currency translation adjustment, net of tax Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Comprehensive income: Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Unrealized gain (loss) on available-for-sale securities, net of tax Other Cost Of Operating Revenue Cost of companion diagnostic services Other Nonoperating Income Expense Other EX-101.PRE 10 mygn-20131231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R39.htm IDEA: XBRL DOCUMENT

Income Taxes - Additional Information (Detail) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Taxes [Line Items]
Income tax expense	$ 33,784	$ 21,949	$ 62,146	$ 41,635
Approximate rate on pre-tax income	40.00%	39.00%	37.00%	39.00%
U.S. federal statutory rate	35.00%		35.00%

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#.X$##`0(``!0<```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F=UJVS`8AL\'NP>CTQ$K MDKRN&W%ZL)_#K;#N`E3K2VQB2T)2N^3N)SMM&25+"0WL/8F)+7WO$Q&>`[^+ MJ^W0%_<48N=LS40Y9P79QIG.KFOVZ^;;[)(5,6EK=.\LU6Q'D5TMW[Y9W.P\ MQ2+OMK%F;4K^$^>Q:6G0L72>;'ZR.:V) M;>?CNXS!^,&$\,@;?]ORW"YM;YS;E\2$'*-UJ MU35D7',WY!,HHP^D36R)TM"7T[4<=&A.,"A.,#",>.D?TZZG>.87=?NA+R6W.I#YF4)NI\X.\/?L8QRYN[D.SL?<8@4Z M_10>:ZIQ]\SG01121T]%U:'"YRDQ-V"G!SYKG&CLV`R9`]E\ZO26?P```/__ M`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T'4\4 M"_'L)MI<3_3_MCAQ M(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\#`%!+ M`P04``8`"````"$`,93SQAH"``!!&P``&@`(`7AL+U]R96QS+W=OO9CS$I!-I`])]YPC^>[^UV%?O(8Q[OJN-&ZQ-$7HZK[9==O2_'SZ=GEC MBIBJKJGV?1=*JI2;X]8.5?U<;8.5Y7)EQ_,^S/I#G\5C4YKQL7%JBJ?CD(?^?^?] M9K.KPT-?OQQ"E_XQAGWKQ^?8AI!RI]6X#:DTTZ-H3V^<+C*SL9_@Y/G@XMP@ M'%F1<62%":9'?W7F&L&PEP:NC&.+C(,B(VR1$2@R;(V!$L->*;A0CCXU<&Z$ M+;\"Y5?9-:ZPR)6M?PH%T.<@2LU9?HGTV%^Q<:X0#IL&PC@VC8,XPCXP"#PP M"/O`(/#`H&R'4&P1[#)WL,P=.UHX&"V4;:`*#=2S#=1#`Z73($5F;QRX;QQ[ M:AQ<*&$G'8%)1]A)1V#24;8$*I1`9;NY0C?W;#?WT,W]K&X>VVH,S8\TYMO6 M\[N*\\=(=&:%F>XG/K^RP,F"G)#A.CFVY#@H.8XM.0Y*CK!K7&"-*[O&%>X= M99>5PKKRLR;VE+_,A/<*/S7MZ1=&/V&;E$"3\NQ@[*?9L1\^?*U_`P``__\# M`%!+`P04``8`"````"$`F)'H?V8$```8#@``#P```'AL+W=OV^M-QD(%83F[4=:._3 MW]C0=((IZKTI-<%/GIGYS3BY^/)NJ@@#3CJ+!V?=[MFJR`BIM/:@T2 MKRR5KKC%I5YUS5H#STT!8*NRF_1ZPV[%A8QV"N?Z(QIJN109W*BLKD#:G8B& MDENT;PJQ-M'EQ5*4\+"+J,/7Z^^\0M_/9=0IN;'37%C(Q]$`EVH+K2]TO;ZJ M18E7S])>&G4OFR#O=2>'):]+N\#P7M4Q7TD_28;NERX5#P*VYFV36W:>?PF9 MJZW[*:;VI5FE:&#K+_T2N2WP>J_7:[[[!\2JL*]?HGR7Z/L,XGW\9T?Z\%XS MPK!2;"JML"]L)G?9%PI+Z+(^P\CBJ*//!?ZC9WGLC%.5:R5SD`9RAO\958J< M8[+8%2^YS("H](=$)OE_,NB@<=,?$1V?\0_8F5MT5;7L$)7^!]WL5:@;3'^3 MF\&AS!4WPC"U9/<:#++GD:.A8*,TNST2-)1;KI_`\L<2L"P;Q,[AR^:0U5I8 M067.B,SHT,2\X!K0B:]0A2UF#FT,D++&QN=@OU794Z'*'-N#37_7B`FY]X#" M<7:X=\JUQ*E@V#UHYHW0K0FY;=P[W#N'E0_8T?G#M2L&Z6[NIQ28K#3X,ZH?V11RP>*V,Q:YT M0+[11+=3%N,`QFM55<(3:+P1;':+E<6Y+]I9H2S&(8SUHX'?M0-YNL&_Q,"0 M4A@'&)[N!MJ20XID'##Y3C]@?;$\M,!#RB=.XH/!-P_[XH@&93,)V`S[XX@$ MI3,)Z#S=)JV\4&"3`-AW^N2((0IL$@![&OR6(4IL$A`[SPK(:VP9'*#$'!Y0 M;++AE!R*[NYHI7.4ZMQRZZY!($71YJ#`Q:$.->2Z M`^?VNM99@8>/852'=E8:(/T#,H5SI13^H'+EOP&I*B&Y59IV:$J["Q?O^;E; ML@F.JQM1UE9L@/DI2OW0%DL#HD^W&,;2)&C42E!(]/Y(P]/0/V;A`Y(;R7BP MX4R?$9V4MA@NW@L,4[-0EI<8$6C,EESA<*)ZK3\>(2[GF]\>\AXF>%KC?MPX\#GO?OZ4G?Y'P```/__ M`P!02P,$%``&``@````A`%?\;OSE!@``:QT``!@```!X;"]W;W)K+CNAWCYT_?ZX/UK6R[JCFN;;9P;*L\%LVF M.N[6]C]_?WF*;*OK\^,F/S3'CMW:WO?] M:;5<=L6^K/-NT9S*(UBV35OG/7QL=\ONU);Y9GBH/BRYXP3+.J^.MO*P:N?X M:+;;JBA%4[S5Y;%73MKRD/>P_FY?G;JSM[J8XZ[.VZ]OIZ>BJ4_@XK4Z5/V/ MP:EMU<7JM]VQ:?/7`_#^SKR\./L>/DS'IY MWE3`0&Z[U9;;M?V9K3+7L9W4L8;PHN%EP7WHJF@,L`/ZUZDJF!NQ(_GWX_[W:]/NU[08+/W1SZ+Y5T M:5O%6]`HG7R67@9?P**#^'Q["(J(N)?IR19X(2O+;!^24&D8/7EBA(-,20Q0'S:9`0 MP',"GX1$F``WBIGGX9_(3``/PIB-^X.H>8]0DV!"C2PL49!`I6?LD#U/37/D M1>.B5"Z:9A:ZD4M8(;L7&/N&2$&-F8EY.UX23$B152<*HDAQ!^)!`IJ:`.9! M.`A`F``93TYR/C,!/.*^4=J(6O`(-0F&-FBF(MG11$%@7R_9ZN,]3^\BQ%U$ M=@N!Z$'KFA\Y"2:1(V60*(B.'`]]2LZT,]\/`DQ>F';/8S'QGYEV'GOQ6,B( MEM0HQ@"XG9`23&B192<*HFBY;DA6G9IFSV7CHE25F>;0H^8,F4,V9@RB%#]" M28());+F1$$4)18Z,:F@%-D]YI`"$J;=A98X+GL@G9EV[OO&\X@6@P%FADK. MZOM#;7B*$"0+3#1&,0S#B/:(%`'\V`\(!8$`D*W,:.J*)$:`:(G'_HQIRID^ M.R.94@!HII&D2C1&!Y`S)QA_>EA%A]PA1&\8MX'!-`B@"^[T_&\YB6G/+S:2E-@&B1'TZ8PNAX,8_$(\5VEY:D0';N M&-6DB9G^>>".)8V)R2D_GYC2!(@8V?&$F;HA\B;R/44`:.,TH@(!&`C\D+3; M#".`_-61)P?^?'I*'B!Z)"X),R4$Z).(\$\1@(.L&G=^B(Q`@(`SCS33#`&@ M4;KC&G#LY-R?3TZI!$2._'+"3"7A.^[D,(``KD0048D`S/%![F-$AA!P^@O' M@D?L.%$KMX7E@,;G@9BJ%(V!1G;U0'`?(NY#LIL03/(AK<*G6L50Y4-V)1H3 M#^W26=`7$"FQ>Z0O"61G"Y=L8H;LSN+*$.>09O-3\EN0G!:RF$_ MN[-P)0U09QFW3Z>EPJAQ%\(1A>Q"JIUH#!)`Y"%T)Z.<>G!'#YC<0Q)% MOAHEY[MI;BJ,)A=,>EZJG6AR'NA_W!0%`H0QO-?%@`P!Y-E@'(F8W$-"A7\@ M5$AA)1JCUO[13$"`CV8"`GPX$Q#BUDQX2*UPI42@=B[]GCGCONG$5"!(K@N( M3*Q4^[D!$?[*M#P<.JMHWN2]%0>Y&PO=V]R:W-H965T[QBU+UFK*7@PVQ^?<>^Z]Y+>/ MJB,/8*S4?4&3**8$>J$KV3<%_?'][NJ&$NMX7_%.]U#0)[#TMGS_+C]JL[#5>4AV;Q?$U4USV-#!D MYA(.7==2P%:+@X+>!1(#'7<8OVWE8%_8E+B$3G&S/PQ70JL!*7:RD^YI)*5$ MB>R^Z;7ANP[S?DSF7+QPCYM7]$H*HZVN781T+`3Z.N<56S%D*O-*8@;>=F*@ M+N@ZR38+RLI\].>GA*,]>2>VU<>/1E:?90]H-I;)%V"G]=Y#[RM_A)?9J]MW M8P&^&E)!S0^=^Z:/GT`VK<-J+S`AGU=6/6W!"C04::+9&(;0'0:`*U'2=P8: MPA_'YU%6KBUH>ATMEG&:()SLP+H[Z2DI$0?KM/H50(D/:B*9/9/@\YDD643S MV6)Y? MR82#4YETM7I;:'XNY'LDQ4[[MZ/^$N).W)K'\<0?4@T87"='%Q/BS%'LI""HHT3ZSS^4ZF@'##S4.F_-,.PA%Y28!KX`%UGB=`'/P@)WIE.IQE=I^.8 M31]P1@;>P!=N&ME;TD&-5^-HB;HF3%G8.#V,G;K3#J=C?&WQ9PC8"'&$X%IK M][+Q\H MR6H#]&ZE/>ETNKU[IL1)4`..@#;M?W]C3(+'="&]ES8P'T_\]8S'$Z^^O)4G MXY753<&KM4D6MFFP*N>[HCJLS1]_/SZ$IM&T6;7+3KQB:_.=->:7S:^_K"Z\ M?FZ.C+4&>*B:M7ELV_/2LIK\R,JL6?`SJ\"RYW69M?!8'ZSF7+-LUPTJ3Q:U M;=\JLZ(RI8=E?8\/OM\7.4MX_E*RJI5.:G;*6IA_:(RNRP--FM2M`@5AVHV;[M?F5+%-JF]9FU2W0/P6[-,IGHSGRRV]UL?M> M5`Q6&^(D(O#$^;-`O^W$*QALC48_=A'XLS9V;)^]G-J_^.5W5AR.+83;`T5" MV'+WGK`FAQ4%-POJ"4\Y/\$$X*]1%B(U8$6RM^[_I=BUQ[7I^`LOL!T"N/'$ MFO:Q$"Y-(W]I6E[^*R'2NY).:.\$1O1."%W0T".>/^_%DC/J!"99FVU6-;\8 MD#7PG84WSGME* M)C"-&Q.$&(FOB%A!X3>YOAC&$#PDO1(B?"#II@M62]?E0-P_CMA5AAB$9=`` M?]_V`P03\9@((HPD8T1;K'1,*$Z04.?_"!6#(`F56+BVC2>YE8RK,!XFXEDB MF272*0+IA(FH`9T.I(#7)BSB+=?H*)*2";MLI;9K^]H"Q"I`W(BX&I"H`(SW M]*](58"&U`N&;$+:8./=KTW`6!NQM8VTE8POM;F.9HZ1F1)M3R6JV0UU6\E`LMRR=5C3K@[<0R2Z13!-(GNA;M2)@OG6+0 M7$61S)3.62*9)=(I`NF,L,[IBB)@',?QKI.,*\^_4"OIL6KU]*,O4:U1I(U- MI57F/J%D*$1($($#3HWJ4;8@3]L`*Q0'/=*;LXHE,V!>@RX^J[?$@E-9>4\DLPCZ22"58K37U$I MFK+Y'4ADSP`'ZJV,C`_U'II4*_U,(,F\EW02P6I%"Z"HG8FI;!C4F(Z/=B*A M?K]$/O&&4BX+*B;$X:T5Y0013@C'OY;7*2*H'T1D.)*P0EC+3R@4--Z7XU)# M)-0K=/4=%6,[=;2"DB`[#9VAHO0[4O5/73IHQ\I$+W!_[&3G@&.G168K?E>! M?*DL"JFC'=,Q`@(:!=K<$P20R(M"+;8I)IS05O1C?:(GN%^?["!4?:X]K%RW MLELB(5C?VS8=BEV?G+-(,N\EG42P2M$:*"KOK#>RH9BI-U-=1Z]V%DG(+)). M(EBM:!`4M3/U1K83:DP_J#<2DCD;1/I/WYBH]M`-ASK1+4&"["1P0BWG4PRX MOE+/L#;1*-RO3;85JK8/*HW:F8RF'A-DMK6=EB!SI`M/D3FDPVBD"JYV/J&J MHW']'/1VJ3ETWR+J9D]8'% M['1JC)R_B(LD"DWD[:V\Y-J2)5R0P#V']CZ!RZ_NO74SP-W3.3NP/[+Z4%2- M<6)[<&DO`BBMM;R]D@\M/W?7'4^\A5NG[N,1;AD97+W8"X#WG+?7!W'!:P,``%D*```9````>&PO=V]R M:W-H965TUW"__']]N;PO>$Q'V#6]:3A?](A/]N^?;-_,CXG=@3(CU@Z,7"WTLY MS()`U'O283%A`^DALF6\PQ(>^2X0`R>X&3=U;1"%819TF/:^9ICQUW"P[9;6 MI&+UH2.]U"2UT]^[3K M&<>;%G0_H`37)^[QX8J^HS5G@FWE!.@"G>BUYFDP#8!I.6\H*%!E]SC9+OSW M:+8N_&`Y'^OSDY*C,'Y[8L^.'SAM/M.>0+'!)F7`AK$[!?W4J"78'%SMOAT- M^,J]AFSQH97?V/$CH;N]!+=3$*1TS9K'BH@:"@HTDRA53#5K(0'X]#JJ.@,* M@A_&[R-MY'[AQ]DDS<,8`=S;$"%OJ:+TO?H@).M^:1!ZHM(DT1,)['@B0=$D M*E*49B^S!#JC46"%)5[..3MZT#3P3C%@U8)H!LPG93J/L]:_206-BN2]8AFY M0(4`>^Z729C.@WNH:?V$*34F][TS)B]LR.H$4154O-5IX;('V5O6)X2R#R2= M=4&U7%TQ^/YGQTXRU"9;1I3;[RO_`+$1JVM$/K4AU34DLA'K:X1!8@F-_T>H MV@1-:'B1A*&=0JDQB8%Q'%V]B*A>1*R?0U@Z(9%_-U1M6OA0S'//1;'3=*7& M%&/7%M%TZIBU,N-IFA:97:?*C*,LG8:Q#5A;@#!!V24#2R$1K*YRG%\V6I.Q?)"FP(\DY%J6&)*.D M&^3FO#+#*+%MJ,S@319=,A[_:M96&!F[+4'P]_5ZCQ38$>14N=00[5$I3K2=<1OB,KTK;"J]E!C>D( M&NB\JF\0)9K!^($IXJQ7<+,8UX-S`";[@'?D"^8[V@NO)5N@#"`]08```L@```9````>&PO=V]R:W-H965TFZMO&D\4,-F-E)56J[T\,QC;*+:Q@,DD?[]5 M%-U4-W;#O(S'[7.*/E6'+II^^OCCM[M_<_? MGS^L;*MNTNL^/9?7?&O_S&O[X_.OOSR]E=6W^I3GC041KO76/C7-;3.?U]DI MOZ3UK+SE5_CE4%:7M(&OU7%>WZH\W;>DRWGN.+_FUH2!5?DX;F']]*FZUB';)IH2[I-6WU]N'K+S<(,1+<2Z:GVU0V[ID MFR_':UFE+V?0_<,-TDS$;K\,PE^*K"KK\M#,(-R<)CK4O)ZOYQ#I^6E?@`), MNU7EAZW]R=TD_L*>/S^U"?JWR-]J]K]5G\JWWZIB_[6XYI!MJ!-6X*4LOR'T MRQZ'@#P?L#^W%?BSLO;Y(7T]-W^5;[_GQ?'40+E#4(3"-ON?N[S.(*,09N:% M&"DKSS`!^&M="K0&9"3]T7Z^%?OFM+7]Q2Q<.KX+<.LEKYO/!8:TK>RU;LK+ M?P1RNU`4Q.N"P*<(XL\"+URNVB@&IM\QX;-CKF=NX"SPX@9:T-'@4US0FW9! MB-OJA<\)%YQ3MMKD[](F?7ZJRC<+'`WYJ&\IWA_N!D)AUGVHW?VL0[J1\PE) M+170-5CE^S,H?9I_A_)F'28BS-*V),93$;%`8"TQ[$X,,,I*Y20"@DX"!5(& M%.S],I"DRO"6ZO4B@BQ;D^`<8WU@IP\D;$"9(CA#GV(`&3=G&DE0$9;%P-'G M2!APD,QTJ*J(!4)F6@P\I"0"H2<:+L-5F&>/X*T-"9$S"QRMHA%A5N0B/UB% M&B`F0"!+L%,8:V<1:L9*&$.I`&1[^MP1K,]]K>8U(@Q<3NK3,R\0,O-BX"$E M$0@]\PMU]GBGCOL'26/^(8Q)A4!(%6+@L0J!T%7`@L!KT*[R2US11VX$Y.GE MT)P2$6;16FGMAZY:K9A^#F$)D>4*7$<%[7@,UUNLM2#)2!#%;_AHPM96\[V" M8%6@[VN3BPACJI1`R$J)@5ZS9M%$(/1*K=793_,;DL;\1AB3"H&0*L3`8Q4" MH:MPH9E-+T*+5JLP7+$Z$/ELM?9=S8=Q!V!+ED)9N@LO4&V7<(KB(1<[WF03 MM6AU_KZO+8]1!S(50$)D!>3(XQ)(R*`&V!*9AFE6O%;D$,E9!0'I'B9$^-P,-`C*H`C9)5H6) MCJ+6"HEAU="?IG#/`8*-6@2DUR)&^L@#+0(RT(*MDFD9<10UUA%'$8C.6(HT6`?3BMV!:37(D8>DA).4NN!O9!I&3$4=4Y>CSLM MCT!DJ#N/5BYKOYV?../>@Q2G*-/WWM6Q6[2Z/@6N]M`6=2"3G21$ED"./"Z! MA.AV\K2N/0J)5FL/WK M0`^=U?T^\M2N1+GGMK$PJ@.Q=4Z^@3QJM/P&\O0M:=2!C%6C.+QJ8L3@0`$9 M5`TNQ35,=""R1AU((*,6`>GO)C%BT"(@`RW8.J?7@QHMK\=P0<,-)P@EV\$+ MOE!_LHP[!"^'PEDNUPMMG4DX1W44=M?I"J@7*PIK\L;M.GS_U8F7^KOX,[XD6;JB!@/0U$",/ M28F,J]_5^)J9:YCFIY8UMD)U(-,*)2%2BQQYK$5"!EJT?F_VDT_]6:G'P$\= MB/QT=U?8(9BA%,[=72'G*([R83:\&B,*$*VU=E?;M49M2/-.2D+Z*E!D0^D2 M3E(U8#-D=\5$1U$+-:]0/H$,TXHEI-#NV&0XDRI,Y):\-H$-SO MTP&=/'4<>Q<-QZ"#;.LODJ,.A*]N9.?S0NT$(>Y10O=N.(3GKGA!B`4H4D3G MJ'24=\FK8Q[GYW-M9>4KGI$&\`Y1N8@_YVO@.SG7OC7_R0SCP;4]: M-09($T?!<_D3',7>TF/^1UH=BVMMG?,#3,.9+2&[%1WFTI>FO+5';B]E`X>P M[;\G.'3/X6S-F0'X4):-^()BY3'^\_\```#__P,`4$L#!!0`!@`(````(0`< MR]$"MP(````'```9````>&PO=V]R:W-H965T M\W#>RI%0A(#0RQJ52;63;,BUI3:3%6]K`DYR+FBBX%84M6T%)U@75 ME>TYSM*N"6NP(43B/0R>YRRE"4^/-6V4@0A:$07YRY*ULJ?5Z7MP-1'WQ_8J MY74+B`.KF'KJH!C5:?2E:+@@API\/[H+DO;L[F:&KUDJN.2YL@!GFT3GGM?V MV@;2=I,Q<*#+C@3-8WSC1OL%MK>;KCZ_&3W)BVLD2W[Z)%CVE344B@UMT@TX M<'ZOI5\RO03!]BSZKFO`=X$RFI-CI7[PTV?*BE)!MP,PI'U%V5-"90H%!8SE M!9J4\@H2@%]4,ST94!#RV/V?6*;*&/M+*P@=WP4Y.E"I[IA&8I0>I>+U'R-R MSR@#\'W-*GC4D!M-Z5C@0D)['K;^>KFQ'Z"FZ5ES:S0A1H,F7(TENUZB*ZBY2;_P M'...0_:]0K6.]39TT-B&%X[?=_N"9*S8S17A>BQ)YA)O MK-C/%1>0D5%_;G3QZFCV1G40#.%%+_SUU*G1+"XTP3C)W9N*Y$W%_E^*D4]( MY/\;JH-B#,4<9LYSISZ-9ME-[2IPG(G)R\?!TIG4(+E\'+K^9.CA4-()&/@B M6#U'&V_FQ#$;LJ:BH#M:51*E_*A/$P]R&E;-07?K1K!+8-@GZPD<@-VZ/3R` M`Z@E!?U&1,$:B2J:`]*Q0A@.88XPKK+$KXT%/:?8X$XYUSU M-WJ7#=^N[5\```#__P,`4$L#!!0`!@`(````(0"8>0&8%0,``+@(```9```` M>&PO=V]R:W-H965T:W+TUM/&/&"6T7 MIFLYIH';G!:DW2W,/[_O;Q+3X`*U!:IIBQ?F*^;F[?+KE_F!LB=>82P,8&CY MPJR$Z&:VS?,*-XA;M,,M1$K*&B1@R78V[QA&19_4U+;G.)'=(-*:BF'&/L-! MRY+D.*/YOL&M4"0,UTC`^7E%.CZP-?EGZ!K$GO;=34Z;#BBVI";BM2Q:RM"V!MTO;H#R@;M?7-`W)&>4TU)80&>K@UYJ3NW4!J;EO""@0);=8+A< MF'?N;!.9]G+>U^OF.RJP2X'8(@J6M6O&:8YU!0H+&\4#+EM(8#P*?1$-D9 M4!#TTG\?2"&JA>E'5A@[O@MP8XNYN">2TC3R/1>T^:=`[I%*D7A'$L@XDKB> MY26A&T;766QUHEY@A@1:SAD]&-`T\$S>(=F"[@R8!V7J'">M[TD%C9+D3K+T M7*""@SW/2S\-YO8SU#0_8E8*$YO&"1,G4\AZ@,@*2MYLV#CGN-.4S8"0]H&D MDRZHEJ[+!]_?=FR0(9.F,KQX^KS5&Y`I8GV)B-,I)+N$>%/$YA(Q(ID(]2^% M!N^VYB!4)D$3CKSPTW!ZA)7"!".,AEA?1617$9N/$!.= M>LYSM5*O%";JNS8.G=B9UF$]CB=NE&KYV3@>Q[[G3_,WXSCD^^?\B3[P;*SO MXT:58%V7]MR5PBA=;ASJYHW#7AAH?\5L'';31.O@S3CL!>$Y/-$4337)X7+= M,YFD:]-GB<(!%VB>9N-XG,(8UCP;QY/`2<]31^E3-X4:I`UF M.[S&=!!+YUVU06UM1"T*Z?55LJX,KH?U;PAH!A;CH6@$M*Q;"0T_'TSK'\#P`` M__\#`%!+`P04``8`"````"$`2"L4BAD#``"H"```&0```'AL+W=O,S.,6=R]U)7U3+B@K%DBSW:119J,Y;39 M+]'O7P\W,V0)B9L<5ZPA2_1*!+I;??ZT.#+^)$I"I`4,C5BB4LIV[C@B*TF- MA.%%EU-G_<-XSC706Z7[Q; MG/7*,OJ899X(5T@8Z1P=ZKCEQ$@>85HN<@@*5=HN38HGNO?DV0LYJT>7G M#R5',7JV1,F.7SC-O]&&0+*A3*H`.\:>%/0Q5UO@[)QY/W0%^,&MG!3X4,F? M[/B5T'TIH=HA"%*ZYOEK2D0&"04:VP\54\8J"`!^K9JJSH"$X)?N_TAS62Y1 M$-EA[`8>P*T=$?*!*DID90!,T6+5@MX?#S39=LC5/E`TJ`+LC75%4#=WZ]8 M+T,YF3+\V#QO_0[$1&S.$7%B0M)SR"19VW/$B,00&IA"+PM48&B^40V")#"# M6VO,[0@3FHC-541Z%;&]A##T02#C0E[6I\!+!,D;>LQW;\WHUQH3Z2[U9E-Q M8[/G!Y-^2\?F*$DFYNW8'+C16_<8FN!%&VM2+]WUYE1.4VV3X-<:,^NT^:&; M1*;VS=B>!/&DZ]*Q.0S=8.*^'=LA-?Z;OR$O,N5=+ID"3V5-SEUKC)85^K$W M:=G-V.[?!MZD*NG8#B/7G4T&#]P=*HC3`5$M#!],^C!61.^)QM25<+* MV$%-?1_R/>SJ"VGMS6&:P5":[*=P477[SF"`BZ+%>_(=\SUMA%61`BA=.X9D M;=DS"%=$]EO!%0&!.NC:`"\9DOU#3&PO=V]R:W-H965T/#S^?>^+*Z>2H+],BDXJ):X\";8,0J*A)>96O\Z^?] M5821TJ1*2"$JML;/3.&;S<[SGV8Q^<-JN$PPY,[$BR=(UO@^4NQOYF9?/YS=E1==XC ME8OC)\F3K[QB$#:4R11@+\2#D7Y)S$>PV#];?6\+\%VBA*7D4.@?XOB9\2S7 M4.T9;,CL:YD\WS%%(5"P\:8SXT1%`0#PBDIN.@,"(4_V>N2)SME1?G'B8*3E3.9GDS@>C()IMXTF@6S^3^XA"<7N+ZX7(CB MNVW9E.Z()IN5%$<$G0?@JB:FCX,E&#?QN,VT@;V5%P1E3&Z-B_6"*!34^'$3 M1N'*?X3"T)-FZS0+C#J:65^S:S2FH@#84D)P7:GITD-OE=$:\QN#>B6'1^MHXMTYSW=$,@QI3]-C`Y'(V(X8&[_QN M&$4#-J<98QM3]-C@`>JRF=X+X0$?KZY9-,PO'C`ZS1BC4T2V5>%`;M?W^.9] MOG$N(QYPQ2^^KJY.,\8UINBQP7/4S6ZTSNA8;!9=_F\#^%P8$^\4"<"J&;&W,@M_]\-G\!``#_ M_P,`4$L#!!0`!@`(````(0".MBA?5`0``+L1```9````>&PO=V]R:W-H965T M^G3PO785W>'/**-F3COA/F?M[^^LOZ2MMG=B:D>QXDSJG,WHA300.=*VSCNX;$\>N[0D/XBDNO("WX^].B\;5S*LVDW+C%Q82^+HN6,GKL9D#GR85.-2^]I0=,V_6A!`5\VYV6 M'#?N%[3*4.QZV[78H!\EN;+19X>=Z?6WMCQ\*QL"NPUUXA784_K,H5\/_!8D M>Y/L)U&!/UOG0([Y2]7]1:^_D_)T[J#<$2CBPE:'=TQ8`3L*-+,@XDP%K6`! M\->I2VX-V)'\3?R_EH?NO''#>!8E?H@`[NP)ZYY*3NDZQ0OK:/V/!*&>2I($ M/0ED]"0HF`6+"$6QG<63*Q("<=[EVW5+KPZX!KZ377+N0;0"YILRN8Y!ZT=2 M02,G^<)9!!>H8%"?UVV8)&OO%?:TZ#$[B4E<9\`D"Q62WB!\!SDOOMVXYR`U M);LA>/E`TJ`+=DO7%4+=?UZQFPR>I,H(=!4_@:@K2J>(9*E"\!02J(ALBAB1 M*$+#J=#YA]:\">5)8,)1+4*]&#N)F8\PD;K(U(K`5D1F0B@Z82'_O:`\:>/" M9@Z>0TO-=#N)60C7QHM(*W@Z#B?(U_8`C\,H3)9Z(;6X/Q_V4%$'%1NK,]N4 M@U55\,4#KWAR=A(#WSXHUU:>6A'8BLA,"$5?K.KCQXS=I3S)YE*),>FT(K`5 MD9D0BDXXWL9UY#KMQPY/4NLY=:G$S(5+`U^K=JI$$^V,Q./H/-0=.HY&L3_X M2-'%.YG1:\+L3PY6]82+.Z_TI\28ZF9%8"LB,R$4?4M5WV/^Y$DV?TJ,2:<5 M@:V(S(10=")X!XX+^9A!199:T:E#>Y"T:'(_YT2]4R4ZUPY9K$3A&!U,*)(S M-?S1&8IX+_"P205:U10NM"=GUX-,Y;-#L!V2&2%J!7EK,%+YF%61;"C@;3N\ M#Z9O_!YD5"MY#!!L9\F,$%4M[P\TM?8#%[T'2KXMYK'HN5<.Q=N+B M/AR+`QG%>I^8:?%1=Z7J@YW\'_IXENY=[5S?(0DRE"JU0[`=DADAJEK>+VC5 MM+E;V&Q;L2))O6*`FTGC:% M89AO61]?(BV.E3A"T5)S/Y^F[P0(A?'=75*CG)7E*%F3]D124E7,*>@+GX,# M>"R&NW)&WZ$5S'GLJ&.14Y`J4_2Z!^K1R^ MY45'+V):V],.AF;Q\0P_DA"8'/T9@(^4=K<+/A\./[ML_P4``/__`P!02P,$ M%``&``@````A`!T+?M])`P``Y@D``!D```!X;"]W;W)K&ULG%;;;IM`$'VOU']`^QY@N=J6<90T2ENIE:JJE^JM!ZID(S7"<*VBRQ:ISQC]2Y!OW_=7RV0 M)16I,U+RFB;HF4ITO?GX87W@XD$6E"H+&&J9H$*I9N4X,BUH1:3-&UK#/SD7 M%5%P*7:.;`0E61M4E8[GNI%3$58CP[`2EW#P/&/IOJ*U,B2"ED2!?EFP M1A[9JO02NHJ(AWUSE?*J`8HM*YEZ;DF15:6KK[N:"[(MP?<3#DAZY&XO3N@K ME@HN>:YLH'.,T%//2V?I`--FG3%PH,MN"9HGZ`:O;K&/G,VZ+=`?1@]R]-N2 M!3]\%BS[QFH*U88^Z0YL.7_0T*^9O@7!SDGT?=N!'\+*:$[VI?K)#U\HVQ4* MVAV"(VULE3W?49E"18'&]D+-E/(2!,"G53$]&E`1\M1^'UBFB@3YD1W&KH\! M;FVI5/=,4R(KW4O%J[\&A#LJ0^)U)/#=D>#0#KPP7ES`XAA%K<$[HLAF+?C! M@JF!G+(A>@;Q"IBULP`T&1V]UW-6P:,FN=$L"8J1!>$2^O.X\:-H[3Q"3=,. MSF-/TUS=/YZ.AT$ MW1N9\$.WYS<*#"888<(>,3$*D+%1K<"'V7Q=@0Y*$+CLR^A'<<]O%!A,U#8" M!X$?+.-!Y$0"M'HLX?74&CQ/O9BE-AB3VO?=(`S]'C')'+TGLP;/,R][7F/: M8+K,V%V,!G"2&*9T;/FRJNN@F8!128T`@^D$A$'L#0HG`O16F#UR;[==!\T% M#,^/$6`P7=MC-_:7WM">B83E_TC007,)P[-E)!C,LIT\#]OQFG727C6(; M-9P7]N?!;Q/4=@8K@W@G'-UO-!O`OT;VN8?````__\#`%!+`P04``8` M"````"$`K&J)+@0#``"G"```&0```'AL+W=O\[P?@92RA&YX<2EHI:R)H012L7^:LEHU; MF7S$KB3BZ5#?)+RLP6+'"J9>C2E&93)[V%=E#JH=@LG\Q^]XTX+M`*'`*2Y M9NGKALH$`@4;+QQJIX07L`#XBTJF=P8$0E[,_R-+5;[`T<@;C@=1`'*THU+= M,VV)47*0BI=_K"@X65F3\&0",TXF0>B%DV$P'%UW\>V*#."&*+*<"WY$L&G@ MG;(F>@L&,W!NR.PZ6M9_H0*C-KG3+L8+*"2TYWD9!\.Y_PR9)B?-RFK&&+6: M\:0O63<2G:#VW30#YSE!?\JV4>CV`5++!6FY7!'T_>V.-1AZ4A\C'/??MWI# MTE>L+Q7C:5^RN92$?<7V4M$QZ8%&?=#W`;48-E^G!W$PZK]Z935Q1^-TQ'W^=;<>!M/8;5ZW M/@J#V,EOVZU#NM$YO1X7?-D^SJ7%+I?SY5E9S3`T8`//Q7+*D8OEUIW8MF[] M/+^'-?H?+"UVLV#J&W+3\';@^1*PYP<>A5O.U@V>S% M8,_-DHH]7=.BD"CA!WWHZ\3;47L?K8(9'&9P)CGC&[BGS+C?%N">J,F>?B-B MSRJ)"IJ!Y<`;0]["WC3V0?':'$T[KN"&,!]S^$%`X9@<>"#..%?-@SX,VY\8 MR[\```#__P,`4$L#!!0`!@`(````(0#>8:X)Z0(``%X(```9````>&PO=V]R M:W-H965T2%0E^].)UA,EB MWN7SF[.].KE&JA3[3Y+G7WG#(&R8)C,!&R&>#?1+;DHPF)R-?NHFX+M$.2OH MKM(_Q/XSX]M2PVQ'8,CXBO.WE*D,`@4:Q^]D9*("`7!$-3>=`8'0U^Z\Y[DN M$QQ,G&CJ!A[`T88I_<0-)4;93FE1_[$@SXCJ2?P#"9P/))[O^+/(BR;_P1(< M6.#]4%L)EW$*=5T,9=BCZ!MP;5JJ5D$7@PL MQVQM$GW:_PH;`C(DCX8EP5.,($<%#?*R"'UW3EY@5K,#9GF.\8>(U3N(V1"2 M6@@<^Q>-2-:7$`1,]\YA)D^=O]]-1X,&;`R:EC".E^/":EQ(;>%4:NA[0SOK MRYB!7&B94[EFH@)82I=EFT&`.XDK]$>!+2T&FJN/-!JJ7%U%I%<1ZTN(@4\0 MPZN(U")L3J.`8'[;]M-I69RRU:LJA3*Q,[L MR0'DWE?[S\6C;U;2J+[T8EA6Y_65%\/J@CKI!\#VWM(M^T;EEC<*5:R`5[F. MV0>E_4#8&RW:;HO;"`T;>W=9PG>&ULG)A;;ZLX$,??5]KO@'A/P.:2BY(82Z$M3\-^3G\=S<;SY]IXFQAO+BYAG6Y/,;=-@6<2/<7;> MFO_\_3Q;FD91AMDQ3'C&MN8'*\QONU]_V=QX_E)<&"L-L)`56_-2EM>U9171 MA:5A,>=7EL'(B>=I6,)C?K:*:\["8S4I32QJV[Z5AG%FHH5U/L8&/YWBB#WQ MZ#5E68E&;W.(IY>P<0A3N+RHS)J&FFT_G'. M>!X>$ECW.W'#Z--V]=`RG\91S@M^*N=@SD+0]II7ULH"2[O-,885"+<;.3MM MS>]D'="5:>TVE8/^C=FM:/QO%!=^^RV/CW_$&0-OPSZ)'3AP_B*D/X[B%4RV M6K.?JQWX,S>.[!2^)N5?_/8[B\^7$K;;@Q6)A:V/'T^LB,"C8&9./6$IX@D` MP%\CC45H@$?"]^KS%A_+R]9T_+FWL!T"+Y$ZPXT@I\UE8>(5BXG,H[3V$9[C8YOQD0<@!<7$,1P&0- M!H5;''!NMUO`'V+.=S&IF@KJ`O;R;>=2;V.]@?\CJ=FC9F$:M8:JBJ!#L:PE M%O#5D."OZ9!BD@I)%[7Y:AU[E"RJ/1(+"QHO%`#PS'0`,0F\V?"`2WV-`#5N M0Z/Y,1A2*(Q@9#JCF+0U8=GU+KDM+Z%F6>TS\5>>K:XAZ!]7^"!-IO.)23K? M/4AP%U'C(Q\E+;[^<87/5_F&,T"(=:Z5ZI<]:I!KYA);XPZ4<<>G=[\J7)!" M3;\-@=5GQ&H+2.=UJEUKD#L)UFZE;CBN3H8B*`]U<=&+F[33+5'Y1&ENA-NXC258T(=KL!1U M0U0I$PQ*5$Y1KZ=S8I57_:E'($%1_T[WCJN$HEXW"!_LM%`_C$$4]9/UCJMD M6HMX0-;1&QPMP/;BB`?X\/W],3@D4?FT%C$R!K'.P^;4".US`$'1(.>01.74 M6L9(SH[>0;6>M2?-YN!ZK3+8/ZX23FH>I*-[4+W;2A'&X(RV*[0F\-U[O5+9 MM!;R(`J[>H?>V4BS.Y!%VVO*^-*[GQ(5,CJI>U1J/7/OEN4)6)@KQ3U45#38@PEH0JT'H9X>%$6(YKBM MDY\Z[B]Z$E?\A)Y`UFX?=*&7N\KD@_08W3[HE]I'->O1ST@I&DR/T>V#?JE] M5+.TG6ZG1[-].':K$$HC,A*:XVH,3FH?=$S[D"(9_:1-AD:Z/:S"3>H?<."N&]SXIR\\L8$E2&!%_%3=>%#*^?HNW<7NRWE-Q M+:*]#\0MG7AOU0-P278-S^QGF)_CK#`2=@*3]GP!:9'C-1L^E/Q:W<8<>`G7 M8]6_%[@.97#M8L]!?.*\_'P07U!?L.[^!P``__\#`%!+`P04``8`"````"$` M5*XA.5\&``#L&@``&````'AL+W=OXT]L>\E7U0C MS4SBP^7X^MYS#'YX_[W9>]^JKJ_;P]IGB\#WJD/9;NK#\]K_Y^]/[Q+?ZX?B ML"GV[:%:^S^JWG__^.LO#Z]M][7?5=7@081#O_9WPW!<+9=]N:N:HE^TQ^H` M(]NV:XH!/G;/R_[85<5FO*C9+WD0R&53U`=?1UAU]\1HM]NZK#ZVY4M3'08= MI*OVQ0#\^UU][-^B->4]X9JB^_IR?%>VS1%"/-7[>O@Q!O6]IEQ]?CZT7?&T MAWE_9V%1OL4>/TS"-W79M7V['180;JF)3N><+M,E1'I\V-0P`Y5VKZNV:_\# M6^4B\9>/#V."_JVKU][YW^MW[>MO7;WYHSY4D&U8)[4"3VW[54$_;]17]L-?[>OO5?V\&V"Y(YB1FMAJ\^-CU9>040BSX)&*5+9[ M(`"_O:96I0$9*;Z/?U_KS;!;^T(NHC@0#.#>4]4/GVH5TO?*EWYHF_\TB)E0 M.@@W0>"O"<+X@B<1B^2,*,)$@;^G*+$8G\*/T\@T)!Z72,TK=[Y`!"`Q+H'KR5%@2*([\Y3< M6$-"!Q)A1'X-@:A!D/NI*?#:AUF>%D4$^,:9AB3CHL8L2@GUW!UG01C$XA0` M\8*FN)^7`A->[!16KY6&2%UL"4M34G`Y`LB$AQ>(R3G$%)@0XX28AFAB(1>D MQG)W.$KE!5+0)VZV5!?*FUVH+B+D;'B=-0W1Y)*03=BYXVDHA+T>+:8R04_`A-:(04F!"BK1O,8$R!16$4$$2.$8E(4UNC*&/LY\1>"[4K:+2.LC'R MV@=Q."D+26]^%8)I*AF^N]R8%FTD:M9'=!L8C,YA+,"V<4'F"""C-+C0"$SI M\OW4M(HC:D1/LS$B=/LH;`P6;T)-!WD#\-1V"\Z:4F:'VIU.KO7LZ,J)QT8 M:JXGLUQ[!9(3 M.V>=-8,QU'A".R;'`-B4V+1B:G";^^6$*S3)FBUB0TUC-+5()I&]\PC(39!S M`$QMED_PJ4^$U"<,1M\YCJ1,B!;F")$$(N$6@+)=0S\UD62,[;[.L[K,!BV$;3LDA0,(N20@G+G$C!XRJ8 MV"Q'X%-'B.R,3Q<+:[IDL1`';,MIDPM5F.P*>.$%%',!BC;4(PHC`Y M!@2Q`T#4E+'?KVTC&FM;1&H\,QA-+8$[DR;.$2"..+?"C:G-<@0Q?7J(;&"] MH`9S33ZN0C`]X@IJ)Q="?U]O"#%UAXBL768PB*:M+%UZUS&8*/$(132^373J M%70_G@F-"?5+'+J?S]%PXCQ.8GI*TYWGB1OY4VA<@9+*L-`878%2PIM3HH8Y M1J0Q/(:?E!J34X+MD+MONRZTS,-2GVQ*$@J9P>C<39^UT?"[D%MMPOQF&868 M&@5]_9`9C%$6)ITG5%-YKI.(()&74C?+*,34**2=LVE?UR@DV&M,5CXW433Y M&%YX7WJ(A1.`GUG7J6E(JLQCY+5O7FR>VS\AQ-G]DSY7P<+`&_;=GC[H,Y#3N=4C_\# M``#__P,`4$L#!!0`!@`(````(0!&8)0=+`,``#L*```8````>&PO=V]R:W-H M965T&ULE)9=;YLP%(;O)^T_6-R7CZ1`$B6I"E6W2ILT3?NX M=L`$JX"1[33MO]^QG=+8:5ERDP3\^LUS7AL?EC?/;8.>"!>4=2LO\D,/D:Y@ M)>VV*^_WK_NKF8>$Q%V)&]:1E?="A'>S_OQIN6?\4=2$2`0.G5AYM93](@A$ M49,6"Y_UI(.1BO$62[CDVT#TG.!23VJ;8!*&2=!BVGG&8<'/\6!510MRQXI= M2SII3#AIL`1^4=->O+JUQ3EV+>:/N_ZJ8&T/%AO:4/FB33W4%HN';<!_,`G-;+DD(%*G;$2;7R;J-%'D5> ML%[J@/Y0LA='OY&HV?X+I^4WVA%(&]9)K<"&L45_"($I1Z=SAR5>+SG;(]AR`"QZK#9PM`!#%1/9Q_.&Q!P;-P?E)*;$.E3A29D20:"I)P MAO,/ARVHY!(H)7:@G"@R(X%`AA6.G3#S48D%!X_(^8DIL0/G/%:9D8S"C4HL M.-7]CDZ'\8VOQ`[U`&8G98Y':9.XN&Q%8 M8!$[YATABQ9P9D-O=N[G\.Z@[P?# M`+3N'F_)=\RWM!.H(158AGX*!P8WS=]<2-;K)K%A$IJV_EG#2QJ!;A#Z(*X8 MDZ\7ZO5B>.U;_P,``/__`P!02P,$%``&``@````A`"BG^N M?OOD3U=OMU\_,?/=-4WSWS>*[DVJ\G.7EPF`?YK1< M%(L'][9HQMG4_#G/:O,6L&Z2 M=0"K87#8S^UJ_1/\<3^>\ZK.2&7F\F%V74WCM\_>__F'#_%#B_J+_+9H%G4& M@OB0S9)CX=.+LZ,3\\/IA].KL^-+<_;A>&"F8Q!5C9.?@5`^FS_D#_&X9[OX MO]=OWKS93TCE>%G7I,D0>$.0?K:]O7NX?;`;3V\/]+:8YK4Y!HINJSK=P[NL MOLW-T7B<8Q@&3;`F_C4PV7$UFU6EN5Q4XY]&YO(NJ_/&?%PNA(L!\/BSXPJ' M+QO,BG\UU;28R!+?9].L'.>8`$S;F*T_79Z8IU_%'Y^5YNJN6C9@S&8$!I[F M36.JQ5U>WQ=-;IIY/BYNBI0)_WE)/MOM9T('V:QIL/3OXS6/L^9.),&8_\C_ MLBP^95-@(J':]UG]4[[(KJ>Y*;,0/FKR\;(N%D6>C#^O\WE63$S^&1*L M2=^38G.3C45H-:;.QSF6QO0C(^?.IM/J7H`&T60FU?)Z<;.<^@^J&_/TS0C2 MSV0+TQ%#=TCQ\)^V!KR2&OJ@4('B`0XE40 MQQ`^!4SGK<"=YEF3WU73B2EF\[KZE/--BI;VHWBV=[W?QZ-^J"N0#K&Y;N7X MRW>D.6!E.5M.A70G.=3-N,@6/;KA0[[XLD6J\G9[D=^PBIX)L2P>DJ.?UPZ9C0K:I[L[NWL`1&T@ MC980"=ER<5?5LIV7(V@1TX@H'IFB:0@4VC*5%\NFK.R(&$3/?OGYEY_CAU;* M;[#XWLO=8/E^T=,1.(,[?'4P>O/J1?\,KW='+U^]XKO.7/&VCR83D%)50@11 MU&X7I1EG\P(B*1D9,+0H%-B*$#_Y'41S\8D2'7_G9FL*L9&HI0N(?9AE$.59 M74+G#4A!@5Z$Z7@?";D(XC;Y@X%#6LU7Q2PP;[:3-'FG\?Y?&%@<:F" M-]#9V6/T[]%J514#(:'VEL[7CO1LL':H,L;:80'3Q&.[7#&XR>ZPX1UVQ_5O MKSMFY=YZ[:S+!726:%0#^^!,J9JR`1,'Y&Y?#)AA!QM[/(D9_KZ:PB":0FY- MBNRVK!K0H5G`6.HU%6?SK`3[AF.;O/Y4C%-+1!EG0*P?8QTH;1S3&5N)A.40 M@F3VJ`WJ-V/`;N.-7N0-Q,18;`T0] MSI%-9D4I;LF"XFG@6ZO.DM/':WR_%S',RT"[V50)#&`8YS/_% MJEGBJ76+*G)U@7B$I<7K'&9N*XA[K5$[$N\,+<>"489X-EID_>N<6N%M``S5 MC%),E_"2XL?_FA>W=_2>,L0[,GA4JI!#)1Q_TN5!W66R!UH> MV504_2VTCE5)!ER2?HC&+RM",*\=P<&G)6LK@<_XE'I]0$@([YOIALP5. M`G]`>756U8OBK[T.PCNZ(2+AFGG5B+%")/4;R>)=;U_#/YJ(>0+;1#$SP/[? M9Q,SR:_A@JB+&>/]#&*KJ,7SPII%:];K\O%HFMDX2K]G:ZTI'_4[HL9!O0_H-*$"\>8%_8'PGW#3H9,<[H=S8 MB![B#V,BU=@`9>T*(CU6*U41!QMVR:@*W?PO\5C/EU`W(!H0&O3;(_W)\[H: MY_D$JY/#$&*UT0R!+&7,%\W:"\VM)0F[*+_"?Q@_Z<)H'5QOBA+!D.XW";JY M+A@Z.!%T-^-78F$[7VD)T\FJ@!X:-7.$JA(3_R*?6S`+9,`I12V&%H$>+A*? MHP6%/;WI.TC?1Y,<_`BTDNZ%,FD7R#]()`-!*J'&OH'TI:X1Z2SIP'#/D*6( MYL8+K_P>L>/A+ZD[A59@W3=P07K%X=6=1KQH3SUP(Q#.-ER(?_EPH841_#K$ M&9U!>P=-BS/D)5",T!J#5I#9[Q_J`G+P!UA/L#41L3@K$9'?@D5C_OZW_TV5 MBZ7^_K?_0ZJ3X%D]D:#:?;&X,W_:N=QQAM?T@:_A"&%>_(.A".YP7D,V%7,R MPA8F_.'HZ%QF([>*I"QF#J78;N'S"$(G()IFR=`R5`ZWE,WG4WAF4.*F7G). MXJK.;QEK@@X6`'+<91M6E!&0LZK#<9X9/`>J:^[F\O28F]E!V#1_%"QQIND2 MX4?9DXN[@"KXMX69+(R(A[F'3PO@5/=T@9OE=5/`MJ\1\=PQ#L M`*?G$N."4I`'\]C+IP6,6XFMD;1;O&/8#K`G>ZCF,']Q2)%H)(H`9&#?#'M6!46PXHF5+"",$`+2(^!^;K)=(@7\%"H&[+:AA) M%2F.1&UNH%!)*)BY=^D>&B/%/!Y!B+OFF*Q!.!RATFO&\D#E>((S_+@L!:A& M:#A`V=__]E^`_!(*!9CR@,4?O9OER4LH>"AP+H=CDJ@YWXVF-]%H!^.04= MNLTM[NHSZ[S&CNU*3FHM`<>LD5G`?0!G$4Y`1^* M`9B@'4@K MM>2P5B\J%+&8;\9LI)=-)![L#@(?6\19'"N0)F?93]@KR!E:VTH2V)7+V5P9 M;G$'D9_=W.`H@E/L`NC`J;*9AEFQ%[5#!9:!%25_3T`"B(:)98*1Y"GP!WE@ MZ"-=!K&CG&RK9"0Z&[3@Q3C\6X@4.+W\7P[JVY?U\V4CUKAMS`2F"3C4?\._ M%!F01.,%:2:21U=R MS9BQ$6E0`/N6#APX\1Q`(@J=L%#?01EA/4 M,/Z,VS3P2YF]S@PD\%?ZDR*QF',+%!'<\W$&,4D:@M-A*0]L`J&H<6JEW*5W M81D.)9KHRJI28(35)A8+F##+%J*,;,< MQ#;9,2?P4?$&T,)_6J\*DI.A9IVPS3'<(Q(M\>4<'UYA'#E(Q3Q"P,7/)#$8/_10C=]8 M^HT?"SG'#Q70\=-3QR;Q"X^+^,U1'RP30`V:ZKTCXS6>Q@_^_K?_[`.NK++" MX;`AR$V3Z$>K*"[=>%5#9U&A7,-/4/E1TF")-[^U%S_Y*DURO4=%$"QY:`F9 M+?YBZ\V;^-';'(XBQL/^+!$LDY!]LK9"8*4PC>?=VMM-BC<\($>)ER<\]Z@5 M$L8!3749,0'VUM[+9)\O#UXESPYZAKU.AI%NTH-`^4,B!%$&B!")8`5J)M!D MZY24"%$O2VPN,;(`DX.F-)@,.5GFHLJ@5%"G)J9=#`<.R6Y@$;8C(+;J:GE[ M!PL/CBK-P816_$?#8RZ9V-V&.PW13PWOHH#Q!J@DG`7`\C=:+V`1C4,/Q374 MA4+]U:XYG<*9S1$;$?D.= ME'@%SLV6"?F6WBC7@#J@52+>.GQ>UGF(MTZU:3J]=BHZ60P. M!Y\P)\G0#1]-9-/61W1C'*RX!BSI!?P$:XI^7V6U1"_<81MLT]K0MRS^$M=; MPT256M`C6I.+NA!7@'1+-=$^T*'9/:95P:26B3RVT+EDLZ1:*O MM8"KE27BPLCY"8T#E@PQO0][ND\'C3#BU<'!Z&#OE4MWJ#IW4EVFHYADB&6$ MR$&!1)AU%1NSW_W4V9*@C1J4LKAG:,<;$8+F/"$=; M!"%DT@1,XJFAN$'P7/V9.;RK`@86'&&9$>=1MFHA(G*UY^"_\MQ]$BPF3=`[ MRJ+`)V0X%R5V'C<<5N4W+P;\"6E03Y#`@`O-0%4`\\=(!:'@/`/9TNB!]),5 M&8Y0X/F5&29N`8@H(<@#>/%X5`;>#\*+/(Z!.8/P'V(*I/J;:EFKII#S*GD! M`J5]:#W7W**>OK7?BD.>:J'?8F%)::Y:^@H2)O^:0L6#AO8#L8`_.I.H3E/$JT3;IXP,RZ!BAO?!3E\.LJ/% M-=@*"%5,2<=W!(_LH;.L6=P3OK0C&'%489.#*["8$&C%X$8G!B(ZS!."ER1R M^L\2*,)<>R]>;+;Y379)/HVF'[U^>2@+K%`.20#D"*'E&>@#G*'!HU`7(RPK M"=^'0+:%9@1YT0<(-PD+@D:]X9C8?Q]$8?[R:'/K(L&;]^A\AVHF)7>5;2C$9BOK-Y1*'6ZNZ,!X\"E2@/B)#@T8^?A%];K*!"PI1W#_X6= MA_@O?:^@A08,`XWB`@`H4REM"%XKK%P4&=]"WGP"O4,-E^C/6:"O`+3?R92" M$?KM6`=PGP9J0\6(<8N\PPYI$0!&JC[]T4*WP-(`S'D(#_0WB%51FNME`].9 M[0]@;&NJD9^E;`DFN4XI`A.$9QNNG$O,5`FL]C&L9EOGU.IL3J?>\0V>B:L[ M+&2[ML33_5<'.PU:%E$,]:C$TL#!W%?8V:$_( M!#!167L@@F*]AH2 MSXPA)6ZY<9(LPSUX!NM02M+U?,+M["5:T$T%.FYO45P`$GO4HK)1<7?4#7.J M:M7ZXC<1""$N"#X^>US&EB`1]RL($%4TF)"F25 M>T8)/Q:ZD.T$K!>@17&B>>/(OJ[9>KRE",:_^?_G^*_B.?J,_TJ/^-LGKY_@ MCW$U5:Z9H3]ZCT_JM\B]ZX@K**#&?,COS44%+<"W-QE4\X.^EN'/9=[%=SUY M-*P7-#:?^%-&>UU\YQR:EHRL9`G`:Z2@#;)(#XTH\5Y/(KY>-U/LYP0.$1S9N;>ZE[",(/"-QONT.+CL#X.5)H>)Y!]SO.O$Q&UVX^;W9*I""A'T`0ALC$[95\.^^[A,UM_">`\A+<:M)H[K=S86H MOAX.`NR&[?7`@Q7^K-FA]RPR85^!HM\$.V_6T(D8=X&04V4SK&- M^=;ULX1UD8M\?%="RMTB$D[(]P/%G1(;9A4%K!YX]:H1X,CC['B&5@8<'F3) MDB2Q6^%:3EAU@5H@P61=-#^):6([<3B!/:'A^5G#B8;2&VS?%G$@U(9F0C1T MEPN985K\A(+%._2\4A/@='-:Q-1,E9G42]%0=3;'9X#N[1*S1!-,4/>OPQ&' M)O-0S+'P<(&2%&DB']&G<$?H+"[;Q[)NRV+,XJ3TQ%3D";*P+:TU&B,\3)#V MDE%+.`E(\8#VC.*\13`.N,!<<\B$63;.H8+14B@$Y3$HNYCEK*63XBNA=B)A MR4092T0#WC(YFUD!=1C4EH9AT4`(@FX0Z6SM&`!9"_XH46W)/PNQVA8AX(VA M=!M&("!<5(7_=M5Z``)PX5\F]L"EW418;>8[#.SLVA(:EZV$Q6@:5T';,C8% MJLDGB3:]L&(@ECMMMUS\PC?/)2GD8RVCL<[;\^C!^G5GN0-+$AZ_UD2YSLX.!%/-G6WFCW95)+$8=[T@4.T@4. M]D=O#I,ZAO53]>P59;*O#M,RB8/1[IMD`0T])2"E:="C5]+SOT[7.4RO%]G: M2V]<>[EY#Y$/T42=F1`<&5B2-V3>-I^N9(C"^O]R&H#V!!3+HE[* M--C]#7I!(50H1-HB2>95^"^$N;B;8! M$$0((/A0-L02`;OYF0<7>Z71-YY_QO8E,F*+\0.(W14H(H(1\,`!Z.%G59]" M!;J;^RI*V(N(SVA[C&3'U'H4.:,6Q=V#4^)BRQ30-YK_C8Q9T[?WR M,TJ[8KKYRQ)F`*T!]MH2=A*L@2Z6]B$:%M",<(-$YBN@53L$9<*)/)4US2\_ M[_),33MO4D@7 MOF7=DJ0HRTNJ+%!$P"'"8;J"M3"AZJ7UD=C#"WI_T,UL&377=05+3^&@:,6) MR^T.$Z$NP!A%[T(O891G`0E&;S'`%(`1@49.3Z?6>P_H"^5"< M$'LB@9`U%8-J'\.8]0%IJ\%$OZUH!])+)O?3B-4>"EC*$(]XY?@!P_",O,D/ M0M-9&@-@9K`_0<.`$&VH381')E<8QU)?H^MTC17\0`,R8U//"&.&>Q=/PVDEZ5F M?(CI$?`7/O&5Y)8P/#%8EA'(!?P!?;%MY;'X08SIL)U*L%\,"L:D8-1202PH MK1P]B)\#?9V,$R.6J5'Q'M6#K*+FS5$0`JQAW5.;)9VK M9T5RCA<58]B/<"OH-**.P/65,9J/1[I%DH#T0>&)*UN/SW^F5>Q7?;=&(?(D MBE5<)%>1(_@-K8:_+,%*HGV%;\2G$;6C,Z,9@#YDB&E1D&`E.H+L>6$X5SJ- M-/A!6F4+@10,*X/!9Y`Z2A@0]!!L)9]\$S@/3$XND9>`K+:?B^SDTI\@7U$J M97Z$S&W@Y4C,%T"Q'!_N3DTXNCS'MI6$_JET!2!\!SFS+);'[.VY\#D;F,HH8%DHB%()`.ZD(N?G1FQ=OI.Q&]->FZ^_WK'?PIF<] M)BZQHE)0?%)DDCIIAA[6UW,>[H_V7DA90-^ZKWK6C<[Y8F]T>"`7//5-\.B- M*XI(*9L<`0*[91<"..3637C.$898.U$+(3591YJ]@-:3JQJ`8>@EAJZ0F('9 M+]P1L$/0]J6>]HYH;6YP@T-U)(B&A#RGI8R!?;"JRO('UY`6X1O;".`EA0@9 M4.W!R]\%PG4"!\G:Z38@BR%2^V#)6F\XP-$1OK(II):>[V'6Y=NHZB(W:*29 MAKGMO]V.^F]%9,!`A^Q`Q`OHD7Q?T%JGF6`]#TV$3LB/)[,P%JV/%?E(V+P- MS]L*2#)B6T+9L@;E!UB5+@+D;CVVG:9BN*VT:II&/6;160RZP\)C6EED=/X9"1YT2UM; M';H;XE<:<[FJ/GXVEZ)%T342?QA*01&VGL*+KY_;Z\H``+>9P]MI_*>V8+\G(E!=,&K M`6P+R'L&5Y'JUZ\TN@"6D=PX+OD#TJ5W`7YJ4:--$@`47K<.!KX50TG_A$*U M]\$@7@&3_6MR*>(TN!6H>][VK%@!UW2ZKW",]O!.V#]*Q2286HN<8(!U`$)3 M5MKYB0=0J-S!PXL5[#@\]7E_N#<08>!FDEL;OH;/#?V[A/`"W('@J?+X73'' MV%FL'91;D,D0.S"%7()#ZPGTX('-5#.-8([ MPKSIB,T#-?#*T[D%\RV"L"VZI(0!B2Y4V>[T?#=,4@P=M1:_U%C5DZH M:7`2(@T[2#:9>"K'Z!OFA1^Q&W$DO>C)4S;\`AEIE1_&#]ZUA)M6XHDV<-'. M;NT@>^XEXZ2;_=P9>_K^.D5Z8QN8B*<-#PCO72),T^/0^073Z1KKZ7V_L_6;K-C#::N,X!\^"*-][]YE204M@Y&A_M) M#N#*,=QT$;"^:RW(X#2I(\';8J'3 M9V;*56">'N.X(/5)9;XOJF:,5"?3MV=R;P[OS'&OY9X;"(]+E$#:1.3ZRBCCSN[_4PHL'OW^YI49.UQY)9N59I8E#HHZ4(K3Y8#;);:RB4[;% MR%$SD;L6?0K-UVZ/XKV]7(<&-6)%"(P"AY#FMQ#HF8-BV]P1@Y=[47DGAH3`A8B=?6NC@WXZ M:*L?-4*B,XW,IPHRF+3*Q\Q+PR3S2=^ MN>D$4.0U;V;LH,8Y^!,'$RN&M5C6ZH%B()!2Z9[8%U=8#N0L!0'FZ=ZK%AL2 M2G9:TR.X;5J-NI#EGAS*$7M'.Y=G:0A-8JFX;N=[NH\TG^T.LO3#&EI:'PRL M!I=<7=L[\>6'+*A&P6H]1^IDT%N]#[D"R\TGP0/C4_=D#7S"NT2NI[-W4`N? M]]+\%]EU0NI[4#O:6$1R?(H.B5VE?F+`BMM(87SBQ8R"$:,$KJ!%D:M6%^:0;3.TQR@47 M)3GKF(1>]MCL0]_)12SK-5YRU;J'0".I,[LP[X9'.;@4`(D!IYG;:[@EB&&@ MN`R0)?($NKH=_!,LX^2?NK,X%V_4$7Z'9@9FDAA%#`HCA!?+N(8!R&W8+C";/H*A:G2/(<0`LX*V'SFL`[T-](!(@'^4?V\Y-H!5 M5QM\(1\!!HB?:8R+$N;8W24&TS-U>#S06.6'I#&M$I*KLUR@F@LF4#"35!@R M],8;/R'[6!6/*!BE(.)8D,U6UB$G(H:\H`2Y*1`^LCU0!C4>4\^`<=JB3\F6 M2X9]33,@UFCO8^NJ`!0,3,GEW.5#F^)G+0"$((-M06@.RK$-]I%B\'<0H,,3 M;-$=1@ID(&JT)#7CU/(?+TB1,,""BFCH*#@'<)]`8`@XAWZ`=P"X@C3L M`T_6.W!WE[Q79Z'KGV#*-GSBER4WH"/)=\.!850D!F3JK]&6S+;W5R14JL-A MTN+>YGS";BL8Z%7]$^'NNDNX6:T%<%H1VX%R==H3A\3"T(.@9!%B[3V0\5FZ MEE/;\.9\`9*]1`)U=6":2Z^5Y`0.:)B8;(&D:H.88`=8Z*9U]^##N"R085T5 MO0GA"\YG<2-TCA./D7K0CD9@G.^!8O)KF%Q2L@H08*]393YWC%\;\ID`3M"` MQ!NVH5G[3Z-_(@UP?Y?`H>UX$VCP(UN802='GM%TA8!@3:KE^P3P,3.\EQH` M48]>M\&7;XMYMJ[X,OWQD4LX<1/$@[E24+%'4NQ>9'3)"^&#"0&Q]U+8;9\] M&/Y,G.S_F#<<%]"%`'_O[\,&M$YXUWH`80&C)JU@ M!1Q34K*]%ZX@A)-2BD?16]S93Q3%H):^KY[KGLPF!#'X\5$-LM=;9X]B&EVQ*M4VGM-/OJ^J62'`04.+GCALZJ03=#P7ME<4JZK]@<0:1#Y MW]TYD[1ST4['/)Y@O)A3( M*1@]\W]H/Y-M(J#FO$A;C0:![8KI+ZSKQ^\_MB:8\H79>M?W>U2!&@@+MX>7 M"A@X^)8*13Q`5FZ+WY*@BWK@'U^RMSJ=.WQLN4]&"A\1E5]2)$,R(/0#(0AY M?>:S=IL<_C=)@V$?;?I*(CEK-Q$R3("[WU;]FZT3]I,/_UX8?\0@,%LL=:[Z ML5I[4FL]Q'Q[VE;PW;1A]'A,K$_C]_H3C_[J5I1`!'<-QZ,UER5S'H'3UDU^ MW/:[?0];KT'1QP2Q()BJ\;R#N^B_#=;?02KSQK.Y"T>/],+1,_ZV7[*D'J6U M+*0:JL^R\$=&MB8V3OY7-IM_'5B0@^9)(#O^'UA#:RFOYR;.D5E-7/Z237=W M)UR'^&;.S2?Q-W5N\@U=,1A`;N61V834-]SQXZ8*][W)EX.FW;8Y\E<,!EVT M:W'G5+J[S*A[49UY*2&!Y"?DXJ_@6<+7@6?I-9!!AP M>S[9GRF3;=B&<2&!Y`/]K3^;L.`Y=7]R[R/+&7OOT'WVHO^YHQL$N!E_D$C\ M!)X'YY7EA^9[W3_?,U!2[P;L.0D&P-I'A<^G61D?T6V*(1,78;?([+^E#&D5 M<4_BB4ZU(%("".Z.#X`:(3O\LIN-V3OX#6B,S>XGD]AVD$V4[?1>3A9O4?7- MYJL@\&4O8VMOF=!L#E[@)I2=\=4WE@+?2^\'NW"N#QA3/TPO8+YXK`U`'U(Z?C='\,VE;CJ101?0Q?(SL/0<3N#CNY^!/>W_K<;V M9V!_"'\&]JC[,[#VVV2QR[YXV1>;;6@RD\QG?9=SXA$^HYQ/Q\5L^E;N:I0\!X$[\QY_R6(X6G='?4?6.*R M"O$Z.8HDG!9&TA`R%?<@!C<@9KW5J)=R'^'&NZ/ZABF6+J27US'%$"P9#!Q8 M/7#`Y.0!A-!-N,9Q[X/5*C#]1B%`MZT8T:&X22.'(^K?;GP1UXT\,`"(+C.C M68M5NV^G!X>OB2Z^9?]*%%ULH1EOFW--W%5)00*@&ZL,XI2T.=/SK2;0-7'$ MM>P<;]H&&`<>VU`8J3%TZ59!UYL1(%K$L<06;73;0ZM`,,,9T?M=@%S:%B46 M'+/33H.;,(HP(F.!8%&[!IP.1!E`]KQA':M4?WGX]L3'UD_LCF*F1A M&&<_01$<8E-+.(O8ZE13[I4Y94$9%>LJ"E``^)`=R=R7$B"GV--=HPW)FOXT M;^$M)2#^M[U_C\G'=D2;_Z!.0Y/:;LFJ'B4GP:R:@@B3C<.H=]MP9Y'0L\0T;_B3OW\JP'NY&L8*VW#U=HYCH(?\,/R;0HDAA_2#!OO2\8^:A<#)WET M?XNL_.BOT'\#>U;ZP89\@Q@N5C:\?+G`0%\,(KRV)28^\9_C!U++<=9>5[52.G3[5^3: M%/XD-+*FH#_P4CPW9(^:,M(DCI@6,N9E&EX63=WV#6B@QW?.Q).>2ELV-;@& MR7RX5"KJ>R.5(#3M?&A7D1:@MBPN7@-\&G4SK![?'K10BRX(&[)*&P46,"A@ M(\",>U030KPO\<#I&S!KV]86?[&"#6TZ3HW[8_B#G<'9M>L69 M:_?\']:F]!N@W>5VL/;S5=:,I"BE3YT&=5"-V]XH[Z=_WC2+[_ZO`````/__ M`P!02P,$%``&``@````A`!G`9C5["P``8F0```T```!X;"]S='EL97,N>&UL MS%W[;^+8%?Z]4O\'R]-67:D)8$R`;,AJ('$[TG2ZVDG52MVJFO[J)_L/MKW]UDZ2OOOOYV753#42$R4Q_ M3M/U=:^7.,]N8">7T=H-X9-5%`=V"I?Q4R]9QZZ]3+!0X/>,?O^J%]A>J&<2 MK@-'1$A@QR^;]843!6L[]1X]WTM?F2Q="YSK#T]A%-N//D#=#DS;*62SBSWQ M@>?$41*MTDL0UXM6*\]Q]U%.>],>2+J]"3>!%:2)YD2;,)WI1GE+RS[YL)SI M5[J6F;R(E@#B=__91.GWO\G^O/O#NW?]?WWW_3]^*]00 MF1"#9IF7_4:Q\'$FN9=;<'NSBL+*D"%$G3GH^B6,OH86?@;)`.;AUVYODE^T M+[8/=P8(SXG\*-92B#+8Q^Z$=N!FWUC8OO<8>_BUE1UX_FMVV\`;+#'R[P4> MA`EO]C(-Y]7SB&@*FR8(@[-IB'>H30&89./-9IOL?Q^PB=,U:M=UC/\X7C^^.YL[Y2NKLRZGX7/5`*QP^ M^#+TK(O0A%Q.UV*_M3_6032!Y4NG]5Z^]-+[F`=-SN^<-L*2CPLK=?Y`?G92 M[Y]`?.$DUO`VN?\X)\'P+GWO>T]AUAE/-FL8[SFQMTXQ[`6(TW7N&9\D0#2> M[Y>#IZ&)PPNX3Z94!0/KFA*DZ*X(A`!B/1I/18&J8\#]K MTD^/0+9/1[KJJ!($BJ)*$"B**FN,>Q*8/Z\I,"&HN*X2!(JB2A`HBNI8,@./ ME4>5(%`458)`4539B$AB786)=L5UE2!0%%6"0%%4I74^*H\J0:`HJ@3! MN:-:#*L6]_<6F\G;[YG5]X_92`[&CH]1O(11:['T-L#18W;O]L9W5RF,$F/O MZ1G_IM$:_GV,TA36]&YOEI[]%(6V#V][18GB;T-)6/6$!QB%/'R")5BH6:0%"T!.%"DA6$*&C=4BAZB-I(28C:2`H(VDA*B- M4'4.5:["D\MH`PONNP&VK$F_G\TGB^II%DB`'\B8PR!(F7U_MA8YX-'6,EUM M!7[9JQMS`U^LQWK`TI82^W:V%#A@94L)41OYO"FBRPDOIQ.0G@\@V?$W]_6W MP0!%6<$"SPX)YOR$ZUS92IENF83[X'+)NOT3,R/ M<92Z3LIV7+$UBSH\PQH\@UR0")YC])LU^L%/POXX1C],!AT,(OA%J7Y(+F'] M,O,!]Y;E20TAH$G=A$0GBH0P%"J0``)6B$`.`U9 M<4P]@*7'4B7D0*42])]*)7!,826G\H16UM$OZ&^PTN+H]R@W$[Z%1*_<#!<- M`(Y264>QJBB&A!UJ6N4"N&AP@06MKIPF;U#'^`1IH\HB\K"2< M"SHK`,T>F4OLAY"D0"I2#0'@*(%``C%0U/X.*`9%+3#-!D5-,(7`M<%GK!,T M$EP+J0@#X%%2*ZI^PH!K,<[H!@)!%4.2;#!4423%H(HCJU`8JBB20%#%D#02 MJBB28E#%D204JBB20`"/*&%(&@E5%$DQJ.+(*A1XX$Q)*`@$50Q)(C$\,47V MZ+1I-HE*YD]'PS?-GVK;5>M$ZJ!NT`1Q+XIGHZ=LY`BQ8&,I,I3&TX6DT]A][Y&MOK!W<+0]%LW6F[JI_K!23%_,9N M,O((:S%5^F%R7=>Z*)?NGR.P'.^(5LO9H+YU8GXG,_C)[=8,:06!DSNJ,:"O MXS35_R!4J?1[D!K M&U/BSHZT[`6;])TZ!/MP#X[GGS>D+MO@U+&_3=CQ336K@:\Z.$22Z5WJX_G[ M*V_,I6:@(JE4VXC3JG!D\C2CY./;`4];1(V&9>*FAJ$60A=*K54.)X9WQFR\ M`^;Y$F1KP]0%S3FKFSAOMO,][5F\B8):VJEOU8??9H7K-%M37P&@J]I4_4Y2 M`7!=15D7E6:Q%"[LDK8&=D.$QG,\#]6R(&T8BEE%*8!PEX24Q#@6(65+*?&B M@,3IL7TZE@(]!3T>,4&*Z[E2TZY3BC7LAVK*L-J<[Z1<]FB89L^;*EP=H&^F MPM42Y`#(JRE@PFW%T3Z4O3;3*:-D4W@GY73I#8`(3^2^89`JDQL-,GJ50N*= MG"9[>KE5.=OMK&`)@JV6POHH.6W"GS4I5U,U?)X://^U_UOM0GOO().50Z$! MKJYO/!_.D>,R*:YT.YL$CDO.LYOYVF23K+)7B1T>*@M&@5UEE:QC0/)369!3 M766!^HS!AF`MD04'<3K+@F8MEX5[4RI_F([8.`23N\JJX@B!H[+`Y*ZRJC@"0B++!"5=955QA"A069!N M7665<321Y2K?CP1]?W4PCGRNXI8+$5Q45A5'/E>'@KE*955QY',53>Z*JXHC M2"7^,N&#KK*J./(\80KR!+6QBB/O^Y&@[W<9E<]X0S#C,RE5[.`=\1&.,41\ ME$FIHL9G^5`PRS,I5;SX_#8%\SN34D4*Y!&+3/A`W*(R1D/>NZ:@=^?VLF!= M/F&PG1&!`8\T=#8^/,$]PN>_LRU%.)](#,*)#B%)SZ[SHBW@A&@IB*\/V(R* M"+K?KGT[M-,H?M5P&U$IC@\Z[)L2$O?'*"I]Q$LPX%($T)_@:?GP('X-_))Y MB,]AW$+214Q9%WCWX)F"+F*@=(:&SS\N&+N^0SA_*2QD\162/-BT. M0>?]ST]PC+AP(FZQ(G4'^]`B.O^R28D;L101@F-9$2$/7@J/?R@J,2<"80F) MB&!K7REBAU$$9?S-CD.L+5S5WC@?` M44MW96_\]*'\<*97[__,'JP"R91_ZT?O2Y0R$3.]>O\1GU@#M1B6?X!N/B;P M%!3XJVUB;Z;_]WX^GM[=6\;%I#^?7)A#=W0Q'S.=7&3PV6,J`#9L$BB, MZ"7ECX/<_A\``/__`P!02P,$%``&``@````A`/MBI6V4!@``IQL``!,```!X M;"]T:&5M92]T:&5M93$N>&UL[%E/;]LV%+\/V'<@=&]M)[8;!W6*V+&;K4T; MQ&Z''FF9EEA3HD#227T;VN.``<.Z89UC1"SF67"72(6=L#/F-^-"0/E(<8E@HFVE[5_+S*UM4* MWDP7,;5B;6%=W_S2=>F"\73-\!3!*&=:Z]=;5W9R^@;`U#*NU^MU>[66\/7.=K?;=/`&9/'-)7S_2JM9=_$&%#(:3Y?0VJ']?DH] MATPXVRV%;P!\HYK"%RB(ACRZ-(L)C]6J6(OP?2[Z`-!`AA6-D9HG9()]B.(N MCD:"8LT`;Q)__/QY M.1`R:"'1BR^?_/;LR8NO/OW]N\*1R5D1SBB!4-?A.KL$S( MP5SX15Q/*O!T0!A'O3&1LFS-;0'Z%IQ^`T.]*G7['IM'+E(H.BVC>1-S7D3N M\&DWQ%%2AAW0."QB/Y!3"%&,]KDJ@^]Q-T/T._@!QRO=?9<2Q]VG%X([-'!$ M6@2(GIF)$E]>)]R)W\&<33`Q509*NE.I(QK_7=EF%.JVY?"N;+>];=C$RI)G M]T2Q7H7[#Y;H'3R+]PEDQ?(6]:Y"OZO0WEM?H5?E\L77Y44IABJM&Q+;:YO. M.UK9>$\H8P,U9^2F-+VWA`UHW(=!O-29#`P<7""P68,$5Q]1 M%0Y"G$#?7O,TD4"FI`.)$B[AO&B&2VEK//3^RIXV&_H<8BN'Q&J/C^WPNA[. MCALY&2-58,ZT&:-U3>"LS-:OI$1!M]=A5M-"G9E;S8AFBJ+#+5=9F]B(K5"MQ:FNP;<#N+DXKLZBO89=Y[$R]E$;SP$E`[F8XL M+B8GB]%1VVLUUAH>\G'2]B9P5(;'*`&O2]U,8A;`?9.OA`W[4Y/99/G"FZU, M,3<):G#[8>V^I+!3!Q(AU0Z6H0T-,Y6&`(LU)RO_6@/,>E$*E%2CLTFQO@'! M\*])`79T74LF$^*KHK,+(]IV]C4MI7RFB!B$XR,T8C-Q@,'].E1!GS&5<.-A M*H)^@>LY;6TSY1;G-.F*EV(&9\F_W4`BA;JI)6@8,[F3\N>]I!HT"W>04 M\\VI9/G>:W/@G^Y\;#*#4FX=-@U-9O]2!=(.SB"QLD.VF#2I*QIT]9)6RW;K"^XT\WY MGC"VENPL_CZGL?/FS&7GY.)%&CNUL&-K.[;2U.#9DRD*0Y/L(&,<8[Z4%3]F M\=%]VN>S?=VP# M98&VO)"8G#F7F4EF3WO9HBW71J@NQTD48\0[IDK1U3G^\7WY,,'(6-J5M%4= MS_$;-_BI^/AAME-Z;1K.+0*&SN2XL;:?$F)8PR4UD>IY!T\JI26U<-0U,;WF MM/1%LB6#.!X1246'`\-4W\.AJDHPOE!L(WEG`XGF+;7@WS2B-TZADU2O M-_T#4[('BI5HA7WSI!A)-GVI.Z7IJH7<^R2E[,CM#U?T4C"MC*IL!'0D&+W. M_$@>"3`5LU)``M=VI'F5X^=D.L\P*6:^/S\%WYFS>V0:M?ND1?E%=!R:#6-R M`U@IM7;0E]+]!<7DJGKI!_"J4W`[[6' MDS^\WM_\&I-FV6WMX7MMEW_XW_RN*,>@_K[!]/:WY5ZIKT1G4 M\@KZ&$=C*-?AY0H'JWH_Z96R\%+XVP:^@1Q6,(X`7"EECP?W^IZ^JL5O```` M__\#`%!+`P04``8`"````"$`=_\A(20"``"N!```&0```'AL+W=OQ^_YD(O'H^S1@6LCU%#B)(HQX@-3M1C: M$G__MKE;8F0L'6K:JX&7^(4;_%B]?U=,2N],Q[E%0!A,B3MKQYP0PSHNJ8G4 MR`?XTR@MJ86E;HD9-:>U#Y(]2>-X0205`PZ$7+^&H9I&,+Y6;"_Y8`-$\YY: M\&\Z,9HS3;+7X"35N_UXQY0<`;$5O;`O'HJ19/ES.RA-MSWD?4SFE)W9?G&# MEX)I951C(\"18/0VYP?R0(!4%;6`#%S9D>9-B9^2?#7#I"I\?7X(/IFK=V0Z M-7W0HOXD!@[%AC:Y!FR5VCGI<^T^03"YB=[X!GS1J.8-W??VJYH^QQY>!WAL%!T"Q] MA;+87W\Y"",7.C+2EG^FNA6#03UO@!M']S`?.@Q<6%@U^LIOE85!\:\=G`L< MVA)'(&Z4LN>%&^G+25/]`@``__\#`%!+`P04``8`"````"$`4#8*`;4#``!* M#0``&0```'AL+W=O/Z9L3W, M/KU4I?5,N*"LGMN^X]D6J7-6T'H[MW__>KR;VI:065UD):O)W'XEPOZT^/AA M=F#\2>P(D198J,7#'J>_;[F*F`O2'DH,X^VV)'3M\YK3X1FL"T88\ M80;6C#TA^K7`(7C9O7C[467@![<*LLGVI?S)#E\(W>XDI'L,BE!87+PF1.00 M43#C!&.TE+,2'("K55$L#8A(]J*^#[20N[D]FCCCR!OY@%MK(N0C19.VE>^% M9-5?#2E%K9'@:"0$[X_/QTX8C*/I>ZS`?,H5^#Y9`/L M8$')@<.BR;"`_?B_X8`X(/N`\-R.;`N4"LCA\R(GE]XD M!B:1W"32*\1;"`P]H_?H0=C0HP=,/9U(KKHO)=V!]&S`\`T*>7BL$89E]A.#(+8ZF9J5H[P=A3 M'Q-9::0G!,E-(NTC#(&3]PA$N"LP-+U?:J;'^]5-(M'$.%!1BAP=I?8:I7>= MJDG[3!IR8>L:GD^$NW([U;C43)]<34R4ENFUA"=VIY=7KV5N^=Z"0WB;2/,)3=OT<9PEUE44>99OHRIPF=.3^ZFKK; M2-HWCZ'0AYYF>/(4W=7X=H+HP^P(]8D\(EIE,+JJ<@"3FHP_F6#`VI";0O'D M/JM2;,5"V+&NMV)M[Z'/>W-[O6@^--0K6"-Z"_9]+SSW4X4M@3X4Z^>X2P<> M+MM6BD*P547D^D1:K6Y%=;-5$;XE*U*6PLK9'MM,7%+M:-L"/XRP$^F,KX(8 MCNC+\22(X:2^'$^#&`YL&'=;0]#)-MF6?,_XEM;"*LD&7/"<"*+.=2^L;R1K M5$NX9A)Z6/5S!_]9"'1&G@/PAC%YNL$)VG]!BW\```#__P,`4$L#!!0`!@`( M````(0"NL_C,L0(``/0&```9````>&PO=V]R:W-H965TC**1J0KI5VJ1IVL>S`P:L8HQLIVG__:YQ8(%T M;;67!-OG'NZYY_JRNGGB-7JD4C'1)-AW/(QHDXF<-66"?_ZXNUIBI#1IA^\B.2]=S=XH*>LTP*)0KM`)UK M$[W4?.U>N\"T7N4,%)BR(TF+!-_Z\2["[GK5U><7HT=U]HQ4)8Z?),N_L(9" ML<$F8\!>B`<#O<_-%@2[%]%WG0'?),II00ZU_BZ.GRDK*PUNST"0T17GSRE5 M&104:)Q@9I@R44,"\(LX,YT!!2%/W?^1Y;I*<#AW9@LO]`&.]E3I.V8H,$` MADY+2OJ5R)(U"M6T`$K/6<#-EG9LV846;=?G>Z%AW'2/%7Q=*-PYSP%P(83N M%^9F#=^K]1\```#__P,`4$L#!!0`!@`(````(0`KZF4*E`,``$L,```8```` M>&PO=V]R:W-H965T&ULE)=1C]HX$,??3[KO$/F]!(<`"R)4 M2U9[5^E.JGK7]MDD!JQ-XIQMEMUO?S,QA-B!-GV!A/S]GY_''F=8?7PKB^"5 M*RUDE1`Z&I.`5YG,1;5/R-=_GS\\D$`;5N6LD!5/R#O7Y./Z]]]6)ZE>](%S M$X!#I1-R,*9>AJ'.#KQD>B1K7L&3G50E,W"K]J&N%6=Y,Z@LPF@\GH4E$Q6Q M#DLUQ$/N=B+C3S([EKPRUD3Q@AG@UP=1ZXM;F0VQ*YEZ.=8?,EG68+$5A3#O MC2D)RFSY:5])Q;8%S/N-QBR[>#Z3&E,PO6J2=`WP4^Z$Y MK!P)<$6V4K[@T$_PTQB"Z$:`0?1_ES"/$48)VS#=ZTO(YV;9/JL@YSMV+,P7 M>?J3B_W!0*0II`&SLS-THG<'!(R MF8VF\_&$@CS8!5J2(#MJ(\OO5D3/5M8D.IO`]\D^C^!RX.#)>3!\GP=3 M.GJ83N/9P_RG"*&=3I.I)V;8>J7D*8!]"L"Z9KCKZ1*<;Z<#\H#:1Q0G9`X+ MEA`-:_*Z'J_"5\AZ=E9LK`(^6P5U%>E%@0L'#"T()&(X"(H1!-<)R3;VAV[< MR(O;5TQ:A0,"61@.@F+8"IWYQJVK);.*N*.8NHKT1PJ'#$R&DZ$X(3#K=B5F M;MR-573)YJXB[2NN[`X9[+_A9"AVR1[V]76LEF)P^852MJ77$V<,J#P+AN>N$;M MT7D5N#EK'#RO6M(;FGM\>/@.7EAJC^KN$4*][;XY:[I\D5S![O#YE4'[AW_DE\8-S3T^F&>7#YN< M">S)G[S5<92[#Z-K`%LET,^AIIM'3X(M'TIFS=$XCQ;S.(ZOV\76B6W5;`-2 M6[RV@?0E=5LS_]F:B\J'11\!T/'(^R!E.WK M[(V1==/>;*6!?JRY/$#3SJ%=&(]`O)/27&ZP&6G_!JS_!P``__\#`%!+`P04 M``8`"````"$`ABB$S68%``")&@``&0```'AL+W=O2-5G97%3M5GLN*T4__Y._BV M4I6Z28I#U+/R M2@KXS[&L\J2!K]5)JZ\520[M0_E%,^;SA98G6:$RA4WUB$9Y/&8I\OV6EOD5))ZS2]9\MJ*JDJ>;^%245?)\ M@79_Z%:2]MKMEXE\GJ5569?'9@9R&JOHM,UK;:V!TGY[R*`%U':E(L>=^J1O M8GVA:OMM:]"_&7FO1Y^5^ER^AU5V^)$5!-R&?J(]\%R6+Q2-#S0$#VN3IX.V M!_ZLE`,Y)J^7YJ_R/2+9Z=Q`=]O0(MJPS>'3(W4*CH+,S+"I4EI>H`+P6\DS MFAK@2/+1_GW/#LUYIYJ+F;VJ`I5NV[,<1'1SIEOSQ1>:`V.CU5C?-"`D]T)C MOK;=Y"5-LM]6Y;L"N0_.U=>$CB1]`X)]_S`WAQ[[68=!3U&1)ZJR4Z%1T!X*F`97UQ(`O!@(68-U-'PE[XE83H92H)_I2 MXI&&!JX,UD"ZC*VYG[*]`Q2F#O2J3A^X5<00FLL(*'TP32`\E/!1(I@2IK7D M:Q).&:$F$4K$4V*Y'HKA?(6!-/:5IIP)$XO<7_H0YZ\8<%E@;*=I64,-6$+= M8VR>\>\Q"YX)'F#"!YCH'G-SK:US+&\[7 MP&$,%#L,12$K7)3P4,)'B0`E0I2(4"*6$9S?"]YO>3Y1>*?"-#!X:-K"W.LP M1N8S2G@HX:-$P(@%6ZGL.?WA,R)$-:*QAKZR%Q.->$S`OI/^#*5P/L/"*>8U M/B/2AT2_A6G;88S,;Y3P4,)G1.?FTC1-75A@`E0C1(D()6(9P?E-3Q?"I@?W MFSXD^BWN<1C3YY6U-(3)W&6`I$,\E/#'A1CWW$8E0I2(4"*6$9S;L*TS#INHQXUN M:=%I8=5S.FALM6D+FR'W#B3H>#CBXTB`(R&.1#@22Q'>T0J?&L*`GBXRH!CH0X$N%(+$5X MYZ%)O^`\?4J8Y!?"$N3H#%JWNV%#GYG"Y.!V@,14#T=\'`EP),21"$=B*<+[ M3@]+0L;C9TYZQ3GQ74AGIX-6K>^V82RG1PBW8Z36RXYS[0#W<94`1T(=/^&=MJ+H0%S[T#"8B'(SZ.!#@2XDB$(_2F M7VSVK47,>W:3SZZ(FO+87 MV<]E`Z\`VH]G>.5#X#YX/@/X6)9-_P4*UH:72/O_`0``__\#`%!+`P04``8` M"````"$`>$2 M^SB`37#P3:>)'TY>SO$Y+XF?/_RHSL[WHFG+^K)UR*2U_OR-]_:4U%T#D2XM%OWU'77C>>U^:FH MLG957XL+K!SJILHZ>-D7%2=/>K[D5=EY<7%")MF28SZ<"CSXE.= MOU7%I<,@37'..M#?GLIK>XM6Y4O"55GS[>WZE-?5%4*\EN>R^RF"NDZ5;[X< M+W63O9[AOG^0(,MOL<6+2?BJS)NZK0_="L)Y*'1ZSVMO[4&DE^=]"7?`T^XT MQ6'K?B2;-(A<[^59).C?LGAO1_]WVE/]_EM3[O\H+P5D&^K$*_!:U]\X^F7/ MWX*+OB[3Z7/*3KY&]M5U?_ M(41D*`Q"91#X*X,0NJ))2,+((@J34>!O'^61!`]O1V3G4]9E+\]-_>[`E@/! M[37C&YAL("!/2S";%L@'O^8COTA<"G0+M?S^PBA[]KY#_G/)[)")7:=GJ$JD M=XBD1SS0UXN$?.DB&>R`^[6[B>07J2)IW(<7][%#)!8UXC>6CMY0!$!FQ@+, M'\SAK0NA^CLGH:]],C+!B`E5(C41BC8(LEP;AV'KCCZ7T4#]Y!TR)FTF0M$& M.VFY-@ZK>6-4R\H.F43LN9"M=>WI>#WP`S+L.4579*.+P[JN2,L9,M&LKO&Z M01>TR_)\<5C7I>]P9$RU-!%*SK@3CB:%N03W#QS"4)&?29$U0=A+/1Q6M]UVG[?$82PMC$)UUJ"4P4@?N!'0PA5 MG)4G\$>TB;AA2\OB(F1,W@TQM825*Y`EMB`A0]K&QL#3%L]-$BMK('>\@>G/ M(!(RIFVQ.Q`K>Q#T(W^0D%'?8H<@5A8AZ(<],3:!)*#AI"?&0$RBT<146H): MN82@=6UZ2T@H$`\DD5;Y5%DE,SN.6CF$H#55;)CO\GD;;015/6FKJ0QQ6YV9 M'Y2/Z<7#5]":K%$9I"R<_-BE2<"(ELU41KFU<31Z[%0+R4?TH+)*4F1-7'I_AR?9Q^U*04(5.3&A%5GY4W\*_,$V\8=HW,'T)8 M.AHE+)AL.X6`[^*S#6'E#_2>/V@;:R]:@ MY60G(=F*$[-7ET,V?.M0A5EY`L59KK3#M%41ZLL9!EK#I#*,)$+B)\.64-59 M.0+%6:ZH8\/DE)L-(6,SF!!%'_^%8WFS"OI1LTK(I,^(J/JL_('=^P8Q5`;S M)R&L7130M9;@5`'@<6E,J.+X2%\\Z1BG=9?0>U5"MUY5OV"DRNJPZA&ZN$I+&2B>.KZV$RXZR!E3<(^E&S2NA6SY@D^O!5"1JM MU\/=*7D+-&?@APK<5\R_,8FK-)6C885=(:'[6QZ[PHBH.JU,(D"3,'>MA(SZ M,,Y]1-5G91A$V43BY40 M'H@$21*/'%36$\/U M.[+947YHIKV?PAFN>-_K%^`(]9H=BZ]9&ULK%9=;YLP%'V?M/]@^;U\)J1!2:J4JMND39JF?3P[QH!5C)'M-.V_WS5? M"Y!5W=27&"[G'H[/O;YD<_,D2O3(E.:RVF+?\3!B%94IK_(M_O']_NH:(VU( ME9)25FR+GYG&-[OW[S8GJ1YTP9A!P%#I+2Z,J6/7U;1@@FA'UJR")YE4@ABX M5;FK:\5(VB2)T@T\+W(%X15N&6+U&@Z999RR.TF/@E6F)5&L)`;TZX+7NF<3 M]#5T@JB'8WU%I:B!XL!+;IX;4HP$C3_EE53D4,*^G_P%H3UW6&@VDO8D-U7 MG#[?,4W!4*!Q@J5EHK($`?"+!+>=`8:0IV8]\=04);JN] ML>*.&++;*'E"T%X@3]?$-JL?`UGO08-&,.<--%H6J]$6THJ^[0-GHB>">L14$!CU M!H(LB^V9%UWK0(LST'*BQ_8TS:)W\)4]R_%@SBYA-^'\;XYM5.>,$["2SS+.&G& M]10?Q4ET";_JOC+ND`!3OB8Y^T)4SBN-2I;!%KW&?M5^)]H;(VOP%H:]-##@ MF\L"/N<,IHOG@,&9E*:_L48.?Q!VOP$``/__`P!02P,$%``&``@````A`&0V MRX!;#@``#4P``!D```!X;"]W;W)K&ULK)Q;4^-( M$H7?-V+_`\'[`)(O@*.;B<:VK/LM9G>?W<8TC@9,V.[NF7^_65*E4U7'+LS$ MO#3-IU-'J;IDE4I(GW[_\^7Y[.=RLUVM7S^?>Q=7YV?+U\7Z8?7Z[?/Y?_X( M?KLY/]ONYJ\/\^?UZ_+S^5_+[?GO=__^UZ=?Z\WW[=-RN3LCA]?MY_.GW>YM M='FY73PM7^;;B_7;\I6./*XW+_,=_;KY=KE]VRSG#TVAE^=+_^IJ>/DR7[V> MMPZCS2D>Z\?'U6(Y62]^O"Q?=ZW)9OD\WU'\VZ?5VY;=7A:GV+W,-]]_O/VV M6+^\D<77U?-J]U=C>G[VLAA%WU[7F_G79[KN/[W^?,'>S2]@_[):;-;;]>/N M@NPNVT#QFF\O;R_)Z>[3PXJN0%7[V6;Y^/G\BS>J>S?GEW>?F@KZ[VKY:]OY M_]GV:?UKMED]I*O7)=4VM9-J@:_K]7X7'U[VE%S#^B*U(6-'OZ:++<+JE&RN?`'RFFQ?J8`Z-^SEY7J&E0C\S^; MG[]6#[NGS^=^_\+K7PU)??9UN=T%*^5X?K;XL=VM7_[7:CSMU'KXVJ-'P;?' M>\.+P?55SU,FCH)]79!^'BAXXMGI%,T5T$^^@NN+F\&@/[RY=I]^J$O26-`E M;YWATM'F3/23PZ5+=UR?1\W9UB[I3CJ%1W78EI#*]"@^UTFX%CVZGM-."440QO7.Y5UV?:OIKM.YKOYW:?-^M<9Y0#J0MNWN?=W[?_W3YDX;(0FON4>.9BC$KU'A0MA,; M3&T0V&!F@]`&D0UB&R0V2&V0V2"W06&#T@:5#>H.N*3FV;<1]=)_HHV4C6HC MKMU[!IU&LQJ$%5QD8H.I#0(;S&P0VB"R06R#Q`:I#3(;Y#8H;%#:H+)!W0%& M@U`2^"<:1-G0N*,?CE&C191-]J*!U4I[R;Z9@$R!!$!F0$(@$9`82`(D!9(! MR8$40$H@%9"Z2XQ6HRHT6NWP7,P93:F;QN%*O=?DJDEOOUU;C:"/TAC>MU,W M!1J1T/QG1**2KC^XV$^+)Z==960&J0G]Z(31LV+=B_C:)D"F0`(@,R`AD`A( M#"0!D@+)@.1`"B`ED`I(W25&,]'$;323N\,HM=D6+1DT*\5F/AL#F0"9`@F` MS("$0"(@,9`$2`HD`Y(#*8"40"H@=9<8%4_KB`]4O%*;%:^)OY_JQD`F76*< MG!9!QLF;P3E4R_0CJW?.&*J@&4=+^K3<[`S&OC48=;'F9J1=]6A"LT^GF"1] M(UI:]$*TGG]S0KBJI!EN2ZQPAU:XNE@G7$W,<"4]&N&JI;<1KWM,-7(S2(VL M*&^L*+E@)TQ&9IRW^X)FG&HMUET7OQ-GNW2CJ9PSZKW7HKZ@,:()HBFB`-$, M48@H0A0C2A"EB#)$.:("48FH0E0;R&P+M0SKML7?GBX]Y61U)XUH=,M@&USM M>T6;M[E@>ZO>WIKL"W*33U$5()HA"A%%B&)$":(4488H1U0@*A%5B&H#F2VG MUF)VRWF#"[4!\,Z`TJLX&3WW:IU,C=?O9'5$$T131`&B&:(0480H1I0@2A%E MB')$!:(2486H-I#9+!];"7NX%&;4;0NM$C1!U111@&B&*$04(8H1)8A21!FB M'%&!J$14(:H-9+:%6GT>&2*[I]7B^_V:\A+-)0?&2X_N1)K\]$5M+=J)32-: MY^P3F]>3:5DG-JVB)4='9Y0^LW9NIJ#@C!AR73,,S0>+E]:PS MAN(E*G]@[2A%HN(SQF+/*!$D7G#&5+Q$Y0^L.Z=,5&R?BSVC0I!XP1E+\1*5 M[\LZKVFA2E1L7XL](;,WJ25UMS<=Z#6TD-UWFW8%3IF"O>_5;J7J2;2HZS2U MO6;5*K^[LH4+G(B*[:>(`D0S01($V(>B8OL(48PH$>2P3T7%]AFB'%$AR&%? MBHKM*T2U@KN+9!.!QIUUSF`IAZ@`-$,48@H0A0C2A"E MB#)$.:("48FH0E0;R&P+=5OG7S7;6;<\6!&Q#">'XR6:LP-!#6U4"=^;^[0JOY^:IIRP>XJQ+.[1\`J6HY*)^I< MF0`JZNAZKG$&$HN)*CSB(=KC[UU?T,-W0D9$.A]9=TUBK5,C'\]6$59((IHRR2-B8^D0R6WTF&+_-M]"AO[>^3L9ZVJ)\^LIKI@!P7BQ54P$^2P#]$K M0A2+%]LG@ASV*7IEB'+Q8OM"D,.^1*\*42U>9&^VJV,[]`.9!K=&_1:I3K;/ M(;"3,-8JM2CC1:L,KQL5_V9@K5!K-FIJQNRAE)^,S&//A7^LWRC3'-R-[.PK^+%](:V_WUJ%Z'&XW<8NZ#VBTJH,FB*:(`D0S1"&B"%&,*$&4(LH0 MY8@*1"6B"E%M(',84NHQFN6=ME!R:[AI)$]CQCZ@":(IH@#1#%&(*$(4(TH0 MI8@R1#FB`E&)J$)4&\AL"[79V=T6L5/B20]H:)L-FD@C^B$3+3R@X8+.J6&B M5=8#&FOG92HJ3C.!V#.:">K&942%(O.",I7B)"I95E:C8OA9[0F9OHG8T>M,[(UO)K9&M4?>NTA]8 MBY^QVJF@@N_=5>Y5'/I4"C(*$,T$22P3T7%]AFB'%$A MR&%?BHKM*T2U@;^VY@+ M&DMT6-(>5-DW&%.MHERB=IH]?WAK;1T%[$,3>V<&L3+UC%7.F$)6&5YV3!'' M1'E#SFC?],0'O>Q:2%CEC"MEE3.N[*2X\H->=EP%JYQQE0=5=GU5'-?1-JS9 MQ[B^3DQF-[:W*MTII8=[DHPHC70:T%HHC+7JG=F#5;(;-V7DW(T+6$7W?Q)$ MYYK;/4E6.7?C0E%QEHX8M;MQU][0M[?)6>$,(&&5,X"455(+&2-G+>2L<@91 ML,H91"DJKH6*T=%:J%EQ+`"SZ]%P^,!LUE-R*X.VR,B@^(B&"SI'WX15LKCMX91,A>,CU''$0[WGM7/CVC,:>(F$L=&_#M(QI6 M.2-(6275D'$$SFK(I:"C&@I6.8,H125]KZT_/74=JH::2QVK!K/S_2,;ISW< M.&5DI$-X1*-5[Z5#O0DKB6#*!9V)(L7&HTZ&V=R:"D+UD_SYBU"8"[ZKO MWUA_1Q>SQ!E!PBIG!"FKI!HR1LYJR%GE#*)@E3.(4E32)W7]':^&FDL=B\#L MDZ3Z2$)49&^V*_52HUW_UGX/;5=#<[?HG8=4JUQW$#K,8UE8IQZM"'/8A>D6( M8O'B(!)!#OL4O3)$N7BQ?2'(85^B5X6H%B_(98Z]ZW=N'7&_NM>BSK.<,:() MHBFB`-$,48@H0A0C2A"EB#)$.:("48FH0E0;R!R&E!M@&/9.>6>3/ED#(T\C MN0L9LZJ[1O+MI\"3PRKYD[DVY/8+-^TG0UZ6FV_+\?+Y>7NV6/]07Z^ANZV[ M3WOIJ/VMCC#4X:AN[JIL'T]%=#`DCV*BO\P^<-D>G;S= MU[7D=F?Q"&W04NT?.D(O"HW4:T!8AE[H&:G7=?`(O7@S4J_5X!%Z06:D M7G_!(V/O>J1>.<`C]-;!2+U`@$?H'8*1>AT`C]`;`=0^S9'+?0/1QYC>YM^6 MV7SS;?6Z/7M>/E)WOVK^*'#3?LZI_66G_R#BZWI'WV&B29$^H4.?W5K2UVNN MU`<='M?K'?]"I[[6Y-A$` M`-57```9````>&PO=V]R:W-H965TU>#R8O7ZL'E-U^OGS:[=ZFU]?; MAZ?5R_WV:O.V>J4GWS;O+_<[^N?[]^OMV_OJ_G%O]/)\[0\&-]NN=?*^>K[?4?S;I_7;EKV]/'S$W7UET_[!OK/>O5S MV_O_B^W3YN?B??VX7+^NJ+6IGU0/?-UL?E?2Y%$A,KX&ZVC?`]7[Q>/JV_V/ MYUVS^1FOUM^?=M3=(ZJ1JMCT\:_Y:OM`+4INKOR1\O2P>:8`Z+\7+VLU-*A% M[O_/E\&WM7H=A!X)+_XNMKNHK5R>7GQ\&.[V[S\MQ5YVE7KQ-=. MZ).=W)SM)-!.Z/.`$T?I0VU(G]KP]LH?C[S1C:J"PY">[NM.G]KPA,&--J#/ MKJ3Q:#2\&=^Z2[K5AO1IZO:A&&F>[F.DSZ[(#QE.M"%]#0$ MVQ%A>O.#[>EQ%ZK_.:]0[D.OWXD?:EHUV-MX33<&-Q\;`!YWJ/J?\YK7XRY5 M_W->7;E+O7Z?NNIZW<[9?0J8W^_NOWQZW_R\H+Q*LW+[=J^RM#=5WGCRMV.^ M2P?'L@&E`>7E5^7F\R75@R;ZEE+8'U]\;_SI^@]*.P]:.0:_31(>P@DWF$H021!(L)(@E2"1()<@D6$J02U!(4$I025!+T/2`U2&4 MF_Z.#E%N:-[1AV/6:!$EM4XT$KW42;IN`A("B8`L@,1`$B`ID`S($D@.I`!2 M`JF`U$":/K%ZC9K0ZK7#^QO.:$J][QQNU#M-!OOT]LN-Z`3]E.9PUT_]%&A% M0LN,%8E*NL%8[:[T7N/#>5=YLJ/4A#YZ<4Q$L)V(*S<'$@*)@"R`Q$`2("F0 M#,@22`ZD`%("J8#40)H^L?J)EG2KG]PC1JGMOFC),.A2[@S('$@()`*R`!(# M28"D0#(@2R`YD`)(":0"4@-I^L1J>-I(G-'P2FTWO";4L682^`,Q"3I1-PF` MA$`B(`L@,9`$2`HD`[($D@,I@)1`*B`UD*9/K+Z@3:'5%^T.\4H=5]SS01G: MW=*2H6_F`Y`YD!!(!&0!)`:2`$F!9$"60'(@!9`22`6D!M+TB=4'=`*S^L#= M\$IM-[PFO88',@<2`HF`+(#$0!(@*9`,R!)(#J0`4@*I@-1`FCZQ&EX=9<]H M^;W<;GJ-`LIU72[R@EN1BUA%L["G$B>HN58-::_1J7Q?G*)"H^+$%AGWC!:( M8F/8=^_;H29&Q;Y2])499'QY@:C0TO@R*M\?VB7F1L4E%L8]HQ)190S[[L7V MN38J]M58ONP!H0YI>&#>I\/=T_KA][L-=0V)#DS1@':.^KC<'O5HZ\]%WGDM MHG'":,;('-GF&@W;>SAU1@X116BX0!0;PW[K!';C)T;%<:7H*T.T-(8.][E1 ML?L"?96(*C2L$366H=V1ZG#7[\@#'48;\J['VK.@U6,:4?+HS49Y+O!:E4^) MI%/!1)@;%3=#B"A"M$`4(TH0I8@R@QRA+HV*0\T1%8A*1!6B&E%C(;L3U6'O MC$[49\/^M&N13[.OZQ[?A_2L#:DO.]6!3M0J*]6/(#WK$FFQ-[Y&(LM&ZE9` M+>*6+YD_%ZPR"WML4-^]""+1*O]V?YCU)C?>2.3FE!TY(\A8Y6R9Y4&5;)G< M#NIV,A"-4K`;9T@EJTRC5`8Y&J6VR_<'=-,MS@P-.SH6@3TZU9W`&:-37R'T M1V>+@O[H]`:BIV;JQIO&RJD4TZEXWH;:,%`+TQ]?AF/1WA$[)DLS5'$0@N.8 M#?=?/.V7O(116Y8WO!%S+&6!L[",5&I49 M3;I%=?XBNJ\Y(RGHZYU^4FB12`HB*\_4=Y/M='>TS)Q5U)=FH9#K>ZA5_HF= MCR[1\B5G[H)+-#,G-L@11,)!Z)E+:[R,,V5'S@@R5IW('8?:3Y:8VT&-AV,Q MP0LNS!E2R2K3*)5!CD:I[?*]X82^Y;?/@0T[.A:!/3K53=89H[.]^*+-%4^L M._5=-(V[4SN?5G5JY].IV'W([ML5>G0KUL)(/_?[2QIL^!>L,KN!&%'"2.]\ M_$!LLU(6.`O+6'5BYP-US;4A[WP&XBQ0L&-G\26K3%TK1#4CO?/Q/5%8PX)C MA=G#2-W+G3&,]#5>?QBU2"0YT=LS3QLZI_+6E47%,N4:BRF)(%VQH!2&K M7++*U*]"5&NDJSP:C<;BCJ5A(ZNT7I6M0:62Q1F#:B^WMS^,J,.ZU0YVH#.M M4A^="E+(W*BXA4-$$:(%HAA1@BA%E!GD"'5I5!QJCJA`5"*J$-6(&@O9G:AN M2S^>&=3\%WM8C41FD-L?-G1.DSFKK/$G%_F02Z0,;0:$/#A$!WWUQO+^-+U@ ME9DYL4%]]R(7)1Q$N_T)QK32B^OVE!U9M9$19*QRMLSRH$JV3&X'Y=T&8W&< M*]B/,Z:25:95*H,N*%&>D\PF8C\';')L65:C\*N>'8(OB_W/UJE[ME=PTB[-[,KU(9B,R`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`E&,*$&4:M2+/C/($?W2^.JI)B([YD;%T1>(2D05 MHAI1HU$;O=VOZAJT/\=ZJ>_C/UY5VS*1!C7J-=@,T5PC^O%JOW7$>AD:%;=. MA&B!*$:4($HUZH6:(5H:0T>HN5%QJ`6B$E&%J$;4:'2H(^G@\3=TI/(BYJU& MM(DPFQ7XM7J@5=9-=F^]W=\.SK5J>+-?N/V!)VXN0B/@YHN,9T8+1+$QW/^E M\<`3UY>)$;";%-UD!O4K*S872^-+%R:JD1L!%U88SXQ*1)4Q/%R-V@C836.Y ML2>WNG:2D]L?7=%L( M%8#QRI M^[Y^LCLQCO3U8.^T$&C43W'R:["9%IW*<*TK4G'3AMI0S8UN`/J!N&R,V#V- MEDZ%5P.L,NYC1(DI<7],%M_!I&QA%267[(Q5_EFYKX\C=D M!1M:0<"U`*M,?2M$]>$212)HV/!8B?:@HJ%G#:K_;WNLO(BZ>`M%O#1L=*\T>8NIV M[HR\I2_S^GFK171XYP$PHP."&CGJ/'^\>^=:1:=#-@P11<87JQ:(8C1,$*5H MF!GD"'6)OG)$A?'%H9:(*C2L$366H=UCCNO",\[,>'48:-3OM8D8RC,M4KM^ M5]>VKNQE2NXF0^V+OB]6*\1H$,B_;HI8865+S!-M:103MWO,AM:Z(0-(6-4& M$*@([)F;LL(90*95[D99LB]G3#FK>(,[HJ^_[*`*ECB#*DU0W"H5&SHCJ%G5 M1D"_1K\5I]F&%<<"L,5N_?5[/5\_/VXF'S0[V%D4;#ET\=;E\1>3>:-OO6E?QF MVNS_H%SRVVFSOYJ5?#QMQJJ7)/?I`=W=XQ.Z;:2W4^[?Y2ALZ/YGJJYXT(;N M;Z;JB@:?T&7+5-VGX!.Z+)FJ^Q!\0J_'_/40OZ/79AZ*Z\ZGJASR$TQ_I<[` M`NX"JN$!3J\7F*J_.4>+AIZH/SW')W?47'<'FXONQZ?JTA1MZ$Z_3DD`U=84_552=ZHYOLJ;KQQ"=T>TU-?*@\'P"=W]$2]5@&?S.B) M>KL"/J%7;$S5&Q7P";U#8ZI>K(!/Z%4:4_5^!7Q";]28JO=E''I"/=?:7'>= M2B]5?;O_OLKOW[^O7[<7SZMO--T'^U=+O+>O96W_L=,9_.MF1Z]3W2?S)WI] M[HK>!C%0UWW?-IL=_X.*ONY>R/OE?P(```#__P,`4$L#!!0`!@`(````(0!S MTS/A``L``+0T```9````>&PO=V]R:W-H965TSOOL>->V;KKM5GK<98_[X_-=^S]_N7^, MVZWS97M\W+YFQ_2N_2L]M_^\__>_;M^ST[?S2YI>6J1P/-^U7RZ7-Z?3.>]> MTL/V?).]I4>Z\I2=#ML+_7MZ[IS?3NGV,2]T>.W8W>ZP<]CNC^U"P3E]1B-[ M>MKOTEFV^WY(CY="Y)2^;B_D__EE_W9FMG;][<_=MGAC22^[E_W MEU^Y:+MUV#G>\S$[;;^^4KM_6OWMCK7S?T#^L-^=LG/V=+DAN4[A*+9YTIET M2.G^]G%/+1#=WCJE3W?M+Y:3V/UVY_XV[Z#_[M/W<^5[Z_R2O2].^\=P?TRI MMRE.(@)?L^R;,/4>!:+"'2CMYA&(3JW']&G[_?629._+=/_\MY1CY+,C3T02KOLE1R@OZW#7@P-ZI'MS_SS??]X>:%OHYO!J-NSR+SU M-3U?W+V0;+=VW\^7[/`_:22E"A%;BM"G%.D-KQ;I21'Z9)'!C=7O#H4C#97W M93GZE.7L[LW(ZDYZH^:"=#5O.GW*@I9],QX,^L/Q!R6'LN2H+-G_C*R('U>Z:E%`ZJ(+T50EOV4KQ;'5'RYSEN+(RF^7.LO1U.,X:O\Y9A8 M].5*?RF,11^I>'YV)%@<4_'E4]5VB@F8S^?9]K*]OSUE[RU*DA2@\]M6I%S+ M$6H\DXNA7\[MWTUMFM-"Y8N0N6M32VC6GBD?_;BWNZ/;S@_*(3MI\X`VEFXQ M90N1,(3LS`1S$[@F6)A@:0+/!+X)`A.$)EB98&V"C0DB$\0F2"J@0^$I8T1S MX9^(D9`1,>+>?6!0"9H1$+;@(C,3S$W@FF!A@J4)/!/X)@A,$)I@98*U"38F MB$P0FR"I`"T@E&'^B8`(&9IW]-$P:Z019:C2:&!$J30IPP1D#L0%L@"R!.(! M\8$$0$(@*R!K(!L@$9`82%(E6M2H"[6HU6]6.*,)ZSPXW*D/DG3S]/:'&01Y ME>9P&:=J"M0\H57F"D^$M>Z))/11J6MLC(K2B!LP`S('X@)9`%D"\8#X0`(@ M(9`5D#60#9`(2`PDJ1(M%K1P7Q$+8:W'0A+2K\1B8L2B-"IC`60.Q`6R`+($ MX@'Q@01`0B`K(&L@&R`1D!A(4B5:+&C_H,6BV(S,E MJ70\D!F0.1`7R`+($H@'Q`<2``F!K("L@6R`1$!B($F5:!U/MUE7=+RPUCN^ M(#VUOYN61*4FJV`]D`B8#$0)*"%%YK011WOEH4*RGL\K+??7O(J)MI MDU`SK7JTL9!W4T)%CVXN?->N=-04T4RB?G4ULB9#(YK*BCO&1;1`M$3D(?(E MJK@:(`I5P6H(#5=7RHI=72/:((H0Q8@2B>H"*6[&\,8X7XNN"&1Q2T=;?';_ MP2I0G_*`FG!65P_15%J)._+2"F;!C+6&\H[;,N>M,N#Z7:7,:*%00V5+I57< MWENV[K.G#%C95\J,`H4:*@N5EJS,:-E*&;#R6BDSVBC44%FDM.I;%BL#5DZ4 M,B$]!8B[QNK(J9GJ=+A8SO7B)E,;(@7J4Y8I@V];<%A26-F4*TJKFB%26K'K M,!MV1D7-^E%VS5Z,!26;$#GN[`V!I.C`3BR5.*ZK`K4$\?=D;/3*W"ZJ-D4UIQF^=<4&QN?MQ;HX%Q M;N*R`15M&G6EVFOQ56/54(.>R8`6Y2HN;NU"H<9R`O(?ROM)B^4"A!OD0 MM5:(UDJ+Y3<*-MQ%>)4 M/"<3!3_8UTHK=8@PEP5Y^1J.;4@DLE">._/[J,6G:ENRE:K-TVL;]^V^L5CZ M7$C5%C!J;%O(5JJVE5[;:$)/P?5N6W,A5=N&46-M$5NIVF*]MG&_.S%VE@D7 MJEF%Q+&1.72JJ]!?V1M%]\/=3W'Z1*L=#_T'JT!:JBA1PVR8R8*]XC4#\=1P MCLA%^85"#?)+U/(0^4J+&Q0HU"`?HM8*T5IIL?Q&H0;Y"+5B1(G2@E1!HTN+ M]P=+@#`WTH)$E''+Y=VVC+D[%?E`%%1!G"&:(W(1+1`M$7F(?$0!HA#1"M$: MT091A"A&E&A(S^3B'.HWT_(F21J0*5#TRMP#-$,T1N8@6B):(/$0^H@!1 MB&B%:(UH@RA"%"-*-*2%1>R2M;`TQR(WUV/!:%PFR"FB&:(Y(A?1`M$2D8?( M1Q0@"A&M$*T1;1!%B&)$B8;T6(CCMNH4^2`6PMR(18$JQYE3L$F M5EII1^O6Q$A]!\HU.!]J+24E6V9Y[/*BKU?(]H@ MBA#%B!*):LYG;;K[UN+ZMP[:<1$M$"T1 M>8A\B2I^!8A"55`%$IX)K)05N[I&M$$4(8H1)1+5!5(<554GZ-\+I#SPJNPH M;8GT26H\(YJR%6U`ROU)S50NM/J_/6B7,F3`W>*V5&&X4:*HN45GW+8F7`RHE2)J2G=G$F9(X< M>W!#6\T/DGQQF%2]_:"7I?.\3QN>L8*L68#5=F&46-ED;+BRF)&167]P=AHF7CG7821/JA,,5B*=]B+=UX/ MZ>DYG::OK^?6+OLNWD_OB1E=XO+E^2_Y_;+!'^BE>DL(F]RFE^UK^)>>\Z7P MQ"S0ITI:X]M(URQ'*+96@WY8A5%Z^$$R>N[6FK MZXAGT5@B$<&INT`/>ITY/7'$(O14UA$/7O$*/4)UQ%-2O$+/.\F!NBL/$^>A MUH'IQ!&O&Z#6;.+02QTUG!HIW@W`*_[$$6\(X(5@XHCW!.A"IQR;])N1M^US MNMJ>GO?'<^LU?:(Y2[^SH!1_*GYU4OQSD<=.7[,+_5J$-G3T(CO].BBETZ"N M6`^>LNS"_X@*RM\;W?\?``#__P,`4$L#!!0`!@`(````(0#R<=]4>P<``*P@ M```8````>&PO=V]R:W-H965T&ULK)I;ZS_]*+Z M7T]__O'P$83?HY/GQ36P<(T>ZZ1+=XU3(Z%W=F.(/SKY MMPBM7?9?,7=QP^]OMV_[X'(#$R_^V8]_)D;KMGKY>@]!].4.[?^AM=X^V MDQ_,_,7?AT$4'.,&F&NF@?(V6TVK"9:>'@X^M$!T>RWTCH_U9]W>Z>UZ\^DA MZ:!_?>\C*GRO1:?@8QSZAX5_]:"W(4\B`R]!\%U(IP>!X.8FN]M),K`):P?O MZ+Z=XUWP,?'\UU,,Z3:A1:)A]N'GT(OVT*-@IF&8PM(^.$,`\+=V\<70@!YQ M?R2?'_XA/L$WJV'T3-WL@+[VXD6QXPN;]=K^+8J#RW]2)6VE5@QI!3ZEE5:G M87:UEGZ'D98T`I\E1BJ\M^6-\"EOM!H]TVQW>EUH0L6-<#5I/'RB1ZW1-LQN M+XF[XLZ.O!.FT7TN+7DC?-[I4H>QD:8J[^4OME/'KA5?T&UUU\"8E=Z@J?_BK?`%O7VQ7W7HT+217^W99CJ@D_DQ=&/WZ2$,/FI0=&#$1C=7E##=%F9Q M9J19S>;*9U,%YHBP\BS,/-:A)3`)(IC?[T^Z93TTWV%.[J6F7Z)1%0-4B`DH MS`XI&%'@4#"F8$+!E((9!7,*%A0L*5A1L*9@0\&6@ET!-"$]68Y@)/^.'`DS M(D?8NWT$>=(,DA!4X"U#"D84.!2,*9A0,*5@1L&<@@4%2PI6%*PIV%"PI6!7 M`$I"H#[\CH0(,S#OX*-BUD@1%)I,9)(L99(L38R,&'$8&3,R863*R(R1.2,+ M1I:,K!A9,[)A9,O(KDB4K$$7*EDK7_RQH@EUDASLU+XD6E+>OK5)$N15F,-9 MGF"3EXF42&!1N2,2H58C24F[6&X-3<]\);5SD(FP`4-&1HPXC(P9F3`R963& MR)R1!2-+1E:,K!G9,+)E9%,E*70\(T-&1HPXC(P9F3`R963&R)R1!2-+1E:,K!G9 M,+)E9%B.CA=JM>-3TLHW?H.,Y*5);_74]6.8BMJPKA7J5TL5C3(1 MUB^'D3$C$T:FC,Q24HAZGI$\(!;U(C-4$%E=->IE)L*H5XRL&=DPLF5DEY(T M:B6)XERJ9#$]:"4E+#[Y^^_]`+H9UIV2:=6"'8<\9@DK:G83PX_U0D<-.!I* MU"ZN1KK54?MEE*NP8QR.QAQ-.)IR-).H$.JZ5$&U**CHW)6J=B?9J\+> MD,[;7(#=Y^26$8US5.%LDML2YWYP1C8YTUR`EF>Y943S'%4X6^2VI#/2LF4N M0,NKW#*B=8XJG&UR6^4MV^8"M+S++0-22X`X3A9'3LE4AP>!V5Q/3Y]P/$3; M?5TBJ#)9\@V-GD2DRH!:D:E8H1SF*C0_0B3JS?M32^^1@Z:#@N1);5*1QH@J MG4UR%3J;(DJ=Z4:+G%]F*,B=S1%5.EOD*G2V1)0ZZU@6<;9"0>YLC:C2V297 MH;,M(MF-6H?,X1T*$F?J$!&'U^(0$:N$839^N<\5#Q%H/4E1NQB_H9&4#O!& M&%E5@T6:5U0FZ<21M&5TTZIC:G2!<=`;;/0_]S9&E>*-[D\FI2H:TU2-R6IU M27&:H9G*D.:HJ@QI4:JB(2W5D$Q3:Y'%;85V*F-:HZHRIDVIBL:T56."R6B0 M?MJAG<]B4L>Q>!I2',>_*'7RX4FQU$FDECK240/Q_!V&_:]*79F*=L$(;:73 MUC2Z=-%T4`'FJD9OF3<^>LM4-*8I>DQC,MHMGU??`FW@X:.E2V#&>O+I^3,RWA??%*4RS=E!LV M/%?F_+EE/T.,_$*_9<,SS1)NVO!4JX1W;'B04L*[-ASN.5]8-AQD2KBNV6)K MS*_L+&A:V86AKMLCV`#Q6V"3:(M](+\".SI;;-KX%=A^00!E5_J6W2\-8 MXO3#;0TM&\Z8)1P:*8XJ_,K,LL6!A5^86[8XML"%9I9:>%=\H M=O:.,%JTY$P0IF^;TQ]Q<$L.>2]!#"^)DZ\G^*\`#]YU:6*1/P9!C#^$@^S_ M#)[^!P``__\#`%!+`P04``8`"````"$`5[1A9N,-``!W10``&````'AL+W=O M;QO>=:MQM7O='A[VK]]N&__Y(_IMT+@ZG3>O#YOGP^ONMO'W[M3X_>[? M_[KY>3A^/SWM=NWW2N5/!Z.+YLS_7G\ MUCR]'7>;A[S2RW.SW6KUFB^;_6NCT#`Z?D;'X?%QO]T%A^V/E]WKN5!RW#UO MSF3_Z6G_=F)M+]O/J'O9'+__>/MM>WAY(Q5?]\_[\]^YTL;5RW:4?GL]'#=? MGZG??WF=S99UYW^`^I?]]G@X'1[/UZ2N61B*?1XVATW2='?SL*<>*+=?'7>/ MMXTOWFCM]QO-NYO<0?_=[WZ>K/]?G9X./^/C_F&Z?]V1MRE.*@)?#X?O2C1] M4(@J-Z%VE$=@>;QZV#UN?CR?UX>?R6[_[>E,X>Y2CU3'1@]_![O3ECQ*:J[; M7:5I>W@F`^C?JY>]&AKDD?/_-?I9);Y60I\52FI:[^B*]*DK M>M3;0=?K]E3S-36I-.\]?5[69$]7I&ET89-#79,^=H_W%'/!*C&0QX[UZ,N7]A5K\\FTW\N;)8<6_3VTQYN%B,[GRC! MYKRYNSD>?EY1]J&A>WK;J%SFC3Q2QU.DZ'4Y:=Z;,S19E)8O2LUM@WI"L^%$ M$_W/.Z_?NVG^29-SJV7N*V1GM-U\$09?2'"[C9*=`QQ):41U+5-+U!VH/HM?C3^==IY<`"0$$@&)@21`4B`9D`F0*9`9D#F0!9`ED!60M4V<.-&J M#G&B'2#)7[@\*D5NF#0A55:8!B),I5`9)B`AD`A(#"0!D@+)@$R`3(',@,R! M+(`L@:R`K&WBA(FV';\F3$J1&R9-W#`-19A*H3),0$(@$9`82`(D!9(!F0"9 M`ID!F0-9`%D"60%9V\0)$^TNG3#5YU\E[<:B(!V_W,",@01`0B`1D!A(`B0% MD@&9`)D"F0&9`UD`60)9`5G;Q'$\G:8N<+R2=AVOB3,)!BTQ"4JAY85%G+_L<_$$L MBJ,:;=UYM-][&MFQ`!2@5(@H0A0C2A"EB#('N7U6QYL+^ERHS1A6>N>RHI:[1Q)*CD>.90LI"`4L-RFD8(HH8V6X`70E+N6X0 M1^W42!DWV+K<`4(YW1D@5JX_/^VWW^\/-/HI250D&Y].F?IJ36D1>;]`EBO& MZEI;#1+3R8#1T/*.EC(H8BE3,4:4,*)US9JPXH8O-5+&.[9=KG?4?OZ"Z:.W M__;TT<@U2IYUU=TL>:9-"Z\Q7>:'P$BQZ2$C%0JZS^QT_,ZP+[8]$0O1('A? M>\Q2M38DE5)=D153+>479K4]VCJX-?G:G-^@<_U7M[V>8$Z3D\& M(K^/U>6V&K.T&+SOE^W^ITNR))1UR-XOJ^\IBE:DU(C!2; MD&KD=W(3VKWKCNA=QI5ZZ%_*'I?X5XF+J:V1.Z;EB5/=U']B3)=2W+G05&04 M(8H-JO%P8J185XHH7EQS\6%>Y4&6J_,&CW64H1J?5E4]/-G MXOG>(=05+1097=S?V*`:]8F1XHHIHLQ!SG1OJY.!/=W_V7A46H3#"N0N24.Q M/Q[GS5-%RHEUXU&K-W,PU!5U%O#ZK;X_;(LE(6+M^33,?1\SJFTP82EJUY@% M:[Z6XC6IC6L^ZZG(`VK+7^?W/PYOY)?*7:@]4HN3`VWZ.?SW[0(Y([5$5G=P MUA=2?O'.A7K2&VI=%HI0?6Q0C?K$2+&I*:+,0>Y(53MZVV,?S.'B`.!X1B/: M_)JH#D46&;=+*;8S0!0BBA#%B!)$*:(,T031%-$,T1S1`M$2T0K1VD%N>-21 MXH+P%"<0)SP:N>$11]ZQ>ARG4HT9I0&B$%&$*$:4($H198@FB*:(9HCFB!:( MEHA6B-8.*P\_\%$*DYJ3J0*9-]PM@$%B$)$$:(848(H190AFB": M(IHAFB-:(%HB6B%:.\@-BSI9V6'Y(!;Z!&>G^_)0Q^EJ3(MB/D7,,VR6R MUAQ<>@NI#BT]ULHD;A!"K8ND.-01HAA1@BA%E&ED63\QR+)+6C\UNBRIH;CQ MF1DIMGZ.:(%HB6B%:*U18;T;5W7.L^-JI;[/7_BI;;[C8S`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`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`^H&3';W#T5)?C'P\ M',[\!YG;+'\RY>[_````__\#`%!+`P04``8`"````"$`%158J#P8``#]@``` M&````'AL+W=OV M/BVK)CDUEOA-2B3K[.ZUQU$2U\11RO9,9O[]:8AXV4`W!4O9/.I^T40# M30"BI%_^^=?3UXL_=\\OC_MO[R]'[ZXO+W;?'O8?'[]]?G_Y/_^*_[&XO'AY MO?_V\?[K_MON_>7?NY?+?W[X[__ZY7+[O=ZP4I?'MY?_GE]?7[\NKJ MY>'+[NG^Y=W^^^X;O?)I__QT_TK_?/Y\]?+]>7?_\>#T]/5J?'T]OWJZ?_QV MV2DLGT_1V'_Z]/BP6^\?_GC:?7OM1)YW7^]?*?Z7+X_?7Z#V]'"*W-/]\^]_ M?/_'P_[I.TG\]OCU\?7O@^CEQ=/#,OO\;?]\_]M7NNZ_1M/[!V@?_J'DGQX? MGOT5*7WXY>,C78'I]HOGW:?WE[^.ENU\/Y>.W'?4VY'LW0H!ZY_^OP]\?CQ]8T?C>3EQ<,?+Z_[ MI__KC$96JA,96Q'Z"Y'YN]G-]61$;9XJ,K$B]'=`)-#ZU#K27^NX>#>:7L]- MVP$W>O5PY?37NHT7[Q:SV72^,)<>\)Q;3YI#YS1X:]WH[YD-CFA8=%GB'C[I M&D?H5/,_MM'1:9[HU9';K?W`"/2.&7U=L-RS$VQ: M@DB"6()$@E2"3()<@D*"4H)*@HT$6PEJ"1H)6@=<47KZ'-'\^4_DR,B8'*%W M[P`X:6.1$%C`92U!)$$L02)!*D$F02Y!(4$I027!1H*M!+4$C02M`[R$4%WZ M3R3$R-"\HS^!66.-J*#U1F)BK7J3/DV*1(K$BB2*I(IDBN2*%(J4BE2*;!39 M*E(KTBC2NL3+&G6AE[7AU08JFK$^)`>=>F?)]:&\_4-.%?LJS>$^3VX)]"*A M>XP7B2FZX]F[_@9^&/M=WQ')I18 MIQ#=B$)DC2@(QVCA&ZVM$?UQC&Y]HZ@W0DF+>VV0I">ND&@M[84R%'"/96M4;07O3:X-L%:E[+U=:W`F:W@A"K2OD#0C: M`9XQ((RU/R`Z0@,"3:TLX17IVA**@5,]O?8[/^J-(!0KH421M/=RI<5-/.N- M()TKH4*1LO<*2%>]$:0W2FBK2-U[N=)B%C6]$:1;5\A+HMF4GY'%@[F?1HO< M/`(YB01:]-F.-(J!V#'1*`7R1\7$'Q496Z$7Y@H9#=P9)[14M?OS;F])>PV$ M?S?JD)=(B_B*UK"Z[1TCC6(@=DPT2H%H=#K3>RH3:8/@%G,XLGRA40GDRXO- M4L56Z(D-$,MO-:J!.*Y&HQ;HH.4GTNPFW40.)(Q.__J,=9M/+V,6^1H8!20+]D*\I5&&XVV&M4: M-1JU'O+S:C:<9^35[D_=F=BA,0U\SMA4K'!6YIS`W%(IO6RE\]I;H613MH)6IE&N4<$H(%^R%>0KC38:;36J-6HT:CWDY_6\\P)SY"Q6/!:- MO8S-Q')F!:LWYFLG[\_JF5B71M`RA?_/#[/)[5A4UQ@6)'=\%"6P"L:4PLK3 MDC%EL*)=,[EAS=!:R"<96P\K1D7!6L@G%M8.5IR;BVL#J\[76X MX]:,W,L6"6M@=31A+2R.!>"/67.6X=:B[CC_W,6"41&KO@Z-O>W<3*S!5N9= ME!-*5&^%21Y9Q_'-8=R.;N8WXK8=0]H+0.8A@94WXZ15"BO>BF0(P%L$ZD%J M(P\&44`^&$0)*PZB.BF(#3LZ`TM>XQ96?/!1:]2@Q:/]WL+IV"7[PX^LO.'W MQA+'F(MQUJ$Q+[)6YFTULB(4N-ZUM9KP#(PTBED+0R]A%)!/M5:F41+K55IM&$MR&\UJK5CHU'K.?I)-$="__\:8@^6W&5.AR;>,F#>F1DQI9,]?F_6\S]/CB(HUBBQSYA%%`/M5:F48Y:Z'3"T8! M^5)K51IM6`OR6XUJ[=AHU'J.?A*I6)^31&,NDM@A?T\T$ZN"U<@Z4N)XRNF\ M6BN^%T9P9!1KE``%Y5-8L5:F4:Y1`124+V'%\I5&&XVV0'SR5`.Q5J-1ZR$O MKV;[<49>#^9^7BT2>R)Q++VR5F_@KA@MIN.9O`G`XE@QZFX")P60 M0HL#R.#8!3`7F[T<'L'6"X@$[X$EM+CU"HYT",#S82;.BS=P](*8B7.D+;1X MK-1PY!8;('3X9"1T6EAXK3ESU!]@YO#/77R$J[\I#Z)P6"1V*F(4K.`8G'IK M6'$71)#O5LSC^6(BWZZ)X47K5DZ"<\%VA-G0@Q&DT.((,HLFT\->:7*MAI@5 M#C9?0#C8?`DK;K[BYIVKD^-\`T6/LIS;)IH+)H=1?`1`T\&W*P]0(B9'Q\=I1HW5G9`H57MK`* M!K'E('C@J0YOH(4.GXQ%A[>P.-::/^[,T>P9MY#H[*$J]&7/.TG/%*-"= M:VOEKFPUBED+O9(P"LBG6BO3*&,`O*EUJHTVK`6Y+<:U=JQT:CU'/TD M4JJ])/Y<\3`J8F'4(5/)>%[,1:%;F6VC<0R6[36LN(A&%MDB.AW-%[IZ6.UC M1=16CU,B2'4$F46X;]VJ\G%*\P6$@QU0PHH[H.+FW?X5$WH#1Z\/]'VK[P,, MM1J.W&)C4=_E-Z.%:*Z%E]?)$<$CZVGPJ M@;2\^J%0;*T<^8110#[5\IE&.6NAUPM&`?E2:U4:;5@+\EN-:NW8:-1ZCG[] MH%1[23P\^SDWGW.Y./WM?+.ZE;FUB/:Z3OV0IVO6,7SO7ULKLW)G+?D&2@2K M[O8X72RFMZ)6/Y81V#S5?0 M\G9;/&H[!(!I8]5FX68@LM#`Y=(,_&LUAI%M2 MY-WL7_OO5$(&'RZA$8MG%:C$J>%HCSF=@WQK1>7!Z0A=:CK'2?>Y+_,ID,@Z M.BAF+60V81203[56IE'.6I`O&`7D2ZU5:;1A+6Y_/IG+1ZMC.'D!2.D$5L$`4K9"`)E%5.5-`&+'F,,AV'@!JV#C):R*F;MA1\=*]L`65GQ,4FO4H,6^O^6[]"V;UK:T4[63A&&L6L!:N$44`^U5J91CEK0;Y@%)`O MM5:ET8:U(+_5J-:.C4:MY^@GD3K:2^+/U0ZC(G+;(;,IY42JYYXGUBHX>];6 MRENV=H[TEO7A:Y>NZ4O$Q)H_AM>Q&MJ]LWM2!"FT>,!E<.PB4,7#QA=LO(!& M\/)+-,YOZ%1`;]S&3@EBRT%@H-60Y\MM@+C#;\2-H(7)L6OV!M[TO//(@[D_ MPBQRJPO=*G55"I)W5PC?VND;?F3Y MM\@\*N:4?WEJ8:W,.1A;Z;QV\F[YAWQ7C6Y&\[&0CF%QK!AUU?^D`%)H<3G, MX&C+H2B%.3R"K1<0"5Y^"2UNO8(C'=-QO\W%&?$&CEX0ZK$>:/%8J>'(+39` MW.'B!*^%A=>:DTM_@)D#1G?+\L8`Z\XCO<+1(;$W$>\@K>A-W,/(#$Z]-:RX M"R*+[-YD/!O-1B+',;R.+9;M"#LE@A1:'$%FD=V\^M\8D<,EV'P!JV`' ME+#BYBMNWAUB8IFS@:,7A!YB?1_@9E3#D5ML+.(NOUZ()5T++Z^YHV.,1J(W MQGYJ:3LU*F+AT2&_MLF]U,HZOE7;K!9/M<@Z\M)6/_(,$W+F^>_T@QUZG78X M@A1:'$&&T+O)+C]-G\,CV'H!D3>*F[K^"HXT:/CBYF+X;P:#T".O[P(>>:K% M!EJVF%]/Q^II(I@7G-.E_M#3Q[HOK$ZTB>W4WMRZYRL,7*ZQ8G@<,]86RNO M?G1:#HI9"]V2,`K(IUH^TRAG+<@7C`+RI=:J--JP%N2W&M7:L=&H]1S])-+` M5?5C?.XSSU.C(NJ'172XP[-W+I;C*^L8OOFOK97_-I1\TR2"57=_G$U&TUNQ MUXAACAH%)H>>_WR*`R:T5OO1].`.718@Z58$0%5-Y8I71QA[NI M@I:W<-&%QVIY<>G"T_<4QFB-"PIV2P.K/E?7EIYV1Y'>#LZ>3KHUJD?.T'8BLS6JLZ(W<=$WD95W4&R1M\8Y13[56IE& MN98O&`6B+[56I=&&M7"-6XUJ[=AHU'J.7G)GYQW"'LS]8@1$:TPN1C?B[K=B M*US-6J-(HUBC1*-4HTRC7*-"HU*C2J.-1EN-:HT:C5H/^>F1QZO.W`LO"6;Z MI-4B.J9!#E8:K36*-(HU2C1*-8@XXPQV)U[N$N.F45>4.K9+&OE MK_;4*F302JY2(UAA.::_FQ(6QU9CW=!; MX7HC=@2*-4H8!3H]92MH91KE'O([RVRDSNBL;M_E=5:'_/,Z^?##:F8=@X-C MS5:XFL@BO.VQ&"WDX7,,KV.CPY:(4R)(H<5+CTQ%<'LKC^S@=2P"O\MI6)W3 MY<9.5CPC$[.E:R\B>P"@:1PHJ#R$X*(F?'X2#\?,B=6WB+,-?;-8N?&ZE&18S4#M%# M+;BBU;Q#X>/&M;7RRXA<-$6PZF;LX/<^P(2?TTM.BB"%H[_^$24I@U4?@?K. M@QPF^CL/Z(=MP]U^VC'>04;T>[>O\P9JCP(C:6VUG#.[2*/8(D<^81203[56 MIE'.6OU`[7[`M_N]T*?=\^?=:O?UZ\O%P_X/\^.\\ULZ;^YQ_\O!OQ[NIX+? MT2\*'X:CY.-E.V3_ZV3Y*P5$D4B'R;(=Y+-E>S@%E?9S^BGC(9WQ@EH^/"@F M/6;7)'5X!D"]0E=!AR$Z*OHD,84U'-=D>4<;.>U#&_REV8WJ5VA3OS1;]J%7 MIO3*D`_MYY=F/ZI]:%N_--M2_0IMY9=FHS[TRI1>&?*A7?S2;$RU#WU8>VD^ M2JA?H<]L+\TG"O4K]-'MI?E@]M`K(WIEJ*_I$Z7TRM"@H8\HTBM#[=`'H9?F M8\ZZ'?IT+;TRI$8?UZ17AM3H@_!+\YE,K4:?AU^:CV;J5^@S\$OS"?>A5T;T MRE!L]-%<>F4H-OJL)[TRU$Y+PYI^@T8W`K:WK%?/6`5J,/ MKM,K0^VL*6CS6>IM,MJL5P-OK!> M+*.AJ-:WRV@HJC5%97Z13#=!OWA%KQP:O^K33C\^__W^\ZZZ?_[\^.WEXNON M$]W_K@\_J_'<_7Q]]X]7^W5)O^U?Z6?G:75`/ZB]N_^XHV\QNC8_[_IIOW_% M/ZCIJQ_[Y]\/O\G]X=\"````__\#`%!+`P04``8`"````"$`R$-:<>T"``!C M"```&````'AL+W=O M/D.2HB152M6MTB9-TSZ>'3!@%6-D.TW[[W<-A@675JW4EQB<)[,*L*P='E+&OBFX()A!;>B]&0K",Z[(E9[H>\O/89I M@WJ&1+R%@Q<%S<@-SXZ,-*HG$:3&"O3+BK9R8&/96^@8%O?']B+CK`6*`ZVI M>NI(D<.RY*YLN,"'&L[]&"QP-G!W-\_H&7;MR(J?O@B:?Z,-`;,A)AW`@?-[#;W+ M]184>\^J;[L`?@@G)P4^UNHG/WTEM*P4I!W#@?2YDOSIAL@,#`4:-XPU4\9K M$`"?#J.Z,\`0_-BM)YJK"JXNW74<+Y;K%=`@8S1:0# M0N<&\D:-X,X':-0L6J/.4HN^'C;^BPXM00/"%@1&?8`@S0*VP_**:P:T.`/% MELH18LN$HG.9\ZT]1*C!G9K1'[/C=WE>6'&FYEO(;%;])$#HY7,ANLDB?SDT M^)N[3--,)9H=6,Y$V"F.(-L?4&#+"GS(_)W-KVFFLLS.5%9DQ3:";%GP&-FR MPM@%LG?JTCQ3769GJFMAZ1I!HZY^B/9C@Q%1DI34M70R?M0#<@W],>Z.LWL? MZ@?-VK^&F1[,[8=).H??1\F^>V!MGBA)HSF>.$F[86WCETFZG,.OS#O&&PM@ MQK>X)-^Q*&DCG9H4<$3?U3-=]&^)_D;Q%KR%0<\5#/?NLH*7.8'!XNNL"L[5 M<*.-'/\>[/X!``#__P,`4$L#!!0`!@`(````(0!G;R&PO=V]R:W-H965T&ULG%E=CYLX%'U?:?\#XCT!VWR.)E,5 MJNY6VDJKU7X\,X0D:$*(@.FT_WZON0;L2$D?9DVX\/E^-R/XW@>/WROCM:W MHFG+^K2QV=JUK>*4U]ORM-_8__S]>1795MMEIVUVK$_%QOY1M/:'IU]_>7RK MFY?V4!2=!1%.[<8^=-WYP7':_%!46;NNS\4)5G9U4V4=?&SV3GMNBFS;/U0= M'>ZZ@5-EYRC/[1"MRF$5V7- MR^MYE=?5&4(\E\>R^]$'M:TJ?_BR/]5-]GR$?7]G7I8/L?L/L_!5F3=U6^^Z M-81SD.A\S[$3.Q#IZ7%;P@ZD[%93[#;V1_:0"M]VGAY[@?XMB[=6^[_5'NJW MWYIR^T=Y*D!MR)/,P'-=OTCHEZW\%3SLS)[^W&?@S\;:%KOL]=C]5;_]7I3[ M0P?I]F%'WJZC\$,4EJ#,)5$`'LU3I?\\AG?O!^%`<9]1O\ ME'79TV-3OUE0-?#.]IS)&F0/$'G8&?(8]WIMJT!/!ODHH_2Q8!F`P&^SKR03T(;>C&87[<+UJ,I,Z)(HD!+5:\@2E4O MGD0WR1%36,XFP[&M3PS&B"R)`N&;5TP(`D@7`"8W.9)OKC2&`USGIK44EK[" MJ)0&[B0*9E2M8V\P,2V;O.0TUGC)8?:^23&7/6D$% M4=J*@$_:FA3E6-8HOI-6'.(FM6D<*6H(&M(:<6(5*=,!?A1?:P7.["Y/8A9W2$&55GI!PS5LX8] M!-<.(.PN>^C1YA36=JP:`N>_(N8+4HVIBH&J"D],O6XHQN^RAQY-B-$Z4QA\ M,?.IWZ;&^DKXT94YQ^_RAAY-F$W3"253&,4L=J<1@;E4ZRAI$$Q5:"HF)_W= M$X3+ITQ^C-$3FP(I@B*"KVUCG2N*&`81H?#":^(1DUB>P!SG/OP<)Q=C1)U$ M@9;&VR+$%%%.Z_M%Q!EO.`6?%%!91A!*M(K3X4U8AOR'3 M1'.2QD2!%$?F\B`@D-2$'SBH`I21W`W MY->.+9P8QXTL+QB(=NI0&4<0J@E2DAF>]J_>V$IM$;O>M$\SXW?9!\?1;W0- MU2=1("BYL;5F]`:+N00Q^1$7D1J^_SV6HU.874-()`J$&@5PM*.#!X,HC4'# M:;@:%.5)]/[&[I^BTY&46J)`ZH`R.YRJ961X_6PJB*W<5H?]4X0@/8(F"J3J M#(Y8C)9#:D+".(JNZ2@'O38@EP>X0%LP4SSY%[:)`@WT0L$T]\!N-B$^%_X4 MQ$PS\9<;542?,6F2\9P(!"F:@GLA*8341,!7XVO??86<])J(-[)$?S!94C?L M0P\SA;F>&TZ)5%KJ-A,%PI]:RI3RIVP&+J%G-J.-7I5Q!.']60@':[(+>94M MHR`@B#QMM")'O*C&>]RJ:/9%6AR/K977K_(2FL$MSOA;O"!/X(*\OTUVQ@6X MGSYG^^)KUNS+4VL=BQT\ZJY#>'>#-]SXH:O/_37J<]W!S73_WP/\):*`:U]W M#>!=77?#!WEQ._YMX^E_````__\#`%!+`P04``8`"````"$`W2#E*A$$``!O M#P``&0```'AL+W=O]'VG=` MW$_`$`A$24836KTSTJRT6NW/-0$G00TXPJ33_?93=M$$&P;(WB2!?#X<5Q4N M>_/EKWW*DM_ M9"6%:$.>1`8.C+T(]'LJ;L%@JS?Z66;@S\I(Z3&^YO5?[/:-9J=S#>GV8$9B M8NOT_8GR!"(*,@O'$TH)R\$`?!I%)DH#(A*_R>];EM;GK>GZ"V]ENP1PXT!Y M_9P)2=-(KKQFQ7\(D48*19Q&!+X;$>(LG,`CGO^`BMNHP'>K,F7!PNG(Z#S% M=;S;5.QF0,F!87Z)10&3-0B*L/@0W.&P0#S$F*]BD!P*-(=>& M8@`BTS4P'AT!0WET9NXZ2^W)R"P[C*<2T1BA>`.1^=X$O#5AFFU67%>/"C*! MS*L3D"#0$X<`?+8B=_.*-7@SNM9$<4WG30S2+=[K`A.'C"\M$M>S"=&BA\`, MB[YJ<3RS`M:MA>J3]\@H3]:0:`!I193XP=O3C=^X.0&KYASGGA>,&S(8MV40 M+$,]M0@H[H>MB;ZHK1O3J16#5(ONTF[UT2(R:!&J+PRUA25"8(;%\/]8%(-T MBUIQ[9%IJX\$VAL4(3##(H%5[/$PRE&Z22V3^P923.B%.,2TZ5`JD6A]8KP4 M):T:[-=B`[7%N.JM,PVA3.$7]L3"W2G'"7NXS'=70>+I=4@0&GZX+-5H%%'# M)U;S^?YP[8?/=H'M=Q`RUB`:?V.(Z@^F^8`_0:OI=7M+#4$(T^NYH=X"(P58 MVDMRKV#5F]9%)G([T#X<;0G9BXT?3&#$6Q<8\_90^R`#_:.W)VF@T;J;W4#( M0QU$TE,[EP8:]3>[BQ"MC4SD=J!_].NNVT#(RE]I/3"2S_Q(ON_ZGON+-47K M'Q/>!AI'O^X0PJW5H+^O!=P+/-[B#+VAUHA'-*[:DS5L<^$\H]V/X+PE[UOM'W#U3>_00``/__`P!02P,$%``& M``@````A`+!@;GEN$@``[E\``!D```!X;"]W;W)K&ULK)Q;4QNY$L??3]7Y#A3O"WAL@YE*?V]??=]_7Z_T) M67C>?3S]OM^_A.?GN_OOZZ>[W=GV9?U,)5^WKT]W>_KU]=OY[N5U???0*CT] MG@<7%Y?G3W>;YU-M(7Q]CXWMUZ^;^W6TO?_QM'[>:R.OZ\>[/;5_]WWSLF-K M3_?O,?=T]_K[CY??[K=/+V3BR^9QL_^K-7IZ\G0?YM^>MZ]W7QZIWW^.)G?W M;+O]!Y?M[OMU_T9F3O7#<4^7Y]?GY.E3Q\>-M0#Y?:3U_77CZ>?1^%J M&IR>?_K0.NB_F_7/G?7_D]WW[<_T=?-0;9[7Y&V*DXK`E^WV=R6:/RA$RN>@ MG;016+Z>/*R_WOUXW*^V/[/UYMOW/85[2CU2'0L?_HK6NWOR*)DY"Z;*TOWV MD1I`_YX\;=30((_<_=G^_+EYV'__>!I_VR4:9.CVY_[';;Y_^IPM' MQH16#HSRF%JMR\>79].KB_&(ZAI2G!A%^FD49V>38'HU.Z1(9MOFTD]N[N5@ M353:*M!X/ZXF\D*K2#^YILG9U>CB>GPUW+<1Q5"[5`53N^7Z;#2YN#S@E%$7 M"_+K<8T=401TG1**8-@Q(X[!B.2.K.V*:Z/_&-71Y5DPFXZF!SM)@=`ME8@, M#YIS/6+;!(CN]G>?/KQN?Y[0K$+NVKWZ#P@>E#RH?U#YH?+#PP=('MSY86>"Q#Q(?I#[(?)#[H/!!Z8/*![4/&A\L?+#TP:T/5A9P`D+SP]\1$&6& M\HY^#&2-$:*)IA.:>E'J1+HP`8F!)$!2(!F0'$@!I`12`:F!-$`60)9`;H&L M;.)$C5SH1*U_=><934FWP6&GWAART4YOOUU[03"EE,-=G.PIT&D)K7U'M$1) MNRW19&)/MY.9UYY.AML?`8F!)$!2(!F0'$@!I`12`:F!-$`60)9`;H&L;.*$ M@M;M(T*AI-U0&$+VK;#["=H)=;$`$@-)@*1`,B`YD`)(":0"4@-I@"R`+('< M`EG9Q(D%C>"7M.EX39SX*+B^]":D3ZI(`2`PD`9("R8#D0`H@)9`* M2`VD`;(`L@1R"V1E$R<6=%1R8J$VY,'TC":8([?DRI`;)D/K*"U,GU(4) M2`PD`9("R8#D0`H@)9`*2`VD`;(`L@1R"V1E$R=,ZH`*<1I-S]2Y=GACT6JZ M@3%HTEYQM">?.:((48PH090BRA#EB`I$):(*48VH0;1`M$1TBVCE(#,@UW_J MR'.$__0)R?&?1F-:Y;L=T6CLSS+D7N7E,2U)EI2WAXV,U(3VUB(U\6X-8I'B M("9BGE$JR+(U]FK,Q)9(!5<7[AR9BQ2;+\0\HQ)1)8JV^<`U7XL4VVH<6V[$ MU'GGB(B9XY$]XC6BB'%U%A%!GDQ"*X]/P7BQ0K)F@K192)HNT9+]2Y M2+'Y`FV5B"I4K!$UCJ+K976\L[VL[\G:Z7[_?7/_^\V61BC-$SWSS9@.C.:6 MS!P2;>=KY#C?(+FIB=0](\5CXB[=WA$T%BGV3F(0Y1FC%%&&BCFB`A5+1!4J MUH@:1]'U-/71\72/1^D.N'.I$O=64X-H[>YFC>!J[";97-WODV)`ZW@G-?+G M@TBDV'\QH@11*FC`?"92;#Y'5"`J$56(:D2-@US'JW.9/<0/.-XN'-U`E71M;>KBQEJ<$F M9;U2?I-R(S6FC.UJ#*Z\&X&";3GMFGJS:I!(GYD=^(VD@9OXRN?+\T M;*:=\]UAH$Z)1PP#?:BDF9-'\,W((#?__..@D3J4?]H62;'YF!75M/K'I\GE M%&)N=.P(0&:G;,8>K""5B137GQLTIB72"K"WP2E8T6D$!ABZ5[&B]+AFI'L\ MGDR\#4/#`A/E)3>:ZIQI1_/7UBU]6G6";`ZPMON"*V\`S]43I7?D>B?%3HZ- MHAG`XPM_`"=LV4D@?_I.6>I`8D/]N5%TLGATZ:TA!9MW&H%!!O,5*TIBUP:9 M'@?7?H\;UNE)675*M8-\8.8VAUH[936BI]8<@?FH0S+,(3\B(S66T1HC2L06 MFT\%#9C/T%:.J!!;;+Y$5*%BC:AQ%)U44C.5X^5?2J76BKM?,6A,NT=K0O$V M=W.6&AS*D9&B'^R*F)&>/4;!""9,EG#F*L@E(S4>;$#&MJ0!.2LZ$^;,F[4+ M5G0:`;G$MB1Q*E:4&FM&NLNS"Y@P60`GS$"=]=^?2ZVX%TY]6V#GDI%2+X5T M$<9<,E)V+B%*Q!9'.!4T8#Y#6SFB0FRQ^1)1A8HUHL91='.)!I'CY5_+)67% M<[Y&[A9TYFT;YX%1I(EY*!Y&2L9:;!1YOSGS)^F$+A>PWKX!H4J!N#(_)&7S#8.XK60OOF M%(^\N:"!OD5&RLD;;=Y"B=AB\ZF@`?,9FL\1%6*+S9>(*E2L$36.HILW-#LZ M7OZUO%%6O+S1R%V#9MY8FP=&BA)C*&^T%,VQ[(K8*%+'VCT[#*R$!4CU;UXS>ZG'#`CU+D+J9."*5S'6' MM9U3[\A1@)TEJ$.6!_PU/C**5M[$B!(TGPH:,)^AK1Q1(;;8P26B"A5K1(VC MZ*82;=H=+_]:*BDK7BIII!:_;JP%,^_H,%!@I)^'\TWYL;/%I M__(:=WC&CJPNZ;L:D+'48`-R(^6,<(?7.8:C7[VK$;618B\$ M,]SU=0T@T^Y@4.=P.^7\P?#O[0L%J_=ZEX887T92W3`:S`G?.ED9J4.[0:TX MUN\;J[IR1XR_O# M1]E`:7KIIY']+-5(62A"%"-*$*6(,D0YH@)1B:A"5"-J$"T0+1'=(EHYR`V+ MN@&PD^)`+/2%@;.E,TBVF',UZE7$!$6(8D0)HA11ABA'5"`J$56(:D2-@QS_ MT2IZC/]:<7I(L7F"S'/J$14B:)MWMNRUB+%MAK'EANQXP[_:K?LS3X&V8_S&,DCN,@@ M)Q;X+%6DN.D)VDH19:)H>\8[!.8+M%4BJE"Q1M0XBJZ7U;G:GE?\Q?9= MSU+5/93O?(T/-'R7&D2S=C>WT,[*>Y9J%-6M6B?5,P-I6_:Y4!3%RR"5BM2`^4RD MV%:.J$!4(JH0U8@:![F.5R=)>X@/+YUJX^P[7B/W(@N>I;(B#>DAQQOSCA2< M(HPMVJ:U9W1\ELJ5T2[Z[GZ4:*>.7T6SJ/BM%._:AA@"?YU@)M"IS\N_):,#=2 MA_+/7`'(+47,BN:6`I^ELH`=`X5K.@T`@,, MW:M847I<,](]'E_Z*=6P`-[+J&V8D]2_MFZ90ZAU7=,:IK=[;/?ALU0C=>"] M"9%B)\<&F0'<\RR5=9P$\E,V9:D#B6VZ)S<-.=?O7'7`Y1N;'VQ$R5)V%IL: M!=56NQ.F M__()*SJ-P`FS:P2'NF)%J;%FI"?,V73L/;AM6*!GPE1G_2-RR5P-V#.C1DXN M=6C`==%82SFY!"@Q4I;Y5-"`^0S-YX@*L<4.+A%5J%@C:AQ%)Y?4LN%X^9>6 MI=:*>_M@D+LLP;-45J3!]/90CEA*)NG8(-YOXC,AUAE<$5*6&JP_8REK6>+Z M'458ED1QH'LE2UF/5QE)CVNN\ZZF@`?,9VLH1%6*+S9>(*E2L$36.HIM*-!__#:FDK'C.U\A= MEN#Q*EU0*\7A52$R4O:RQ.BMAXT)"S@+`JQ*[ZH_$UL[M**%$B-EF4\%#9C/T'R.J!!;[/,2486*-:+&472]3+%PO/QK"Y6RXF67 M1@>>N*K;5J7HS/?^\(M8BL:J#%+_8B(V4GPGT//$E>W(@I,R&FQ`QE*##=V*18N\DB%)$&:(<46&0U=02426*`TVM18J;VB!:(%HBND6T,J@O MD/Z-A;6&O?^*=ZIO+>R\943+FH0(/C#`4C2[6E+>_B0R4K02MY\LO!AYKVG& M(L#N2\0RHU300&69V#*5>>^JY"+`E@NQS*@4-%!9);;Z>U:+`%MNQ#*CA:"! MRI9BJ[]GMR+`EE=BF9`[!:A[@O=/[?1A6'^9961?;`4S_RF`D3KPU+17"@Z$ M1HH>9+8>F'AO2"1LI;TD;S\&D#*RG_K!8I/U2OG5YU[U8^]=GX*M2/4EH\'J MJUXIO_K:K7XR\]*L82M2_8+18/7+7BF_^ENW^NF%-UVK3P>K$4(73]U0TY\" MUE]"?5J_?EO/UX^/NY/[[0_UF=^I>J6WP_H;Q#>CBW!%'YXA$WY),`O5:Y0] M)9/+4&WS^TJNJ*1=O#UK]*WCS^U6W>,W]`WD]L/!/@^H\IX:/H_#S]3QGJK' MX:H]R/F&IO21Y3YYZD-O%Z@'?1VX(6_T.N,Z7+5GVI&$:H^`+:4E+E2+ M#I;0!H(:VU="4WJH9FW4H?DW5%,LEM!D&:KY$$MH9J,6])7<4`MN>EM`N\A0 M;2W0&NT<0[67ZRFAGJJ=`);01B]4&P(LH?U>J/8%6$(O`(;J];Z^DH!*^D8% MO709JK?24(?>O0S5RVE80J]@ANJ%-"RA=RQ#]5X:EM`G<$+U01`LH6_JW-J63>6Q)12:RO4+WQ1F]?4DF?=Z)Q0"5]K::78$/U_A^VC=Z% M#=/>$GK_E7S=%Q_Z%E&H/L."UNC[0Z'ZNE!?R9A*^O(V&TVHI,\:?90H5%]M M06OT;:)0?;P%2VZHY*:W9$XE\]X2^DY3J+["A-;HJT%4TM=J^J0-E?2U@#[> M%*KOUI"U\RYT]+7UE[MOZ_KN]=OF>7?RN/Y*T_1%^_F=5_V]=OW+WOR=QI?M MGKZW3B<`^J(U?5=_37\^<:&^H?=UN]WS+ZJ"[DO]G_XO`````/__`P!02P,$ M%``&``@````A`"M-KA*L`@```P<``!D```!X;"]W;W)K&ULK%7+;MLP$+P7Z#\0O$?4(XYKP7+@.$@;H`&*HH\S35$2$5$42#I. M_KY+ZE%;=H,4R,44J=GQ[.QRM;Q^EC5ZXMH(U60X"D*,>,-4+IHRPS]_W%U\ MPLA8VN2T5@W/\`LW^'KU\<-RK_2CJ3BW"!@:D^'*VC8EQ+"*2VH"U?(&WA1* M2VIAJTMB6LUI[H-D3>(PO"*2B@9W#*E^"X4POZ325: M,[!)]A8Z2?7CKKU@2K9`L16UL"^>%"/)TONR49IN:\C[.;JD;.#VFQ-Z*9A6 M1A4V`#K2"3W->4$6!)A6RUQ`!LYVI'F1X764;F:8K);>GU^"[\W!,S*5VG_6 M(O\J&@YF0YE<`;9*/3KH?>Z.()B<1-_Y`GS3*.<%W=7VN]I_X:*L+%1[!@FY MO-+\Y98;!H8"31![&4S5(`!^D12N,\`0^NS7O$X#&;S,(D`CK;.5^*2/@[6/BZY^OOGIX&D$^^] MN*66KI9:[1'T%\@S+77=&J5`-IC0,8RV_,L5R,21K!U+AN<80<(&*OFTBA>7 M2_($]K,>B,:CF!4@.`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`EY80J#KB%($M]PVP%G M4?W/FS,04!O0MT*Y,"IOJ0QE4,M(*DGNJ.T_2Y:[IM>.QHWO'T;!Q;O3[]37 M[XS-)=H$KL6"+53'5K*1#V(?)#Y(?9#Y(/=!X8/2!Y4/:A\T/KCRP;4/;GQP M:X%32D^7(VK#_T2.E(S*$4?WDH$D+?02PA;L$OD@]D'B@]0'F0]R'Q0^*'U0 M^:#V0>.#*Q]<^^#&![<6Z3(Q"?PCKC-@M`A(#28"D0#(@.9`"2`FD`E(#:8!<`;D&<@/D MUB9.+BB(3B[TM'.BUC7#:5&.;EHT&8?=N+8`$@&)@21`4B`9D!Q(`:0$4@&I M@31`KH!<`[D!T&G%R,!QX9>T&WA`K\$`B(#&0!$@*)`.2`RF`E$`J M(#60QB9.P&AY\XJ`*6LW8)J,2+\;0(+1U!O,C1']6$8SURC21F/J7F(T]H:B MN#/BH2CIM)FD';&$1EYI62SD[W*:5M9LB32A%7-3"$%DV19HXP0_/O9C%G1$+)2"4`LDZ+SL< M7E[SSHBE"Q`J@53@50-I;"\GK+1]<\)J#=?[K^N[/R\WU`YI^=H3[A'M!O0> M08FXT=;$CK8A5K0U&=,HUC7U\-S;6L2=$8.9`"O$H@%7C50!K; MRPFMVN@ZL>V)(>V5.8BMN1M%1E2$A&@Z,A;$*J;C.*O"[>B16',D848(H M%30@GXD5R^>("D0EH@I1C:AQD!MXM=UZ^5BA'BEXS=>@L1W2<#KV`V\<:3,Q M%/@^JXG7]6-38CAMM]CCR9DW"B=<2W>.\0:GE*T&JY3U6OE5RHW5R)Z+PJFW M12E8RZG7Q*M7R5:RI*@$6='S*U$;*Q.78.K'I6&9=F!WFX':Y+VB&>@](6W: MN`5?!@:Y_>_<;P;:ZE#_ZZQ8/C;RH1I(OW\8GT\@Y\;'S@#T[)1E[,8*5IE8 M`%.])M=K&"($=BQ4&.#3(->'3F-^"$?9P. MY`_?*5L-EI^)%9>?&^3TXN#F3&7N39D:A1==+UZHI[1D16@P==IJ)*TU-HX62D2+`YP*&I#/4"M' M5(@6RY>(*G2L$36.H]N5U,;QU[N2WGY2,KFNE^I`AR(]HAFOZR3AU%O2+=AJ ML"E'QHI&59:/&>G1(P@#'#!U!4+*95V9_5PYBT;%X%QI/U=UR)[\F&LI*W%QI'7FS-_D$Y863;,*:/!PC*V M$L><"W,<)][<7XCCP+V4;-6>5;>KBHJ1W%[-)9KE--Q>PSX]RT:U5[8S>J#? M*'.OWVAD->R%.H![P1RDK9Q^`R@1+6[8J:"!T&7&RI+/$16BQ?(EH@H=:T2- MX^CV&[5MMJ/\MN6<4O&"KY$[!\V\MK8(C-6!.4A;.7.006;-#@TK,,'73R[4E:ZMA3-OZ[!@1QJH.BN<@MC*Z7#^;C\V5KS;/[^` M%1[KR.R2,AJL0,96@Q7(C96S6\(5'FO1,D=N&59X;&7-5(P&*U$;*XY".(-5 M'^O@[!62]&!C^&/S3%GN?:!K/8QL9;S6H)3;;10WYH6QHMYIQ0&[HG8Z MU-L?L7&T4"):+)\*&I#/4"M'5(@6RY>(*G2L$36.H]L5U6[X)UWQP-AG]M'6 M;HJ>"ZF`V^>?B")$,:($48HH0Y0C*A"5B"I$-:(&T16B:T0WB&X=Y*9%[>WM MM!S(A3+W&K]!LL160F*$,6($D0IH@Q1CJA`5"*J$-6(&@>Y\5.;S%?$ M3^])[=V,>B>0@G7@A)2M:+LBXRJ.)UK+.:8+X(S4:)$5=_A$Y!FE@@9*S$1+ MK/"<5*Q8OA!Y1B6B2AQM>6_)6HL5:S6.EILQM0-_1<;TAMW)F-G#RT2["`VR MSO`,S;(7JO0RLH[RPFUE5IL#XU`G16'-!9'1@FB5-"`?"96 MK)4C*A"5B"I$-:+&06[@U>[O%8'7FT4G\!IYYRL0>./HK(QQZ.^SPEV$MJ+6 MU)ZKX5FJ6K"JJ9O&LY]G.66KP2IEO59^E7)CY>TK_+-4UG+JA?N*+@C3CU:K`P5@?ZGUAQ M!&)&YKD,GJ6R`:W:NO)AFYJRU6#_S\2*R\\-SH5`(2S%;R$*9" M5#/2=SPZ]U]/:-@`G\NHAV-.IW[3O-6J>$G63PR\ONZ?I;*CTUJAKXL5!SDV MR#3@GK-4]G$ZD*^H MAS*\XX9]>KHLW9Z3Y.$IM:1PYK]\PHY.)7#`U.&C M+/']5>PH)=:,]"W/)B/OX+9A@YX!D\IWLGR@+RESKR]IY/2E#DD$8$:*U))! M[9SE1F)$B4&6?"IH0#Y#K1Q1(5H7!\C/1XE3D7+[CB-.2 MD1^L1,GRUD-K1G+'-9?XT^-5]NF9EJC\UW0E9>YU)8VLMKY0SY7(ZM"TI*V< MK@0H$2T.<"IHH&5DQLJ2SQ$5HL7R):(*'6M$C>/H=J5_Y,D$/6R`X)LG$^Z9 MD/>L:F$1G,:T8_N^.YVQV[>:0QX3>]2YE[OTLCI71VR@N*O!**1 MMK*:?XPH,HE2,J1(MC7B*JT+%&U#B.;I35#MQ^*/*VBM`(KA'=(+IUD)M(&B:<;C2\Q:)3<7_F M8F3/W>',?_@D5I(>HV5W%T`).J:(,D0YH@)1B:A"5"-J$%TAND9T@^C606YZ MU!;[)U/>@4SIS;E])##6B$KC'"P018AB1`FB%%&&*$=4("H158AJ1`VB*T37 MB&X0W3K(30N-1$Y:#N1"F7N3C$$R9R[4::ZR$A0ABA$EB%)$&:(<48&H1%0A MJA$UB*X072.Z073K(#<7:H-M=Y$#N3#[<6OYITYR*?"TXI=^T2&9EV"I%1E' M53=9'EUX,U,L5BR?($H198AR1(5!5NU+05:]_.5*)5IB%0;>V4DM5ES[!M$5 MHFM$-XAN#=*U=_.JGA'8>7W3:G^LGS0XPZ!Y^&"G&U!D'%7]K-QZT8G%BJ.3 M($H198AR1(5!3FZAJI4X#E2U%BNN:H/H"M$UHAM$MP;U)5)MVW\]D7KS[R32 M(/J1%,'W'\;&:G#7%!DKN@MU>!V>!=[[MK$8 M;=@MY\#0KA^%.$W$(-I&=DTDG/G_-(Z^P*@F@`/'W[U6L+,W5G2HT49@[+UQ MD;"*//U*&0V??O=:^<7G7O$C[Z6M@E6D^)+18/%5KY5??.T6/_:W`0VK2/%7 MC`:+O^ZU\HN_<8N?G'G#M?K49IOHMGC=U/2G,_4G_!Y7VR^KQ>KA87=TM_FF M/HLY46GLL/EFYSB8?R0E:JW>%=JHTN<\VX]?PI60KK0+;[@RHBOM:L2[0M\& M_=CK087TED%%]-E_'%%UVT>?7@&75')?P9=CJE'?[4WFM^UFS=<)28A>`\:` MT!ICKF;]OBOG=*5]N.6IT9*`BN^[0H/T7(W#J$8CZEP-FGB%AK^Y&N'P"HU5 M5(.^*Y=4@\O>&BSHRJ+W"JT%J09]=THK";K2=S^T=)NK*1[K1BNX>=E[A=[- MG*LW+]&'7ARD*WWW0^_#SM4+@^A#K\7.U7N#>(7>CIVK=P7Q"KW^.E>O#.*5 MBD+=OK3@9;29SNES+6A_24J7O4H+NK+HO1+1E9A>P$6UB"(3]T8FHLC$O6KT M;O)E5FLWIVT,]]A=S^G`. M\F(ZI\_G("^G<_J(#O++Z?RRCR^F\T4?CRA,??6,9G/Z_!+J1Q=S^E`0\F0Z MI\\%$3_M&@)]4_AY^655+[=?UD^[HX?59QIH/_Q<```#__P,`4$L#!!0` M!@`(````(0`L6SM/'`T``'I$```9````>&PO=V]R:W-H965TDY+TWG8VEY6UO:EF7@TY\_M\^=[^O]8;-[N>DZ%Y?=SOIEM;O? MO#S>=/_SE_?'=;=S."Y?[I?/NY?U3??7^M#]\_;?__KT8[?_>GA:KX\=YU_4+O/.SVV^61_MP_]@ZO^_7ROFJT?>ZYEY=7 MO>UR\]*M'2;[]WCL'AXVJ_5LM_JV7;\<:Y/]^GEYI/@/3YO7`[MM5^^QVR[W M7[^]_K':;5_)XLOF>7/\59EV.]O5)'Q\V>V77Y[IO'\Z@^6*O:L_P'Z[6>UW MA]W#\8+L>G6@>,[CWKA'3K>?[C=T!J+;._OUPTWWLS,I^Y?=WNVGJH/^NUG_ M.+3^WSD\[7[X^\U]O'E94V]3GD0&ONQV7X4TO!>(&O>@M5=E(-]W[M)9L+=RB<5KMG"H#^[6PW8FA0CRQ_ M5J\_-O?'IYMN_^IB.+KL.R3O?%D?CMY&6'8[JV^'XV[[OUKD2*O:Q)4F]"I- MW/Z'3?K2A%XYDG<',)!MZ97;?OPLZ'RKKJ!7:3*\&#F7X_[H_3UQ)3UH>DD/ MY^)Z.!Q<77_`9"Q-Z%6:?/QD'!I)=6(I=;\?BL.I%?\Y86,9%`XG5/Q'-NVW M.L/6E//I4'^>..H[AZ4SXCZ@_TB;W^A)RF7=D[^3U%X]WZKI.UL>E[>?]KL? M':J)E);#ZU)46&?BD#-/W+I;FJE\;B;3%!8NGX7-39?.CR;I@IH6K-FI*?@3HJH%#6BH2Z9 M-I(F34#F0#P@/I``2`AD`20"$@-)@*1`,B`YD`)(V29:UJ@+M:R=7IMP11/J M*CG2T%6XR43?N39RT8BXV0S('(@'Q`<2``F!+(!$0&(@"9`42`8D!U(` M*=M$RP5UHI:+^K)S(58G]K2(AGI::C)PF[HV!3(#,@?B`?&!!$!"(`L@$9`8 M2`(D!9(!R8$40,HVT7)`BQHM!_:.%VJ]XR5I=3R0&9`Y$`^(#R0`$@)9`(F` MQ$`2("F0#$@.I`!2MHG6\;1,TCJ^-?B/3YO5U[L=%1A:#)Q(2)_65O6*2YCH M^9"DO0AS^L;E9"I%M-)KBIC3-XK8K!8-:.0T(G=H+-;FC8@KG==X,_$;HHS@ M:$%CI$3NT%B)A(V(O1>--Y.H(3K"'*"(Z6 M-T9*Y+K&];MH1.Q=-MY$M*%#>=.&SHDA0C?,/$:$6A\CDM`M72NS`_WLI[7( MI5NW1@1G-FM$'/02-B MZP)(V29:7BDA'\BK4.MYE:15BR6I-UNJFRD@$!](`"0$L@`2`8F!)$!2 M(!F0'$@!I&P3K>/%!L4'>KZ2ZUTOT:`]7=RA,<>GW)!N*2R3ZJ0**J]4N:/J M1GO<-P4>V]`5Z/S!?%990PI8I7F91PPY)!K@ZHAF$5^<]#*O/A&KK''%K++& ME;PKKO2DEQE7QBIK7/E)E=E?!<=U+H4EVVBGUPI)'\1BYZ"]BV._+#CU1@/= M>'*INF-$\Z25/V,'9RI5;UP96#5H[.>,VBL*QQP>'JOHKD$%T3KG:N'CLZH] MW^#R%"@5GV/(2*RAOM]>C^'F;<$*:P`1JZP!Q*Q2O9`PLO9"RBIK$!FKK$'D M2L6]4#`ZVPLE*\X%H`\]F@T?&7I";M3/&FGUTQF.C36)V/@5#>GE_-B8L>JJ M-?3JAJZU,GFJH<7>9Y4UB$"IN--#B63%=D>7M!>OG^""6YV;\-7@CUAEC2!F ME>J&A".P=D.J&EJZ(6.5-8AZ01]\8J^G7?=^ZTY* M;,"98U(BK1Q>&7=`4]GPK7)8>[FJ$,RYH;40>*PZ-P]E.93VUD(0L%?U%*]J M&#*J"\'5\*IOK%D6K+`&$+'*&D#,*M4+"2-K+Z2LL@:1L`/B))I8W(-Z[$0FZ4PQJYXZ:$39T&66;E3*KJI[Q5BN>(/.7%7>`K M9+$/T"M$M%!>;!\I9+&/T2M!E"HOML\4LMCGZ%4@*I47V>MYI4&JY?7W*HUP M,=)=(Y>69,UU#78(IN)1NFBH56]S931CE5:7S:7G7*HL=P_R8.KJX;.S]?@! MJZS'#_7C#^A6Z=+8I%JPD8H@8F2-(&:5=O4P>R#A"#0O9E MJG)667NFX+CJR^.@/[@>&CMS)1M5/:./4#IGZPC]:_=*(^CDKF)KRT@\ZC:' M:(VTBM0@-6IA#3Z37GVU!S%'Y$G4LO<5LM@'Z!4B6B@O+AF10A;[&+T21*GR M8OM,(8M]CEX%HE)Y0442>X1GUCYO7'3D[F+[]D]N0;;VC\2G%F@@M)ZKS!#- M$7F(?$0!HA#1`E&$*$:4($H198AR1`6B4D/Z-*1"H*7EC5P(N7%%D*B="T`S M<2D0#95JCLA#Y",*$(6(%H@B1#&B!%&**$.4(RH0E1K2"6'DI%3YT42JV3Y4]HTPAY05'S)674L&RJE`JMB^5 M/2%M-(G;/&TTV6=V)==G-J/V7:4[-!8_4ZD2+Y9AHU0<^AR1A\A7R&(?*!7; MAX@6B"*%+/:Q4K%]@BA%E"EDL<^5BNT+1*6&]%1_;#]5+-Z-(LY(E>QV&=JKT7>N'K4VU*T]\05[,Z5J'WU<(;&0F$J5:*VG1]8,U:I MW;@Y([KY5PW-\>&QBG:DE*IUSO6>)*NL001*Q><8,JIWXT;.E6MND[/"&D#$ M*FL`,:M4+R2,K+V0LLH:1,8J:Q"Y4G$O%(S.]D+)BG,!Z$./5!\9>D)N5-`: M:144']'0#K>\);&,C1FKU-[.7*(W'M&HAA9[GU76$A`H%7=ZR$'4\[U_Z=(S M&N,1#;[^U<2J^!&2.28FT<@B/:&3#M\IA[44GQOTPYX;TCBIT6`Z; MABT5ED.ILA:"@(_8>D3#J"X$SN7`O38^%[=@"[H63)N0CT,4DC5QN3;UR+A=PHB#5J[5E.W099 M$C&3JO9#&D2>\N(^\!6RV`?H%2):*"^VCQ2RV,?HE2!*E1?;9PI9['/T*A"5 MRHOL];R*+C8=?$!/L@/A_-&E/`*FM,H1[38#0:F^5VP4;6H")668.*6:5YF1V5 M<%":EUFGTY->9FHR5FE>IBIGE;6S"HY+/LL97UZ9095LI)U@ZW#ZV*:@K&/[ M?8]WQ!K+K&4UTFI9@RQC:R:]VH]W$'D2M>Q]A2SV`7J%B!;*BXM-I)#%/D:O M!%&JO-@^4\ABGZ-7@:A47E#+Q!;SF5KVQN5*M#0N5S5J/G5:IC\S5(==?UJ^_[;M=[Q_7T_7S\Z&SVGT37\2O M0FMP\RL!GZM@#'Y'OQY0?=7>Y.ZD/*7_W)]\IAAI3)L-^O0S!*?X8%)6JTY3 M/YR4U7ZIR9T1151]E=5\QQU33-6'9XQWZ$G+1#Q'P:CHB<@D//D./;F8)"?? MH2<,$_'\`-UHHW^U(,]'D^(4GXXG]'4`U/OC"7V\'WDTGM#']9%GE)"*]YJ$ MT"\_O"X?U\ER_[AY.72>UP\T("^K;__MZ]^.J/\XRH\L?-D=Z3&PO=V]R:W-H965T*/15+/)]9L[O7BBW'JK$MEZ0D,V^_#0%-$-T4%,W, M3>1\^KO10`--$)+XZ=<_WEZOOJ]W^\WV_>[:N1E<7ZW?'[=/F_>O=]?_^2WX M97I]M3^LWI]6K]OW]=WUG^O]]:_W__[7IQ_;W>_[E_7Z<`4>WO=WUR^'P\?\ M]G;_^+)^6^UOMA_K=WCG>;M[6QW@O[NOM_N/W7KU=#1Z>[UU!X/Q[=MJ\WXM M/5POMX_?WM;O!^EDMWY='2#^_WAY_QMW;:O?[MX]? M'K=O'^#BR^9U<_CSZ/3ZZNUQ'G]]W^Y67UZAWW\XP]4C^C[^A[E_VSSNMOOM M\^$&W-W*0'F?9[>S6_!T_^EI`ST0PWZU6S_?77]VYHTWOKZ]_W0>`_.K+>G\(-L+E]=7CM_UA^_8_*7*4*^G$4TZ& MK1/G9CH:#4Q$GA5D8QOW.G(&8TOB&2LG,"K<@(=^\E>P)(X!@"O MRO8O]&*FG,!KVXM+A].!67",Q(%A_^NA.-!UZ48GM]LC2T(=S*CX@_?#9@ES M0#:J)\//I\#!_(D__D;/)Q@$_,'#_\GYX."$$'\H+V>['U?VG MW?;'%=1`2.7^8R4JJC,7#G&ARK%LE^ZIE0M+5GCY+-S<74.W8%'NH=Q\O_>< MX:?;[U`B'I7F@6L<4[%`A:@'PNV2`I^"@(*0@HB"F(*$@I2"C(*<@H*"DH** M@IJ"I@-N(3UMCB"[_T2.A!N1(QS=!P0Z:2Y)""K09$F!3T%`04A!1$%,04)! M2D%&04Y!04%)045!34'3`49"H/K\$PD1;F#=P4MGU8S,%#PH$92M5D0DBU;2 MIHD1GY&`D9"1B)&8D821E)&,D9R1@I&2D8J1FI&F2XRLP1`:6>O?BV!%$^IC M.FLM+$Y9`LIMSI%'7/0DBQB`FQ_MX9S9V1N2Z MD:`CHSE5T9'(SJ,EL0`:E0#?6D$I4Z4&I-+(,2FVV[PZ&@S'9 M^C?HZ%0$YNP4-_O=@Q=[01%';J2B*.1U9Z%A\O2Q%',2+9EC,*HQJ1;,L=TE73H.!48^8T$D<4%TPC>:(!1P[8]P=Q M'`LSBQ0Y-HV4(;SHPD1#7RI?\(+N?86\;F]V9DD:&2T1CN3HLK:Y4RKL,NY&8`SH/6[0!MK^R6J=&\KCFJSL:D[ MFY&Q;=#H5&OF?!*G)Q?,)W78TIU/"L%UN9TIKD=JY4(<>HE99UVJ2ZW"P?4Y M"C@*.8HXBCE*.$HUTAUBA2[3*@PUYZC@J.2HXJCFJ#&0F418;)V?FH%@U?=.6&V*)>.9%&G232(&(,0NU\ MX!I/)0DZLD:0HLHZ,EFOBK:8FT%-AU.RP`MT8PVI1)4>E$HCRZ#49OO.<.8, MR6INT-&I",S9*0ZD+B@Q\OP*9CLNK`?Q03),V',['ZDZ5V):%;KWT;V\0H\F MY%H8J/==F(MMA6,%(425W@U$',6(U,[']<@V*T&!M;$45=9RFFD5]C57"'<^ M`W(O4*")M?D25;JO%4HX54CN?B3N;D(6: MH)'1&JV?*:JL7HX*CDJ.*HYJ@QD)E$<8AW01+EF9^11(E(96#; M'V5H729+\:4*43^,^4@38H*-3$9C34YQ87C`]Y0&G,3TE.K?_D:IS-:95X<+U'>5>7J=G,U*_`_7^ MN?T/,(V.UV9@S'LT&I#0V:'6J.7-&778D+>8-V5$C@GG<;F9= MCWQ6NE`J$5NK8O=/2ZW"T?4Y"C@*.8HXBCE*.$HULH2::16&FG-4<%1R5'%4 M<]08R$PBS-E+RH*0D[(@D6BB30__U,M5AO#2JGJ2J%3&_*.7>%_Y.K/YP18- M7W3IAJC22R?2J!,J#2+&(.3FQQU/9@XY:$G0D36"%%76DEYVONSR\V6%SFQ^E.I< MC6E/H7'A^F@H+]*.ZY!;Z``%UAU!B"J]U8DXBA&IW<^0?F,E08&UL115UH*: M:15V-E=([7ZF])L_!9I8FR]1I?M:<50C4KN?X8A<%AH4G&K,G$>@NJ3,"3DI MHDJ[CSB*%<+=CS<= ML,TT6AG-T1*:HLK:YTRK]'22PT#Z3.I%@89&$+3/):ITGRN.:H6PSX.A,R89 M;-#*:*[39W-:B=/@[KU9Y\M9]@_HQ8^!Z`R3J/O-5*7JH"5'/D-@X2.9,+=1[:^?@&5JM(CZ>_ MF+C0J+,9Z2S2XUW^4JG,KZO2>QY?J[`P!1R%'$4V.#KE>^EJ%HQ-P%'(4<11SE"C4B2OE*-.&EE!SK<)0"XY*CBJ.:HX: MA?H2*4Z1_GXBY5E4]]C150B6;^>6CTS@!:H@ZQT5N2HOE6HX/GZ[S!TXY.3" MUP(CYCE.`"MB`GIYT(:KTC4JD4<>0!A"C2@;0\REC@@IK`"FJ[#=J MO2H:4XXJ&5/?Z5^!$FM0):KTJ%0:64:E1I6*H&_SC9)3$9B3]++S1W$"0"XU M"@V[XSLC1\`+M+/>WBRU"I>7KQ!<0L62=#QZ>Q6@#6PL;;-0Q:VWHA$::A33 MQJ;D=CE!&VMC*:JLG'0^LH03EWT-'$]O%&',6ZQ>/,)9_!)&AA-$5WWRFJNHN+G?AF6H7]S77KG?[2[Y`5 M:&@$0?M;HDKWM^*H[F^1%((^U:$XJ>G#YE[;'(N=TKDEDUBRRV!=H!Y/I M=&59:A6.O:^0JEF>-YF2Y`=H=&II'6^]0E3I=1QQ%)NMN4+SN#%%6(T\.BOFP)4P$PYW5JH8\)QC]#0N&[0`&)4R0`\ M$8&Y]/0SGS5",+N6C>7,<=`/.XKD%G![".].>=^`\9RZ.;+@-G,?,Q9$+?P<.3^;B?(2_`X_#.,%6_@P8/GXO7P:C*O^SK>P(CT\0<8 MJH?>H8*S[KDX`.5MP_DV#-7Q5)QT`TY'X9T^&SB.GHMC2^X-3J7GXO22OP,G MT3"\?>W`T2:\TV>30#-]/(5&^G@VF M9_BQ^KK.5[NOF_?]U>OZ&1;HX/B(FYU\(*+\ST'5W"_;`SS(\%A^7^#!E6MX M/,-`'-`];[<'_`\$=-L^"O/^_P(```#__P,`4$L#!!0`!@`(````(0![^Y=; M!@,``.8(```9````>&PO=V]R:W-H965TKGM%RT8;HK21&JFJ>GGV@@$K@)'MS29_W[&Y=/%NHT3*"\;#\>'X MS.!A<_U<5^B)"LEX$V/?\3"B32Z,BUI3:3#6]K`DYR+FBB8BL*5K:`D,XOJR@T\ M;^'6A#6X8XC$6SAXGK.4WO+T4--&=22"5D2!?EFR5@YL=?H6NIJ(QT-[E?*Z M!8H]JYAZ,:08U6ET7S1"2Y\H!.K<3>K[GM;MV M@6F[R1CL0-N.!,UCO/.C9(7=[<;X\YO1HSRY1[+DQR^"9=]80\%L2)-.P)[S M1PV]SW0(%KMGJ^],`KX+E-&<'"KU@Q^_4E:4"K(]APWI?479RRV5*1@*-$XP MUTPIKT``7%'-=&6`(>39C$>6J3+&H>_,EU[H`QSMJ51W3%-BE!ZDXO6?#N3W M5!U)T)/`V)/,G%DP7ZX,R2L+PWXAC,/;%__>?K[0[=0;,VZ)(MN-X$<$!0;Z M9$MTN?H1D`TN=`RC+_^S!?S0)#O-$N,E1K!C":E\V@9K;^,^@?]IC[DYQ_A3 M1#(@=-I`WJ@1W/D`C9I%:]2IU*)OAL"):$O0@+`%@5$?($BS@.TPO.):#YJ= M@.:6RA%BRX1%IS(O5_:00@TV:D9_^HAG\GGE6_E,^L>0M(OR)QF$+^)4B:ZR MP`."=Y:9IIEJ[",PG(BPZVH$V08MIK)>-TB#IR_O(K-P+*GD-#(Q`#Z-,P-6 MG@/*WFF!)IJJZ"-3"P*K1D:0;8'N9O;W[T'=OU.6IIG*ZB-36:$E:P2-LKKS MNCNB:BH*FM"JDBCE!WT6KZ$6Q^C8)G:!SH`5OX'V80Y;.QY$R27\+HQVIMW8 M^#!*3(;M^#Q*3%^PXXL(RN""GF64F,/'QJ_Z-N>.#Z#-M*2@#T04K)&HHCEL MW7.6X*7H&E4W4;P%SZ'9<`4-QMR6\#]!X7`SI95SKH:)-GC\0]G^!0``__\# M`%!+`P04``8`"````"$`H6\S.;D*``!#,P``&0```'AL+W=OKW]_6D`CI)RUWW^<'A]NNW_YR_GCUF_=[[L7A]V+_EK=MO_D9W[?][]^U\WW_+3Y_-S MEEUZI/!ZONT_7RYOUF!PWC]GQ]WY*G_+7NG*8WXZ[B[TZ^EI<'X[9;N'HM'Q M96`.A]>#X^[PVB\5K--'-/+'Q\,^L_/]EV/V>BE%3MG+[D+QGY\/;V=6.^X_ M(G??MCGQ_?2.+3X>5P^5&(]GO'O>4]O>:GW:<7NN_OQGBW9^WB%Y`_ M'O:G_)P_7JY(;E`&BO<\'\P'I'1W\W"@.Q#=WCMEC[?]>\-*S5%_<'=3=-!_ M#]FW<^/_O?-S_FU].CR$A]>,>IOR)#+P*<\_"U/O02!J/(#63I&!^-1[R!YW M7UXN:?[-S0Y/SQ=*]X3N2-R8]?##SLY[ZE&2N3(G0FF?OU``]&_O>!!#@WID M]_VV;Y+CP\/E^;8_NKZ:3(C;]N`A9%I'0STID[]<(H&Y;@KAK&]N^SN M;D[YMQ[5!NJ?\]M.5!K#,J@J\0`NAUL]I'\VHFDH"Y5[(7/;I\!HL)YI&GZ] M&QG#F\%7FCK[RF:!-H9JL60+,4^$K*V#E0X<':QUX.K`TX&O@T`'H0XB'6QT ML-5!K(-$!VD##"@]=8ZH./P3.1(R(D?(!\0'$@`)@41`-D"V M0&(@"9"T291<4"-=%3KU,.[J6636B#7*Y;18B:FY+ MTNBE)1"[)&.:V'4BC?FUVB6KVHB[Q`&R!N("\8#X)6F$&``)ZU8=(4:U$8>X M`;(%$@-)@*0E:OB&?9UE_5J625"3#D=A+50YTNXH MJJ^S[*:69;*M28>CN!9JOZ.DOLZR:2U+1)G(A]1(%&'?"BM6#Y" MM$&TE:A#/I96+)\@2A6DIEH\=>N%?#03QW5MM;N9]?)YG9[?V/-"'#=1:3#I M1YU/4Y]:R\K*H,?+VJHEZY6\W%^M6'Y:5(?I9#C5SE@\6FE"*+Y3]E@ MC$-.G(8TJ]L["UEU>-(L:24RY_5X6(H3*U'EFFL;I-NNK$;-@50V;"!':O'M MKB7JJ&$NRGN(?*G%\H%$'?(A:D6(-E*+Y;<2=6KDJ^6K^N9"86DDBYJ9_&( MM&:=3F\N6TEO7H7,TMML;(ZUQ=+G1M);P*C36\A6TEND>IO.Z06>VFT;;B2] M;1EU>HO92GI+5&^S\7"N[2Q3;M2R"HD#H69):)R]%:/GK_R-AL6[NQ\AHPV? M$BFEHD8=L\$6;TQ):U2^(15O?E:(G`HUY-<2=0A\A$%B$)$$:(- MHBVB&%&"*%60FAZJXDIZ&G7UG4R)EEHI+5'SK89X.T]6#60C6B%R$*T1N8@\ M1#ZB`%&(*$*T0;1%%"-*$*4*4M,B#GE^8=8((A]1@"A$%"':(-HBBA$EB%(%*;D0CYZ_D(O"7,U%A1J'STN)9%'#IY'* M2GG[8W(/Y)6'/T&T191 MC"A!E%:HY51=/#`H>6V4OH\_D!0J6KK+,[!&ARTKJP:R*_3."Q%IQ;WC(%HC M(*$(6RH4PDO+N)I!6'ND&T110C2A"E%6I+Y#]R0F7B"14CVH#4 M.P]CI+W&6[(5K70-*^VTQZZLQC]]1R(-N/LS4&K]Y%V)-&#EC51FM)6HPUDLM=KO+)$&K)Q*94)J:1='.\UE5I0` M02TF=&58B.G7:$/ MQ>^+`Q:-+^@#\N)K:YV;]&%YB^_[D75/SUPQ.K<=L6@*VW!TM)-T;9=H6)JK6A6HQI5/DL4-[Q"9VT++$BXY5P:B5M@R6< M64G;4$EI=+5Q>VZMBE-R;:BXIK?XG5OT\AMY/+>2-KZ86HLVO\NI11^) MH(X]M>@SG!8^L^BK#N3^U*)O.Y`'4XN^\"`^J&^,_H3A;?>41;O3T^'UW'O) M'FGZ#HL76:?RCR#*7R[54>*G_$)_O$![._K`G/Y8):,3OJ%8&A[S_,*_"`?U MG[_<_0T``/__`P!02P,$%``&``@````A`.<<9Y*=#```HCT``!D```!X;"]W M;W)K&ULK)M;<^(Z$L??MVJ_`\7["=C<74E.!=_- MG3J[^\P0DE`30@J8V[<_+:2VI&ZCD-GS,DQ^_JO5:MW:LGW[Y\_=:^W[YG#< M[M_NZMY-LU[;O*WWC]NWY[OZ?_Y*_NC7:\?3ZNUQ];I_V]S5?VV.]3_O__VO MVQ_[P]?CRV9SJH&%M^-=_>5T>@\:C>/Z9;-;'6_V[YLWN/*T/^Q6)_CS\-PX MOA\VJ\=SH=UKPV\VNXW=:OM6EQ:"PS4V]D]/V_4FVJ^_[39O)VGDL'E=G<#_ MX\OV_8C6=NMKS.U6AZ_?WO]8[W?O8.++]G5[^G4V6J_MUD'^_+8_K+Z\0KM_ M>NW5&FV?_V#F=]OU87_N/^]AR@_VXW/X[&_VO'E_V/]+!]'&_?-A!MZ"?1`U_V^Z]"FC\*!(4; MK'1R[H'YH?:X>5I]>STM]S^RS?;YY03=W8$6B88%C[^BS7$-$04S-WY'6%KO M7\$!^+>VVXJA`1%9_;RK^U#Q]O'TUA_Z,&DQZ&S/%])980+_#` M&(Y,V:_E6+TT5&&,"BL/PLQ='=H!H_`(\^O[?:O9OFU\ASFQ5IHAUWBV(D2% MF`#";$1!3$%"04I!1D%.04'!B((Q!1,*IA3,*)A3L*!@:8`&=$_91S":_XD^ M$F9$'V%TAPATI_FD0U"!12(*8@H2"E(*,@IR"@H*1A2,*9A0,*5@1L&<@@4% M2P-8'0*+Q#_1(<(,S#OX,69-Q^Z"H1+!*E.*B"0L)64W,1(SDC"2,I(QDC-2 M,#)B9,S(A)$I(S-&YHPL&%F:Q.HU"*'5:]6;+ZYH0GWN'`SJ4!'8#LJ>\/I- MN[O"4H3%(D9B1A)&4D8R1G)&"D9&C(P9F3`R963&R)R1!2-+DUA]`4&T^D)N M.S=BKW5WBRAH=XLD[7/V=MXU0D8B1F)&$D921C)&$6,P#,2,1(SDC"2,I(QDC-2F,1J**0EGVBH M4-L-E:2E=\ZP),92T.K;2T&D1)!4&>L%27GB4H3K15+:1I*6Q#!$:\M*0X:H MW[)=RDL1VBY*VT"LH(';GPB:4-M!D\0,&B.1(O!C1(CD('$I0I\39BAE)"M+ MF:9)1IJ7(C1=F(:L<,#-R"?"(=1V."0QP\%(I$B_S-!B1A)6*F4D*TN9;2=) M0UZ*RK:;AJRVB_LJJ_'&:GUZV:Z_#O?0?Y"]5JP@+;@94+<(PHH=E+-AN)5#UH>VAYY"ME,]VZE0J7P(HW:=+@.15J'Y&)'HBN_W7KO=:@]Z)&])4`0[ M]F7K*:J9^2=B+A-Y*^82M:V6 M],D2'HJ#!#%FX>=R5"*MTC&7!?V>O!>&F^%.ARS&"1:#?>NR\1153AF35I78*$NCZ](HC\17Y5SFV-:(7M,#^P>#L6]#\3WHS%=JK!Q ML2Z(*.$HU<@1X4RKT%;.46$A>S"*+/<3P5))L1DLB7Q8!_1(&)`I&HJ3IBL& M8ZG"UL2J(`Y&K]GODA4O0=L?C,72MN$G78(RM*43PUPA-1:]]HU/)D.!A2K& MHDA@S?#^WNXCTV#H10S+4!S`0CQ;=M3),A4JU4=#5-H"%9J/L:!HL)`]W47*;$;F]\:C M3+RM\2B1O24-2#H5N*R%EAABIKF^)[OG0>]R2_8L]7S:M8!T1N[HK[7_OW2UFHF7_)%-\*O$36 M2"V1,\I2U9*/;,2)=2SZ12PJ&B4*&>93C1SF,ZW2([7T"U%AJ>R1*C)Z'C%\ M:'/]X;ZP<\[M)ME"AIY2F8L9R>A"K4'W(XYBCA*.4HXRCG*."HY&'(TY MFG`TY6C&T9RC!4=+"UD=*38?UI%^YP96[T\^ISE;.GF=WBSFY\>3=G[AF(]`8;)OE`WED:FZ4MD'B-I9"QJ-&>.E*IM;EG>@&Q:L5;A3$PX M2CG*.,HY*A0RO!]IY/!^K&T9J@$Y-IIH%7H_Y6C&T9RC!4=+A:3W=K^*FT6S M7W\K3_:%%;)A260$+%0J`T4*M>UMC20ML59A=!*.4HXRCG*."H4,OT8G',TXFG.TX&BI4%5'BIO$_[\CA172D0I!RJ\SCQ89P*%XRT@4 MA,S74)$;ETBIVEUYVM7TR*UNK`48OD1;1I1JY*@LT[;$B:K?],A-6JX%:+G0 MEA&--')4-M:V5&6D91,M0,M3;1G13"-'97-MJ[IE"RU`RTMM&9"]!(C;=G/D M?+#-RKM\:YM5R#Q&[+/<5(I$%N8:(54J>H<:^U*%9R9->F2CKHO9H4/H2]%'JV.IPL;&JJ!:"OMM8CA!PYH)@DOU MVV--',Z98^WWDG%UQ&;L59A_1.[?L_K#,@DG&(A9P!F MJ'(Z,-A.R$\R^U[!H6@5O0QU,C1NY%2 MP0\6C#E*M"U4I1HYS&?<5LY1H6VA^9%&#O-C;FO"T53;0O,SC1SFY]S6@J.E MM@7F[7ZM.N:$5P[$K<'U;PB))['D%E$A\HR6S,(05<[A'2F5O1'25#)&E5QW MN_T.673'&TY?5J@JO2)I6>HN.23/:9A-%E;Y@=KE9"3M4HB M:ZTJD6,Z1O`IFK`%\PWG<4=''S= MWY88/PLV%5<\9N!>"!4=06^,H1G$OP*?'[X4%T+5%*A M'_I@J((_M(('."?C%0Q;\'UC%6\'R_.['[1YG6!Y?H)-.)Q,!^($D]<`I]&! M.!^NNM*&*U5EX/`8VE%U!8[S`G%BQZW!V5L@CM?X%3@H"\19&+\"IUK@0=65 MHA<4\&8G+S($UX:5KH5P19PW\S+P.`%*= M5GXA[07BS59^(>L%\()W!>\'\*9S!1\$\!9P!?>:05Y9P[`7#"LOA+T@K+P0 M]0)XQ9W7$?4#>+&[@@\">.FY@H-/L:RA48Y)^$+V??6\F:P.S]NW8^UU\P3S MN'E^MGJ0W]C*/T[JQ9`O^Q-\&PMK-'SF"-]";^!]C:9XAOZTWY_P#ZBZ47Y= M??\W````__\#`%!+`P04``8`"````"$`Z@3.>JT"``#^!@``&0```'AL+W=O M7SS9CA:W;S(&CUS;81J,AP% M(4:\82H739GAW[_NK[Y@9"QM0-?"J4EM;#5)3&MYC3W0;(F<1C.B:2BP1U"JM^#H8I",'ZG MV%[RQG8@FM?4`G]3B=8,:)*]!TY2_;1OKYB2+4#L1"WLJP?%2++TH6R4IKL: M\GZ)KBD;L/WF#%X*II51A0T`CG1$SW->DB4!I/4J%Y"!DQUI7F1X$Z7;&2;K ME=?GC^`'<_2.3*4.7[7(OXN&@]A0)E>`G5)/SO4A=R8()F?1][X`/S3*>4'W MM?VI#M^X*"L+U9Y!0BZO-'^]XX:!H``3Q)X&4S40@">2PG4&"$)?_'H0N:TR MG(!IQXV]%PX*([8W5LF_W($1)&R@@L_K>#E?D6>0G?4^M^<^T:G'=O!PU0)Z(T<0YP,X.A3'T0&40R^G[@98M[&J!:U@&"D+ M`\B_5O"?X=#]80"2%$K98>.$&?]&PO=V]R:W-H965T%TI):V.J2F%9SFOL@ M69,X#&=$4M'@CB'3[^%012$8OU/L('EC.Q+-:VI!OZE$:P8VR=Y#)ZE^/+17 M3,D6*/:B%O;%DV(D6?90-DK3?0UY/T?7E`WF4L MJ4<'?_'D5N*[B;!_$BC=(9X-&>&WLO'"=&[&"LDG][E%,U MLL0]"ZP]RS*81^$RF0/'&W%)'P=K'Y?,@G0>)I%[^7D@Z=1[,^ZHI9N55D<$ M#0;R3$M=NT89D`TN=`RC+_^S!3)Q)%O'LL9SC"!A`Z5\VL3+Q8H\@?^LQ]R> M8Z+7B-V`<&4#>:-&,.<#-#H6I]'9[T3?#@"!L14$!CU`8(<"]@.RQNN M]:#K$U`Z43E"IC(AZ%3FY2NC`7LWH3W\2^GI>1PG,A83K2.H-&B;BYTGX+DNN0[7M<&,75PW_P, M-)^#)(Q`,902TO^ MG>I2-`;5O`#)8>!&ANX&6;>QJ@6O8!8I"_/'WU;PO^'0_*'SOE#*#AMGS/@' MV_P#``#__P,`4$L#!!0`!@`(````(0#%4]`#``<``.D=```9````>&PO=V]R M:W-H965T2J7"8^ZP] MGATPP17`E.TD,]]^U6ZK<4N.DZF=ET!^_"W)DKK=[;[[_N-\JKSY41R$E_NJ M63.J%?^R"_?!Y?F^^O=?[K=.M1(GWF7OG<*+?U_]Z=3W3*, M5OWL!9>JM.!$7[$1'@[!SA^$N]>S?TFDD<@_>0G$'Q^#:XS6SKNOF#M[T3G#?/\R&MT/;Z3_,_#G816$<'I(: MF*O+0/D]=^O=.EAZN-L'<`*^G9!N^C_W@^9A` MN9MP1^+&G/W/@1_O(*-@IF8UA:5=>((`X&_E'(C6@(QX/]+/]V"?'.^K5J?6 M-HVNW08K3WZF5;,Z3;/9$EY+KFQE5\(8R*XL]]3-]/#YBYY,J*=, M[RTUY;Y,3(/X@MX:-;-A?'97)AB6ON#^OG1?9ANO@"_HZXLY-"%YTMLG6:S+ MADO[=^`EWL-=%+Y78%*`EHJOGIAB3$=8P\Z5A5.]_%$K0P\+*X_"S'T5;@"Z M-(;Q]_9@&^V[^AN,F5VFZ7&-J2OZJ!`#1)@=4#"DP*5@1,&8@@D%4PIF%,PI M6%"PI&!%P9J"#07;'*A#>52-H&M_1XV$&5$CS&X/P:UH%BD(*O"2`05#"EP* M1A2,*9A0,*5@1L&<@@4%2PI6%*PIV%"PS0&M(#`I_(Z""#,P[N`C-VHZ>@EZ MF0BF%25JZI*^DJ@R,3)DQ&5DQ,B8D0DC4T9FC,P963"R9&3%R)J1#2/;/-&J M!BED5;.:-?64^O)D)PRE=<-\]S("IE21;*-+RJ1$>-F`D2$C+B,C1L:,3!B9 M,C)C9,[(@I$E(RM&UHQL&-GFB58F2"(KD]FLB850\7(*GT'B0KTLDC32A5_Z M0.DS,F!DR(C+R(B1,2,31J:,S!B9,[)@9,G(BI$U(QM&MGFBU0#6+EH-RA,O MU'KB,Y)+/",#1H:,N(R,&!DS,F%DRLB,D3DC"T:6C*P863.R862;)UKB807U M"XD7:CWQDMBWAWQ?D=O49-KD(3.0H@:,235_68:MSU]#)<+YRV5DQ,B8D0DC M4TER4<\4N07$HIXK0SE1EZPZ%TJ$42\963&R9F3#R%82&;561%A&:T64:^IT M!DN.P>ZE%T*68;%7,*IL6#O+%;4PHM=6DER6^HP,)&G`P%:%-+LM4D@EPI2X MC(P8&3,R860J22[$&2-S=55)B`LEPA"7C*P863.R860K24'58%_Y_ZLFC.A5 MRP@TRZTB-FG2?B:"V'(B.DBEJ-%*MU>68=+QJ7['G+G*+)*1(B6.QLJ0V,>! M([(KF*C?T>Q4F44R4Z3$T5P9RAR1.UJHW]'L4IE%LE*DQ-%:&2J^HXWZ'HN(C3Q]J2)W&I\T MBWP#`#M"#*-G2M3(QV\9I*3]3`6O.$N;)3.OJ9HDB MLTNT4QK3"E6E,:T+532FC1X3#$:+Y&F+=CZ*2>]CB$GKXT^Z5\C)5)J+MH4+/YOJBE0T!4.T)8=MTVK3QZ2+BOQBETVL(U3EQQU3C0M5-*8)JF1, M5L,VR9B;HJ(TIAFJ2F.:%ZIH3`M4R9C@A,#HD/7&$B6E0:U051K4NE!%@]J@ M*BM>J]TR]*>B.,1)6^6CF&3_RG,:^9[[[$?/?M\_G>+*+GP59S#09P]W"JL# MHL=TMTIX3QP"@[>H]^PLO>@XN M<>7D'Z`)C'0[%LFC.OE/$EYA]H*3LC"!([;TZQ&.5'TXB##$6\)#&";XCW"@ M#FD?_@,``/__`P!02P,$%``&``@````A`(=F6J)<&```T($``!D```!X;"]W M;W)K&ULK)U;<]NXDL??MVJ_@\OO)[;N-BO)J;%X MOT@DZ^SNL\=1$M?$41EG?OSCCR8:!`&($M__\Z^G M;Q=_[)Y?'O??/UQ.WEU?7NR^/^P_/7[_\N'R?_Z5_N/F\N+E]?[[I_MO^^^[ M#Y=_[UXN__GQO__K_9_[Y]]>ONYVKQ?@\/WEP^77U]KZ?7U\NKI_O'[I76(GD_QV'_^ M_/BPB_CC%[NG^^;???_SC8?_T`RQ^ M??SV^/KWP?3RXNDA*KY\WS_?__H-SONOR?S^`;T/_Z/LGQX?GO)Y]_G#Y2^3J%_.+J\^OC\TT/\^[OY\\?Y] M\?)U_V?V_/BI?OR^@]:&/)D,_+K?_V:DQ2>#H/"5*IT>,M`^7WS:?;[__=MK MO_\SWSU^^?H*Z5[`&9D3BS[]'>]>'J!%P>;==&&<'O;?(`#X[\73H^D:T"+W M?WVXG$+%CY]>OWZXG"W?+5;7LPG(+W[=O;RFC\;R\N+A]Y?7_=/_6='$65F3 MF3.9D\F[U>3Z=K8"CT`Y.'JH'/ZZRB>S=Y/Y]=+4'2BW=.6@$V/0)]5WZ\K! MW[/JFT!:#H%.O&8ZJ<8)-HWYAZOSYMWT9C%9O'62$VA-6RDU*_PKT"PF[[:$ MUZ"GUH9M.H%_G-6HDQ76"O\XKUDA?S;>$Q-Y93OOX5J([U_O/[Y_WO]Y`0,, M=,^7'_=FN)I$$S##J\`VUG!='+LLX'HP+K\8FP^7@]<07J&',&E\Y_(D;$Q.<+6O4-`29N*A*`"B\02)!*D$F02Y!(4$I025!+4 M$C02;"382M!*T$G0>X`E!$:D_T1"C`U<=_#'NVK$-7'G1#!^#:*%R-(@&=*D M2*)(JDBF2*Y(H4BI2*5(K4BCR$:1K2*M(ITBO4]8UJ`)5=:FBW?##?/DP`VO2*Q(HDBJ2*9(KDBA M2*E(I4BM2*/(1I&M(JTBG2*]3UC#PPSJC(8W:M[PELS`?QB()K.5N%\X$?SQ M1#=<%#L13`D]T2T7)8,(A[1T\$:2#<0W$K7E@Y$GFHM;83&(T+LC#R1+*V9A"A]V;P1K)5I!U*^=9+WFS=($*CWC=B'0+:_XP.8=2\0U@" M'0*K6CM"\\#8$?A#J9Z+V7LRB-`H54:9(OE0RK<6-\9B$*%UJ8PJ1>JA5,"Z M&41HO5%&6T7:H91O+:ZB;A"A=>\;L23"JOF,)!HU3Z(E?A(=\9+HR,V0Z$21 M5)7*%,F'4OZYSW@'+@81GGNIC"I%ZJ%4P+H91&B]449;15I5JE.D]TNQ])A- M"I8?NP@^3#E>OSX^_':WAPL#5F2[21RILY!(1V5<:U8BXO5B/-*1"^PTBLM]JU"*B MEN@TZA$=O'@BS0K:W\T821ALD`T9LPMN6(!AG'<3A_@)BOO'VJFFD'%J97F7 MB4F%]HE&J489H8!]3BJT+S0J-:H(!>QK4J%]H]%&HZU&K4:=1CU#/*]F(7Y& M7NVZG>75HBFDES(V%].9M=FD-)SVZD875-4P`KW>"_*4!4<0W)4,2\94X$J6,]1 MC0LQS2I1Q;QD[ZY0%8RK1A7SDG$UJ`K&M4$5\Y)Q;5%U^%#G<,=M"?FG+1+6 MH>IHPGI4'`N`]UE0L3[[:_/9Q@E#U*#"BSQQ!:>K M0[^=K)8K<=M.T9H%(/.0H8I=<5*5HXIF/@4&`+/D4"=UD0>#J-`^&$2-*@JB M.2F(#17T0I7GN$45[7*T&G58X]%V[['0L5/FW<_LV9PQ9-HM'NCAV!'NS&== M9C"D2=::4.!\8Z>:T168:)22%]:8$0K8Y]JKT*@D+[2O"`7L:^W5:+0A+[3? M:M3J@IU&/2O(DPBI9DG\N3'$N(@QQ*(9F^8LQ`UJ;3ZHA(*SX-43.Q7<-+$I M$D1V*%U-%K=B!I6B`JYBNLCEE9.=%$!.7AA`@2AX0RE1%0RB.BF(FKPPB`91 M,(@-JH)!;"D(M&^Q(+5[A^AHN_>H.%8;[WYFM^F,,<1N3K$QQ"(VA@PHD/G8 M?.1MNAZ=7*)1ZI!GGQ$*V.?:J]"H)"]L](I0P+[67HU&&_)"^ZU&K2[8:=2S M@CR)9K?IC"3:S2F61(OXFF@A9@5K\U"`&67@S_$K.D85W0L3C5*-,D1!^QQ5 M9%]H5&I4(0K:UZ@B^T:CC49;1+3KUB(BKTZCGB&>5[--=49>C5S6-5;-P'GY5^O#MG!Z&8^7:B;@%,<&XP.L_?LI`!RI_+N0@46M`$LQ6*O MQ!+!VBLT"=X#:_2BTV^P("P6Z7I8B,WA#19D02S$/M(6O:BOM%B0:NP088// M)L*G1P6KS;OKL@YF5L%G=+"#G'H/8C\U MP35W)C&V.<3'MJ58\J^=ZHVQ#;WH4DL0N:%E/KT5Z^\4%<`]*H[5QOL=G#+K=^$/`$PWDAW,(F_JN78J0-[EZ/7\0\ICI_)GMAJEY(6M MDA$*V.?:J]"H)"^TKP@%[&OMU6BT(2^TWVK4ZH*=1CTKR)-H]F'__X.'WKB@C@VB;O1PJF`$ MN8Z@<`CO6[=J^#BE^@J-@]77J*(&:*AZK^66XH+>8$'6!OJ^-;0!=K46"U*- MG4/NOC6?K"8WHKH>2['JO*N7=ST895C7>V/\,'(Q-[*(C1\#\IK%B\"-'U;% MQ@^%TNG@A2%]A6A@'VMO1J--N2%]EN-6EVPTZAG!7D2 MS0:G'#^F2_,MCHO3/\XW:IE;A]B-8"EWUUS!\+T_=BHSJZ)11GZ`DJ#*WA[G M-S?S6S%F'ZX@L'J&_2" MT8":20\I0Q"^2NQD;-&+QH_6H7`6.E0-65C=B"ST*#DT`^^-,/"HWNB>9SWT MQG_M?\`0,OIP";CBLPIFL26[HT5LJ!F0UQ!ZJ+&JF?U6D_FB1>+L/90ZY-EG MA`+VN?8J-"K)BSK.*='7VJO1:*/MMQJUNF"G4<\*\N2:[4Q_J'GC?F%W/]F< MQ*(Y?4"SAKN92;6'8HT2C5*-,HURC0J-2HTJC6J-&HTV&FTU:C7J-.H9XKF` M^]VB`:(]52A6*-$HU2C3*-"[,#N`9UX7=,&37A45O/,ELUF20Q!E<,71[T..=4T$N/978KTK0BW9*4D3T MU%I&R/<2&W(YJEB-K(!4.@24BJK$B%*BQ1E6PQH946.,&$=6XU:A%Q.W% MGG)'*K3O$>F']6`J>DX?.J0_W@E(CJ;&!$/72R-$E)AZ"DB\LHTRA%Q M>S$_*$B%]B4BLJ\TJA$%[1M2H?T&$=EO-6H1<7NQF]V1"NU[1`=[=NV;#Y_/ MN/8/(R'ZK M48N(3KO3J$D0OM"HU*CBE#`OB85 MVC<:;33::M1JU&G4,\3S:O8MSLBKW>9@>74['RQCZOEG6-8?LL_V6G1>QU1J M2PJ]W&;(]7PBYCHI*J#+'>]%&:J",>6H8EXRI@)5<`)4HWK^&57,2[9"A:I@ M7#6JF)>,JT%5,*X-JIB7C&N+*OKPK"7DG[;X,+1#U=&$]:@X%@#OLV:3QN^S M/S=9L%L]K"N[W1_XXR51S,'69D%H9AFLP\O&BDF%%WGB$.P?F.?VE[.E?+0Z MQ4(L`&F=H2H80$XJ#*!P"$8#$X!8,998(%AYA:I@Y36J:/[<.&16[%[CBBMW M0P4]E6R!+:IHFZ35J,,:A_:6G]+W6.C8*?-N9S;%_&X7WFDS.P)R,FH1+$@Q M)6NG,FM4:A5YOK%3P8H'"R8:I>2%JHQ0P#[77H5&)7FA?44H8%]KKT:C#7FA M_5:C5A?L-.I909Y$Z'XLB3\W=A@7L6*TR"QQ*)'JN>>94P6OGMBI8'*+39$@ MLD/HY!I^9TO,^5.4'!M#[2>[)T60HQ=%4&!!&X$:/.R)F8_$Z/1E/Z[0(WCZ M-59.'^@TB-ZXC9T2Q):"P-9MT9Y.MT-$#;X2-X(>)"J5.Y=EGA`+VN;8O-"K)"UN](A2PK[57H]&&O-!^ MJU&K"W8:]:P@2^+\O`W#@YPGT2&^"E)//&-!Z,_'KZ8857073#1*-US M5)%]H5&I484H:%^CBNP;C38:;1'17E.+B+PZC7J&>%[/VS"\08+LB#48SWH17VEQ8)48X>(&ESL MX/6H8+5YN>0=#$[YC-$??B]*COX.F0^"J>O(Y][76#!XZ<6HHB9(T-X]\0P_ M<3D1.4ZQ%(O`.V'7PUSHP0AR]*(("H?4'+O67->S MWN$(J=Z/B"O6;P( M#NT9.Y4_M]4H)2]LEHQ0P#[77H5&)7FA?44H8%]KKT:C#7FA_5:C5A?L-.I9 M09Y$L_?J;V_\W/!A7$1N+>)37O7,\]P5#`[<,:IH&$T<5UN)IPLV6)`% MH<>/H0VPJ[58D&KL'!J:?'E[*[9\>RS%JO.N7M[U0,6Z7GAM/#=RT<$`O:U]FHTVI`7VF\U M:G7!3J.>%>1)E-NC9OPX^YGGN=XU101;%M[]44S'UTX5OOG'3L4_-I8?FB2H MLO?'Q6PROQ5KC10E<).BH&3ORDX**D;N.B!QWFQN/3`8U60/NRC+9Y0,(@.54.NKN7C\#U*6`1>KG@W MAO&7C47R-GC:P])S8R/&*(N\063M5(`"O2AV*OB,#-LFT2@E+U1EA`+VN?8J M-"K)"^TK0@'[6GLU&FW("^VW&K6Z8*=1SPKRY)IM3SW'P1FC1XWK%&B4:I1IE&N4:%1J5&E4:U1HU&&XVV&K4: M=1KU#+%$+L[;B#W(^=6(""8\-("OQ#1F3:HA/1HE&J4:91KE&A4:E1I5&M4: M-1IM--IJU&K4:=0SQ-,C]U.]030\MUOHK56'8"\$<[#6*-8HT2C5*-,HUZC0 MJ-2HTJC6J-%HH]%6HU:C3J.>(9X6LR_E#W]OY,)M8]$70^X6#OFY4"C6JD2C M5*-,HURC0J.2(7[.9OOCC'.VNR7^UO["(O.L`(T4ZA?-407S&$\E]@]C5/%% MGMCK24B%/3Y%1$]O9H0"->:H8C7*)6I!*JRQ1*2?\5S`#8TUJ7=UG_[MQH.+ M&).-,?^Q8J>"#_0QL!@1FS2I'PLG%19,$9%7IE&.B-N+^7]!*K0O$8TTF%E5 MG]$'W2+%/;R:RM@Q5 M;!8O5?FH2L94H.IH3"4JCL7$AP:ST#\C+79?@`T-%ID/%NFBET]UK1>N(`R4 MI))-$),*>U3BD-MG&?O!3"P$-1RWSE`5#"`G%090O!E`B86.!<`;W"SRSFAP MNR9D#>X0NPY68K]OO;"JMZZ#087GFU!!1*E&&:%`H^>D0J]"HY(AWEAFN7A& M8]G5)6LLB_C&JWR*9;UP!8.=(R85GDWB$'Y^=3.YD9\BI%CJ6.^P&Z^H"D:0 MDPHC*%0$M[=R[Q5+'8N`-SETJW.:W,C%'>"8=$YY?+;RP8['HQJNAIU@3MX>*A@5<^[YU204\E1_X,5<$@:0O\U%:#P".R]Q*F^O/-$H)2_LDQFA@'VNO0J- M2O(">]XRD!XV./Q<3S4NHJ=:!,^3X!FMEQ:]L9GM5'P8D9.F!%7VBAW]`0^4 MT`.7V4D1Y%B0SW_$D%2@:HA`_7A%B1+]XQ7P_MUPLY^V'WNP$>UNUW6LHPXH MT)-BY^7OQVJ4.N399X0"]KGV*C0JR6OHJ/8]P_;=JD^[YR^[]>[;MY>+A_WO MYAW"JPD\7S%@]X+C^6WT"SB!A3@"FY>1V7\;.;*XCLS6S]@1>%\R[#[H(_`B MY5\.6P:R%B@PIK^;1OV8_I=9]`OL[NH*[F91/WX:_M M1^9;^2-'9M>1^5[WV)$)'!GK&/#]5#@R5@]\"SXRWW'7;O#5:C@RY@;?U84C M8V[P*PB1^4*N=H,?0XC,]W+U$?@!A,C\O,'($8C-?$%^[,@$CHS%!E_TA2-C M]?301>$%1-KL#@*X&RVRAB/KT2,Q'#&_.Z'=X%<+(O.;!&-')G!D+.@8@C;? MG-9EX(D#VU5DWNJD#[2K MJ!N[K-N;J!L;4%KHM6,UPPNB(O-&*%U#N8K,*ZST@6H5F1=9Z0/U*H)7_(WP MFPC>&C?"H7^-Q03OQ(K,&Z]TB705F;=VZ0/9*C+O[M('\E4$+SDA69=Y/I.N)5E(S%%-]$R5A,,73IL9ABB,F\ MUPQJN!I&]Y>/[W_82<"+RG?WGW;PTU77Y@6^G_?[5_P?4\&?^^??#N\Z__AO`0```/__ M`P!02P,$%``&``@````A`!,=`DHR`0``0`(``!$`"`%D;V-07B^CVJ^TVWR"=@1KMP:,YN[RH MA*6B<_#H.@LN*/!))!E/A:U1$X*E&'O1@.8^BPT3PTWG-`_QZ+;89;C[VX`I_V?%X;DK*E5 MV-LXTZA[SI;B&$[MG5=3L>_[K"\'C>B?X_7RX6D8-57FL"L!B!WVTW(?EG&5 M&P7R=L]V;ZY-O&\J_#NKI!CLJ'#``\@DOD>/=J?DI;R[7RT0*TA^E9(B)=>K M?$8+0DGY6N%3:[S/)J`>!?Y-/`'8X/WSS]D7````__\#`%!+`P04``8`"``` M`"$`X=XWH*`#``!U"P``$``(`61O8U!R;W!S+V%P<"YX;6P@H@0!**```0`` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````"<5DUOVS@0O2^P_\'0O9&3 M31>+0%;A)NXV0(,8E9L]$HPTMHE0I$I2WJ2_OH]4;,L)K:"]"!0Y7YSW9CC9 MA\=:CC9DK-!JDIR>C),1J5)70JTFR;?%IW?_)"/KN*JXU(HFR1/9Y$/^YQ_9 MW.B&C!-D1S"A["19.]=X)CA9.E-C5W^#6K5"^7HJ0K7;8U*9>> MC<=_I_3H2%54O6MV!I/.XL7&_:[12I<^/GNW>&H0<)Y-FT:*DCO<,K\1I=%6 M+]UH]EB2S-+^88;H"BI;(]Q3/L[2_F]6E%S2)0SG2RXM9>E^(_M,W"=MSH6Q M>;9Q%QLJG38C*WX@;6?)Z)Y;\N%,D@TW@BN'L+Q8]Q/6LK'.Y/]I\V#71,YF M*02ZS;#LR_;7XCP_?Q\DL#J4]!:Z2'!P&.-".$GV=CGGQD5"/G_?CSE$T47< M!;1%D8$;;*8<\L6N58>VT/W(=W>XU`!:6:H85E9+47&'GX]<ZE]R\ZP2=_.16V&97K*Y(0LZ!W)%`[KAYH$$#&W(.L]^ M]LPR$54IUMP0/(1]Q\X73YL-:R0A6SV?<62$1MSKA18*AE0GMUQV1*[(6Y;@SRK0_KN$+U&=ZF)+?@C'?![)_"O MUM7_0LI`K&OD5:V$3]W4VA;?"-"@V3(DZY(ZQ`,I&@ M([&\)L>0^&N.#$D/4R5^AR-<&7(SS(BXFP*O4-6"-BC0GDOT)S;=\"@B?94; M[OP3`(2]@2NZCX-X#)!I54'Y32^OU7]#Y;M:F??:_OW#ST% MY=^TIERC#5D65?E*I48=2!&Z4Y%]XD/#"^W-%/T1JNXRK;R(#X0CLN$1(9W$RMT"/>5.FQS',. M.8BJ]/L?VR,"#S[.J,H!_V_=&NV[UQ>C*AX83'6X;N$GB3A'IK7&`/?C&3ND M1?6;;=3N<*>-NXFVVMW5HVY>=M"=-$`YA.)@OGDQT7P1ZL%^:Q;Z"H_8=F0[ MW,Q""5889K;G^XWL,Z8U([V1RS5>(:JV,J\/_(!YUTW1^>GYR?BO,6;'WEZ6 M[N?E_"<```#__P,`4$L!`BT`%``&``@````A`,[@0,,!`@``%!P``!,````` M`````````````````%M#;VYT96YT7U1Y<&5S72YX;6Q02P$"+0`4``8`"``` M`"$`M54P(_4```!,`@``"P`````````````````Z!```7W)E;',O+G)E;'-0 M2P$"+0`4``8`"````"$`,93SQAH"``!!&P``&@````````````````!@!P`` M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"+0`4``8`"````"$`F)'H M?V8$```8#@``#P````````````````"Z"@``>&PO=V]R:V)O;VLN>&UL4$L! M`BT`%``&``@````A`%?\;OSE!@``:QT``!@`````````````````30\``'AL M+W=O&UL4$L!`BT`%``&``@````A``N;]4PU!0``_!0``!D````````````````` M!AD``'AL+W=O'WFL#``!9"@``&0````````````````!R'@``>&PO=V]R:W-H965T`]08```L@```9```````` M`````````!0B``!X;"]W;W)K&UL4$L!`BT`%``& M``@````A`!S+T0*W`@````<``!D`````````````````0"D``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-A(%)'Y M`@``/@D``!D`````````````````RC(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*QJB2X$`P``IP@``!D````` M````````````!3X``'AL+W=OD"``!>"```&0````````````````!`00``>&PO=V]R M:W-H965T&UL M4$L!`BT`%``&``@````A`%2N(3E?!@``[!H``!@`````````````````;$D` M`'AL+W=O&PO&PO&UL4$L!`BT`%``&``@````A`'*0A79+`@``F@4``!D` M````````````````.)(``'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*ZS^,RQ`@``]`8``!D````````````````` M`9L``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`(8HA,UF!0``B1H``!D````````` M````````LZ$``'AL+W=O$2&PO=V]R:W-H M965T&UL4$L! M`BT`%``&``@````A`&0VRX!;#@``#4P``!D`````````````````(+$``'AL M+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A M`/)QWU1[!P``K"```!@`````````````````5MP``'AL+W=O&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`,A#6G'M`@``8P@``!@` M````````````````D@H!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`"M- MKA*L`@```P<``!D`````````````````_2H!`'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-O'R=9,$```3U,``!D` M````````````````#$T!`'AL+W=O_N76P8#``#F"```&0````````````````"/70$`>&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`.<<9Y*=#```HCT``!D````````````````` MO&L!`'AL+W=OJT"``#^!@``&0````````````````"0>`$`>&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`,53T`,`!P``Z1T``!D`````````````````7'X!`'AL+W=O`0!D M;V-0@H`,``'4+```0 M`````````````````(^@`0!D;V-0&UL4$L%!@`````V`#8` *K`X``&6E`0`````` ` end XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8

Reconciliation of Denominators of Basic and Diluted Earnings Per Share (Detail)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Schedule of Earnings Per Share, Basic and Diluted, by Common Class [Line Items]

Weighted-average shares outstanding used to compute basic earnings per share 75,070 81,692 77,323 81,632

Effect of dilutive stock options 1,755 2,548 1,989 2,459

Weighted-average shares outstanding and dilutive securities used to compute dilutive earnings per share 76,825 84,240 79,312 84,091

X

- Details

Name: mygn_ScheduleOfEarningsPerShareBasicAndDilutedByCommonClassLineItems

Namespace Prefix: mygn_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8

Goodwill and Intangible Assets (Tables)
6 Months Ended

Dec. 31, 2013

Summarized Amounts Reported as Intangible Assets

The following summarizes the amounts reported as intangible assets:

(In thousands) Gross
Carrying
Amount Accumlated
Amortization Net

December 31, 2013:


Purchased licenses and technologies
 $ 4,500 $ (2,800 ) $ 1,700

Customer relationships
 4,650 (1,208 ) 3,442

Trademarks
 3,000 (100 ) 2,900





Total amortizable intangible assets
 12,150 (4,108 ) 8,042





In-process research and development
 4,800 — 4,800





Total non-amortizable intangible assets
 4,800 — 4,800





Total intangible assets
 $ 16,950 $ (4,108 ) $ 12,842





(In thousands) Gross
Carrying
Amount Accumlated
Amortization Net

June 30, 2013:


Purchased licenses and technologies
 $ 4,500 $ (2,644 ) $ 1,856

Customer relationships
 4,650 (976 ) 3,674

Trademarks
 3,000 — 3,000





Total amortizable intangible assets
 12,150 (3,620 ) 8,530





In-process research and development
 4,800 — 4,800





Total non-amortizable intangible assets
 4,800 — 4,800





Total intangible assets
 $ 16,950 $ (3,620 ) $ 13,330





Amortization for Intangible Assets

The Company recorded amortization during the respective periods for these intangible assets as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Amortization on intangible assets
 $ 244 $ 231 $ 488 $ 506

X

- Definition

Schedule Of Intangible Assets.

+ References

No definition available.

+ Details

Name: mygn_ScheduleOfIntangibleAssetsTableTextBlock

Namespace Prefix: mygn_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.

+ References

No definition available.

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 16 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8

Amortization on Intangible Assets (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Finite-Lived Intangible Assets [Line Items]

Amortization on intangible assets $ 244 $ 231 $ 488 $ 506

X

- Definition

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 17 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule of Total Operating Income for Continuing Reportable Segments (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Segment Reporting Information [Line Items]

Total operating income for reportable segments $ 82,999 $ 55,586 $ 165,903 $ 104,168

Interest income 1,330 1,385 2,691 2,753

Other (185) 14 (623) (114)

Income tax provision 33,784 21,949 62,146 41,635

Net income $ 50,360 $ 35,036 $ 105,825 $ 65,172

X

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(b))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 18 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Equity
6 Months Ended

Dec. 31, 2013

Stockholders' Equity

(4) Stockholders’ Equity

Share Repurchase Program

In November 2013, the Company completed its fifth share repurchase program, which authorized the repurchase of up to $200 million of the Company’s common stock. In November 2013, the Company’s Board of Directors authorized a sixth share repurchase program of $300 million of the Company’s outstanding common stock. The Company plans to repurchase its common stock from time to time or on an accelerated basis through open market transactions or privately negotiated transactions as determined by the Company’s management. The amount and timing of stock repurchases under the program will depend on business and market conditions, stock price, trading restrictions, acquisition activity and other factors. As of December 31, 2013, approximately $273.3 million remained available for repurchases under the sixth program. The Company uses the par value method of accounting for its stock repurchases. As a result of the stock repurchases, the Company reduced common stock and additional paid-in capital and recorded charges to retained earnings. The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to retained earnings for the repurchases for the three and six months ended December 31, 2013 and 2012 were as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Shares purchased and retired
 3,185 1,231 6,991 3,067

Common stock and additional paid-in-capital reductions
 $ 25,096 $ 9,372 $ 55,036 $ 23,122

Charges to retained earnings
 $ 52,713 $ 24,311 $ 125,088 $ 56,760

X

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

EXCEL 19 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W M9#,U-CAC834B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;F1E;G-E9%]#;VYS;VQI9&%T961?4W1A=&5M M93$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T;V-K:&]L9&5R#I7 M;W)K#I7;W)K#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DEN8V]M95]487AE#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E1E#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O;6UI=&UE;G1S7V%N9%]#;VYT:6YG96YC:65S/"]X.DYA;64^ M#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D5A#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-C:&5D=6QE7V]F7T9A:7)?5F%L=65? M9F]R7T%V83PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-C:&5D=6QE7V]F7TUA='5R:71I97-?;V9?1&5B=#PO>#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-H87)E0F%S961?0V]M<&5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/E-C:&5D=6QE7V]F7U-H87)E0F%S961?0V]M<&5N#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-C:&5D=6QE7V]F7U-H87)E M0F%S961?0V]M<&5N#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O&5S7T%D9&ET:6]N86Q? M26YF;W)M/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E M;%=OF%T:6]N7V]N7TEN=&%N9VEB;&5?07-S/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U8G-E<75E;G1?179E M;G1?061D:71I;VYA;%]);CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O6QE#I!8W1I=F53:&5E=#X-"B`@/'@Z M4')O=&5C=%-T#I0#I0#I0&UL/CPA6V5N9&EF72TM/@T*/"]H M96%D/@T*("`\8F]D>3X-"B`@(#QP/E1H:7,@<&%G92!S:&]U;&0@8F4@;W!E M;F5D('=I=&@@36EC'1087)T7V8P-3$V9C1C M7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!296=I'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A M.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'!E;G-E'0^)SQS<&%N/CPO&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR.2PY M.#,\'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPOF5D(#4L,#`P('-H M87)E3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W M9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C`U,39F M-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA&-E<'0@4&5R(%-H87)E(&1A=&$L M('5N;&5S'0^)SQS<&%N/CPO'!E;G-E M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-RPP.3`\'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XW M-RPX-#`\'!E;G-E'!E;G-E*3H\+W-T M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPOF5D(&=A:6X@*&QO#PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W M,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X M8V$U+U=O'0O:'1M;#L@8VAA2!O<&5R871I;F<@86-T:79I=&EE&-E M6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E M7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U M+U=O'0O M:'1M;#L@8VAA#(P,4,[0V]M<&%N>28C>#(P,40[ M*0T*(&EN(&%C8V]R9&%N8V4@=VET:"!5+E,N(&=E;F5R86QL>2!A8V-E<'1E M9"!A8V-O=6YT:6YG('!R:6YC:7!L97,-"B`H)B-X,C`Q0SM'04%0)B-X,C`Q M1#LI(&9O2!O=VYE9"!S M=6)S:61I87)I97,N($%L;"!I;G1E6EN9R!F:6YA;F-I86P@2!A M;&P@9FEN86YC:6%L('-T871E;65N=',@:6X@86-C;W)D86YC92!W:71H($=! M05`N#0H@5&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T M871E;65N=',@:&5R96EN('-H;W5L9"!B90T*(')E860@:6X@8V]N:G5N8W1I M;VX@=VET:"!T:&4@0V]M<&%N>28C>#(P,3D[65A'!E8W1E9"!F;W(@86YY(&]T:&5R(&EN M=&5R:6T@<&5R:6]D(&]R(&9O6QE/3-$)VUA3I4 M:6UE6QE/3-$)VUA3I4 M:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQD:78^#0H@ M/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P2!H87,@8VQA"!E9F9E8W0L(&EN8VQU9&5D(&EN(&%C8W5M=6QA=&5D M(&]T:&5R#0H@8V]M<')E:&5N#(P,3D[(&5Q=6ET>2!U;G1I;"!R96%L:7IE9"X-"B!'86ENF5D#0H@:&]L9&EN9R!G86EN2!A="!$96-E;6)E$$P.S,Q+"`R M,#$S(&%N9"!*=6YE)B-X03`[,S`L(#(P,3,@=V5R92!A6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@34%21TE.+4)/ M5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P.SPO<#X-"B`\ M=&%B;&4@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@ M=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB M/D=R;W-S/&)R("\^#0H@=6YR96%L:7IE9#QB$$P.R8C>$$P.SPO M=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF5D/&)R("\^#0H@:&]L M9&EN9SQB$$P M.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@ M,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-A6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R M,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XQ-RPV-S4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*(%1O=&%L(&-A6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/C6QE/3-$)T9/3E0M4TE: M13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP M="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C M>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/ M3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T M)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M+W1R/@T*(#QT$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XH,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XX-"PS,3@\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@-65M M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($UU;FEC:7!A;"!B;VYD$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@ M.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C,P,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@Y M.3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XR-C@L-30R/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE2!I M6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C8T+#(Y,SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/C,P/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F M(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C8T M+#,R,SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C0Q-BPX.3,\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS.3`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,3`P/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C0Q-RPQ.#,\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4 M+5-)6D4Z(#$P<'0G/@T*(%1O=&%L(&-A6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS.3`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$"<^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM M5$]0.B`Q,G!X.R!-05)'24XM0D]45$]-.B`P<'@[($9/3E0M4TE:13H@,7!X M)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ, M05!313H@8V]L;&%P$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/D=R;W-S/&)R("\^#0H@=6YR M96%L:7IE9#QB$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/D5S=&EM871E9#PO8CX\ M8G(@+SX-"B`\8CYF86ER('9A;'5E/"]B/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T* M(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C0P+#0Q,CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C8S+#8U,SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XX/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^ M#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE: M13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP M="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XQ,#0L,#6QE M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XH,34\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(U,2PU,3,\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4 M+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XQ,#D\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^ M)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#XH-3,W/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(U,2PP.#4\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P M.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!- M05)'24XM3$5&5#H@-65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($9E9&5R86P@ M86=E;F-Y(&ES$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(T/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$P-"PR M.#(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM M3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%1O=&%L(&%V86EL86)L M92UF;W(M$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C4S,2PT.3<\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/B@U.#<\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C4S,2PP M-C0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF5D/&)R("\^#0H@8V]S=#PO8CX\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L M$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C4S+#DR-#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\ M+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C$W+#8W-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XQ-RPV-S4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*($%V86EL86)L92UF;W(M$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XR.#$L.3DV/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,S4L,3@W/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA! M,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XT.#@L-S@R/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M6QE/3-$)TU!4D=)3BU43U`Z(#9P M=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4)/5%1/ M33H@,'!T.R!-05)'24XM3$5&5#H@-"4[($9/3E0M4TE:13H@,3!P="<^#0H@ M5&AE($-O;7!A;GD@;6%I;G1A:6YS(&$@2!);F-E;G1I=F4@4&QA;BP@87,@86UE;F1E9`T* M("AT:&4@)B-X,C`Q0SLR,#$P(%!L86XF(W@R,#%$.RDL('1H870@:&%S(&)E M96X@87!P28C>#(P,3D[65E$$P.S,Q+"`R,#$S+"!T:&4@0V]M<&%N>2!M M87D@9W)A;G0@=7`@=&\@-BPY.3DL,S4R#0H@861D:71I;VYA;"!S:&%R97,@ M=6YD97(@=&AE(#(P,3`@4&QA;B!I9B!O<'1I;VYS('!R979I;W5S;'D@9W)A M;G1E9`T*('5N9&5R(#(P,#,@4&QA;B!A6QE/3-$)TU!4D=) M3BU43U`Z(#9P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%2 M1TE.+4)/5%1/33H@,'!T.R!-05)'24XM3$5&5#H@-"4[($9/3E0M4TE:13H@ M,3!P="<^#0H@5&AE(&YU;6)E2!T:&4@0V]M<&5N$$P.S4L(#(P,3(@9V5N97)A;&QY('9E2!O=F5R(&9O=7(-"B!Y96%R$$P.S4L(#(P,3(@9V5N97)A;&QY('9E2!O=F5R M(&9O=7(@>65A&5R8VES92!P2!A;'-O(&AAF5D+B!3:&%R97,@87)E(&ES2`Q-#0L,#`P('-H87)E2`Q+#@U-BPP,#`@=V5R92!A=F%I M;&%B;&4@9F]R(&ES#L@1D].5"U325I%.B`Q<'@G M/@T*("8C>$$P.SPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM5$]0.B`P<'0[ M($9/3E0M1D%-24Q9.B!4:6UE2!O9B!T:&4@6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P.SPO=&0^#0H@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T* M($]P=&EO;G,@;W5T$$P.S,P+"`R,#$S/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*($]P=&EO;G,@9W)A;G1E9#PO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C,L,S`T+#4U,SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XR-BXT.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,Q,"PX-C8\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5& M5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($]P=&EO;G,@8V%N8V5L960@ M;W(@97AP:7)E9#PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,U M-"PW,CD\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$W+#`W,RPY,C@\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/"]T6QE/3-$)TU!4D=)3BU43U`Z M(#$R<'0[($9/3E0M1D%-24Q9.B!4:6UE&5R8VES86)L92!A="!A('=E:6=H=&5D(&%V97)A9V4@<')I8V4@;V8@)#(Q M+C,Y+@T*($%S(&]F($1E8V5M8F5R)B-X03`[,S$L(#(P,3,L('1H97)E('=A M'!E;G-E(')E8V]G;FEZ960@86YD(&EN8VQU9&5D(&EN('1H90T* M(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@6QE/3-$ M)TU!4D=)3BU43U`Z(#!P=#L@34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-) M6D4Z(#$R<'0G/@T*("8C>$$P.SPO<#X-"B`\=&%B;&4@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M(&-O;'-P86X],T0V(&%L:6=N/3-$8V5N=&5R/E1H$$P.S,Q+#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@ M,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(W,3PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T* M($-O$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XW-#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XT-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XQ,S<\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C@T-CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XX-CD\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*(%-E;&QI;F'!E;G-E/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$Q+#,V,CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XV+#@U-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T M)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XW+#$P-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,RPW.3(\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/"]T86)L93X-"B`\+V1I=CX\'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA3PO=3X\ M+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM M5$]0.B`V<'0[($9/3E0M1D%-24Q9.B!4:6UE2!C;VUP;&5T960@:71S(&9I9G1H('-H87)E(')E<'5R8VAA MF5D('1H92!R97!U28C>#(P,3D['1H('-H87)E#0H@28C>#(P,3D[2`D,C'1H('!R;V=R M86TN(%1H92!#;VUP86YY('5S97,@=&AE('!A2!R961U8V5D(&-O;6UO;B!S=&]C:R!A;F0@861D:71I;VYA;`T*('!A:60M M:6X@8V%P:71A;"!A;F0@6QE/3-$)T)/4D1%4BU# M3TQ,05!313H@8V]L;&%P$$P.S,Q+#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T M;VT@8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*(%-H87)E$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS+#$X-3PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XQ+#(S,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#XV+#DY,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS M+#`V-SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C4U+#`S-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)TU!4D=) M3BU43U`Z(#9P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%2 M1TE.+4)/5%1/33H@,'!T.R!-05)'24XM3$5&5#H@-"4[($9/3E0M4TE:13H@ M,3!P="<^#0H@0F%S:6,@96%R;FEN9W,@<&5R('-H87)E(&ES(&-O;7!U=&5D M(&)A28C>#(P,3D[6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P M.S,Q+#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P M.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XW-2PP-S`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*($5F9F5C="!O9B!D:6QU=&EV92!S=&]C:R!O<'1I;VYS/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/"]T$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*(%=E:6=H=&5D+6%V97)A9V4@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$ M)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU43U`Z(#9P=#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4)/5%1/33H@,'!T M.R!-05)'24XM3$5&5#H@-"4[($9/3E0M4TE:13H@,3!P="<^#0H@0V5R=&%I M;B!O=71S=&%N9&EN9R!S=&]C:R!O<'1I;VYS('=E$$P.VUO;G1H$$P.V5N9&5D/&)R("\^#0H@1&5C96UB97(F(WA!,#LS,2P\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M8V]L$$P.S,Q+#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO M=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/"]T7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA28C>#(P,3D[#(P,3D[2!A('!A=&EE;G0F(W@R,#$Y.W,@;&EK96QI M:&]O9"!O9@T*(')E'!E;G-E(&%N M9"!O=&AE6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@ M34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P M.SPO<#X-"B`\=&%B;&4@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/DUO;&5C=6QA$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/D-O;7!A;FEO;CQB$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/E1O=&%L/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T* M(%1H$$P.S,Q+"`R,#$S.CPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\+W1R/@T*(#QT#(P,30[ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ.38L,34X M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XW+#DP,CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT M.#(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C(L-#,X/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C$L,#4R/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C@R+#DY.3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C$T,"PV-3$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C@L M-#@Y/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ-#DL,30P/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA! M,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C4W.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ M+#(S,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT,#$\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P M.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*(%-E9VUE;G0@;W!E$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,38L,S,T M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XW,BPY-S`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XU-2PU.#8\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*(%-I>"!M;VYT:',@96YD960@1&5C96UB97(F M(WA!,#LS,2P@,C`Q,SH\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5& M5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%)E=F5N=64\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R M:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/CDY,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#XR+#@S,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XY.#D\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@ M,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%-E9VUE;G0@;W!E$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH M,S(L.38W/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ.34L.3@Q/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(L.#@Y/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/C$V-2PY,#,\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM M3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%-I>"!M;VYT:',@96YD M960@1&5C96UB97(F(WA!,#LS,2P@,C`Q,CH\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%)E=F5N M=64\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L,C$P/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C(L-#(T/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C@R,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#XT+#0U-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/B@S,"PW-C4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C$S."PP,S`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,#0L,38X/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=- M05)'24XM5$]0.B`P<'0[($U!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I% M.B`Q,G!T)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1% M4BU#3TQ,05!313H@8V]L;&%P$$P.S,Q+#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M8V]L6QE M/3-$)U1%6%0M24Y$14Y4.B`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`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)' M24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($EN=&5R97-T(&EN M8V]M93PO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L,S,P/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L,S@U/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(L-CDQ/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C(L-S4S/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^ M#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/B@Q.#4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C$T/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@V,C,\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@Q,30\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C,S+#$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C0Q M+#8S-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C4P+#,V,#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XS-2PP,S8\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X M03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XV-2PQ-S(\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!? M.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@ M8VAA28C>#(P,3D[ M2!I;B!A;B!O&ET('!R:6-E*2X@5&AE(&9A:7(@=F%L=64-"B!H:65R87)C:'D@<')I;W)I M=&EZ97,@=&AE('5S92!O9B!I;G!U=',@=7-E9"!I;B!V86QU871I;VX-"B!T M96-H;FEQ=65S(&EN=&\@=&AE(&9O;&QO=VEN9R!T:')E92!L979E;',Z/"]P M/@T*(#QP('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@34%21TE.+4)/5%1/ M33H@,'!T.R!&3TY4+5-)6D4Z(#9P="<^#0H@)B-X03`[/"]P/@T*(#QT86)L M92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G(&)O6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/G%U;W1E M9"!P$$P.R8C>#(P,30[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3YO8G-E2!O8G-E2!U=&EL M:7IE(&)R;VME<@T*('%U;W1E6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P M<'0G/@T*($QE=F5L("8C>$$P.S,F(WA!,#LF(W@R,#$T.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^=6YO8G-E#L@1D].5"U325I%.B`Q<'@G/@T*("8C>$$P.SPO<#X-"B`\ M<"!S='EL93TS1"=-05)'24XM5$]0.B`P<'0[($9/3E0M1D%-24Q9.B!4:6UE M2!O9B!T:&4@0V]M<&%N>28C>#(P,3D[2!U M2P@:6YP=71S('-U;6UA6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@ M34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P M.SPO<#X-"B`\=&%B;&4@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4 M+5-)6D4Z(#$P<'0G/@T*($-O$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C@Y+#,Q.#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C@Y+#,Q.#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI M9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR-S`L-34T/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XV-2PV,S4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XV-2PV,S4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%1O M=&%L/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP M="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C0S-"PX-3@\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/"]T$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V M86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE2!M87)K970@9G5N9',@*&$I/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$R+#8Y,3PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R M:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H M=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XW,2PV,C0\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XW,2PV,C0\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P M.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@ M,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($UU;FEC:7!A;"!B;VYD$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$#(P,30[)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,P,BPP-34\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($9E9&5R M86P@86=E;F-Y(&ES$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M#(P M,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C$P-"PR.#(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G M/@T*(%1O=&%L/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C0W-RPY-C$\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP M="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T M.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF M(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT.3`L-C4R M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@34%21TE.+4)/ M5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P.SPO<#X-"B`\ M=&%B;&4@2!M87)K970@9G5N9',@87)E('!R:6UA0T*(&-O;7!R:7-E9"!O9B!E M>&-H86YG92!T'1087)T7V8P-3$V9C1C7S'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQD:78^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1% M4BU#3TQ,05!313I#3TQ,05!313L@9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O M;6%N.R!F;VYT+7-I>F4Z,3!P="<@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS M1#`@8V5L;'-P86-I;F<],T0P('=I9'1H/3-$,3`P)3X-"B`\='(^#0H@/'1D M('=I9'1H/3-$-"4@=F%L:6=N/3-$=&]P(&%L:6=N/3-$;&5F=#XH."D\+W1D M/@T*(#QT9"!A;&EG;CTS1&QE9G0@=F%L:6=N/3-$=&]P/CQU/DEN8V]M92!4 M87AEF4Z,3!P=#L@9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N)SX-"B!);B!O2!T87@-"B!R871E2!R96-O9VYI>F5D(&EN#0H@=&AE('%U87)T97(@ M9'5R:6YG('=H:6-H('1H97D@;V-C=7(@86YD(&-A;B!B92!A('-O=7)C92!O M9@T*('9AF4Z,3!P=#L@9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N M)SX-"B!);F-O;64@=&%X(&5X<&5N2`T,"4@;V8@<')E+71A>"!I;F-O;64L#0H@ M8V]M<&%R960@=&\@)#(Q+#DT.2PP,#`L(&9O2`S.24@;V8@<')E+71A>"!I;F-O;64N#0H@26YC;VUE('1A>"!E>'!E M;G-E(&9O$$P.S,Q M+"`R,#$S#0H@=V%S("0V,BPQ-#8L,#`P+"!O2`S.24@;V8@<')E+71A>"!I;F-O;64N($EN M8V]M92!T87@-"B!E>'!E;G-E(&9O"!M;VYT M:',@96YD960@1&5C96UB97(F(WA!,#LS,2P@,C`Q,PT*(&ES(&)A"!R871E#0H@9F]R('1H92!F=6QL(&9I&5S+"!A(&1E9'5C=&EO;@T*(&9OF5D(&EF('1H;W-E(&]P=&EO;G,@87)E#0H@9&ES<75A;&EF:65D('5P M;VX@97AE6QE/3-$)VUA3I4:6UE"!R971U"!P2!T;R!P87D-"B!A2!R97-U;'0@9G)O;2!E>&%M:6YA=&EO;B!O9B!P`T*(')E='5R;G,[(&AO=V5V97(L('1H92!A;6]U;G0@=6QT:6UA=&5L>2!P M86ED('5P;VX@"!R971U"!R971U7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA2!H860@7)I860@4D)-+"!);F,N(&]N#0H@36%Y)B-X03`[,S$L(#(P,3$@*&9O2!R96-O$$P.S,Q M+"`R,#$S+CPO<#X-"B`\<"!S='EL93TS1"=-05)'24XM5$]0.B`Q.'!X.R!- M05)'24XM0D]45$]-.B`P<'@[($9/3E0M4TE:13H@,7!X)SX-"B`F(WA!,#L\ M+W`^#0H@/'`@28C>#(P,3D[28C>$$P.S,Q+"`R,#$Q+B!4:&4@9F]L;&]W:6YG M('-U;6UA$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6EN9SQB6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P M.S,Q+"`R,#$S.CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO M=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$ M14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)' M24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-U$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT M+#8U,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,2PR M,#@\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,L-#0R/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P M.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C$R+#$U,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@T+#$P.#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XX+#`T,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT M"<^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O M;G0@$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@ M/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T* M(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XT+#@P,#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\+W1R/@T* M(#QT"<^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$V+#DU M,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XH-"PQ,#@\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$R+#@T M,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=- M05)'24XM5$]0.B`P<'0[($U!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I% M.B`Q,G!T)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1% M4BU#3TQ,05!313H@8V]L;&%P$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/D%C8W5M;&%T960\8G(@+SX-"B!!;6]R=&EZ871I;VX\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T* M($IU;F4F(WA!,#LS,"P@,C`Q,SH\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R M/@T*(#QT$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/B@R+#8T-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L M.#4V/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P M.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*(%1R861E;6%R:W,\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XS+#`P,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT M/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C,L,#`P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G M/@T*(%1O=&%L(&%M;W)T:7IA8FQE(&EN=&%N9VEB;&4@87-S971S/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=& M3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XQ,BPQ-3`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XH,RPV,C`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C0L.#`P/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R M:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C0L.#`P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T* M(%1O=&%L(&YO;BUA;6]R=&EZ86)L92!I;G1A;F=I8FQE(&%S$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T* M("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ-BPY-3`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XQ,RPS,S`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/"]T$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@ M34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P M.SPO<#X-"B`\=&%B;&4@$$P M.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V M(&%L:6=N/3-$8V5N=&5R/E-I>"8C>$$P.VUO;G1H$$P.V5N9&5D/&)R M("\^#0H@1&5C96UB97(F(WA!,#LS,2P\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4 M+5-)6D4Z(#$P<'0G/@T*($%M;W)T:7IA=&EO;B!O;B!I;G1A;F=I8FQE(&%S M$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C(S,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@ M/"]T7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA3I4:6UE6QE/3-$)VUA3I4 M:6UE$$P.S@L(#(P,3$L M('1H92!#;VUP86YY(&ES#(P,40[*2!O9@T*(%-O=71H(%-A;B!&#(P,4,[ M3&]A;B!!9W)E96UE;G0F(W@R,#%$.RD@86YD(&%L&-L=7-I=F4-"B!T:')E92UY96%R(&]P=&EO;B!T;R!A8W%U:7)E($-R97-C M96YD;R!P=7)S=6%N="!T;R!A(&1E9FEN:71I=F4-"B!M97)G97(@86=R965M M96YT("AT:&4@)B-X,C`Q0SM/<'1I;VX@06=R965M96YT)B-X,C`Q1#LI+B!4 M:&4@2!E=F%L=6%T97,@=&AE($]P=&EO;B!!9W)E96UE;G0@9F]R(&EM<&%I MF4Z,7!X.VUA$$P.SPO<#X-"B`\<"!S='EL93TS1"=M87)G:6XM=&]P.C!P=#L@ M;6%R9VEN+6)O='1O;3HP<'0[(&UAF4Z M,3!P=#L@9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N)SX-"B!4:&4@2P@:6X@=&AE(&-O;F1E;G-E9"!C;VYS;VQI9&%T960@2!I"!M;VYT:',- M"B!E;F1E9"!$96-E;6)E$$P.S,Q+"`R,#$S+CPO<#X-"B`\<"!S='EL M93TS1"=M87)G:6XM=&]P.C9P=#L@;6%R9VEN+6)O='1O;3HP<'0[(&UAF4Z,3!P=#L@9F]N="UF86UI;'DZ5&EM97,@ M3F5W(%)O;6%N)SX-"B!/;B!.;W9E;6)E$$P.S$T+"`R,#$S+"!T:&4@ M0V]M<&%N>2!R96-E:79E9"!N;W1I8V4@9G)O;0T*($-R97-C96YD;R!T:&%T M($-R97-C96YD;R!H860@86-H:65V960@=&AE(&UI;FEM=6T@28C>#(P,3D['0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^)SQD M:78^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313I#3TQ,05!3 M13L@9F]N="UF86UI;'DZ5&EM97,@3F5W(%)O;6%N.R!F;VYT+7-I>F4Z,3!P M="<@8F]R9&5R/3-$,"!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P M('=I9'1H/3-$,3`P)3X-"B`\='(^#0H@/'1D('=I9'1H/3-$-"4@=F%L:6=N M/3-$=&]P(&%L:6=N/3-$;&5F=#XH,3$I/"]T9#X-"B`\=&0@86QI9VX],T1L M969T('9A;&EG;CTS1'1O<#X\=3Y#;W-T($)A28C>#(P,3D[$$P.S,Q M+"`R,#$S+CPO<#X-"B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF4Z,3!P=#L@9F]N="UF86UI;'DZ5&EM97,@3F5W M(%)O;6%N)SX-"B!4:&4@0V]M<&%N>2!I2!T:&%T(&UA>2!U;'1I;6%T96QY(')E28C>#(P,3D['1087)T M7V8P-3$V9C1C7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3I4:6UE2!A;65N9&5D M(&%N9"!R97-T871E9"!T:&4-"B!/<'1I;VX@06=R965M96YT('=I=&@@0W)E M#(P,4,[ M365R9V5R#0H@06=R965M96YT)B-X,C`Q1#LI('1O('!U&ES=&EN9R!C87-H(&%N9"!M87)K971A8FQE(&EN=F5S=&UE;G0@ M0T*(&%N=&EC M:7!A=&5S('1H870@=&AE(&UE2!T M:&4@96YD(&]F(&9I2!C;&]S:6YG(&-O;F1I=&EO;G,@86YD('1H92!O=&AE'1087)T7V8P-3$V9C1C7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$ M)TU!4D=)3BU43U`Z(#9P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@34%21TE.+4)/5%1/33H@,'!T.R!-05)'24XM3$5&5#H@-"4[($9/3E0M M4TE:13H@,3!P="<^#0H@5&AE(&%M;W)T:7IE9"!C;W-T+"!GF5D(&AO;&1I;F<@9V%I;G,L(&=R;W-S#0H@=6YR96%L:7IE9"!H;VQD M:6YG(&QO$$P.S,Q+"`R,#$S M(&%N9"!*=6YE)B-X03`[,S`L(#(P,3,@=V5R92!A6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/CQB/D=R;W-S/&)R("\^#0H@=6YR96%L:7IE9#QB$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S M;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N M=&5R/CQB/D5S=&EM871E9#QB$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*($%T($1E8V5M8F5R)B-X03`[,S$L(#(P,3,Z M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`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`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C$W+#8W-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/ M3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T M.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\ M+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@-65M M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-O6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C@T+#(U.3PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C8P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P.SPO9F]N=#X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T9/3E0M4TE: M13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C(V."PS-#$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^ M)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#XS,#`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH.3D\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XV-"PS,C,\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5& M5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%1O=&%L(&%V86EL86)L92UF M;W(M$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C0X."PT.3(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/B@Q,#`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C0X."PW.#(\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/"]T$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P M>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@#L@34%21TE.+4)/5%1/33H@,'!X.R!&3TY4+5-)6D4Z(#%P>"<^#0H@ M)B-X03`[/"]P/@T*(#QT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z M(&-O;&QA<'-E.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0G(&)O$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX] M,T1B;W1T;VT@8V]LF5D/&)R("\^#0H@8V]S=#PO8CX\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF5D/&)R("\^ M#0H@:&]L9&EN9SQB$$P.S,P+"`R,#$S.CPO<#X-"B`\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@-65M.R!&3TY4 M+5-)6D4Z(#$P<'0G/@T*($-A$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$#(P,30[)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT,"PT,3(\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P M.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@-65M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*($-A$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XV,RPV-3,\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C8S+#8V,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT M"<^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@ M/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT M$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/C@\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP M="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C M>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)U1%6%0M24Y$14Y4.B`M M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5& M5#H@-65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-O6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$S/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XR-3$L,#@U/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE2!I6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$P-"PR.3,\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR-#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE: M13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/B@S-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,#0L,C@R/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA! M,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O M;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$T-CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/B@U.#<\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@;F]W$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T M)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XU,S$L-#DW/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$U-#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XH-3@W/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA! M,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XU,S$L,#8T/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA! M,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE: M13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU43U`Z(#9P=#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@34%21TE.+4)/5%1/33H@,'!T.R!-05)' M24XM3$5&5#H@-"4[($9/3E0M4TE:13H@,3!P="<^#0H@0V%S:"P@8V%S:"!E M<75I=F%L96YT6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@34%21TE.+4)/ M5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P.SPO<#X-"B`\ M=&%B;&4@6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/CQB/D5S=&EM871E9#QB$$P.SPO=&0^#0H@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-A M$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^ M#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-) M6D4Z(#$P<'0G/@T*($-A$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XQ-RPV-S4\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE65A$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C(X,2PX.#(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$S-2PP M,3$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C0X."PT.3(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$"<^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/"]T86)L93X-"B`\+V1I=CX\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!3:&%R92!" M87-E9"!087EM96YT($%W87)D($]P=&EO;G,@3W5T6QE/3-$ M)TU!4D=)3BU43U`Z(#!P=#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@34%21TE.+4)/5%1/33H@,'!T.R!-05)'24XM3$5&5#H@-"4[($9/3E0M M4TE:13H@,3!P="<^#0H@02!S=6UM87)Y(&]F('1H92!S=&]C:R!O<'1I;VX@ M86-T:79I='D@=6YD97(@=&AE($-O;7!A;GDF(W@R,#$Y.W,-"B!P;&%N"!M;VYT:',@96YD960@1&5C96UB97(F(WA!,#LS,2P@,C`Q M,R!I6QE/3-$)TU!4D=)3BU4 M3U`Z(#!P=#L@34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G M/@T*("8C>$$P.SPO<#X-"B`\=&%B;&4@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P M(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N M/3-$8V5N=&5R/CQB/DYU;6)E$$P.V]F/"]B/CQB$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@8V]L&5R8VES93PO8CX\8G(@+SX-"B`\8CYP$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XQ-"PT,S0L.3
$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(V+C0X/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($]P=&EO M;G,@97AE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ M-"XR,SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT'!I"<^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO M=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4 M+5-)6D4Z(#$P<'0G/@T*($]P=&EO;G,@;W5T$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR,BXW-3PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\ M+W1R/@T*(#QT"<^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/"]D:78^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^)SQD M:78^#0H@/'`@F5D(&%N9"!I;F-L=61E9"!I M;B!T:&4-"B!C;VYD96YS960@8V]N6QE M/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P.VUO;G1H$$P.V5N9&5D/&)R("\^#0H@1&5C96UB97(F(WA! M,#LS,2P\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V M86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/"]T$$P M.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C0S,CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C$P-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T* M(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XX-#8\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L-C(W/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L-C6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C4L-S(X/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C4L.3$X/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$Q M+#4Y-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,2PS M-C(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P M/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*(%1O=&%L('-H87)E+6)A'!E M;G-E/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$S+#"<^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/"]D:78^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E M7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U M+U=O'0O M:'1M;#L@8VAA6QE/3-$)TU!4D=)3BU43U`Z(#!P M=#L@34%21TE.+4)/5%1/33H@,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C M>$$P.SPO<#X-"B`\=&%B;&4@6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0V(&%L:6=N/3-$8V5N=&5R/E1H$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P M(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V(&%L:6=N M/3-$8V5N=&5R/E-I>"!M;VYT:',@96YD960\8G(@+SX-"B!$96-E;6)E$$P.S,Q+#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C,L,3@U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C$L,C,Q/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C8L M.3DQ/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,L,#8W/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\ M+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-H87)G M97,@=&\@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XD/"]T9#X-"B`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`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U M+U=O'0O M:'1M;#L@8VAA'0^)SQD:78^#0H@/'`@6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P.S,Q+#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@$$P.R8C>$$P M.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V M86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XW-2PP-S`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XX,2PV M,S(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($5F M9F5C="!O9B!D:6QU=&EV92!S=&]C:R!O<'1I;VYS/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L M:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T* M(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[ M/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$ M)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%=E M:6=H=&5D+6%V97)A9V4@$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@ M,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$ M)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL M93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0V(&%L:6=N/3-$8V5N=&5R/E1H$$P.S,Q M+#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@$$P.SPO=&0^#0H@/"]T M$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P M.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XX+#4P,#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XU+#8P-3PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XW+#$S-CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R M:6=H=#XT+#4X-3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#PO=&%B;&4^#0H@/"]D M:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B M;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M,#4Q-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A? M,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA'0^)SQD:78^#0H@/'`@6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@34%21TE.+4)/5%1/33H@ M,'!T.R!&3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P.SPO<#X-"B`\=&%B;&4@ M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P M(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N M/3-$8V5N=&5R/DUO;&5C=6QA$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/D-O;7!A;FEO;CQB$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R M/E1O=&%L/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^ M#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM M3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%1H$$P.S,Q+"`R,#$S.CPO<#X-"B`\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\+W1R/@T*(#QT#(P,30[)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ.38L,34X/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XW+#DP,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT.#(\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C(L-#,X/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L M,#4R/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C@R+#DY.3PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`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`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XQ-#DL,30P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^ M#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C4W.#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ+#(S,CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT,#$\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G M/@T*(%-E9VUE;G0@;W!E$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,38L,S,T/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI M9VX],T1R:6=H=#XW,BPY-S`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XU-2PU M.#8\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G M/@T*(%-I>"!M;VYT:',@96YD960@1&5C96UB97(F(WA!,#LS,2P@,C`Q,SH\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-) M6D4Z(#$P<'0G/@T*(%)E=F5N=64\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T M.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/CDY,CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR+#@S,#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XY.#D\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@ M/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z M(#$P<'0G/@T*(%-E9VUE;G0@;W!E$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XH,S(L.38W/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XQ.34L.3@Q/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C(L.#@Y/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C$V-2PY,#,\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49! M34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4 M+5-)6D4Z(#$P<'0G/@T*(%-I>"!M;VYT:',@96YD960@1&5C96UB97(F(WA! M,#LS,2P@,C`Q,CH\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@ M,V5M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%)E=F5N=64\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H M=#X-"B`F(W@R,#$T.R8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C$L,C$P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C(L-#(T/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C@R,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT+#0U-3PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@S M,"PW-C4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$S."PP,S`\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XQ,#0L,38X/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/"]T86)L93X-"B`\<"!S='EL93TS1"=-05)'24XM5$]0.B`P<'0[ M($U!4D=)3BU"3U143TTZ(#!P=#L@1D].5"U325I%.B`Q,G!T)SX-"B`F(WA! M,#L\+W`^#0H@/'1A8FQE('-T>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L M;&%P$$P.S,Q+#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@$$P.R8C M>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M24Y$14Y4 M.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM M3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(%1O=&%L(&]P97)A=&EN M9R!I;F-O;64@9F]R(')E<&]R=&%B;&4@$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`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`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*($EN=&5R97-T(&EN8V]M93PO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/C$L,S,P/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A M;&EG;CTS1')I9VAT/C$L,S@U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C(L-CDQ/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C(L-S4S/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/B@Q.#4\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$T/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@V,C,\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/B@Q,30\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C,S+#$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C0Q+#8S-3PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\+W1R/@T*(#QT"<^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!A;&EG;CTS1')I9VAT/C4P+#,V,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T M)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS-2PP M,S8\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/ M3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#XV-2PQ-S(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W M$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C M>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC M834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W M95\T-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQD:78^#0H@/'`@$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O M;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\ M+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P M="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$ M8V5N=&5R/DQE=F5L(#(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO M=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T M('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P M(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N M/3-$8V5N=&5R/E1O=&%L/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*(&%T($1E M8V5M8F5R)B-X03`[,S$L(#(P,3,Z/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`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`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XY+#,U,3PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T M9#X-"B`\+W1R/@T*(#QT$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C(W M,"PU-30\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR M-S`L-34T/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE2!I$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I M9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C8U+#8S-3PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I M9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/C8U+#8S-3PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\ M+W1R/@T*(#QT"<^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T M9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XY+#,U M,3PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT@86QI9VX],T1R:6=H=#XT,C4L-3`W/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X M03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT M9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/"]T86)L93X-"B`\ M<"!S='EL93TS1"=-05)'24XM5$]0.B`P<'0[($U!4D=)3BU"3U143TTZ(#!P M=#L@1D].5"U325I%.B`Q,G!T)SX-"B`F(WA!,#L\+W`^#0H@/'1A8FQE('-T M>6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L;&%P$$P.R8C M>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&%L:6=N/3-$8V5N=&5R/E1O=&%L/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T* M(&%T($IU;F4F(WA!,#LS,"P@,C`Q,SH\+W`^#0H@/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!- M05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($UO;F5Y(&UA M$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$#(P,30[)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XQ,BPV.3$\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P M.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!- M05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($-O$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS1')I9VAT/@T*("8C>#(P M,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C#(P M,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C M>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XS,#(L,#4U/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M(&%L:6=N/3-$"<^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z M(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X M03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T M)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H M=#XQ,BPV.3$\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[ M/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE M/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XD/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A;&EG;CTS M1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG M;CTS1')I9VAT/C0Y,"PV-3(\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M;F]W$$P.R8C>$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M#0H@/'`@$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1'1O<"!W:61T:#TS M1#0E(&%L:6=N/3-$;&5F=#XH82D\+W1D/@T*(#QT9"!V86QI9VX],T1T;W`@ M86QI9VX],T1L969T/DUO;F5Y(&UA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)T)/4D1%4BU#3TQ, M05!313H@8V]L;&%P$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P="!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N/3-$8V5N=&5R/D%C8W5M M;&%T960\8G(@+SX-"B!!;6]R=&EZ871I;VX\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.SPO=&0^#0H@/"]T6QE/3-$)U1% M6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T*($1E8V5M M8F5R)B-X03`[,S$L(#(P,3,Z/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G M/@T*(%!U$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS M1')I9VAT/C0L-C4P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A M<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/B@Q+#(P.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!& M3TY4+5-)6D4Z(#$P<'0G/@T*(%1R861E;6%R:W,\+W`^#0H@/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XS+#`P,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XH,3`P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&YO=W)A<#TS1&YO=W)A<#XI)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XR M+#DP,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N M/3-$$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C@L,#0R/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#PO M='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA! M,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\ M<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE M/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P<'0G/@T* M($EN+7!R;V-E6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA! M,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[/"]F M;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XT+#@P,#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M/"]T9#X-"B`\+W1R/@T*(#QT"<^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF%B;&4@:6YT86YG:6)L92!A6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I M9VAT/C0L.#`P/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^/&9O;G0@$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`@86QI9VX],T1R:6=H=#X-"B`F(W@R,#$T.R8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C0L.#`P/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@ M$$P M.SPO<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T* M(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF M(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X- M"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^ M)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,V5M.R!&3TY4+5-)6D4Z(#$P<'0G M/@T*(%1O=&%L(&EN=&%N9VEB;&4@87-S971S/"]P/@T*(#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP M="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P.R8C>$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/B@T+#$P.#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T9/ M3E0M4TE:13H@,7!X)SX-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P M,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\ M+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/"]T6QE/3-$)TU!4D=)3BU43U`Z(#!P=#L@34%21TE.+4)/5%1/33H@,'!T.R!& M3TY4+5-)6D4Z(#$R<'0G/@T*("8C>$$P.SPO<#X-"B`\=&%B;&4@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P M.SPO=&0^#0H@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!T('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D M/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XD/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M$$P.SPO=&0^#0H@/"]T6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!-05)'24XM3$5&5#H@,65M.R!&3TY4+5-)6D4Z(#$P M<'0G/@T*($-U$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#XT+#8U,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XH.3$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XS M+#8W-#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT$$P.SPO=&0^#0H@/'1D('9A;&EG M;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C,L,#`P/"]T9#X-"B`\=&0@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D M/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M(&%L:6=N/3-$$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO M<#X-"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T M>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\ M+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$R+#$U,#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;2!A;&EG;CTS1')I9VAT/B@S+#8R,#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^*28C>$$P.SPO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#AP="<^ M)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#XX M+#4S,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT"<^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N M/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C>$$P.SPO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C M,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P M,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D/B8C>$$P M.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9"!V M86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA! M,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4 M:6UE$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$$$P M.R8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL M93TS1"=&3TY4+5-)6D4Z(#AP="<^)B-X03`[)B-X03`[/"]F;VYT/CPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<"!A M;&EG;CTS1')I9VAT/@T*("8C>#(P,30[)B-X03`[)B-X03`[/"]T9#X-"B`\ M=&0@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#LF(WA! M,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M M(&%L:6=N/3-$$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO M=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO=&0^#0H@ M/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE M/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H@/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@ M/"]T9#X-"B`\=&0^)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T9/ M3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#XF(WA!,#L\+W1D/@T* M(#QT9"!V86QI9VX],T1B;W1T;VT@;F]W$$P.R8C>$$P.SPO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+5-) M6D4Z(#AP="<^)B-X03`[/"]F;VYT/CPO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@86QI9VX] M,T1R:6=H=#XT+#@P,#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^)B-X03`[)B-X03`[/"]T9#X-"B`\+W1R/@T*(#QT6QE/3-$)T)/4D1% M4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X- M"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H@/"]T9#X-"B`\ M=&0^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS M1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T* M(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S='EL93TS1"=" M3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*(#PO M=&0^#0H@/'1D/B8C>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF M(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X- M"B`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^#0H@/'`@$$P.SPO<#X-"B`\ M+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#PO='(^#0H@/'1R('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UE$$P.R8C>$$P M.SPO9F]N=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@ M/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$V+#DU,#PO=&0^ M#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[ M/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@.'!T)SXF(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/B0\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#XH,RPV,C`\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT@;F]W$$P.SPO9F]N M=#X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)#PO=&0^#0H@/'1D('9A M;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT/C$S+#,S,#PO=&0^#0H@/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^)B-X03`[/"]T9#X- M"B`\+W1R/@T*(#QT"<^#0H@/'1D M('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^ M)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/@T*(#QP M('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X M03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3X-"B`\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX] M,T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T M=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O M;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B M;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T*(#QT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$ M8F]T=&]M/@T*(#QP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X M(&1O=6)L92<^)B-X03`[/"]P/@T*(#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O M='1O;3X-"B`\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"B`\+W1D/@T*(#QT9#XF(WA!,#L\+W1D/@T* M(#PO='(^#0H@/"]T86)L93X-"B`\+V1I=CX\6QE/3-$)TU!4D=)3BU43U`Z(#$R<'0[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU#3TQ,05!313H@8V]L M;&%P6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE M$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XF(WA! M,#LF(WA!,#L\+W1D/@T*(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P="!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0V M(&%L:6=N/3-$8V5N=&5R/E1H$$P.S,Q+#PO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T;VT^)B-X M03`[)B-X03`[/"]T9#X-"B`\=&0@$$P.SPO=&0^#0H@/"]T$$P.R8C>$$P.SPO=&0^#0H@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED M)R!V86QI9VX],T1B;W1T;VT@8V]L$$P.R8C>$$P.SPO=&0^#0H@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!T('-O;&ED)R!V86QI9VX],T1B M;W1T;VT@8V]L6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS M1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*(#QT9"!V86QI9VX],T1B;W1T M;VT^)#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/C0X.#PO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^)B-X03`[/"]T9#X-"B`\=&0@=F%L:6=N/3-$8F]T=&]M/B8C>$$P.R8C M>$$P.SPO=&0^#0H@/'1D('9A;&EG;CTS1&)O='1O;3XD/"]T9#X-"B`\=&0@ M=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$'1087)T7V8P-3$V9C1C7S'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA2!-86IO2!4>7!E(&%N M9"!#;&%S2`H1&5T86EL*2`H55-$("0I/&)R/DEN(%1H M;W5S86YDF5D(&AO;&1I;F<@9V%I;G,\+W1D/@T*("`@("`@("`\ M=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&AO;&1I;F<@9V%I;G,\+W1D/@T*("`@("`@("`\=&0@8VQAF5D(&AO;&1I;F<@9V%I;G,\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPOF5D(&-OF5D(&AO;&1I;F<@9V%I;G,\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&-O'0^)SQS<&%N/CPOF5D(&AO;&1I;F<@;&]SF5D(&AO;&1I;F<@;&]S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQS<&%N/CPO'0^)R9N M8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)R9N8G-P.R9N8G-P.SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&EM=6T\8G(^/"]T:#X- M"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB6UE;G0@07=A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)S0@>65A'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)S@@>65A65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D('-H87)E+6)A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA2!3:&%R92!"87-E9"!087EM96YT($%W87)D M($]P=&EO;G,@3W5T2!3:&%R92UB87-E M9"!087EM96YT($%W87)D(%M,:6YE($ET96US73PO'0^)SQS<&%N/CPO&5R8VES92!P&5R8VES960L(%=E:6=H=&5D(&%V97)A9V4@97AE&5R8VES M92!P65A&5R8VES92!P7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA MF5D(&EN($-O;G-O;&ED871E9"!3=&%T96UE;G1S(&]F($-O;7!R96AE;G-I M=F4@26YC;VUE("A$971A:6PI("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U M;FQEF5D(%!E'0^)SQS M<&%N/CPO'!E;G-E/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#8L.#4W/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPOF5D(%!E'0^)SQS<&%N/CPO'!E M;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,#D\'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E(%-E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&%M;W5N=#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS M<&%N/CPOF5D(')E<'5R8VAA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T M8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S M-38X8V$U+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W M,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X M8V$U+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A M.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA M'10 M87)T7V8P-3$V9C1C7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'!E;G-E("A$971A M:6PI("A54T0@)"D\8G(^26X@5&AO=7-A;F1S+"!U;FQE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XQ+#0V-SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M<#XT.#D\7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO M'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO2!)3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q M-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P M-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA&5S("T@061D M:71I;VYA;"!);F9O'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO"!E M>'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,S+#3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T M-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M,#4Q-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A? M,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@T+#$P."D\6EN9R!!;6]U;G0L(&YO;BUA;6]R=&EZ86)L92!I;G1A;F=I8FQE(&%SF%B;&4@:6YT86YG:6)L92!A'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF%T:6]N/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R+#@P,"D\'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPOF%B;&4@:6YT86YG:6)L92!A'0^)SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@Q,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPOF%B;&4@:6YT86YG:6)L92!A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q M-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P M-V0S-38X8V$U+U=O'0O:'1M;#L@8VAAF%T:6]N(&]N($EN M=&%N9VEB;&4@07-S971S("A$971A:6PI("A54T0@)"D\8G(^26X@5&AO=7-A M;F1S+"!U;FQE'0^)SQS M<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T M8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S M-38X8V$U+U=O'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A M.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO M3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!? M.6-A.%\P,3`W9#,U-CAC834-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO9C`U,39F-&-?-S$W95\T-F4P7SEC83A?,#$P-V0S-38X8V$U+U=O'0O:'1M;#L@ M8VAA7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M M;6EC&UL/@T*+2TM+2TM/5]. M97AT4&%R=%]F,#4Q-F8T8U\W,3=E7S0V93!?.6-A.%\P,3`W9#,U-CAC834M #+0T* ` end XML 20 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8

Term Loan and Option Agreement - Additional Information (Detail) (USD $)
1 Months Ended 3 Months Ended 6 Months Ended

Sep. 08, 2011

Y

Dec. 31, 2013

Dec. 31, 2013

Jun. 30, 2013

Debt Instrument [Line Items]

Loan Agreement, principal amount $ 25,000,000

Interest rate per annum 7.00%

Fair value of Option Agreement 8,000,000 8,000,000

Effective period of option, in years 3

Residual value of loan agreement 17,000,000 17,000,000

Accreted value of loan agreement 23,000,000 23,000,000 21,667,000

Interest income related to accretion of the note receivable and the stated interest rate $ 1,104,000 $ 2,208,000

X

- Definition

Effective period of option.

+ References

No definition available.

+ Details

Name: mygn_EffectivePeriodOfOption

Namespace Prefix: mygn_

Data Type: xbrli:positiveIntegerItemType

Balance Type: na

Period Type: duration

X

- Definition

Fair Value Option Loans Aggregate Principal Amount Outstanding

+ References

No definition available.

+ Details

Name: mygn_FairValueOptionLoansAggregatePrincipalAmountOutstanding

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Income related to accretion of the note receivable and the stated interest rate.

+ References

No definition available.

+ Details

Name: mygn_IncomeRelatedToAccretionOfNoteReceivableAndStatedInterestRate

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Residual value of loan agreement.

+ References

No definition available.

+ Details

Name: mygn_ResidualValueOfLoanAgreement

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Net amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor's statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor's rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Article 5

+ Details

Name: us-gaap_NotesReceivableNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Yield on the receivable, on which interest has been imputed, as calculated from its issuance value or purchase price. The calculated effective interest rate considers factors such as the issued face value or price paid for the receivable, the time period between payments, and the time until maturity [full receipt] of the receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_ReceivableWithImputedInterestEffectiveYieldInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition

The principal amount of the receivable or note before consideration of the discount or premium.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 835

-SubTopic 30

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399

+ Details

Name: us-gaap_ReceivableWithImputedInterestFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 21 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding (Detail) (USD $)
6 Months Ended

Dec. 31, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Options outstanding at beginning of year, Number of shares 14,434,970

Options granted, Number of shares 3,304,553

Options exercised, Number of shares 310,866

Options canceled or expired, Number of shares 354,729

Options outstanding at end of year, Number of shares 17,073,928

Options outstanding at beginning of year, Weighted average exercise price $ 21.75

Options granted, Weighted average exercise price $ 26.48

Options exercised, Weighted average exercise price $ 14.23

Options canceled or expired, Weighted average exercise price $ 24.33

Options outstanding at end of year, Weighted average exercise price $ 22.75

X

- Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average price of options that were either forfeited or expired.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Net number of share options (or share units) granted during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of options outstanding, including both vested and non-vested options.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)-(ii)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Weighted average price at which option holders acquired shares when converting their stock options into shares.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of share options (or share units) exercised during the current period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28,29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 22 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8

Share-Based Compensation - Additional Information (Detail) (USD $)
6 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2013

Options granted after December 5, 2012

Dec. 31, 2013

Options granted prior to December 5, 2012

Dec. 31, 2013

The 2010 Plan

Dec. 05, 2013

The 2010 Plan

Dec. 31, 2013

The 2010 Plan

Maximum

Dec. 31, 2013

2012 Purchase Plan

Dec. 31, 2012

2012 Purchase Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of shares approved 3,500,000 1,856,000 2,000,000

Shares reserved for issuance exercise of options 3,733,317

Number of shares cancelled or expired without issuance 354,729 233,317

Shares available for future grant 6,999,352

Service period of option vested, years 4 years

Options expire from date of grant, years 8 years 10 years

Shares issued under the Plan 144,000

Options to purchase shares vested and exercisable, shares 9,218,423

Exercisable weighted average price of options $ 21.39

Total unrecognized share-based compensation cost related to share-based awards granted $ 52,276,000

Total unrecognized share-based compensation cost, weighted-average period, years 2 years 6 months 26 days

X

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (i)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition

Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of additional shares authorized for issuance under an established share-based compensation plan.

+ References

No definition available.

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)(3)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (c)(1)(iv)(3)-(4)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

The number of exercisable share options (fully vested and expected to vest) that may be converted as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

As of the balance sheet date, the weighted-average exercise price (at which grantees can acquire the shares reserved for issuance) for exercisable stock options that are fully vested or expected to vest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(2)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of share instruments newly issued under a share-based compensation plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 23 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8

Cost Basis Investment - Additional Information (Detail) (USD $)

Dec. 31, 2013

Schedule of Cost-method Investments [Line Items]

Investment accounted under cost method $ 5,000,000

X

- Definition

Amount, after adjustment, of cost-method investment. Adjustments include, but are not limited to, dividends received in excess of earnings after date of investment that are considered a return of investment and other than temporary impairments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 35

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=29638308&loc=d3e40346-111594

+ Details

Name: us-gaap_CostMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_ScheduleOfCostMethodInvestmentsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule of Share-Based Compensation Recognized in Consolidated Statements of Comprehensive Income (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Total share-based compensation expense $ 6,857 $ 7,105 $ 13,792 $ 13,704

Cost Of Molecular Diagnostic Testing

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Total share-based compensation expense 209 271 432 560

Cost Of Companion Diagnostic Services

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Total share-based compensation expense 74 47 137 104

Research And Development Expense

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Total share-based compensation expense 846 869 1,627 1,678

Selling, General, and Administrative Expenses

Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]

Total share-based compensation expense $ 5,728 $ 5,918 $ 11,596 $ 11,362

X

- Details

Name: us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 25 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Equity - Additional Information (Detail) (USD $)
In Millions, unless otherwise specified
1 Months Ended

Dec. 31, 2013

Nov. 30, 2013

Fifth Share Repurchase Program

Stockholders Equity Note [Line Items]

Share repurchase program, authorized amount $ 200

Sixth Share Repurchase Program

Stockholders Equity Note [Line Items]

Share repurchase program, authorized amount 300

Share repurchase program, remaining authorized repurchase amount $ 273.3

X

- Details

Name: mygn_StockholdersEquityNoteLineItems

Namespace Prefix: mygn_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of a stock repurchase plan authorized by an entity's Board of Directors.

+ References

No definition available.

+ Details

Name: us-gaap_StockRepurchaseProgramAuthorizedAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount remaining of a stock repurchase plan authorized by an entity's Board of Directors.

+ References

No definition available.

+ Details

Name: us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 26 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8

Share-Based Compensation
6 Months Ended

Dec. 31, 2013

Share-Based Compensation

(3) Share-Based Compensation

The Company maintains a share-based compensation plan, the 2010 Employee, Director and Consultant Equity Incentive Plan, as amended (the “2010 Plan”), that has been approved by the Company’s shareholders. The 2010 Plan allows the Company, under the direction of the Compensation Committee of the Board of Directors, to make grants of stock options, restricted and unrestricted stock awards and other stock-based awards to employees, consultants and directors. On December 5, 2013, the shareholders approved an amendment to the 2010 Plan to set the number of shares available for grant to 3,500,000. At December 31, 2013, 3,733,317 shares were available for issuance, which includes 233,317 shares carried over between December 6 and 31, 2013, from the Company’s 2003 Employee, Director and Consultant Option Plan (the “2003 Plan) and the 2010 Plan that were cancelled or expired without the issuance of shares of common stock by the Company. In addition, as of December 31, 2013, the Company may grant up to 6,999,352 additional shares under the 2010 Plan if options previously granted under 2003 Plan are cancelled or expire without the issuance of shares of common stock by the Company.

The number of shares, terms, and vesting period of awards under the 2010 Plan are determined by the Compensation Committee of the Board of Directors for each equity award. Options under the plan granted prior to December 5, 2012 generally vest ratably over four years and expire ten years from the grant date. Options granted after December 5, 2012 generally vest ratably over four years and expire eight years from the grant date. The exercise price of options granted is equivalent to the fair market value of the stock on the grant date.

The Company also has an Employee Stock Purchase Plan that was approved by shareholders in 2012 (the “2012 Purchase Plan”), under which 2,000,000 shares of common stock have been authorized. Shares are issued under the 2012 Purchase Plan twice yearly at the end of each offering period. As of December 31, 2013, approximately 144,000 shares of common stock have been issued under the 2012 Purchase Plan and approximately 1,856,000 were available for issuance.

A summary of the stock option activity under the Company’s plans for the six months ended December 31, 2013 is as follows:

 Number of
shares Weighted
average
exercise
price

Options outstanding at June 30, 2013
 14,434,970 $ 21.75

Options granted
 3,304,553 26.48

Less:


Options exercised
 310,866 14.23

Options canceled or expired
 354,729 24.33





Options outstanding at December 31, 2013
 17,073,928 $ 22.75





As of December 31, 2013, options to purchase 9,218,423 shares were vested and exercisable at a weighted average price of $21.39. As of December 31, 2013, there was $52,276,000 of total unrecognized share-based compensation expense related to share-based awards granted under the Company’s plans that will be recognized over a weighted-average period of 2.57 years.

Share-based compensation expense recognized and included in the condensed consolidated statements of income was allocated as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Cost of molecular diagnostic testing
 $ 209 $ 271 $ 432 $ 560

Cost of companion diagnostic services
 74 47 137 104

Research and development expense
 846 869 1,627 1,678

Selling, general, and administrative expense
 5,728 5,918 11,596 11,362









Total share-based compensation expense
 $ 6,857 $ 7,105 $ 13,792 $ 13,704









X

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

ZIP 27 0001193125-14-036458-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-14-036458-xbrl.zip M4$L#!!0````(`$!J142%N*BX\Y(``,S="``1`!P`;7EG;BTR,#$S,3(S,2YX M;6Q55`D``UB`\E)8@/)2=7@+``$$)0X```0Y`0``[%UM<]NX=O[>F?X'U1\Z M[4P1X_TEL\D=OFF;F=TD=;)[]_:+AY%@FUV9]"4IQ[Z_O@`EVQ)%V91$4'3: M?$AB$Y3X/#CGX!P0P//37^ZN9Z-;G1=)EKX[06_@R4BGDVR:I)?O3N8%B(M) MDIR,BC).I_$L2_6[DWM=G/SE_3__TT__`L#H[&P49FFJ9S-]/_ICHFGYBO(:;*DYV31\JV].GNFO6'E3\O?8WO[B[7VWTG5&BFE3JNK#TV3 M(J,8B><>9M'B\;.+I.F335-T^L>OOWR97.GK&-01&%.YC..;QSLOXN);==_R MPJEE%4`$"'JX9:J?OJAZHD)/WEQFMZ?F0D/SZ_O+=.W!KDW'Q=/*6&QKA)_: MFB\M[V]TT?@XU96&+[#/,"W7'VF)G)TN+JXU31J;\D73Y*%I4=[DS3#M%?L8 M:/TQ)L:DR_R^^9[EQ8:GG\SSW'CNMON65^V->/U&?3>Y:K[)7FGXIB2]U479 M?,OB6L--Z?RZV02G97YJ>^34M-!Y,GF\P?C>R_=D*:C=-R_SK;:N3LW5$^.E MHU'EI[.W167-9_IB5#G-6_NI[TZ*Y/IF9DV[^EV<3_)LIMNY9W7'5:XOWIU8 M@P4/EOGFKICNX;WM`\/I`M;2W=Y^N8IS[=N0:V.63HLJ)GIY'J>7V@9D__ZI MR>?XWO[*^Q[GTX_SZV\Z_W1172V\>7F5Y9&FI[\HS"TUGL_//D40" M`O/'((3@OTQ\(.=?OH;G\'P!&C+S7X&(%.I.,$$Q/QG-TV3Q"47U\2>CJ9XD MU_',>.J'C^.343)]=Y),SXF@"B-\[@6$0.D'@$4"`:J4!#+P(<`DDEQ!A1#F MYS8RG<.3]X1!^^>G4V<<+"@VX>EME)9)>6\^]CI+OY39Y,]%TT_SLAHIS>BY M(U_44F90[,I0*"'!*&)`>H$'*!\+X#'F@7`D3*Z!R?5]2PD_<"*T$I M53^=MD.Q;E1!7%QYZ=3^$_U]GMS&,\-8X95!G.?WIO7O\6RN=P2.(2=P#?AR M/#K_[4NXBAZ03?!2$X34# M:86G1D&=K`]%,=_=.S9`;_9V`UXO0#2"`0>2,`8HX@;JV/,!HN-HS$,E^5FS\_$;GYYO=CS=8(2HT ML33P@3 MUA13<>B')(H,QV)LZ(T(!Q[E9OSA'N?X_Q3_J4T]`]FVCQJMW-?OH'HB;1VJ%Z.6!W'Y&Z" M%=L(5AL1>?]LR^EX0I2Q\$5R]>R`4D^4&AJ^4DN5=4MM`>EE,QUJ=].3]ZS> MV<\__PMV[2*#Z"110JT2I:WY\"])_"V9)66BBZ`JL,LN[;@;C-C8+J<,JC6, MFT^^CLR;3.;7\YDUZD_EE<[M();K*S..);?Z0SK)KO4O65%\U.6GBZ_QW?!@ M4S.XF!R)KJ'>$=4Z);^EN9YDEZFU=W/1UZF^2,IB>-"Q#==0(+F&?\_YYF)M>7]YUELLI=T:HNHF^M!N@&R M08TSQ;89Q$%X:RQ.IXEM'L\^Q\GT0QK$-TD9SX9'"L4F-BA!*%]GI?GY-TS% MSD46)G>-O\WT<.,?,]X@$<'UCF]X^EKY8D>`JVPVU7EA>[J\'QXZ6LWI2*;6 M`]WFHZ]#.]-EG*1Z&L5Y:D:U8LT/+I)),L".I,:#"91\W59?1K*./%RF,6?Z M5J?S`9NM,#4\I&0-;//#/Y=H[C,C]P*Z;JHAO%$-F9XS'SA]%3D5/WEO*GZR MD5TT`ZCAG,VR[_;5V3C+PVS^K;R8SQ["T9F>Z.1VT/'40!?UB?:=(&U-H8>' ME4`+%F.Q+7=>QS).S)/H7TPN:09-4S!<)@:U5Q2Z7`U+JPE%CY#'H0@1'`?F M@\<1H*$%[WD$,!C*$`6>06QB[+G)"`C'Z]V[.ZZM]:"#>-1)1PM;"/)M96## M>X`5(S")X*M(%;C%2"1&VZRY$<@Z[%_C_$\SXIK^_Z(G\[RZ[6.63H8:K1"W M4U=2T/5BZ'D8&P/JC4F#HSL[BSO6'APMA6Y#@6L:^'<$ZTGH` M_JC+Z&XRF]O)J0'WI1E($2%DO2_;8&DN.I^2"G//8%W2U&:*+E!O5IY-$.I= M/345S-:A]YC=CJ@(_N=OANJ M>C#>,@,S5&_22P5I\E49!T5BT-@"HYQ:3*U/* MY_>OH5_-X,29@J265FQ#T-**#34#Q&KB&!8MPG".$[RJO@)DV(RRXIYMV]J7T`%`Q4PRBF(H.*` M0C/4^)ZG@%(^9[X9>:CD=AT&-7^9D49!7EO?M16$^V5M??2F?KUF;P;P\:3;8%-X$ M5\PEIO7,=BN$IKQAL.B4K4B)4DUYPAH>NWGCI5KU^(;U%#(@_Z#"+`!0GLSA$( M/`4#($,_H'"L.%%VL;3EAA/.:G,T[<"U963P)-"*!(Y:DK#B(=L;549D%QW% M,\O7SW&2KKPL^I!^J':*5=.<@^>G*IL>O:<3S,?Q)BR5.Z)4%6B@&3X'[4R. M.:"[<7`<.S"0'#K,(G4RI2EG@[8$URS0Q@+]%<55UP3]*'$5*^R2J"J#$R:E MY4-V)^)2T0) M[)`JNIRKQ6K`=5P/+"SF:K'<;=Y^.'').4$F+N$?/2PY)Y$L3RET%Y7ZV31@ M**-"(%/Y,N,T[M8NH`ZW$/2]HJ,_CERL[^AK+ZME21%I6**2[)<3M%K)5DV/ M*['^!N70C:TN%L[V1X@-1ES0MHQL+-!TLYBQ/_S6;?A!*QM[=Q*F""/N.*G" M+>:TM4T[X6_H_XZW$E70.;\34&)$W6TLPG9CD6HN"]OM*W(*W/S$!!/F)R'9 M?N-D6QKP,&E`T!#@#CBQ_6^/C\"\_A9E`+A7NM^D<$Y90,-D8>^E(*UP4]O[ MHG'%T0!P]^7\U#K_0%G8\XU[*]S,]K[=W@4Q9&QPP/OJ?F:[?V`T]!+U%J?H MPT&%O5YZ'-D>KW93"Z'J&T+:(7_:_/C7I+SZ<'TSKV8L2YWKHAS'$VTJQ?G. M>\/L&B+99IL4W)R<]8@:(X6`4/9,_S"2P)-8`.KCP-"*QH$<+WHE%*LCI!+I92J\XD]$U92?/"N\F,K$"WI>E`@DDABONHY[4Z()UY`J"`8 MA(*'QGB8!`J'%)A*"8\A1HR.U:,"$:[;CB,%HH8CZ@X1/MBPJ^[.6$>5&(T@ MJC;/>`PQFJTP.SC1%+TB,9KGPDBW8C15\6!/C\'_+T;3QLOV%J,ACV(T]K1K MDR00A65O8C2'?OSO9B`U79A6!Q5.S'^_9O97R\ZL#H?HDW$:A!B'T1A`R,U8 MR1@!'E,,",BH")108^$_Y@OF#CM8=L=U6S+ZT`/:(U+LK;*"!J<'Y'B\<*H' MY'1('Z`>4,^6.C0](+?=?:@>D/N0.+CTJ/T8LM#J(ZK/$:1]UM2EE)/;,@.U M*C,<2CD=4)VWQ%A).=G4;ML!WL>0?!PEIQ[,5IR\)XHUGR;L6,GI>73=U+$.E9QZ MZ!RKY,0D'9Z2DWOLW,Y>UKT*T34STH.?4P?E8:;)S+ MX2@Y]9#VVT5HA"&YGO?WKN340_?:HQM(73'$F9)3#X/L#DI.V[?$A?I;^6M< M+G^R:S&2]%.J_Z;C_*`-MP?@)Y0CB!`!D3=&@"KJ`5]%$>!00>H1QHD,EILJ M))*M]Y:V15J/S47YJRZOLND!.R+;DK&YRL;C,*0*AB"2?@@HYA%0G'M`!0(; M<\"1C\5Y]G#Q:JVH M627N1#9FHEH*?+6-`-Y%J7,3`+Y>Y=G\\FILTC<;"YZ6XO7(#&/44S)$@`AF MDD\9A,!#?`Q0.,8>CCR*@O%RU]3F8-T9X'[W/!]B2!2%*!`"<*$4H-1GQJ0X M!P&,E(\Q"0(_>@5":3T$36,Q"E5S>\<72G,/UU0I"M9>5AU!**V'?JW>RS$! M:UE[.Z&TG0*/+B/%5IU7`<)@8/C]YUC(SI!MS9UU*P_70NV8$).:+ZK*S MQY&&ZP&OE8932I(7';=;:;@>$CC<.*?@5!KN`%2M-C-PNXO'6"@E5#+9@.LX MRG`]=*;=L<64.G0)?[<[M]U/>5IA.%BK07;9JWWH<.,H(7]^J&F9D6\.-0?( MX/40:?N6P>L!DI7!VX#D6@;//2Z[09#R763PHNN;67:OC7_EM\E$-R]X,R/H M[6(EFUW;5GS-RGBV>MVF=(:\OVD#ZV$Y3'_37>T7^)E@S#"NG3SDC(%N9Q@& M/K&ZF&6PFP.[G&5X9HZUZ\,\W`^)'>@W[C51/>"YJ<5TO*JO(SH(91^*EX?X M$T-,!E*`$.$`4*P$D$$0F>Q9AJ'/:,2@&JCB90^OC!OMH;WB94O#^6+8FNGE MS_=A7`[0-6RQ)*78\TW5)L(]1Z-ACSH+DFA=0W0?I=YEJ[7%3Z> MZ/S\`_R@Q_9$P9[8^CYPU?T+FE@\.@Z-YL\ MN1R:*UE`S"6A;>>*CQ2/W))`*Q(8?2TJ-WWS@Q\.N_ZQ(Y);$NU*OGT$7X<6 MDARK)XIJ4@%Q.2SEK;Y)L+M=D$"R+0D#"TG.^;$A2?W@(V""8KYSH?V>@$A4/H! M8)&P:S>4!#+P(<`DDEQ!A0S_]ICDZGTE$800)+H_I[U.Q;!.Q*\Q[?A$_&HY MP89TGN,3\?O9"MJ!M&NK=0>O4_ZV;XY>I_SM$TL'JIVV6@B\<$;<\7%`+O8' M]<>(57:D!^P6@TBPM%O,[=P, MX^2X`HE-N/M2#92VVALB"XXE@I7M?6/[9@QJ.C;AN+#[TLI42Q6+P9'@5B#8 M8JU6L$FUL_-`*J=0P/C MH9?`QY?JAL,)?+UT.+?];?=`8L:@V`?XPPG_#\I8?EPDD_:@D:0ORN&V%FIB MB$J?"P$4M7.,GCVQ5$H)Y#ABDB)J5Z;8Q>R5XI=ZA+&.M28I]3!;OVQ[@';45@Y:J4>U!&U/OY(4UJ2^=\34@I!MMWK3 M_YDOWCKV10PQYD.HCX`2OBWL<`!4J"0(*?("20+!([S8Q(%I;0_'GLAJOG%Q MH2?EHUC3U_CN+"YU8,`GZ=S<]\F8=35-L$/MNY61&Q."7G".@!./$07&46#W M"![&T&=T00=9,FP>;7-DW75XZ/=-EDNMI.,_- M?<;7DFS)9E\F(86*`A(@X(TI-K[B8Z`"J``SPQL91YX(&3(<0%OK\_7`OPN< M5EI7:;3/74 MO_^ML-,G2S,R[F2-;<<%*_UQ8<<.$U5JAWVVQU3+CXP336U8,>[UM(!C\>). M3\=Y=FU?(<_+RK\^7=2'J<6N]+ZB95Z=CL=TXB#C!;<;B9D2U(U47JPB*KYDW^?O< M!"5CB=-Y%;5W/?VN/U>R+!@_6J^H7T32<'1<@S+BT_*G_\QFU3OP.$GMJL)/ MZ5@PMOCT#X8:8Y)=!)[. M2;*',6/!UFG:!J`.QR0C%4`Q$5=EN`E+"\$D*:SH88(WY8U MV`Q`G#X?1IKPO-3]#X<>/R:^PZ3`FCQ@LK85OQ6WDCT"%[\-/[ MZMSI7>C`Y':S"M'\DYG4P\17O9C_L4%_$@]#[PO4-4K]3B6$?^:H:5,+6/VP!CJ6%89BI^58GL MBFT:P_P-<;1OAE6L:PJ#]1`&>XRZ:Z`UKI0JK)EX<#Q\@HED57#;FLTNN8J%;@`]_994X6`VYW"N5P MW,*RHZI:>?]T#0MUJKF=#M1`$3&A:UARG<)N==`&M]3SRB[P1CL M>Q3C&OYXS/X'+EN2IE<`6_7X69:[@U@Q^S7+`A\CT[B;!7%AY8C%"@;J[M]D M\=8QZCN"+G5](:FXGI&:N>I/S+EGWM&NVUAH5%!XD%PG1UW@IFZB#L*3H\W2 MZ7@R6U%K)NDR3A;=T9OA:RAWSB^EF>#*0!4PLB(9<@51NS%NM("[=03K^F8(Y-<6J5K:M MSU1U\R*B3NBBSVB#I?$"7IO[B)T]6`X6SYJLY6+I?B":UED6_8A7!O#R#&,Y MEFT9"ZN-P,`<@?5I(U@?T( M#E0D62Y4S6VC./1XH.PC2E!]_<<:;IR!V0:R$Q'[[V+;);[TOO;N/W5OR\4LW MI7T9D7,6VF/J#S#5TO>6TLL8AZ!>-"6T1$I5R'WFT;#KQ/0A"*>O(F/UXM=/&!>2MNM2#Q=A.B"< MK**<2W3.F;`#-^&LL`5-BT3?32>[4^N: ME&*8`JV6*45"%LE+M\9[_L`&L1^:3IE+5!&P)KU4IK9$5U6?N_!`Z'AXM_73 M/^GK:#30CO^8EF7)2E&)*\3-:4]/&A0T9M=2WX1\1.,*H@Z17DK[*N)6S<)T M?%YE'H(M^9>\;!86:"HO_W@0/KH99INDVURYLXIDQ>AC#0I#,.1.3U!%3061 MJZ:@JZJIV&+;M+K]=$+^Y,77`_;XTT-\#;3A)[Y+0Z)XZM%?+CHWW^S>-Z%[ M\^E3^^MM[RK_XYH,@51AZ(R9-[VZ8V.(,K_0[^1;,';\[,>(_46O)'$27Y#[ M(!S0D-?,`#OK39P!+KVSS]'$2"9'][=!CSU]]+/^,;'^)!^?WB4>#6\OR9\KM_RA1.<'+LO"%Y-?9OHUP,T7CG.-`H\-^(HW3#=J'0_(@R_2 M4VPCYY%"&_>4^F2"\/<0GKR?DL_3D#D#@@B>F+E1BT#0>DG>Q]#73\YXDH<4$.1-\6%[OYK=W^6NH#Y!)"+S%,NG&!,>;#]^/4OW;\`9DD(6XYQ-!> M'!`DWIE,/.9RY0\3/"R/CX7T(?&R2XY`#?"YPN8L/`'O]Y[<$9;&()AX9Q%B M^LHTWO:Z)1(O^<`L'PMH;^EH,+[+05-*@'_*R2\H)FH7)?9 M/-IHZM"00G/1*$@\F#,XC4+JY)+[_\3GXDW[*`S@7$FL:QB.9,#BFMJ!HO"# M&%02-R$I<(VS`)L>\B6(3&'I)."*\R;^D?@TZZLM7BMBB^!2TLIUC-.YDJRV M[X.8R3R)C M4(]1-&/"AE'&"V8*C4IIHZ!Z4Y3&3!'`0L(@`%<#F-^XH8A*E'66Z@C\2I\F MU.4C"KWCO`A0E#-+,N&+.('?9CPF7$^1QTMN[">O:^A3&YU:..!OE8Z#.J$E M!(]P;GVA!51UD`F_:R(J3%Z4SMCY#\@'IA_8S\PN.E&4C+,=YWCDH"(X_)XU M+IJ0*P>:\/',4#DII@=?]@K`OM3H#&;74/)G77X0^0&[7_5:VA%.BLP*KI@: M+6B!?`B'YLTEMW1`?@=8`D7G;5V!W(I>-MFHJJ!BJM_L0"PA M2CVQKQGPK:&OBB5F"OZY_>VWCU^$NYNO5X1K>/_FRYW0;W_^^.GW*[(0/V2/ M=V[N[FX^7Q&NX-EWGWK]NRN",X`WW2U>FH7.2_R4>*MR(H\9V6^MBVTOS9*`U8]SYE$]#DY%_HUE\1IQ;BL&K=E M`9@EOYL%70C7H6&-J,V0WUTLCY_@F3P82XW?K"-E]2N[^K[I^J!=EV/E.,RU M>2.57&$&\OYN^;+4T4:[WJ!]]#9_++1?KO MOE5_#ZQJ+5W4W@:K1DM2]+?!JMK2S+V,ZC/;6XOIG=WG-794KST[)\)+P$)I7H%VF6[8RN]GB*H1A^WE!5=:*NZ)*AZ6]=-6^]9'?$/#6'L^::^ MHHBJIBD[J-*^E//]5,4Y;-[-XGDW977>[56JXM11D6T/HBG\^FC#@CYV5Q5G M79G8`D0W.\9WAR9@]TE'L:_8HFEJ@F7#ZZHM]X6.T34$4;:TOJ+*MHD8Q`V2 MCIA6VW/6<;8/BZ5%PD&ZQ3#':9=V$Z))6I,F2YOS/2_X[ M+?/W[;(QLJJ>1MII6_X4Z:SY4TWSK/G3Q+VD13?.%;XD\?`ZA7VWS.W4*NRK M\".6EKF'PKZSZM^I<#]3!Y&7@QO_6XZF;ON#+X$_`U=SD-Z>,CURIVM*O:XJ MB);4%U33DH5.OP?"T&6I8TFB9G?-C3(]XOX3/6DNAF=STN0(35'+&9P;D>8X M>Y(Z[F&YH;FA;F+$PZQ?+LS5OWXV9.Q:C]CGP MZ10/Q_V'QF28@-]%WCL_']R8;9EZL5J*MHODV<'23,OHJ,=[Y<5%6:"^.R4LBI+&:WT+LT?76KJRB_-MC9D]7I&=BJ*LM;*9T9H\ MU=M$WK<\J[8YVXKCR)'Y/MQ3M@^W9`0V-:Q[[7!S#6GDU\BOD=^IR._T\@'* M&F]U#E/8V#N%7_!VQR4K2PY/6JE4^-XFJ\LKY^'/1R*JK+4TT3@_F;S!?:T3 MT#9%;9G:7HXIG)M_J\!R-0B2>X\>:H'251;LEEKZ^98 MV&XTY7PUY=S@;^<##V_DU\BOD=_IRN_T,@)O]GC'*^YE';]P5,-H6?I92^<- M[G>=@-Y98DO7&O=WH]7LG'#CC00;"382/'4)-J<_TC,"DBB^*ZTCR\][J.\V MR1UA'%!X,U]$/3I,99/CR=:^7WUI"2[-"2F9A`R^8]X4FG&#,7R,L)++D-`G M=X1%N4D<.E@5.'O%'Q#'=<,$OF&(=J91O+%V+"FBM(/:/I5BX,-A6JOXHP]L MT3OGZ9L34V@N\%WFL;3L>)SEZV]C)T[B()R6'MY!8:4)13 M[XF&+JC6UY"YNQ#L-A79%/$\3[#V(8L MGMHPI'NJ=J4KBJ2+DBWHI@'RLMNBT!:[EM#IF58?A&?T0'*;5+O2]UOMJNM$ MHQ9QX;^$_IDPL(LHOQ:W7N-47`QZ`RLWH/<0+:%5X5^A$9Q)&>N7.X\.\U"H MPC`(A!7V+0Y+JZQT7W'O7 MS7'!BN#7'\'"UN_QCZP,XT+1:S?(?)?[+=DZ-4'THA@6QWA!$//*?[L5Q[FC M/7"9V2IV>TFDN6VY5*5EG1:L]LB9/;V-H.=4N>@K'5RM7PRK,%JZ<5(XQU/A M^MRM>'O!Q6^.'A\'S:=G8M?MM=L)A5`A'C&?!#XE4^J$)V=E95-JF:<%<]P5 MVY:UBWKS9VYGG]-_9PA!R4S](;P,@^1A1(;L,?WF!/T.16N)TDF=F-X5VY*Y MBXM"S\K%KJ?_KZ3N#>"[$=E;0,N<#]BTD=\Q@'4W=:DV"7B.':UGFBW5VH6_ M?UXR,782`YV])3XGQ%,CP=U:XQJHH)=@'\HHBFX0Q9]I/`H&A39M&KDAX_", MW4,F%%%4):NG"J9M=@2U+\M"V^CW8=61-,U2+;MM6ZL@$VNW[?,_K@G:.V'H MC)DWO5I8Q/B/$?N+7BW=LR_NT5?W\#>&MJT'GKV7I.5PM>*#2Q?1!/_`H2,< M[D7F8\?;2Y:;NKK0Q+$3/C!?@`ZO.!PE^YQ.ERNQ\!52>(5PD[)0UX[`++O, M82:K02$M$H\H05"1XT_)R`&QD+]K+9B)^']H@,V8AC_)-X?YMN.[E-Q1=^2# M6_+`:-0"T;B7Y/N(N2-H(R+WE/HDI"X.^@`:27P8?-X3;GJ3,9\*'-_B%X*/ M[O4-/!(2#L*;?VU?DP"A`/2'O^6$SG^TKB.<,P/J(VX0_N*.'&XRDWO'XY1& M(TKC2W('35/R'?_C!]`4?<1)2(*0N"QTDW$4X],1=.0@JP/F\E;2C]`K"[D0 MZ!.+X@A%B[3281#2L@QSMJ&7XGN,LU`4)[R:MH)Y*$J1DH@]D3$,ZB@BU,C-L((3^Y(@+3=#CC2+]@3VZML=2Y2UMM"V MNK:@2K8AM+6^*O0Z5%?A0TC@-:T&VZ2[+FG?%4V5`TJJJ'Y MC=!\7NB#/),@.&DJ(0UL(0Y.8DR\8*1'$DSAQ$$6[6;!\2P]:9 MQO0H-3\-BAE`!&=%,694@_3H[LD9.ZEEG-:5S[M@6FYIZBY*29\4TU++,JVW MQK3<4K5=,+V9H3M!^,7Y`+D:^37R:^1WNO)[>['T;$.9NY/S*T.R&/N'O\VB M[-E3B_O.VWF>WN$@E"\.U?26*>_"53U#V9AJ2U9WD;(X0]D85DNIE]-_>[(! MO1%WO87;O=%2R[;PMJI],7.IVV!7\IEB6)FBIJYE9X^&.Z[;6$@U]W@:NQQ06N M^`R'O..`$3YB)+LH=3R[LN>%F/A#PW9G%X_E>-RE^/(A\QW?98Y'F!_%8<+9 MA29".O2H&T?\36<<)'Z+>'":W7H6$1;#H'@>PH,I!ES,YV&8[^--JH'/ M;^?@K_)['H$BQR<.8N$1&CYQIH@A7_(X-!*'CA\-\6H#>(EXS+EG'HOY"]`& MUS-OFC[EI"_?T_@[@O33"WFAB8D3QKPZ)S*1L3">#R]!3#UY3Y^`B0E>$_KS M946$T,:(P=P/W=$4'PDPXOR+IM*!L!-I8SZ$G%D0"K3A>QS4C"S@>0+V9X)R M\N.`OS6'5:<(>8\^4F^7`&C]#>"?K?6A-'H\DV,=L$4R"FE,+K>`I+`=7)3"G81B`:4R/<$T+ MC^67Q\-*Y'!BH^0>\YTQK,S\_GB^9"2PP()A'.L8'/%Y49'(;C/-%_X<5 MQ\K2[E+;/T^@SBZL_R][5_KC-H[EOP^0_T$H=`-I@$KK/GH[`7PN,MA):E+5 M.]A/!95$VYJV)8^..OJO7Y*2+=OEHRSK(LT$2*IL7N]'\O'Q\1U"FJ#6_H+" M8Q3^";$K%X$FVUT(@D#,>'W@Y5W'N/.B\:O;7RI5^RL-WNRPDS/V7EGW M98^L\K*-XX9JZ["L4WMB+:,'_&PM_K^\3J@D/68O5A#40>=)#8B(6 M_4X=7<2+\M$A:2."G->\G2=AC+9?MOR4C1T'MAD`EDRQ`U\R\R./B,1$E,5R MF8!;Q,D#,B_7910^(6:).:`7NF3L^<;.1.Y@&N)*C\1Q.'>IA[M$5P7T M%1DIX5KXT06L^_$#Q"D63B'BH_OP$AL((:$8W3A@!+%3*V:"`-7.7&FQ'^XK M6+'8.%U@%O57QD"S&P0)*U]TXBR7<^S@FLG>F,D7?#>[FJP'DET:C=<;:L<'S,?\YO- MOMW$C#S_?;ZQ#O=2%"GXDT9#<;9T,'L2,:X2.E*01\8&JDY5M.LKS`+.D;KJ M_<.Z5#@(HR5YGQ`>PU5.V@!K_AOEH5<1&KQ[SE\6MORERL^/+Q1F%PIC@FD: M$`.D><97.3=E?Y,HI@1TG:JTD'REL+M26)=3!WJE$@=NL-4I(\,H$1C).S5\?;%+9'\\]N MIZH=32:0)!_Z&J#QPGOGY8>3P`&27OP@1;/S?0DCDO8F+I^W-@W\K-82#>1& M\*"+0)K'Q-9[)Z>M/C#4GJ[:XG@T,$5-M@9B?RB;HF0J@UY/4:2^KCVH#_+- M%^F3:A84OY^,;?*+9+]W<(HS'OV`RS!"E:9?BXP__=?\R^IS^`[UP7BL:))H MCHRAJ(V4OMC39%TTQD-I*!GZ2!H>S.';1EZL'`B<,PD&*20+.,RP)7F>,/C" M1[3DXE^$9[2A\[IEHEOD&3N#_=."Y)[DF1]@:2U62S``$O> M//U1J77>_DAI''-G1LK60]N/[/K1Z'Z]PO>/LVN4?5JT#2!7$KFJ42UE26I- M8$MMF[;52Z$B:4`RI'II9$%T.<;CAG`90=?/LF831>$":Z;^(A\T+ZE<:*>G MM6[-V1"A,M",*B(^4F6%J5GV=L1RXYIE.[\%VZI1(/&@Z/+]4E86KEKIYXI5UFC),8,MMG^K-&?(`HW6/OYHGU%*` M;G+5$E@G0H5Q2+2!=GX;\HPHDFW&UH:0!V6C4D?=Z@[J6"V]HG!_>4&TOT!_ONI:N M&PIO6!][OCS^F[$W_ML;YU/8U]<\FT;.M1KG3I>_ M%*BM:YZ:(]6J69?Z"B?,B+*/PR8]IM,9056!:;6_AI@YA&=A: MV]?>QJDV%"!K;=^$&Z)5DX&AMFF306$FX-)Y[1OOL(DUQ5'CJXZONOI18_VV M^@U>IG9#WTS"(-ESN*R>2P_N4%SOG`.FK(9=`FK=^4VJ`*=!2%0=2&H[HE;W MUXLLZ&J<.,(\I57"VXG#)I_S=/3 M__YK&HM3QUG^=N?.H)?.X?=)[O[P@]B-^,'T:S`)HP5QXNJ_YE_>PY>D/P_= M/[^@!H7?UXTDZ"-4,8W#_!;U[YZ4/`SCQ MDSBK\#5P(XC:&\+L_PJ0\.-04V3SX8^[X0DXAH8YEH>V+-I]RQ8UR51%6^HI M8M\`AD%,EE,OBIQ@"O&" M0BMK7>36><4?]9Z=R"/__"^,DS7<2![)(J)R(&IF3Q5[IMT7 MM7%_W#=ULS\88"C0RKC5_F]C551(RY[M,POG'HSBT7]2/WG]%B9PZ,?N/(S3 M"*YW7640*')?[:FJ*=KCP5C41EI/[$G#H6B8JM3KZ0/T5\D@P%PC9QHK)M05 MIP6T:7_>D@NC_9.ZN]6PF52_,/FY.6<&0%O MXW:RN21MI_M%U#+^)\;:U^24&F#+.V5+-:#]?/3=BE@LD\4L%&Q0N(W":>0L MR$@+F^9ER^/]&@C?PB=B.T[B[@(AF4$A2SC_BI;C8CF'"?0$Q+&$B3])9@(Y M/K!]9$X8:F29D0:$YYGOS@0G369AA/D=::PH*H03(5T*22C\I*!S?.'/Y]CI M.9R@-C:ZW5P'^,!;+%"A&"^43_O'BZKOK=H/$>O`G0[1Z>,F811OCLT18O]E M11!J8F.<.4&XZD_JUD@/CA,U$*9)G#@!WF@[H[[?P'0Y=X(88[#1'T(7U=^L M(TRB<"$D/GZ"#+/_PT@@'N*"XZ(MC6U6$1&/3NRCUF91F$YG>`R(M0H+)_H3 M)D*">&OLN)C/QKCV,O*?4*7YJQ#`:9CXI(&M0@X>AHS22GIJ`U1LU"T:NH=)?$QC MU'L%1%<.`0NY\GQ MYX2_YR;$*YI1"P75V:K+:=]>&RG&AR#C1)B!IE!80+1@O6R/H(G'&&-B<0=X M3[Z!E]#C8##2>;):L*34UA*/MSJSC5;=XA^0=D^&N)IH,8DX6\[$Q8,AR/K.Y&C&0^+.$.!SAQN(=5YL/!]QK MR.(@-;"]O?`,$5MT<(/S>?@JGC+I+OB:N:2>QK96XN;A/YO92"OU5S6'"!O3Y==J$X ME6(5WC<4D&H`NQ)'(PI(58%4/MSY]=CN#TXK$\2WJH3&V5G9J)LZD.RV3;Z; M(M8&:MTF-)VA56_/P*R%58P.8Z5-XR@&A+/!$74G+=Q,5X#YOHL&"XM>`VK= M*6LZ0ZR,#RJK[0C8C:UC`YAU&TR?;Y[T7M.('8N*PJJIK-7&]R61J;#=!K$` M&KTLH8M^O`_Q1]^+E])[3$3U)AJ]GF7IDMX33=W616TH&V*_+RFBJMJ68H\5 MP]"L0R8:AQ]JZGN'[PEQNE@XT>O6DYT0+K.PX*OGR^(5\<`;=/:ZO'K4VGW* M.O:0Y>?/O_S]RC1*O%^9^OGO5T>J5/5Y:UWSEYS]BD?<^B/^X5NZO1'#"1G& MX[I0\9RQKI.]GV^78U,_NR;Y7Q`?L;FR\2@XSA.,G"D\71"^P,CUXW>4)!8F MU<+-^ITD/_BWC*&<1/A[&L"-0T?*#IW&+RD7JU4UH*D:L,VV(UXH5MTC7#$^:55<4:^.S_\/C/?<$6J?[K;* M=7K,]/'28XED5KQT):91R$UE"5@&=9K\RX6C3^5CI['.2]^SXETGP);]'C;6 MAR]+.FTL=`V8RM7%X5*T3VKS:Y]"!W]V@MQP2:%M&?2`KN&PDKL<-YTW%WWE MXB/8!)*I`ENIY4[3/CYEM1A*&UH,"KDS2\$*B-U*/9ZMB1J0T45>[)N MB;(Y5C1-DX=C63[K%;QF;_3$XCS9^2(_778^):<1!^T\T+(#NF'4VL!J M%",@N+(544BT(+&C,CVE^>L>T//Q9DH^YMC%W9J3TJ7*//8'A>W9VN\(_ MP/^D/AH+SKK*-S,?,]_,-)S7^HGMW?A&+NO)@]]/VDZ:==X[T)YQO(_XG8IO MP2B41TBRTBH=(4>J8:3HWS;TR3RGF.*FJ-.\I'/Y:[-1R;MJJ_O_LA9H9`0< MLI;43)W84:S9+'"+,HX?QZ\1_+I`1.=08^'N?DPU=Q_B.%GN(05=.:EU3H]- MI2D#W6['H+TAE*Y9Q.,0=PMB5GGYS_#A^G<:O"T1T#C7Z5,''9.S> M&W/D#6/DDD_@38K8+9;C-%X;C=VDC`4UP-'7JC!:ACCIG/`8!AY)SH:DX02R MKP"P-*#H3"L`JD"I[N"G]"/TL73DWU]8O'5;.!ARS>&!Z9,2C['@?Z2![_I+ M9YZQ8.89KV)80-7:B9=-$4RJQ%GO*=9;7KW')._%.TO7>/J%B]CQ&'HPPFEP MIS!P7P4_CM,KD(8-)`W;[<2)I`@EE6F6S%^S.LS;T095*XG#QU^S*-2+<_PX M?IW&KPM$=`XU^O04IRW&WH;8V7C38EY,UF0#6%Q./BDGVTP+RE5`]%$NK]]A M4GFAR2:0+2[A7NE9R?'C^'4:ORX0T3G46%`&'XM(5'A)@#,R^;8S4NT%.\2T:MDAK(FP/#@Y1Y`C2*<@RQ)N M)X+T[XW8+2O+ESTANU^VY<3N\X#@ M$;O;`>TZ(W87M.[+$L^#>)<.XKT_*PJ/^`!O/F:^F:D^ MJUD)X*U)0)-K]FVIEMBK#DO-D:J8VW5XV]`G\S`=P-M0@:&W8Z/:(M4U^YS7 MS_`N:X%ASE?%?C!J]C=G[56>'1,UCA_'K]/X=8&(SJ'&PLV;A]\^?";+D@8D MHYTL,Q3!U(Y0VQ!`URP$GP5Q:QO4Y.Y85WK^4XC==&8S*B8$PA]E$LK@9@,@T+V%4^X MS>-G'UPABBX#G3.6TPHLGMSA%._559,SWYVM)5EM9NIF0":^S@#:6%_.(VB? MWF$UBS;T(_11Y0+QFXU522@5_A!%H4J;X\?QZS1^72"B6@:P;>Z@<*5G)<>/X]=I_+I`1.=08T&+ MRR-?GWM4ZZH,-+NT^$*+B%<2'5EG7KM;-AHV:S+O!?M',MHT;Z!0U&4IRBY' MD"/8>00[047W<#L1(?M7SW_"O_[^:QJ+4\=9_G;GSJ"7SN'WR=J4?QQ&=TA4 MO%M+BC^@&P:N/_>=Q`^#>USF'KXD_7GH_OD%M2S\OFIMY$2!'TSC6QC=S9RH M*":@%A+TRP\X^7P#P_G#[9BF2;0$QZ=&/T;XC#44'B&6,R!GN@\P4<5PDM6- M\4^XZ``UX`2O^69#*]+^+]+J`C45)WA)AVD2)^B:A3K_A!H:^G/2X1GC0;5V M1U1F/*@9,B(@^($[3_&`2!4/C\A_@@*<3*";X):V"-BX+J(F-LEYPX?:F-Y[ M1,($;&Z@1?`WV#L],-BVDM3WN M2GNIWJ1ABZY-,I2-I['#W+TS#*E<0@'K_(0":GNA]7G7M73=4$*!^J3MR^.9 M&_OVSOTL@E!`S#:9Q0(,O#=AWH?0A9C5%\-#%^_Z).&V\;CS7UI!H[F$%X]$ M)"-]/JX^(\DN*,^!@:5Q)M;E(>K>93%!+75\[NKG$1U_*%ISIV$A*?^VS:AX MG'@^YBL9,UN&C__:52"LU`;%=5Y(L'U!9N4(MEV$H6+W&AUPVIRK5W=;U\Y"2-B MCID0:R@L.\?^"VIATQ)HO^V/@$T72`W\RB\\0M=!(C9I+#-G1:T\A^G<$V9( M6D??PP"53GQQ)79_P@:DJ,8R3"#ZW)D7`GEA-DOD>R`\SWQW)BR<5]1.42P) MA4F:I!$\0B%`K6!"G3BW567!C-1JT(K45+@5*>^:6Y$>L2(MNL[89O$[MRO% M=J4=P:1KX6:U,$7`C M>-#U%\X\_GSS]=OXC?.Y,NP/U=%(%35SW!.UD6J(/W8B+V]V'$83Z&.=1MP+O-'+TH\RY]>O03:2U1-H+WL!70WC-O)= M6`'.?AQJRO^S=V6]C1O+^CW`_`=BD``3@/3AOLR<.X!D2<&<>Y.9&T]P<9X, MFFK93"A2X>+E_/I;U2[8P`?^URHDRL\4A11SGJ[S^K^H6FU?!N$J_E MJ4-I60C+JK;".)>6$Q"6EY6<_#I;W2V#>92%Z4F6NJ2M86[:MCY1+5VZ5`+X+HB4## M\3T@O&5Z`^`J>?-8N^(V]/\#LTOGZS)*TN3X92G&EBQ/3%N51LH0\%(=4W), M6Y$<>2A;AF.-G)&]K2Q%$\Y?"IS$:A%X->A`>\//A&;:,]RH#Y85%B#XH?0! M@VT=YMR7JMDN>D@3F%>ZL6@F/KP6S8GPX"8@F.BD8'N8<=`?9^F;YMQ;,O>6 M\JZYMY1[2WD6/O>-MG\1!X%8`,%;BQ,??K3>(+H$:XTJ8VZ5[F;-6,U7/F_3[-U,!OT&*E<-O2NXLR7(GKJ%OKYKV M.TF(&WMW+*V+W),@6J#WLO"#=H[1V0U=;M8DR6;GU--7[WO15,^/V8FF=>)" M$/U2Y:Y($("9*0JW),3KWD5V*=!T[H=^DN)!)B:G=I31&:*EGEU9$$-TE+,C M6E%$PSD[J094:R:_4KU\=Y5M]KNN`L>/X\?QZRY^?;";]U^WGNR)(CI,J0Q: M?U6@*=H&OV!R:VCU4:+(^XB-HHE60V5;NP%.H^Y,KO!RA8/CQ_'C^+U:X7W1 MQ9-'CNE?3AWX$MZ3)*4!Z5_"$;E)!^'T5S?^B]`1CO_._/2IRE*`'_.R*-]C M%P.V!TE"TF3D)UX0)=E)+K2T+Q5[-+0EQU(FDNZ,+,D97@XD>VC:FJ6:ICT> MG<^%ENIK+K2LYE6HIIWZP9?NO._.!9??JWL?A3LW$;S`31)_YF,>1IH(\XI> MOZ2W7I.29EJXQ;VNTBR*I<0-ZF4KBR(Y]9?P6D0WCK$7%^'#8+4YS=R8N7Z, MLX`&R;!VCHAP4;R:QEC$M"64O]%),>JME M^@1C2_U`*,:'%W3^LC(TO(1S';RV9&-&*RB&(8$9+![A%-%L2# M>?`D?XJUA>`3LWOG)+V+IA?"R+_'7XK#?/NA[S1,L'F`6BCI85@ MG'3.W3GT1W_R@+6)PFV,1%=H0Q-+>*\_4?Y>S`(.I#9]L!3V+0WAY@E6V)]1 M7$/F:<&*.-&%"',*;90_NNF^0D[_RL):=+XFYS_1,E,\*>@5%W$>4$+):"X] MAG=]DJYYBL4*\+L#V;'U&_PP*)@M_:;*A4'62P=T[;W MFV_D0[/F--%1.Y4TM6D?M-9W7!FI;HFEUZE;6UQ>U[`,CX)`UY&9JQ8[BD6!-=?CJ-<7QX_@UB5\; MB&@=:GVPW?*WB7CCW8%8Y\X!'X6ZK8#3[':3PW&MM)61_<`#M/ MJZ)X$<5N2H2;*)RR;)(P2@^MB/J6J_J5YH&MBZK1:P?`,5`Z=:WA[B/TX>`* MVS_WT>J&;:6=NJ1;][3$72SXURST/7_A!HP%]Y[QJJ8M:GHS=>D[!)-VE&M: M>PW1A\/=>[WDO;BS#+W)&HL]T(@G9(JU907WEH3>D^#CW:;]9\HF:,/.LZ[Y M.6>&H_6:)?/3K!;S=MB@FGKB#2]>K+3:T7Y&!!]4`[W[_32>:$KEJC87,,]4UG)\>/XM1J_ M-A#1.M3ZX`S>59&HRI(0UU(DV.5CG5:'#[UKV;9%_2AU__N#R7%4WO[@\3K] MMC5:[2MVB&6?9(?T38750#9-HPQ8Z%M)P\-[;*<2QA'D"#:CR/8)MT/*Y2OJ MXG%#R>['97VRQHVW#Y=7[%Z=JR-\S[M^TZYYQ>X5X'G%[I5;L MKFBM05$^RHMX'US$>_.]*+SF+Q_SR<;-MT3^?I=0%O4Q--HYD8U0:I/G'.^>D9WNM: MZ#'G.\9^,$^<;]ZW4_G^A*AQ_#A^K<:O#42T#K4^6-Z\_/9VF:S(NBB;S=PR MTR&8FE%JWPB@VDK`]F/"^?O>5V'5,UVV\[-6Q%\5(Q>Q#ZH!SL!.IE&12ZK_B%V[Q^ M]M85HAJ*:'#&LM^!Q2]WV,=[#'%Y MY>N7BFI#4T3=.5A]Z8J*=R`ZBM%[[^ZAU;#[IO.^8O_(9I/A#1U4=?M499F*FJK_M+-6R[I^*E(%=>ZFN38J1#-A M2F[2FH(*[WJ!FR3^S">@RR:[U5G!C0D^-(N"('J`/U-X?T0\,K\A<049"+KC=71_OD7?,ZVBO`\SK: M+P-BJT_@P9TB7ZB0:FN@T%&753V*[=Y:];REWNKJ=8HFFU4SAD)Y3 MW71E'V>V=,//OV3<=U#LT0Y25$T?IM)-LY?## MJ[ZJV,];_PTM]W,NK,8A.Y^#T?Y$$W'\NAB-]1*#I^4!*GAAN>Z__SG/[)$NG7=Q<I`D)$U&?N(%49+%Y#MY M3(=!Y/WU&7H4_EGT^N4_X MW>#!C:=?%_AD,GXDL>1,'UM[&M6+($_RF:(DO_*\N*=GWU?72MV/HUA@THJJ9D/@ZP<$E[X4I\?RY&R3T&-"?PH/3:\T"]JVHUYHSTFSK MIX+-G.:"#IVN5$F5CCD:*.K@WH^UI[_UG1+U2MFH:W!6AE^RIG,/#<5Q!9J`8J@Q"79I,S)&D#X.:MD%_3/S_D(\;@ROJP12KP19Y MX($BRS\](YQ"_^G]DJI22+:`S(J:6]K/&SE)_<&-VDZ&'ZJI$NA+H MN3%#^]4,)^OI(0X;ROQE+^RC7OL+!?<20H&4\=X)?@/8U%";D)L[<^*GB M7RH-VM%%(;TC`BY\-WP27%C:4XP,"J<"[+D4#]/Q`6R$KG5AX MA*<\>"<2;IX$>B0/DR?X81I!&T5S\/:4S'S8W^@8<,L6L)=%`,]%,V%.XEL2 M"Q]P-)6Y>/GI5_H]'F,4KU6_CC[]+$!'BRSV[F!KU@8SBV+A1]62!8`EP&'[ M(0OJAX:2[.9/XJ7XICO],\L9,'VE;*#JP_F4Y.D`?HC!5&0:DB3!=AZB^"\D MUG,7/DV4!6HB&'X,9$<9-@D]W!`@'5"9^R$@":-P/0\V@!MZB"F%$"EF5%8T M7@C?:[."&-'6LM3'VZT%/\5(+O+H)RD;07Z?PKP4'M!5(5OJ`5V(EON4SVB) MVX(R;L3#`YD3UX!<'@H8ULG(1UC6!-A&_EW\ML M?@Q`1$^$7)'X'K#>+'%^B^B<@=A`V9+05)3Z[Y=1DOX6I?\F(!2\Z#;$D!\F M;R91G'^%SRE'DQWZY4A51^.)),NF(^F&H4D#PS$D2S9TZ]*QG(DUO*8B]9OZ M;_-7U1Q5R+PMR.H+&L:RB2M@:F MH>CVT+0LR=$=`'-@#B3'MFW)GHP-6U=TR[;D:^U:5=Y_MBQ-U4!9K=!\$47+ M8'P)81^2[^[C!DWQ:"O%,53#&399)Q2,+\"*$6_DWJ6XJRL6R_+T;]!$X*$`)%L!V62)\"=(T&3J>TQDP(\/=[YW MMS3""&P5?/4"VL@--2&!6?9GO@?2$A`"AI$EM/>4S%ET=4(6+KX%6,0EAX/V MD=B&=A#FW<)0+35C>&I$,KR*^$ M!S<1?M0TT;)U$5BJB//@+F#A/=)U!,#K\D^HE2QB(F&';&G@^ZB_P"1-$9D? M544$QLV:V#Z6=SL"Y-4-?6O.AKXO=B.0^(_/H)]2CSHFTF^JHJ*;6^C7K$WT ME]3C4@3Z=44T\2QX;H*L?FBJ&,LM` M865:*=-)"16FPK^RD-3&(!?9I1!UI!]`,.#2-%LQEY#E0.-(.!D41`\ M2=$#FD6@^R?^U$<5'L@I+`Q0$JAJ*&(*R@,(;?P_S"HBRJ@B8!@@`@$S4]DH MXTHKA$:@5[K6*%H5JL3<0+*8!30/YJ+=-#18MF>*&F%_MR` M,6WL*H(FRF=CPE8'<-6`9=QD"]H5
QM>\&I'%V6S?R9GX`C^`J$>'?_X9_ M)Y4%MCKQ0'V:Q6%"1?>*D*3&;2$_V4)C.4D!S&%*44\NA`';GM`X;0,="'/: MB6ZKS`P?Y:+):A MKQ;?UUF]P]^9H$"?0K+6WPD\[Y8U'NBCP4A2E-<4JVGP@F!5> M;SC7>%`!$7,?1:ZR)8*Z_++GQC$JPD!9#(LJ?8!UM7$`)@6P&D:I-6U<"//Y>:?@UJW`R4>@])#0*D(T;+P4=5%/7=*"NFH@"D M-AGP"38W&'WY"LL/17*"T%H6D/_B`'&_,NOEF48AU379_&8+G&*LK>B(FJ&B M1IRWB@8?&TJUX2KRP'XI+!>PX^]1;0_R-LFTW*2(4;Z5-P-1QZ&.0K&^]^*P MW1AZ8TZ]NIM$=G[$RBR@;8J6*+/K\:&<)Y30,@>47(%5.PBLD;R'N>6KH&`D M=!\3U[LKC%C:ZT6^KNL32P]6J]EC5@XLC&U<2!5N28CV!4PZ$H<>`=C@3VRK MSJ(LS@_L&&O+)SL%L<"^+#SDC75$HV/ID,D*E MSD2,R=K"&.YXV7TRWM@9!DJ:B_E.XP5+S_7\PHX19C(?G!<%DBR_\%";]K_)%6L MC@MW'W*&=]5F*/3CJ(K@0?UDX[FC=E!(?*-)M+JH:[KH6/*SWF])3B3^>&#J MC*I<'*5:R8GV0=M6?6YV=6Y=:Z(FZZ)A-'/M89-U(LP+W6[O^FXOG_\?DFRP M$;I?P::+8^X>+]U5=:'@I86:UD%NJLBB;39S?U2CRM&%>@P!TDM>^IP5S\X> MELY@NK?V#5VTU&9N;&]2C]`OM+=?^QU,,.]/J0JN*32M@V[Q-6QW-SJ!=#;<*+T4'NW*?B%=WGS\^+\,/CM9,>32;[HG:* MH(-ZYKHCJHHMZJJ6GQ]#0_2,EV5`Y+$.U,"CQW[`MEUX@/GZA=R57P8V8*[2 MA>9O_?N!YJTCD_2V&^JI;DL7A'^QV+G@?`\`P!G%(,M/98$Q<^J\1S7 M40\YJY9??E:M-7=6S;OF)_2;WGW]T;.Y:>]\QRS.JFL6/U/]30-I<`2U`^.- MXN@T.G\;$+I:"2MZ*S3X=4HOBJ$H+=ZN+\)MU#VKHF-GJ>-S=Q8'`SOO^(D2 MFMX]CP+B98$;"U/?O0WA6]\34A:O?Y!EWD0DB=RY0X%#*;4Z=[G`H85UMS>'6)V[C>^U%.LGOB^D?10K MVOF1+'?BXL7VJFF_DX2XL<#X)]QW^@K"V,O5]G^)8JF&)D_"*=?PM0-;WWH?NN5I$3 M09,K:T\I4H5B2+#XE!FY@T]S&SLS.S\UI)ZYH=R;*Z"OQE M:(JN:UV97)U/46W[D*+:TQ7D)NKY&K[#M!%<1MYU?V3P&M>K\ MC\ZV7,O%8KY#Q^/9(!&F?SQ-EXE7I/Q)QY-05C9SZ>83?GMCS*;5L[],(@;] MW%Y]$;$:^'N!%Z/\XDQ61B?"Y2",1OQ&KMO4IW%>:?T+]1B0,LW:_\+KJ&*R M$.47FP2A0)^SK)-(<%GDIB/,*W6G%T*R`%KG%XCB(X#&HMS1RX#3($YX]A&, M31?AG\$.8Q3:`5`S9.1%&WD?>]PCM&-*$+$:72=SMB7FN[NXM^NS-PKS<_C\ M"C<0\=M>L@`I9Q1&"?O'*7S'-\4TC\X3?.:B%22_J(>ZPR#TPR?&B[/S>T)I ME&T;3,$;LG%6S1FI*'(\&C@(4^&ZH2`,I.*@;&6>V7TO@32.0KR)9F',Z36Z M:\,=WL\NB9M>0!JOZY^G`<[V`TQI[$1)7O;TW88"_+.T0OAL\W[>P@^RBLE9 MOABFB6?55MD_-"Y<7(,W+^$=*-/TLI6YGW&BF:65E&AVRD51*QRZS9U90OSV M#(4_HC#F(J60UW3M1-$DC[@OO.YPWK$'8`U!1<<%/8BK9:N`@H>G&W!09O5T;8V8$/F7)N9GE;8W+?7%?C2=\B^63YXM]).36L4 M.;4GK)>*:.T/["_'CO`Z`#(BFF^RBF[2&X9U7S=NY*IK&SV_GUEP,'PJ@(MH5 MR.,V/*5"]W:+OR/CKPY`U`YKIZ"?OQY%O-6GM9_(]QM4]U<1247:?8.P=*F) MI-S3P`\AIPJ46*)
FAU4+J+$5;_+5:2$VUD#)UCFW6A,_S\)A-T3`GKW-H MAUC*ZZMH'#[;Y1Y648=-9_%-VMZ\MUI=[J1HKE57ZBHX6ORUZDI3U96Z&TU> M#09NE9AZR-I6G6G5F5:=.07!TN*O56>:JL[42WEIGK*R;^2>(=IOXMPY'92< MH"=G7^)01*OUX.S"7-N[+5L,5J-'G!+>]BF3T.;#MOFP=1NZS8==0GR;#[LC M*MI\V/TG>`IF]6UQ`?^3!H6K0U6YS85MU)QK,]/FV6O:7-@C.S/*A_52$0UM M[UJJ]*QIO/']G\#/2&GX]=N\=<<+\CI8.T4M/PVH_95OWJ;4?OZF0)T;J74 M.AT_A)PJ4&*)NMIJ(66>DH9CBT&FZ0]G!+>]LFMQ;S98]YC?+_N M$FNGD.DF>&F$-^KB-;H1CS$^9V\IW"UKK5? M)K&M[)-);/QX)K%:73IO._11ABXIB?EXPO+P;%5CW=ZY'T:TD("M).^NO**M:@S=L9>:X*=-Q-^T<&L3L3&?^"3(R,)VP/ET3_.(LG]R<+GG[WWA4\E)PZ=9>U?0:P1\ MNEQ"CO?**?U7CSWCXV^_IK'TY#CC#W^$H?>=^7XG\#[/]GJ';_4NBUT_C-.( MWM.7Y,H/W;\_03_";].VMZ!VL6<Y;4L113TJZ4:Y/HI']M]1^4!W+Q27XOFW-\[`G3(F+NZ!/&A-[2,7+3X&D- M)O='PA*@?5FS-.O*DM1KHR=I/?BKHYB:I!E7:J^O=733,!ZPX2?OE1OA-RL\=V;+QT-Y;RJLH MO:%D])=CKN[V<>,TLQC\S`-^V,L/*8Q"S":&3=4+`R=9RH\4AH( MSM-31)\0<)3\(1Q&X*P*/460K".&%N5F,%OBQ^ZO*I99`#.T+2`I"FL,.EGAM-(@-UD]DPG@5X`!_`6J#F# M`S6T&"<.@\%&9U[J^(L+'['X;[1Z3B/7H2^^+AQD`1$205O!9P.`!D8,$C:8 M"(XPAGECD/M"9S[[F_IL"`($$,Z))!Z'@E'*[*TBM"4?`4PH=;NK+ M"^.L'?1#`^240CA.D+L+242=!-$@"C#Q*8SKN^'P\`[BBBL&S9`LR(;XE.-RX!O/!2-\GH9$82?,\@D8R'#JRV2U/H!4D`"'&^ MYKS-B'KXJWE&`2Q:&B<1HQG10R=3VS8%_I7"XA2F0R-.3C!_X=')-P'TE/HP MHT$4CJ!U"!]E=5!@<\/7W,;-)1;2=3BB?!KT98Q5C_C/(:Y7X9>X&-FOWZ_H M_1L8VLL:EO6RR*$*OL/-!O#-!O;C\#MUD#\*I M6%]OX\:>^ZZG(FB@;569O-41UV<;CNG0<49=E?F:TLSC+ M]Q,TJ?2G9C6$Y`\%E(B:83:-DQV^NO9YK*XB:NJ1Y=1I:6I3@_$&(W'C^-@E M,43%.NU"W+8E*NI.D6ZGQ,.(*.MG(J,L1;3M(W/L4U#/WLJRI+26I5K/M(ES MKLU,3TM?:2U+]11Y^UJ6-%DT]+>(`VZ"9)0&JB`HY,JBGI:F=HF5)5>M]7^.A,)J*:)N- MN@'L;596E/VDCE9I@\6BQV]J36GO26=J3 M5`OM#V^1-]\$>Q(Q1=6JVA%X7!`UV1!UY<@!&Z>@N9R/0T@N-J M$^QMVYC7Y\5['$KG3H=["M[FZOHF&&-$U3JR+;E^ZZN(AGTFO@)%-/4V?NL@ M;G:#M\XTCH==DOWW=3/,R&?GX+PTE+VW#,$C6")>INW3C#L5V/R)@]KZ:7E2/?;_)6R"G1)2HNBBKU:A:]:<7(NNB MI51CY*PKP1BZ2,PC5UHX-7U5!9'DA>FC3\L2@ON/6"?=X:SPUF*PI;RCX.V5 M@.9?/?:,C[_]FL;2D^.,/^1)#[<\6H0%3UT6NWX8IQ&]IR_)E1^Z?W^"QL)O MTP;7X6C$$AY/T@F\:Q!$T(H&+J/QFK:""Q_`PRT=_'Y!0__A6\\BIBS!'Z(2 M6?J7+!/UX>Z^^T`L[0%#F8BBD@?Y0F#>[Q?,>U!-S5:(\M"SK2Y1%$72==F4 M--FRI8YR94B6T9?[1N_*D.7^`S;\A'#F8$[1MBW,>OK#1P&%JC1P1LR??%C1 MK/DO8_8/_;`VQKH84[T<=E]&Y=BRD.[X=4R.Z5G@@L%N+T\=_4380D!-@C%J:QX/H.&W$H M!9\^.3[:P5U*<:%BZ,`-GVF$45,C)TEH%`O)T$D$:!M3.!O!$Q5@D5G@1!/X M-HW@=3@0&.#M,8U90&/LQ'$3]LP2P-Q[H1/C!YM+@HJ\3P#!>:)9IM$`W_`E MR.!XI#ZCSQ3G/!%\YCPRGR63;&(C9R*D?L)@MM2?"!&-X4D81.$H[P3>A'[* MLS"SCF,Z`^T[\WW0T1)AZ#Q3P<'W`#N@Q/$`"?`A'0P`>]!+F$&>SR@'`F9O M?XQQ,_/3-C3VA`%@!D@&T1K&#(<5YY%HV71@@C&\C`37B8?"P`^_Q^]76=P* M3_HQ%K/(GKXY$][P/NRX_TE91+]%H9?B(M%.'-,DWI\CI0'+6K$XU!1B/OQU MU[T0/.K"DOCQ[Q>2NL*UNH;9)UV;2/85,"Q--E7)ECN*=&7V5')-%%NW8)P' MA5Q\LF3;`MDPQ\*KD"P"SOW/N&H1'=(@AJ\R!]!?042!%_Q#O?\.?23]/QP6 M_!G&\4UP1]TTXK3;`:)'YI_B?O@&E!%Z7VER,[AW7DK%ETXTZ\HP3QO_]''#TW@)K8\_(]FNYC0B0!9Q7E^!]#9)7 M^,<7)_J;3&G,V6C;P.Y*! M!1Q!5=57.,(VJ%8P`EL(U0GEG<"`<`2^3H'7 M!^[D/G)@<[LX&QB+/_E\;AWOWVG6>:U57@.V\1(_.P[T.["`,(65F.^2.FY\ M3JE$M\W7M_X2-(OPYRRREKL1A+XF&[JR".-TQBMFNV4RJ36YFZC-&J:N+\"V M!8HEQK"H\^".J".8-K)3W9:7%+?5R:]A>T4)7E/5`_5Q4[76J*5+DW^-YWR+ MZ-AA7A4:^*[\1@4-G%CR:_QF$9)%N.>6B2Z+IT:UFT%][5;`8R54*PL0;X5A M_5$;1-4M':>1.P0,W0S0^A<&=\E!WH,CGK-1I;1DHFAKS]F;@5D$OEG'2R!N M1386#6X[GBQA=]>;!Q,#18UN*8NB9F'>R[(TYI;I'-Y:0@54"A1J+%'I\LQ7 MENK:B8??,%O`H][5Y*\8#T7]S-!?]Q._8B,'-E5BRLL+N2-42T?\M9:!.D*. M9D_57#H>YH4`U^J&Z6,R2/VI0EQ'0&&G0G_VHCZQ#8A%<(N%2F$3 M=`IE2NL(+3!=S2*+)^TM("SQ*"!Y=)[!/WB2?@9]"_"1N3:6M9):`B_#;E85 MS5QB8#\`UM)VIKZ/WA\:@,SR$7?>B`4L3E""/==9^N)12-<)L1?W]T[PK+-> MP6$I_VUN!ZTCT.C+,12BK1CSUP&PJ_\B/W#4D=X)JI6V;._HN\@AV=%<^V<> M25!3R4TXA1-Y-RMM`9A=356@G-?63@4R3=+5UWQ62Y"LZJ,W@RJ(>\?-#.=$ M32/VJBXZF_6^WJBFZ*;F(=ZH5U75HAIP,_@<)$[PQ(!,*K` M[,G-H#$>>Q5-U*JV;$GX4=AV.L1E+I3Z;Q0-8U:,E:/XCB`MV^YCZD0N*HQ= M8#-^.$8338TU/?3QJ-;2^68K%&O=86]/91WZ9,>KJM:U)?Z1!) MT_K7DJU:!@\"[W4,I=\UKC9%?:\MWFW,"G6_ED.Y4-I[(:\2XY4WU6,<4B'F MR!7J*Z).3X!9$U,&T$$7\HA3/X_9QC*%UF">Q`,.2G3'#JH[0 M..4.VUCD'T?4YW&W@/#H"09(0AS#80&\`P818%0S5GZ$+C"`-YHM#G_+WR6\ M)C%V%B]5XWVWH0(OCUOF+;`DI_"=1M`>._0QF'?U(KJV8OJVV'[#;"NFMT.W M%=/;BNF[X*.MF%ZW9:JV_G95T+6UTYL+75M%?9>KES.-?7:8R=5MKK_OE0-< M:<4\\8"2GLTJ'4=$.#6>!ZB&:+])+>(&@*J*LO$6-[(>B8W5A6E=OVY,D%9- M":6SLWTOYM5%V:ZZ*F19P-JB>NPJ.[6!5:^N!E4%5`S"6*FR?M()*&?76\R= M3>%FNB*:NQTT3H'H-5$E5=^;4!:P!`65=>1K7VH#K6Z(YK%K*NY$ZG3UQ1)ZUPIDGTM MVY*N$UGM]SIF5R=9FHVNRWD,T4'0%1"4A=K=9DXGK![@XHD80S.^A@F=I\NA M7S'!;V;9LYFKZTA86O41:M>&:O>)(JF]OBEI1.Y(EJQU)4!>AUQUNMV^HJ+[ M].*3HLC6'$<'`5A`U#V-1G^&#H;C9G[3SE-$>7V?8];#,O6.I6L:D7J:I4N: MT>M*5Y9N2*K9[>O$(L36E7.IAR4?4@\+ET_`]>.'J&P%H8_9(O*N&U$0ZR80 M[N@X67(*6-R'2\1B52>!Q7&*=B[A)Y1?LHS_"T#=(^C&1UR`MG4-M.[2P`N% M*Q;&+J.!2T6\5>*]<#DO"W7]`)]3V\OCEXP(OF#W.6,&\TNWF((AU?$4^;J$]H%;FI8XO_$3, M&:4MT.6K,+;G9G?ZI;HSNS6?4K11 M$N[8X.$EG>ROWR/A-[#C8!MC@;E5MVMB8Z'SG*-SCJ1'1[_P@GW@-@*^0)\K M1/?#'7.#O8@?&3?0-XKPO?LE7SH0>L-#E[<6UA7+.6-E8F7'/KW#,L''L6;C:Y@LS+ M%COG<]\X]R&>4!^G%@$&\XJ,#/S=[(I=X<^$\WEW<9/K(C2R<,2SZI*;H!#1 M"V!WL_,-*Y#$_%EA^.+EG`U]=1&G\&I7)/A96< MNM*/S/]#PQ/78^^XV\M:BE?-?5,G!:]LK8?".ZZ^W!,5]%:,':!;"`>"W.G-T)E2__?'1!T:-'7N$S M(,Z5`Z M:F]&>^4.+DXG8.+@6+(,<^E$>43@N2+/=N+7*/1G5HE&V[ZY^_H\8#U4'IVW=*KGFMUG:7K:+GK7UP49=0R3,5%E M2BPQL=%C`&/Y87Y51P/8#_C*4$]S$5_]LOZ*KNC^PM9R_?J^3( MCV\CUV-\5;-Y(U?LI)W?R)4\#!\J(+JR3A"/&W@A:WLN)>_P:\ZEHNU!K0WY MN;XMLH?\B)0[6XP4V_^+G9O9OLU^(7]] M98''UN<<^)"5T^;R[7*YKIT1=;`T>'7I2M- M35=D7S0)PD`Y[X63J@)*E\YTZ4R7SG3AN$MG3HV?#$)(AUKS5E_>3EZ:EZSL MR]PSKZQ*-G?:`TD+=W+V+F!U1;L=G#+.50?GZH4I^(NZW/G^;Y0SBS@K!*60 M0C[S*A?UE_1E8GQOL+*?1:6&E7<87!V\:T["WNZ M47RHT+]:9&^;;\2).OW*)'N[JW;MGG0G8>48M^?,OFBL=>PV_ANX$]*>?>T. MO^;L@K0'M39D^=V)VC?WU;L3M6_/*2#G1K76Z=@)G%-`0J\,O=/AU M64A3LY`ZO.9+-O]9&!545'!"E8-PR%V@0K!C(,TM?K0LE)-YBTAY MV;]EMY(?KE],,3*/*JA^1RX_:D2G>D[4N03'-^$Z1`031I1:\AAP'4)S`R[( M7+\!&QCD.JJ@B!NP3BT-XQ-9<3%D09S^)(@C9C-,:>B_+1[ZZ+_PC^Z<;>8/GJ1^)A[^RR`^]`Z"B ME.C/A,)X-]=A&/;L@3;0%!#/43"Q=<4F5D_!P]ZP1PS2;K97;/9SRB]O_G)O>Y[/?^*.Q7.Q MG2:/8>3_'SL`0TTS5`1)DJD!9D33*;%@M))\Q(G%ZU8'ZLWGX1KBM@/3<-IS M%&-`-`5;%E6HTU,5I`^H::D6O,'D)HKN],N/IF59NH$*H!\'G3)J.`!!I%(5 M$%1-7=W+P^&>AG4+@5_K$T/!V#:5GDD(]W".`9YS0!R+XZ9SW$!?EIES<9OE MJ4=F7<5'E!EQF6%T:B8BLHA,J8[W"V2E1-:YR.KE1ZPC222F".D('T]BS"6& MF*7IN^OX]S#T?OKC\%-(?$UC9WQU@%P M#/:M]`E8*>X;5+%0'RNVK:.A"F:/AU86HOF(+$R2*@4@C^WLZ?@VM$?_I#ZT MD<9^P.*8Q:*D57FX$`<+JPA$6$VI-=T"Z&`RPJ,6-DVR&.R69F*KA'O;D)(C M334"JGRG1J(GV0@-!#ND0:BJFJ=L* M=OJ&8O<(51P;#R$(V)`=X24:ZAH:Y>0[%2;Z\3!!LTF;?A@F8K%Y<'_/1HG_ MQ+)!]N4^ M4NZG`SHSGVR/RJ/BB7<*,I0V8S#W91%=^M1!ZTA8FB8 MBK3/@O@.;M*T(2FB$.B'`P,<,R:4J."V-0I9T3NL+Z'8*,-V,?O^.$UVF0Z? M0E!+"(I>%W0F15[4_V5\PQO&_!.+W`0- M*7Y)F1$8.\4(YVU]1Y%*X/':3VWOWVF<\&A;$RXPA2`ZS'\4B_3`#:K(4:P^ M9+=]K-D.U1UB#M"=R+*0@>G;J+PM6&%@S-UKMMA[ZSY_#@CX(?;&R'#`&1JZI0P'D"YAC3HP)=*(`OF88]L(J3T#9VBH[W1K96"4 MEF)KW/`@O?_&$LBPO'X:P>^RF).!69-!0-(^<'1'4^PA1C!0>DBQ'-52#$-3 M]>'`)GT#(A'/C7C[VT+"5FGR.-@`E,/`\&J<>\X91..&9 M?)H(#+_<%_W0KK'T((!,2O$0$:PXR(:I20^B9Z\WU!4=HF;/)H2J!LT`,DS5 MR`%4B9BEO.W:^*LHKE;J:V$845BWU,TN^W,-8KC1*5X2=\IB]\(B%(FEBMH_DQ^%K_-YC2YS`(\WN1@V>^G,!D ME)4O/^-U>WA5AD(@A?0D%5(:=I%$+/YOX737>^GYRY MVO7HW&/W8;0,XBS^Y`YE8"(2W?RN"?%+[^Q&"VXRU-JX)@7;V%8!Z1 MK+7A4!LFY9RU:`1>Z#\$3AI%+!B]W$9N$+NCV=:X^"NK%KI,*F5VU2:X:D3+ M^>K#I#^4[E(?)GP06UIAFK69W+(!)9FUS7D[V*3YK<\M,E3(Y*E-2`L\B6$4 M9'R3MB-L?M51RQE@>%:*B[2Z#5W/"]>H7(%OS^M67L22B0((+K5I:N!M=4/5 M\[:9ZW71O<3);%LM*R4OGTR<\Z@;!BZXE'R_J]UB/URVQ`_\..'C]4EB M5P/1T+`,,T_#+B?-IMP=XN7LVQ[\^-Z7,GYP36OPS(8\>ZW_Z[[HR_TLQ$@H M&@Q6S3#,8FZSTNG"LMZ*0:\?*ZE30*)AK=\?&HIE\"UPK8<4:I"!HCIX@"V^ MNS4DV>2RN*BY789BQIU5&@.3[B_KC,D[.DV>AFLJ*63A6X38.(?C^E]D?_): MK\'9:AK=-`_;),'*;G6V\,J-W$O%1.PF@,@T"0.QXFU#4ABG8_B^L`!>JX67 M7+?7>"Y!LB77@V1;@\>!J/W`O-OP&TM?/FZ4?CPS6ZP$JT(T![2'6MF M5]>!,<&!X8L7FJGK>+>Y7O7I6:U2@ZLP"-TO5SMPV:6NTU2"IXTWS'6/<,3H M=`(*\Q73"TFLMPZA>:!3]YQI5&6]1SY'):B?>.-60&WV6X>(8+\$6<6-OA/: M;QU"&X);L.UX.@8]_8":; M7Q)-#H%K."\CIAMX]^,RE9!"]?JXDMJ,%&JN'/JHCQ1:KZ""%&J:^(F:1)&+[F'#T>J(K:H.+:MOM.-M]BB.XE7%XGVB+`($BU6WX+EM"3:/0=0 MJ<4F<7"@D,^`8VV!E$YC=8R-:.PW-!P M&FT=-B+6S(M'SL^<1EN'LQ9+^1HJY:UEH-'6@0D_H(Y5LV8:;1V2<>*0:A1V M,>JDT=8@I`6>!%G6CA4!9CDBCK4$FRK>5--4L^I3C\V@/$:[<_A'?"S6IL?M2>X5;A8=(66IS M$',>;4;0V9.;<1P>;0VV"^&0$%HX+W-"'FT=+@AFY[J>"5TGC[8&T3#G@A=7 MSFOCT1XB8"D>;58YJ3!#.AF/M@9]6ZO48`68UG8OQV8Y MCTQ-G=?/75L5.!IA\Q0"\C4!U4#2&&\=,@OCK>U.CLUR'IF7.B>S;=@SJK(%V7QG[K$%I4HRC1E]A?\[7O\DWN?11?QZ)%-V&^7CTDR?7]]_?/GSW_)9LQ^N-[[M MXX?K>7=F@E_G)/\P79:'SSJ?N%'2YQ-5#J$"N*H:M+'X=/$@"[R5QV`2K?&F MO96'/ERO-/[A>J:^0W6Y,@BEU&6678B)?V:^([>@SVR!B8]C-X!O^K[[$,!' M_FC.53E#C<[B2*,U^BD]9$O.)^-SC>LU1CMDK66#5NR(C.4HW92GT3 MU5B,G6>DO:/KJYGH;#ZM+:5MRSUQ0^4TBNK6:#=Q:YM"NXE;VQ3:3=Q:I]IN MXM8F-783MU:HL9NX-5![@L=>,R")X^"SK;KISM#W\G0-:&C-PU=4W2U9E6B MAJIRZ-^?J2JY)K&*>)U)T"2E1'\F%&NZ!1-:2+3XA!:;)EGP>BS-Q):<6M[. MZW$B%H\`P;#GA_'(9\&($WO>T.[N&=]W>(<+:EEYTB7`Y;ORS0T>"K/@3^ZS/TF/NXPC MG0EE"SD4&8A(NEBS;<%D_M'MS_`!:X<>NPE<$]4GUP1.`GC4_.Z.00SR#"9.#4F):4/7C_['':>L][+X MSW]!F]R07_[@:6#>R!;.C$?*^NQ'LKPDN!OOQ[.D,[>=)JE+A2'? MA+QL'V<=!NSEDQO]S9)A*EF$;U.*R$WH7(VF07I2*=)P2V/\G]]O(^;&:?1B M!][OX1.+@BK/!78Q?MV2SMQV&J(NG3X3@G0BZ1[,T`_\A/WA/XD[YG)74?;` M"_\[C)RQ&Z^NY-]&KL=5A=R&B3MVW/B1 M_Y\[M"=W+&@T@6<_N?Z8W^P-<^+O\&EK%$4L0HFD*]>O*LH>C=))*BYA+RJF M75L-F8HDW@G>I*+V;ODNU"'K1MTV=;1X1VZF%XW(6@UPJUX@V/!4.A]SVJ06 MU$3OQ?71)B4`=LU40IL&Q?D2PH_I7$2)44Q2^KD]3TE+*9.=QU::ICNK?3EK0*0SH/$VF65KJJ/[= M>*_*DL[<=IJDKH[JWSJJ_RE,Z%R-ID%ZZJC^78ROT)+.W'8:HJZ.ZB^_?CJJ M?R/5UE']FZ*NCNK?7.5U'%@Y%=)Q8!NAJ(X#*[^*)-XBD8(#6[\Z9%W!EHL# M6[=>.@ZLG&KI.+`2**'CP$J@#YGH=T>7&62&2NJ=FQ^MVIT M)[LKX>&KQBYZ@@0[4U+\Z$8L7F`^$=L5[&/V\8?K^=]9$_Q7A=_[<8B11N[^ M_-Y?:V3VW7OX;K>6[J#C=X6>>?X3:'(I/__=YW3"("\-EYHM\_8,F\V_%\WV M61!._."UAC=ALVQS_<SY!&(W.(OGA`4>\Q;=R-H?AZ/98X\1N__M\C]\[TZ'9!UIZ$YU+,?` M)E8&JF4J6'60TK-M2[&LGFGTA@["U+S3P>/'+0Z.=F"'\XTCY'\"^>?WB&(?EBU*+G< M80#-?YWO`+BE,(U&_-,)`.4&#S"P`N7/[Y17A_P9Y'C_P>YHN$[XEZ\Q\$WH4[&D4I?.)#,('7)5DX M6PJY670[FNOL/@HG!P_`BWRZU=VH>57C\ M-956(!=NHUR%X=PFN;`$6=N+3(P,3,Q,C,Q7V-A;"YX;6Q55`D``UB`\E)8 M@/)2=7@+``$$)0X```0Y`0``[5UM;^,V$OY>H/]!YP*'.^`<)]EM>QOLMG#> M>@&2=>!X>\5]*12)=MC*I$M*3MQ??T-*MB1;E"A;6E+9?FG7"E_F&0V',\/A MZ/V/+_/`62+&,24?>B='QST'$8_ZF,P^]#X]]($T9Q;3'Y_=#GZER/^ZSOP MZ)?S\:US>G3B.$]AN#@;#)Z?GX^0/W-9GY(`$W3DT?G`Z??7\_T<4W;F?'=T M"L1E_C*F$?'/G#>91Q<,Q3/[0-.9^$XU^'YS;KY MR>"7N]L'[PG-W3XF/'2)E^LH!BOJ>O+NW;N!_&OYI9[DD@:!CK*% M^-5?-^N+1_V3T_Z;DZ,7[O=^$!.^9S1`8S1U)`UGX6J!/O0XGB\"U$N>/3$T M_=";KV9$8P.O!;G!/.1937`0NYWB*D5^3 M;LU!/R>">Y>ANNRO,7+XA$+LN4'SF&Y`G\W1,`@1(_#BEVA_$+M#-4[MA^KY4&FYPP%ZPUQRMR(""`,9<,I.+]WR5-KEW5^+1\-EE_F@A&O)1 M%`I+0%AI#8A!D]1\1G:-D4=G!/^)_!MR`630``O#S]]H0)!JT9ZA)^@"RCK6 MWJTQ;%]ZFF192+W?GVC@@]DLEFRX:GCA:([?CA2(R<=H$3'O"7C/FWB1VT,V M2+@0!S!X`BQ9(A0LT`)&4$@9"`)(#_9`E5[B(`(9N7(9@>7#[Q&3PK4WML-F M;>6]#<'PEA."R"<:X^K%"R(?^=>,SJ_N'\2JB,(#17//^9J$C&92-1)_C`*Q M\C-+HN%U6'NFYF&"T,CAP1^5JG!$8GUV2SD_%Q87Z#>PDQ$/$ZN9^",P\MGF MU]6+4)T'Z..&Z6A%^"(_XXV<-`:A8M@&`4P0F]]2EPAFR7UX.&-( M6L+-BEO=>1J$>$%Y*(PJ?D.6L,,TCTU[@B;5=_3(T1\13'6U;!R0UN#-1-4^ MTA#Q"=WL#:DC)CD*EJ+GT4ALB76]Z#HCMXTE%0SXIXCBP#*X<]GO2&[OL9>6 M!G9$E`O!SH_)A+G"8X^7?78QO83G`;A%C;&D-0*[RMF)Z%Y7@1LCLVTNIS/' MX9$TG"(]&Z$`^4[XB3[\2K1MDUEIS^C-=@;EHRZ M\[;-A^T@5_/O7#V#,6P-O].J>5J7Y3A($4AKG;]C)))VD:8"0QMAU3:Q%QS6KNXT+"@ M[S5YVQQ1QZ;:%(MZL[;-`^$,W*'PB?H95_42<8]A25SS^/5G;!_[?([C^87G M+0]@9@@:H5;U0LUI6[=G\D&_%O9S]0P)-B_-3!:)R3F,T!817R1IQD_%7`WD ME\83#[9F;I,G[GN8B"$ M8(""D*^?2+'H'Y\DN<#?)(]_30*B_-Y="<5[$3&1\[F>*7`?4?"A5]%X8)#N M,?(07@IJ/J)0C_K"+H8PL`CYM]A]Q$&$/71/))1I4NT8,B+4UO@ MWP&26QOQLT=:]XPN$`M7]X$K$R1$"&(Q+P7;S/"&>2./(PO2RT0:!,C?:`J& M<34+M$8Q@G1S3G3O8I%@YRYPZ`8J1(K61BA/CFN+"NIJ@JT(3Y-J8H%(D M'PL+9BL'.;QP&5N!32,]6P7U>GV-H`+SC!(9*2T%L-W,!*V7:(K@_?MC!(95 M5+%S*QJ;I!LT5BS&E1MW60];$'RDQ*L-(M/)!(ZU8ZZ@>/-G$[1M1PJ`6W&R M*.B'"KJUNIK`=(M$"6*KK/5=)MTE'O$K%_R:8@^K MD&AT-(%'V_*RQ-;Z1-CFDB@X:.>(`/.4VES5>D-YYA!AR/(@7.:M1X5_[IP@ MY*MY)"T&/)K'1Q=]'*+YNO^4T?E.Q&H]&54%BQS*@-FRI,SWQ\<]YQF)JBGR M-_Q:,$S%%?L/O=.>$W$@CB[B@)VMZ,J7_P;LR>EK`%MEX:5PW[P&N%6!EA3N MV]<`M\CN32%^^QH@YDSE%-MWKP&;7L@J!?TJU&\1L']W#=B6R9[%IWG.D6ZJ M)Z\(?&E()(7M)V8F)J9[UXA9%4^8"KEK^Y%J_)84L@=,JGU@NIY&UM];)IN MTQURJ>JSH"PO(F5!AY:[SI&$5@QSFPDG'5K]=9G07#YQRJZ8.Q0TU,1<-U4^Y46'-D4]7N@<`Z?P M]]D0+;SUE*\R;Y3*W3+R9G+0MQ=`Q3V1LAYFLN@YS)[8\TJ:LVU,4?LZ.TJLAG9NXRK8 M\#DI,,=AH#MYSTE8K90;NZW-4+[F7$S5FMU*TA7-C61ZHC`5"5629ZZ-F7Q4 M0O,U>S$;B*)&WFC"7<-=+_$/Y M*['L_-^B6,PK-L^6)K.);^+$P`W$><%_P`(5V0A@90I\(Y*I/\@P%_6%X">9 MW2,P)/T].7?P=`9Y)XR2S3(HMV#*>AA#4%=5570RAD-\O88GW%3G\18V-9._ MRQ&X@R)3Y!(H":B,1)6SOKR/&122B:KM8?-G(QG%F;?\@-@2>XBK!4/5V@CE M*`B$$@03D;FB"-+0GV.">5PZ.$MMMDZF;-"$^6N6:/(Z+-\ M26\'AG)FF2HPT\DK465(BP.3AUV#,I7IL/L)>FMJ",8A#EA83*2%7J+X_ZK3 M^3I#F*D5EZ8R;F4P*B"5]3"!X.H%5C1/;YH("ZWX0]M)D@^9#3WPR,KJA!TV MIMU4U!.BXAY3["^Y<=>UQ>E%*1K=#2)9T*''KCP#!55G:F`5-[7 M"E0@]'XDY!N5>DO5_0S5V/00\N7IS`WG$:A;D!SIJ_)/Q$<,U@10+8@D?K$+ M*^YIBD\!QO6PI+C%GT`K*37:XIRFN2CBB/)[X*&0TM5H6D?J:X]C".T2R21H_A-`K63I@:F+J+D=R]0K%2Y>H5-[:HGFFMT&J],AD^>##^%%Q>J[(A.NF*M%DB1UEL,8 MHIVFT)2S*O6+36#8)TLMGD8APY,:E-<$'K50J69`Z*XO?"% ML68[5:&;A3E;T-0[26R*RV%?&&=*/E1P\N78Q!I)G)W\\%5+%D_QUP"Z5$VB MK1UI]R[\7E4B/NL=%?",O8#RB*$'[PGY48!&TVMP`V3Q7_",ADL7!V(13*F\ MBY,&F)$1]09'4W73TU<<]F0?+U-LN+DM:2#B<-D-3E) M1$>8BLIZ@[J]ZR&;KV9$TGMRFE`KGI1,)BNII_561"@F4UUW'?HLJH#9X,"? M%Z,(-;6"L71@LY]"JEQJN=+3NH+=R=BM'B^:7#:=#.FVP:;RE7=@G-?X=IR< M]0#LT?02/8:9;P-NBGH/^?87$XF_S3X#M;XS<`K#'&D!_AL"!D8L/&;IW+!= M03%C+IG)6[WGJ[1)F(+:.HA+1K$(Z0YQ4CSKX52,8=0&VO/%9FWIFASKI$7=%IMT ME$>'RHP4;3E#$F()$_;KQ!Z)OXV.?%GQZ_Y!;.E1:,$VB6;2Q2T*[ZU>K65NQ2U<$&*HD>[W6OP;A!L#D!S'Q),$F;-4E@)N7'/M/P M)TK]9QP$J:V73Z'L'L4F;+PXT?16))KN,#"-\&N4]=MC(!-60`F9N>]WZZ.+ MNUF&15U;JZ*3&6N]@*.Q^RP*XB>K1FF[:W6V`1?P=U]4A5V-;M9ZPI?=O?=1 M-0IKU?+\N$9YDZBE3EIT=59`WM#3TPB=-.[W98<1//6.[2/R(7KDZ(](?.)G:1&!'VF( M^(1NO+'T=%YR=#1-7UF.S^XS>6#$OT`L=#&9 M,%<>R<@5EA7WE_`\$+4#O@20DS@KWR:H*95Q5DB:12*UO?P"PTY:#+?SM1V( MQ<*WLYL7(]K:OGRTJ;:0X]L9,G9R6$FEA1Q-3ACC(T?Q(4[;I;>:7@NYO(GP MIN1:JJ5+*;60LYL@M>V"FPG_;KLTKXMT"X5$[;;9SGIA%>U\*O`2<8]A"<16 MJN=S'-,JS&^9V#)#T`A9+^M;#JF.EGX_$+,_@M4*/_X/4$L#!!0````(`$!J M143,.BO3ERP``!UO`P`5`!P`;7EG;BTR,#$S,3(S,5]D968N>&UL550)``-8 M@/)26(#R4G5X"P`!!"4.```$.0$``.T]VW+CN'+OJI&/PMGGTY^?SD9/5W=WI__UGW__ M=S_]P]G9R61RFOEY/[DP_O+DY.YDFR_'1^_OW[]W?0GP%\%H4!"N$[+UJ< MGYR=;;;[)0?LT\F_O?M`8*O\91*EH?_IY&/EIRL,0;:S3T#Z=/+A_<4/9^\_ MG+W_X?G]OW_Z\,.G]Q?_5QT=+=<8S>;)R3][_T(&O__+&9GQ\63R;O*N@N,_ MG3Q%84Q&+Y8@7)^,@N!D0F?%)Q,80[R"_KMBT:#`]X10-(P_GU90?'W!P;L( MS\[)-A_/-P-/__[O3O+!GUYCM#/A^\?-\(OSOS[@8?8JS/>\C+Z.I`#HGS!'TO\XV MP\[H3V<7'\X^7KQ[C?W3_Z0;_H2C`$[@]"2#^%.R7L+/IS%:+`-X6OPVQW#Z M^72QGH79=[KXD,__Q^O(2QN[$G(VZ1[CZ2T*R<=$('B,XNS&7`4@CM$4 M05\2;L%%CXG!(\!0EOP2*R=SF"`/!.IQNB/,;P%'00)Q2#[\"K9'XG`IY=!> M@7A^&T3?X[O01QAZ27MH#Y?J#.TUBKT@BE,,*0/STP"2+PL0_@4$*;R-\&@% M4`!>`DANV1,(X!/T4DP^-XPOUP_@=_)C_L/ZF6PZ"OWL$(RGFU]E;W?/T/1" MK@>0%$",I]?P)2F!*F_$**;?[N:/%*T(V&$2$^"VR-SFR"B@E3)05!)J3KC! M)54OJ("&89SQZI'O9TP#!!UD0:L]>CD##``P!N$LN[R7ZW+((UC3GT;?`?;' M2SHP'J<)U1NH2J?@&*B$YHCDFD`OFH7H3^C?A5<$C"A`5$WTMQR0G&HZ'L,Y MF4*8=R-86WA4DBR)O&_S*/")DDVO;+)6?'$$U^_G%-#-)W"98F].:!^K M^)#[2RH$G!X'HO`$*",)9;`$%J($)1$F!X&<'N015GJ-@I2( ML\/5&K=NN_;RW49$\^X!@WKUZ0^M"_Q='BYO&)WHHTZ7@T6^ZG$F4X MRUACZ$]@0&]^Y4HHOH?2.ZE'DQR:;'EBO6:LNB(11CYOP!BK9=_H2PS]2 MLM7-2CE"0HNK\:I]C1(8/T=;V5`:8AE%B:;H>5%*1:*L%2VS#_)-Z M<<@U>`#X&\S$>VZEE8X=ZN6"1/*C\!D#:K'GU[YZF5Z3RX"81#:P.R;RN7.N7ND=*=DE@UE@/&!^RE6?TR[PF$XG10?.C70]$VS0W\5 M'=LGLQ/?T1C<%9\,V7W[IL.^DTO]-V?OH`TWQ=^T:9_>SW+NI,B]%@207F^P MP%X&X*OZU@KOV#?N6Z]."4(/TIZ_BU8<%7]9D;WZUZ0+5U>_=@9GD[XQK#B& M]ETJ?>(LN:U95%!\T%MMWC=%V+ZI/H^%W*Y]TX`:`P\PF4=^Q52]AK&'40:< M>OS%=^P?]\4"Y?M3RSL+P,P@&01[Y0N2V_:NS^PZ_7J0Y^P="MP`]D318V2] M;O)I:;KK7S*L01"LA7-+(G",Q].01HD M-U54/I'YI;%$!\1>[=+,+LK[P[ZEBP3>`,Q>1TAC?UA_4-W#V<@R/<>O:(Z!KP_HG^8BO#LTWKQ$@4U$.W^?0M/J:V-\"YD M1-7;+%-H?6(&2S%GBJ.%@##:;!G5\;J3"/L0?SZ]>/_^W7OR?V1TILA^HA8I M]#^?)CB%Y8_$;"4:YDV0F7A$0\Y]U*-H0"5*'X<#(H'6G.)Y`\#0W+' MA"G1_(OU:.[)CA*U?[,>M7I%HL3PWP>"X8&Z7J+X']:CR/9WE%C^:#V6M?KX M%L&+]P-!D&^XE?AJ4G!J7:/[6->:[!LT#ZR#\I#J^H8'SO-]A!@6S>Z7VQBN MLOC\=+[K$^[13RS8"*.U-38%\4M&XC0^FP&PS$TR&"3QYI=]VZSX^;H-0QN;T5VAWL"/8A6%)JO,!&#OG:*)AR(H>C?(_""@KQA01," MC/&:H$\7:98G>PV7&'IYL2[Y=P`S#A'ZU2*=1QP1#I:L'P.0E7S2I,KE@HNL MFN4UTR8KL*HIF*>%G>3\C:?/X+69!$*K:,%T6_GR"!!M&0"6*`'[GIZFT5H@ M+PK0Z@&MEI'I@&OT0@T#CWD[=@?I@[.!8^V,T0ZE$%'WQ^J`FC:KH1DO>SUK MDBN`\9HHI%DF)`,+L;E:L"I5;"X"^\-TP'H-IY"<`W\"5S!,&_0BQF"=-1&724&)H[:FZ22MET&_[9QVP[>>YDF^7MSHAW*H! M;J&I.G"ZAR"&M'[HCNALT:K([<5$76-@PIDPK,AA!YJ6A@^+B)41FB$D(OBP MAJP9[/II)N+2H$P)3]>,&U\X&F)K'X(A3GT3]-D'X,U1"/&Z:IGSN"%G@A[X M-X7HE>:2W(/#FV$*!HU:5<,D'7ADN?,['CP&[#4#=<";.6ZXKH;J"&T0EH3B M@ED=I@/61USH^8U&9-U(31`O`=IT9^/SC/JQ>J!F>%-Y/+MADE%XL/D&=XII M.#1H`4)3=>`T@;1U2]FZ<\?9/T4>8F$D,%$'/MOXWD&0>0_^FH%:X:U+[F8, MT@.GH`5EB,TD;2499A?]'.)M^^=G\'H)0W*IF)H+:_3Q4SYV/?C[-*?I`@WQ M@&WNP$?S$EC%D1,3%26NYF6TBN/:9-"46)J7U"J.99,SO,32O*Q6<2SKC+H2 M,_,26<4QVS'_2I3,2V`51TG,6U_B:EXJJSBN=?B8E[E,5@#30[]JB=X`N.Y>^M<6MP]O,YE2C=!6/Q\OHEA^2W.-X2ZX,[T< M)>+F6L:*/GH567,-Y"[(\D:7N)NK"RKZT(P\E)("YNJ(S5D/=4K4?B6+R07< MK3%EU8V87,K=#EE6(J[)]=SM,.5_3W.OJ4R`&92<%E>S)7/.N+=Z\U-`2 M;W-MO;9X-R45E+B;:_VUQ5U=L5Q))7.-2.4G9"\BH,DD.V@CU!S^WU5(=X/N M`^PB)$>0?7^UR0T^Y#`3U]VUM_QH;"S`SQDQN+N`R,>4,:IJDP]-[F?2#LW# M*CV3NYFTPY%9M6QR7Y.6J,J6HFMO=:*,:Y'R M"*A=/"`U%%/'@31=_I*]VV$KZ/T)9FFP6'XKJ$J7FH-S97:A.)CG'T< M/Q,'F\>S&+B)S-2,4=[>:90FH/GM@ZL6KE77)=F8X&3]>`DRLX9)IN#!96F<":;`W\S8FF:YZI6> MJU=ZRSK9O%54U=PM3#M1F49#I)%^C)S75K'75LX"LB'\+H:XJ$)A0PR^#<:' MJH8-,?CVF&Z4$1MB\.VQK&]S;'T$1LB#H3WXT@>ZO&MJIQ6;QEM0-U);ZT9&0M;9 M?P69^!KYOZ M^8=$<+)+-QE.L]1?B0HVIXZO%?GD,_@UI:&(\;1P)HDF*,FN8A"F!\#QO*!R M:QB/98-BVFXM?;$R2<]P-8#&<(7;T.Y$(=9;A[/^5B=OKS&3L)=GMZ\FRYUI M0UNT5B@W61XV-$QKA;@(SMH:J37C+.SWVTULV`GZVM"`J!6>7(>`#7U-6F'= M8,C:T->D%=ZB1IH-S4U:7^O=+`D;.I2H\P#77/T>_*@VM+L]+DV[QCBT=]5U M=0EJ$R>9CK[A5"#4>[B'4V]0^I&'4UD@(%2'4V!0&T(?3E&!@*TWG)*"HZ;> M#:=$@9E/-YP2A;U$,>TU"M4':T6&YZ6$:X^ M8M>6:']7QI3B(QW?KU,TL/6-M^,QB+YIPPZAR[X8H:=LC3Z-=1M$W^,[`C:& M!'<=G=.V3ICX.9I`+PH]E#UT5/+;YXA"^HBC%2(H7ZY_CB'ANENC8N0E:)7[ MROC1[EZVTE*")O:T62T1Q.::@U6]D)5"CK&$#ARK7;[WFGLS4.+-<(5@-Z\> M)+=V^UH/M28W.CKTJ=I"](&,6$7WR.H=9E"\VYIF4Z&&DW6F0MV:.JA01D^N M4;PL>H2.IYO'+6NQY,_14KZV6`*$-W7ENV^JWE)U``9$!V>5C(K.UE12N,.` M[\*]MWE8.#7.,PN;LMN1-$*5J<;@1-\4VGCN]AYC%L>.O8A1>.Z\A":'776J M&3AMGDBJ>&*%D:J;:Q96_&*:YGEF8%.&@?)6\PT6C,0"AN!W\-JI*%[[$\W` M9_?986%L]J:YTO)MQ*#.W!97U246,!N_ICIO^84,PC+S'(V\/U*$X0/`WV!"U9HRS;,!)?Y<([`BA]]/Z3F'7(]+\SP]7=LC#T(_ MRT:AS2-I(^--I.CGT(>8W`D"-04R].O=8/1UPI@,"U(:`\J.VSB+\C`IT>N> MNJE(\Q$)W`\@H:=T/9[*G'KI=31ANT(TV%S3\9J-&'N*EB+FVF/%@)XQV!6+ M#Z=8G)8D>-$LI$4)I>]?+@@GMX:^](`^(\^[3Y5S8GXV)/D>BU`-`1P;$H:/ M12H6W[8AS_A8-.++9QM2BX]%*>&8HPW)RD5%#T0X2"^RH1^&:CH<).]LB?!Q"`];VE$RU#XK M8<^Z[C-B4AX,$LIS@".=.:F]KY9K.*6^%T_YJZ&JCT3?V7'ED0R?+3MAS MU7OM72?5=8J1*N*WH85Y%[P/6C)H;UUN2J^<(W8\N48Q%3PIAD_>'/II`,?3 M6X!P]DEN(SQ:`110)*=1UD6S5/\OUP_@=_)C_L/ZF0!"OW$`XG@\W?PJUS1E ML9Z%6?+=Q8KB.MD`T4(X>0 M,\$L^(ML/NJH8SXQ*SI;#C/626)N]@43G;WL.4VS[2KG9B.?ZQX]5KCP<7&D M5DHO.'(7-J=Y3BW'$)JB"P<9X,V!NA%4G?!%>!D1LX.H72])@S`1FV-SVR$& M1[F%?O90PXPVC*?A+)ZT90_64Z2^X3R9?G)8[*W+(9D15S//AN8=2 M8.+`\/GM@VL54!#K(0V1AY8@N(Q"G\^\:H=J*?K9FAO[CWA-(&&O5%E?9+DQ ME^OBZZ\/;,S]$J$N2UI"`VZ)5-OEE$B)YR@!`17G^V9^>&!VL:6'_"+]I[[` M*4B#K?FRGP/$DB_US]2QN:#^Y!ANLH]JA`GW-@!ED20O40&V[_`Z_+#F.F_; M8UECDMA09M4>8;8=:4/15$N\^5:2#85/[1"O5ZQL*%:2P[?)S+.AQJ@%QE*. M91N*@UK0H(7:IK_F9V!YR>P,`P5&TDXN0FN#8\A9"XJ)+!P/L2%?2A5Q5(9? M;,B3TD,W?DA'>R:549?1@/8BXOD&'1U%YK[B_9RAQCULI)+2,\1=WVCJJ#PK MUIR))Q3.`K@ISKHFVDY'U&L6-!G_7U$R1R$YM/2DJCP"G(6MH8S''VM"1QZ,!+UDORE,TI*09XPXZ;D#*80*9H0HJ+5Q[):7M4;F^Q<_OH M=%+I`;)Z MDC3,S28W@O%7'+\V9**;QO1KR6=N/KMI#+^.?`:GQ^LB7UWH3C:Y7D_F46W3 MW9'OHQRVNW`:X47^T)(*5_'-8AE$:PBO$88>F43+;J(P3H,$A`GU\23K;0]E MVBJ975+8D?3J_#\G5R+ M-?G?8,6IV969/I1`IRF!-D7]`\`K6J0+?N.`G3%:GI0E1^HK6/""PSM#=,)8 M>_X8@RR!LU._C?:03D`XXWWR\N_:H./>F^H(XR&4_L;,0#\,`9%7Q,YBRXW# M04KW?OX>->]=#M(3QL^A^#F,E]#+XFUHZEZ_I:J-,$,POD[']^R9L9YTHK2U=6NH4V&KTT(_"RC\#- MZQ+A_)F?#'P>@92L;]4).O"TJ#HW]WJ[/;4%^VM*)=1X6GI;\I>D1FDRIUDQ M3/N^SQVMI."QZ#8H:E5UD9J_Y,ZR#"'HD7\^1_2GFU>(/11GCXBG'`/G:-L/D[:_0C2;9RUR(`8S M6/P%/F+D,55?O4!9]1URMI?U6_+[X@ZU>VBATN;AA(TQR/'LU(]U*;HJ^U?6 M^51W'H7;\Q.:A!>G)$`.+5MZ4=8[;;>)K6U#IOK3XY6A+A3!TO^>D-C=//!\ M5T_PCEM7_^$5NI6B"-ER'VMC:N6Q,SF-M,&E6\FB/_#P6_%&FS2" ME3""]F?86C1+4N3:MKC&IE>:U"LNMBMJ-LRBZ;BKGF63:H&PDLZ[/$L' MD24@T),T'7G?^P,*6+_$(NW=J"E!(S,[-<4LF;<7OV MH/.YI!)5AL8;3B5I(3A=;LA1$F]SB*(>*R(HYE5[O<"$U^7]G4 M""-#D&4$_2ZDU9!1@'Q`4-Y&:>/QE(['<$[-MA7,NP`KZ6%+X_CYZB`DH%PC M,`O)3\@KL@/J7S*4FJJD8UJ^V0,AK)<&`)>;/>>)B4U@-LXTMAOL*,@@(/\: M3_=S+2AN<5-\3O4N0^F/VN5A17K_MM?SOJ`<]T5(]@R#,.#VQN//&006G;K\ M#2N98@)C2+2+.9'*UW`%@VA)R44S&,.XH5>GP$R]Z2%J.*)8JHC*O;10#09D MS=D7&!+]*R#?=.0OB+(4)U1/6\'BL_(?/)9;PYP`D50LY^@NZIZTAWI_M=(K M,V#?]3$^"N.LZO=&B^79"FA/N\]`(D'JV;68A:N'9 M$"IH@[F`#6Z#WU\8=2E%TP:GO#3FDJJ5_I)+EQ#1@^5@;G*$.?01DJ*R'6WT M^()I1'<>!034..]WI^!],K-\;`P/[BV:)O/L0$S@;`SW^L@S=E`#@H>^D&O7>-D+)7P[EI>`V3S8'KPFDUX6HTB6,Y9@6J(JLYW1LI;77 MC=+KP`/&Y+,FX2]AVAMCUM.>;S_IH]%>3%IH%#21H97F8ZTU MT(\EH$4OIG'>T$,!*N*^UY",0B$5E/%X>@EBY-$$$!2D2?E1R:W.KK3-T5"; ME+0RC+_W`?:^S^4ZYT!7`8B9Y2=*EM2(%ULA[+"<#J5QKX(N;UY0@)A+S$KA M[LC_/8V37&NHU1_;KF8,YH3W,*"5P9BSBD&8'@"7G5`Y/!EK.-.@BVF@AM-6 M'H+KP.$&:V*H(W++:V:^`GXD$HE(&^U:NBG$X@DH[2%/05.FN\9EM[E3$F!$ M0,^012NX;2[A!2G9X)80[.;QB:;&IDG'M,_VJ@,%T"\`?()>2HB)X`Z,%0`/ M/R@WO4;-VCH4JHZ0LXPBYY+OXH^*R-\$IZ.I$PH6M2MX6F M.N'16QMQV1-J;M8CNV&XQ.EDM`07I]*`]=&V=.3Q032F#.'0RPNG MQV%>]'P?Q?$E)'^"=^1S8A@G^>]$#QDG+&1#*"G&EM MKBSCI-6-U-GE3ZBAGT;*3N`*ABDSJ77[9Z>)'U$3YQ>V[XRQ`LI.W3\ML&N. MFJA>M&BY3&,"2!QOE#%>0PKN'&>=.>O,&.P%C[ELQ9I&>ZNY/YLQ%N*'<]FT_[PBG.?&.H^*15L_=&V_K#DN@1,3D#KBGBM9:H]F4RT.8R( M,KG;6'.'06I72P0;PG1"LTT3&,VI<<]1`H*]DWD;X2O"<%&8DI]J?+D#\<)U M??/B&;P6?MY+&)+OQ4K`8XW6`_D*YLF^.50;/S83=,9P^WV?BB+8,>,^Z. M<3Y1(8AI..4KX5V[\&SB*@S@^9.<7W)0GC3G@S+!"V.F#\J9N';:0,.S=MD* MUZ!-W0;QK=_J[?.+,XP#BYRV\ID_NWJPK`=7LQ%\"Q#^!00I_2<*0>@A$(SB M&':Q=3N4/64[;V$J`6:H3>SQ.O2_JPB3LP,2>`U?DC)+G9O+TP(_Q%QRER]L(E^-V%RS2),V`NN/>`-\,4##Y(8_#!!`P>(*`L,7-@'AX4;GZ*W!IO M`DM-63I[_+.&R8JAV#1]P+B9\>7^-P4!2K(7UDIU)2YJN9XC8@1[(@ZCKJO: M0PF>9[#+BLZ/G]/P(0KA^@'@;S"Y34.?KZXR!FN!.PV1AY8@N(P:H:X;J@/F MGY^><29CUJ/0_Q*M(`ZIL.$"SY^C-S0N;2M4#6=QMJ_=J2H603\*-,B9-[74$%/K3"((YX`L6Y0'4OT_\.PN+,B^Y>C*\D9 MD@,.3?=`:DY$1GLD4SC10X'CP=R$CV-305:9U5Z%I(M`$N9@0:./AMHOO>>` M:0F";[,58*RX<5:'X.MT2D_5J@1N0DY;F9)>)!%%(3/Z*KZ`EN!R+7B[KW., MDEM(C@\(:$5"2@!9[PR60EQN99L#THR&%I5#S@HIL,>IAH#YIL7!F+=8VG"$ ML,(Q'A?@G;AME>CAH1B@6BY$#HG<.?/\6%(8RL@VDUU7"I"6%'CF6UI<3F^N M[?06U=XO4>1_1T%0=FY+0)@9*KFM;XPN//+^2.D3B[>4&O">W"%_'U:62M-J M"1TZQZ;6-@,TSL]U#C/DYKPTSQL4-II2=^K@8N=CLD;;;%6HH>.&Y3`(M_VS M3MCN%DN`,-4B.36BC,%&Z_Q=;+=)&L`XZP/Z`'WD459)9'P>?2+'F]T946RB MYK0JXW6+-A0!>NI-GJ-E M0PTN9X8SWCGJW4W(\J6OU'GDT=RHF1_49>O,P M"J(9JP.3S$PE4#YCX,,%P-_8X.P/.6KBGK!?8NO3;O`6###2(T\H6:95^@XO MC(M^M,>^V>0T.>+5"]Y,YXG)\2]UY[]>N.D/?QWY%&3FK,D%RRU%0TN3RN3: MY2YG7]8XUE[-+);Q*Q0NL#A,)H=D*P^R^>61[8@@[?HRJ0:2V]1&WI\G>#CJ M71#:;XE@;YNCDL6,[`F!BOQV#J>M&!6U;+>TN!@D+81BNR4-S+.<5)V'`Q]" MB;0NLTF,:[:,A$A(%*NYIQ[RV,)%.[CN=RDDY`TO*?*CB4=FF%5I51?(.#QJ MWI5%N4T[5)H>4*D^-M`PR64X=2@P[+FPT+J6`&_";'$?`?JN=='9:H9A=@R-*2BG[3+OPICM&*HE>;QM9/$)R_OSQ-/_*=7H3:ZC-F@:#*GO=W.@%B$,POP4>S"]N&TPKL]44]<,8^2D(BF?_,J&]D=5U5YD[_M@J M=H,,KZJ)M4)SP.JT!&F$3ZM^5?IX>//XD\DY.1)TZ*:SF)R<(TL$ICIK<8N^;Z!-^BR^T!)O/(+X%C>7KJQ]KLK1BN15PVK*C]:DU./>'I!N(FUH&,,W68 MK.]XMJ?LV:MOFL;[M@.V3KL0C\',M1NG+=KL--]L93J.%IW@*7V)X1\IP>IF M99(^,/Q&NWTWIF5X$Z^(B>&18Q-=HBCV$`P]VMB.7>+('>]T+K4Z%^.;[05H MV1^K?J".$_\(UCFKC(KKMSG4D-NSIG&:'CT/AH!P[Y_#>`D]-$70Y_(@]G@M MT%/G`B7J!BP.YZD?JP7J7;G4:">PAAL`.[=K0_U8`Z#F6B]U0TV`F>S'.]V, MT89`SN8-"LGVP#(T1_WA M4:&3RE5==KTU3()H_YYL]U2#BK.#8*UP'K+[28(XS;:&19XGCA9F;C1-&7J- MBIWYY??2J-8S.>WE]HTEC.ISC!T`PW.(' MXYS[6:W[6;'#L=%I=SA0*[QD5C5Z`_:.$$%J6*5%IDWM M/;,Q?,X6J)4D@;N0)D:.0O\!X&\PH3C?$,4W63]!+R68H*PYT!7$"3D;M$\, M^9QY16RU2/,UN22L[UM[N6R6I.O2;+DGRM;S^]ZVZ7%\1EH&!EZ0@>``)I>[ZFGR2C&H2:H7\ MDDYUV,_.':T`"BB1;B/\!`)8GO8)))S=0P'*,EB%ODWG99T:Y=0HIT8-1HWJ MSF:TJTM]J)0M1*'V=!.G-E;4QE+CH^4MBR6A1W9ZBU)E6O$2/\T!AI>TD?4V MN:*[*ZI#/ZV.(->+F:ZKNO"3D=JATXB<1N0THCZT@,YL6+M"Y!0!=8K`L-Q$ M`Q."6]OE9K$,HC4D-@M>(0^6W[/ZQ4=!!@NBW6FH23,+T9_DBV>MEK)C(.X[ M4;V?7NHQP,<8A+/L$EVN#V[(Z#O`14_=^!=B-4%_%/HWKTOH98V`Z$^5-EV2 MKJFC`^14.*?".15N,"J<3M:F7?OK@8K*Q:OSE9FD(C\EY*/,HX"`'NHM%%&9?:0*7F]=RN4Z0-BLX9<-Y+9PXMEX3B";))!O``Y1.(L?("G0@>O`@68)U.X%HA<)W%:[#@*G/-"2`^"E+Z MUE699W[SZ@4I.2BWY#C3R%*:%.$D68VFAXWTTNM7B&9S&HA<00QF\&M*&5T1 MW8PEDRMDUG+JC5-OG'HS&/6F)4/1KOKT4>VD3`*Y7`:3%,.G_)I.X#+"M'>0 MRV*P13D4^'`,V2HPTRDR3I%QBLQP%!D19J%=;7&"64XP.]^-P>*Y3*G>^Y"5 M-_0NU\4?)4H]I%9S8MR)<2?&AR/&VS(5)]I-$NVW`.%?0)!6,A!5=-(P2YRW M9\A\\M3S9_XQ$LQ/-/8KF!J;E!+`U`GA85K4",9RWA'V`@-+)'X<3 M&O[!M%=LZ'^-0KSYS^P=`J'@NI*EG5!W0MT)=2?4CR'4.[%`)_M-DOUW(1D- MG\'K@"/=7;J;6O4'[9H:QV+MAG9:T7\PWMA7:)XI,0Z&&N4XA<0J) M4TBL5T@D&89V/41=9*.3-'(E?";I8\\0+^XC$!)]+._"/9IAF/UIP#X54Y00 M)]K[:4G,4.[DSGJ-AB>W@%-'G#IR;'5$\HAKUTF<+*[(8OIPPP-,YI%?>1SU M&L8>1AFT6AL=B@-7S]#%Y[M&B$[+<`X$)[$'+[%;L%8GL,T2V(L%RC\74;CH MT^4HG$$R"*K-2.@BM:4@9(ENJ46<_';RV\EO)[_?D/R68[).B)LDQ)_2EQC^ MD9)_WJS@SN/B3HXY.6:!MUL1G,QKP`"9.=Y)82>%=?2W81]@)W#9`O>G<[K% M"X@A^8__!U!+`P04````"`!`:D5$4A]H.1M3``#^J`0`%0`<`&UY9VXM,C`Q M,S$R,S%?;&%B+GAM;%54"0`#6(#R4EB`\E)U>`L``00E#@``!#D!``#<77MO MXSB2_W^!_0Z\[."P"\2));^#Z5FX.\D@B_0X2-*[L]N\^%,N^B?`>B8KH6< MU8>S+T^]^=.GN[NSO__TYS_]^%^]'GA\!->NXT#;ACOPJPEMZ!D!!,_&N^NX MZQVX-UZ@[8-[Y/SV8OCP')#_6\!UP*\?'^^!?J$!\!H$FZO+R^_?OU]`:V5X M/=>QD0,O3'=]"7J]B-4_F5!78'RA8[E2OSRZ6\>Z`H/45Y\\:`2X-;"P.%=` M[VO#7E_O]8?/_-%2K__ M!D^NX^/6ZXWA[,#6#1^A#[PU:%R%1.]078&LZ_H>SE(KO+YY]X7JK M2\QFU*Q'ONII>F^@7;S[UME/A.&/GFO# M1[@$5(:K8+>!'\Y\M-[8\"S\[M6#RV(I;,^[)/TO';C"S](B'&:$@S8F'/X2 M?DT=[0R0EE\>[[@*S3*T6*=+)J1-_B".FA$3O@?0L:`5"4JZEYB+4J>6ID0) M6=?,$+2)S5VO4'%*:VGX+Y3@UN^M#&-S25SQ$MJ!'WU#G;/7UT(C_R7\^MO< M-#$2`@S5!]=&)H+^_,4//,,,(FY4QP]G`ATN8_E)EXP&'O3=K6?"6B9ACZ>F M%-_L%])I;>,N)/Y`I_?EZ0P@Z\,9LKX-)L.9KNG?)MJ@/QI\T[YI9S\EM$!$ M#'R-R/WOCTR.=E4+<%R"]\?73V^FW]S+^I_AF9&<^&.%@F&+2]/%H683]#*/ M<>FY:R%?BOB[PC:Y5(<>_\'8&2\V_+3U/.A4("??6#YJM14'TXSB/%! M2`B$E)1BY1"M](Q6&T:H`\C@.%8!*HJT5XF(1VA"]$8D^@4&8K@H[*(`'45R M"'J3KDUGPQQ&$G(`T^L&5`Y6D0+FV3,L"(Q(42\F>@YLZ/O`L&WW.TDXP=+U M@.5N7X+EUDXZN$OPP^P_ M=0&69=Y=!$ZNO15!U-OB1!89+\A&`1Y'*_'):2\7G,5"B,;YV6`RB9%)2($4 M+>6H;$$W/:V;G=!2C)=R5\N!I<0,]9"RWJTDV'#)VAN/!L@FZU6PRG?2_ M#4*WBHB#F#K`Y`&A#Q(&X"MC<9QI4U&`.*KR6H>4YX:1HUJ`#?1N8-@%NJL( M+4UQ3")-(TLI&J(C&:_A!B=6B.(>?[8A^3!WK/G:]0+T!_W^P7,WT`MV#_B! M!OBWF]^W:+,N'=';(2\W`6A%9M$Q=3(;Z?OX3[,&,6^`&8`T=Q"Q!Y0__3V6 M0%F2(=]^-'KV#*HT/KQM#SQG"I,@WUA8ZJ!.(XR'K1ND8," M>(^%L^[P#,-9(9P2S7T?!OX]@#)1MH]T)#OH!7;H-;6#/&S7=_@LL&M:LZ5%"\95%)N" MG>0O4%1().9_TZ$V[>O1LD3H?PJ@5[(6T::>FFH]JY8=VE2V**C0N=.=L^QV MA*D'U-1:A(CYCAI%GLGZ1YU'RSIT)7I0:01'KN%8F\VJ(P0`DZ^8M*2\W-$R^7>) M)=1@Y/^V?D#&+?_9?81$642W^)-)_K/[R?!?'SSW#5G0^KC[XA.@+S:DYADY MJ[D9H#>ZXU!5=GD,5E+1V;[\H@@8Z=HH@G8L!7AV02P'77]+K\?A'XDP()(& M?-P!(@\)!K%$(!%)?<&H:OOJ>?L&+JD("NWK8/N&2WSX>_*72U(CTY)2(QJOFY=[SJL^-JO@JHH.*I%0V80JR.8M8,A66#2D-"$^_.8+VVZ9J#V(?FQFOJ@?RM'2R63X%K_O8(-]@17@T?%F\P-28F?>FXJ:2" M>Q<#;3@>ALO*E!4(>;$I)N,&(G88B&`.&$L"42%YYEF(=K89U2FRC M8M5:BGUH6&-,PIES:!@8\E&WEGUHT$C6N0^R9(L1<+%\A-;6)/'BSOGDKM>N M0UDV"8`-:*F)?_4%%1R7IWU],,J$/XS_(MM%JV*:+ MP>_(YF&QC]G!ITJ3M_^,O6M"ZQ28BY8[;(,QFH^C^`+TG'/DATY#Z/W[%-OT^T<18T`X@Q1K$D_B%`MS!Y0]8/P5S0FEFTZ/3->+;>=N:!@! M,#(<@3BX>7BBU.2Y%:7^9Q\B9S!Q:)^8O!31=]V_3-JF*D;"/IOEJW0$4?Z9.T MSZJOUFFNAEX./;D.7%K6LJ^C.H>N*#C)M)'NSC4/8!K.^EK&FX]:#"(6B9NH MD`K()NO>F:JMM+QT2!$.(Y;?R^`L,%H04H M,9!04PF-0Y5+'3VT)+J]4=WPO'>)',,Q48<2^1+GV\<-SRY*L,,]`8GW:/D= M9**'*X5P!J)I4:E@V9%>BO#3CGH40#=^@-;TV(T$1(HRQ7:T&M?12EH8J,11 M)@Z46Z);@2"L3H/6)]?GIIB"O3L1(C(B"9]Z.]!F`O$"Q,0!H=ZU\-%<]73= M)5;.Y"BG'F^%[BH&OGWK=`N)U_`E^&P$D;1+[`BWZ`T^OWKN=O7Z#)U_0\,[ M$*]->'0"U0T$%\Y&AQ--!/M$!)#(`*@0@$@!0C$`E@-003H>*(YM31I.KG$Z M;U`;+8F-=H3D.3B%(',`$L5"45/[GV+`BN=#1_+2A/X)!:I8:.&W(_2Q4()2 M*T@E:PJG&:":6;$D.)W.O*,A]MH,3UGK=SXT+9Q(`:++<7*I2AY=#5%5@@M/ MX?N34?,PA:6(HQ0-62>:2[5JS5RXM1ZZ22J]:L6"=:G72V)0+&-N/5"65;;695G<^>&HWK M4VW<*-Z<4B+4V##)QO!)!(/6$I632DB>D+.R8?CW[AI'\0/]I8!@!^&^+Z6P M:T^&C7(,QC'Z9@<(SVXC_T`;G1;\^3AH$@,XINMR(/@7"EZ1@Q,6DJ6T.?27 M$.Y@8.!+*YP^#R?3)@&"<::S$,+[I)*$EJP63SJ^,UM$LXY37!"IQE.3P%)A MZ),),&VM=W"(=CVPU)Z3#T?31MM&^:!R*HL9+5B+'TQ.=;VB'$$'AY-#5B9X M!_EPY?C9X-+U(+#822?.JJ@AN?X-1Q=ZIE\L M&/X,C$C#'B;2\TET\I/HA-8;@]%,=9-]D)KT9R`0MBEKD/`&A#E(7\9W1XXA MBOFK.&-(NMUH`&>62;G>JVM;Q(.(KRH\6*C-P):<,M2:C>5&;W+V^5&B=RGA MSD;O,JEK($"K&;U)4!:*WC3,_T?'[M:>0)/836^FD!6[9\QD#EP15H='[_8L M-RP-WRR#Z'[\%@EM]>-WI9553.0_&C[R%\OPG'O\D#ASN/UV$J?;>\Q%7^6= M#(=A11,E00XW2HBHF0P?IHN>Z(+'A@"](][KS+S6BD&&11`^%&@\&I1`ZRNA MU2$\U=6,BZ(2S50B)^5J57B)3*$")>0ZL;ECD7]NL$1O.*?$&>(\^&1XW@Z/ MFV5;*&)])2)(2"#AU],FTS"=HQ<`DMNGZ8<493`/0$3[B'L>&^@AU[IQ"B=? MQ]-]&.M.CN&FU_3!E.Y&`"#^'F>&3+XCJOX4&%X@5_E1I?(O<(4<5P M*Y9+N#)J,AM6P8]Q`!$+$/%0K@5MB M0E5`KC,@*A\)FP\._?XTA<%NC7R'::47::4:.L*#6[=&M4H$J''[FEZA3]/I MGGK_;B!^[-2J';G<>U6[K+M>([;I2,8:EV[%0,L( M)GP32#(.).192I9FD#K95?GYQ\>S@YZW@]'<#M(PV<3E,["M;<[.(OL9O@(Y"9&N83N63-BI9V.]+K@)$T"Y=!G>S4Q1C>_.(WG/Q6M#.6LZ55@. M[YE\,+R%]Q20DB&Z(AK=E53B&U4]):.V0ASABP*GFI9`-;Z8%9,%"P\PPN$A MZ_&E6^KPV:;2>[>PGH.-T8%W6&IX:1Z#(N91##PJB#_?!J^N1^KWJA_V7@\U M0,N+(>IK^-.X`&",'$CH*0?500H6@,DH54T!FGBNQT%1H3TZ@9X[W]^*(R=L MK1(U3`3AFLS)>,)'#*/5$;0T4*P`*8BKDC*49%VL%"$I&W0"'8MMX`:7 M79=V48F3E!S"\XO1N,\'2XI@1Q#35,4"V+CERBG#3H$#E@(H;Q+%*"JMA,LW M4X.66I4^_5%_5H`0A:_N'Z1)`1!^Z%_TM63RDDZ]@#;JG_?[?>"S@&`$9$?[ M`@RTSN(088-0`J3U:+`$FJ*BRJB4- MQ_L:(DI-\=A7Y7>Y8;#4%FJ@XVU?NWO"ZDM(]4^)0((OPVT$R/ M\]:0'#N4*O7&O.*2DM;4U+-J?G0=B^T7_N(&JC?'!/PP"Z8JHZB!DQ]\AGA6 M8/$/%"EO*Q4^!0((E[>.AO&&EA\`1D?=B3_MZ40QDG0F9YB0=[[Q3&WK6-"C MQSF"-66A%C`EGI8%"L\BG0'(-?1-#VW(7*FZQ$.TOVH@%0DE&JS[@]&H%%P@ M1;T3-1W',(`>&X`=&I'0[ASPRCRX$HQ<0[6T1.+C'+-@UO8$O3=D0<1,25K:RTK[36$:6KEEW:UUP7UESAFDPM MX*86:,3-U6*$^8QU,K>VX24,GW&$0\ZJ*L!4]E037ZK$$AS+IM/!4,N&EYAR MVM]"VDJC2ZLJ:]U0622VM*JW+JJWXL@B"MA<8!&RE:JIQ6+Y"-^@4[*QFFXC M>8H0,Q:_-';4S\(H)*`NRV^F0P()=PG6,22L!!*!.DB4^D\^><_JK\K-2?GW MS?L&.CXL6UW*-)/L[&G>PNLO^G"0^#M;F8QHJ-J^.$"3<7(V@TGU(5OXL$0? MF9Y>Y$)Y9]_3O)UT$3\I$SJ6^Q&YOHD@%O?.,4N2Q++VTE/#$F$$G6.FC8>S M,"&,J(&$W#G9NKM0E0:VI9[&4X]HIS3A:TM#/:.ANEQ.`$U)!E>E?/,!S8?F MQJWII3?1Z]B($'$P`H9**RA)[+9^X*ZA]PAM.OSX MKVA3L1%?TD-FNL<70_Q-L4&TX1$2`QEJJG?@6])0YVNH-!^L]KQ,:EAA#17@ M(54`PD=`A/5 M9**DQ-GR,.'90CU.GLG%*$)/D;54A@_*7M2!IKH^XF"#TND$+.IK1"'Q9+Y" M:VM#LLQ\[SJK'F:[!CD]_3)%U8`DXVE\@"1640..)<13)BM<``_G3]S'6=A8 M*D2*)!`N.M=&\0C"Z$1[+R"DI`HF!VNE9[3R^#M*\K!0YEA9.'"U5XF(9^-] M[OLP\'^!@1@LBGHHP$:!&,('NVM]/0<03`TPU.S<" M'E>$%YX5N@*:7[#FM7&3ZJ08.HDDPKXUGFCEZ$EH=@=`#?6D&$K2,:O3:-IW MQ2I`Y:RB!E,;#YJ(KL;-'6N^=KT`_5&TB2G20RJ:N&*(G[,^B@>BA!BM'4B3 M4X6B=O33]_0CM01&A7[R<%3I?ED0E1M%"8+BQ3I6.@L=GPI$U[BA1:LAZ#$B M+X8/K0=CQTYAK%AG/HRH3!P>)*GP$6;C:?BNLY8;IFQSIFU>K7,)2U&M`*P3!@Y_#%T.M)\3(M=]5[1U6 M'9)R2R=`P>[.6;K>FB5(Q2F&>#_9%9(B0@FZY&`V'O19I61$E=4$4[H@1?C8 M.4%1/#N.MEH'M"VOH&Q=9?UPE:646M:!:5QR*6RMXY=>1J*PDC=V-=5E+Q)5<`\2K%\3"'IK!,,;Q[CE*37WW9CF)Z$\5DE%]6.EE4?UEN!]EH M(`6@8EA(6BI!0LQ>W%VT63$.:+EN)U#03*E"#)0K)1\!>XY5[/]9"\CS_M1H M=,\I"ZML+AD'13*(^LUH-LZ#(9-DW*NJ#FM50;VQ@C+Q4>9Z>9!P32(/*6R$ MXK^M4MQ.,C8RS,6#Z2"?*869A+IW5`Y72*^KD$S?+W2FO-/OZR[/VY\QV9+' M0G^6[-N$I[@'Z/DX3[JK\^/:PNM"PLOTV;1+Y%TU5D_%BOJ-X3G(6?G1_4L5 MNW+*?@L65N%2*$""-\$-(YJW0L\B5+J!D+J*T7AP=5`%0PRGE2&@43AS@!@ MCO,L9&\#:-4;.@J?4B]<^--&]IGAY\-UI[>['+5 M.;3QW;82?QP3=0&1H5R"#SQJK1!QH0C"KRP-)S,NPD):W0!3$\7"JB6N%JH` MD_.J,H"DU>X"(*KJ?_CM%8*B=@G*8!+=DER4^2LOQ&E'/\[,IDM`*2V;*;>" M$K`LE]`,XDM5GHWW1R.`['[T+19U@<=O=E(%[\&*$Y`))V&I1/U/B^_6BFE' M%P61UT$>9#0!PD#17@[C@$H`.>;C>>^HS51F5Z&XCI@X\%>@.V@_F:A^AZ= M06@]NW4'LH^0V`;9X;L!P2VTL*0VN6-]BP7991K7W6C0^'+Q=`&6H4'\V"">HAVE(X"I.HS4-W$K M-;*Q,&Q7;+%<;'@5J+RFLBMA.7*('B8^F$W#8T(3N&[8-J:[!"ZE=2&WVK4- MC7(!*-R872P!HZ6@H+4-K?3RYW2.31NX29=/-WQ,WMA?O+'/5%A1(^7G`VCC+[D#2M\@$+ M#U#J`),'A#Z[D#L$&_A*>*B:31_%!OJ^#=S(!LN:-I`V?M=U\(&8&2#<%)T5+L$H6E>-4I%0'-\R-,P]OT*` MT=FG"JM++`Z*!DG>T=QH2M*24-SP4JWD/<'TFX1SFTJ`/Y%[0TQWY:`_H,42 M*_IZX7W%49QMF_F+>!$"G;'3B1'-#EA;P>K M/SI4I4G_O[MO:XX7+=>BM.5;M.E7LW-OIA0\ZD M;<$!F8DK6:=1 M?YU:B\"F07,M3IO@XSGK^'Z+>'M3>KC^TX\/"6^"(_^=R?);E/XW32LIAQA] MK_%<B2*-:@_Z0O,/L1]B)U-,C?O.SK+WE_RIW&9QF]L&B)J)G\'!*B4#9[*OBIM55KQN=0$$A*[9/Z3N>/AWZ27C[XB?]+@ MX3'C]8W_0F/_H=CGO\+;VL=U+U9NO5V5XEITX*\F+S30Q`Q`C(^Y-C2S]W M27K81N38*N#N,X.25Q<46KXG6<)B/#!/"@`MBXC:LTCN(Z;E-&2];Z^B[#2NP?/X4'^N/_TE>= M_AO/V;3>\\$[]+OT)"M^)3D=P@F1C!*2-0\2R.LJD#7KUAE3S$B0)1)=-(B, M):NGD?4***Q%^`"L\PQ+;4JR!:SWT9,?G*]E&G^V"A8Q9H?"9*L:+/X0[V,% M/'W8]X#LV[/HNEG4;5<2T):5?@R.-'[GI_0ABO6A3OTIJS9;&QK^[6>SFNER M*J0@@V7`_67Q.LEBSYJ5YE,WZJ;0MFS[&WT(V&7P,/W-?]*N/L\?LVK=];'A M2[EM/8JOR!!&!\N^!TCC=9/&GH6KC:ANX@JY4<[E>&996\F/^D,VS[5J(T// M.&:K;5'`0^1&HI?HZ"^&!Q;#VEF+TF1J9R%-<5%L^\>>)LFM_^,M#>E]D'[, MQ%"?RWP,0C_<9]'^-;OZP?>0=%]R$$V;R!G"*#CA8UT4&1?#\4N1^8"$C:@_ MYRU')=6P2."TIBE/TA2[:'V7:XKA2WOVB@KU,1!4\PR#=>VV(\FOEH_J2%0T MG70D"D:A4]UV758^Z>I(RE$G7V(`43]?HE,V MAB\I;Z:)!JI?J,\Z,!UNPF^4M5%E3(:'WR*6E2-^9+7*Q(E66Q&D44A;]"QC M\`LO8K#([UY+-R#S?L/%P.2&=43+Q^*WK.3!>>4_YIC8Q4K\8DS6E2=:H^T? MZ>%TY)T8)46RG\1\[1]SK6*ZFC$Q)GNOI;_^1]!YACC_>/K9_J2 M?1[]+7+@RQC.P\@1O.;R:M-P#V]?91LOB1-.'?7N^`3">W7AKR1Y\6^(=[-= M)63;-84*RJH98UM79>,K&`!4\`$N"+C=;!NPD^BA;]R-)J376TCK&#.8HA)9 M.M6X@B=PV*Q\!QE1G6MLSA>+M1E2[H2N@^4\1U4>D?%&M:YA"199:E6"BJ9/ MX?,I3?AT.5?>!8"\@8&D)AO@-@.;Y:R!(T$N#P#G2*GM8PO)092+Y`1H]-:F MA(Q&?%<`XW4&C.<&8+R.MK1=KS:VXPYA48-24K'8'LF`IH;#+>Y.5A-14KG<(P MT+B5\(4H<93KW&(CYV?77.`CWP;-_O'Z*3F&JO[4SB)3M:]X] M^83>^/5FJYFX\MU$+A^+E(.1HKPX/D2/#@0I_^_D'P/F5%[D/;=OH@S5;?3AR*J` M*UJSFZ?)SE3Q0IJNK();H*V*G-"F:Y#&K.U)YZ.2VX@4XSI0;]*FPK2149O* MT@XJ0PJ9^D+-$$GU^A:7XW54I2_&H.B\M^E2G6*^7JZU:ZI.G@:C)H=M/8WC M8/"*?XP(J.%^I6^!$=VB3?00NGZ@X?[U4Y*<:**ON*5_V/K"2\<),%:>+78; M+U]:Y4VE!"TBB"$5SAI'K#F26"V+GU%D\[2RX:UJVB!4K5N,*A@'S\%]^LA3 MT;_1YZ*D5AP]Q/Z3`=>M+UG'=QM'0*-A5Q8*G#.2^5V.BBC)J6(!?E0YY]AR MMGB`487UVH7%0!J1 MY$.Z<^W+EJ9$EW!9%:Q]8$-;KGH(*&"@O@*D6\>\QMO7+_[?H_C=T4\2T]VN M#A3<\`GG;,$[9"ZV(!?P]I7P$0@?`O>JUT1J\"HUO-&IX0ZJ!@<0KS-V(,"5 MNG0,S[_&4=(#Q.(U-Y#+>8$&J,O%"A:S3RA.@!@ONJF#P>@;4(!$.5:Q3H&^-^HMBR"^24WX)QQ`BX8.-NM0.C-:$Z# M4]:%"9H(=)"&C M>P=P!3)'&5;MFD%!510=_@R.VL]9_-DF5O(QH=8R]Q;YC%.\B1/_]>+;FYSO M%QK?11-P/J^Q3J[W_SP%,6ZOZW-CKL%/EA$3:==A8UJM4C9;:FAUHX&`61!C MX#KR\\T9L'EQRV8H60V!7GAK.D74X>8/4X1M1'8R>A5LX?IT%MMM20\=B;B& M[LZ5L-;KW:XSO-$3&2;4!0#ASF/9F*C00W>8:/[T].P',4LU_JP_P-0\C(#. M.@<=&CR<3[(5(;[&Q,79`*DXGB1ALG7C@R'2MHTCM7FI\*+0`08N*C9N[L_Q M*S:-CFS32/-!H6];1`Z0)?"VQ7:3MV^2C.[F7C&C2<1QT#6%Y`JXG>^$8L*N MH_7*..RB+11@AOOHB3+?P'I)O(O"-`A/0?B0]X^(PN0MO8]B*IZ[]7_0Y$L0 M1G&0OF;BT,S"4CXERU1$+ZPO-'V,LK^\9(_P&DXZ>[+(@4T'84\L:*2XFWMY M:N9BC]2,4@$AR1_FO-("B9)P64>>9\1S-NW"5Z)Q"S.P8VK7V,M M?8T[H>U`_)0R'E"=GGW/4'.GK_3ZF8J_^MRC-?K^GP0L[ MY\LX^YZR9PI6OV4_G)GN"`1MWYXDMF-F[2FUHQQU*IP`"6?V4@9M`T7J4QO MX*%%9@-_@8ZE; MZ>/E;C-O11-JRO5X8K8ARH%,:I!!`E"%G"5=KO7!62^F-ZQC2LD&.)%CM:A' M=*Q=M$/9*V.)Z/45T2Z6C$;81))>+X[@J"W#Q/@*+I(Z9TRL-D4RM,;.T#-% M1I/R#$TN["B;S:X%.D,R/(Q[MEPYGS7W7?7/X>RPUID`&L1NN9[-:QNGXD!G M\ONK+3N@`X29VQ<&LE4Y0*(&7M'OV;9BY&QG4"'\V#!5E8I6/X,(SR[EBE>K M[6JC@N:$59HAJ.PN@P*1&)6FAPNB`")>(6@C`%3XZUNL>>3P,B\;]9:&]#YH M7:*=/8T15-99@*8P>0`P60DI)E@5)#"NG`TRKP,P, M_'[WJHI-.2E2T"2?0E)0)3E9--7E)5"/:L%\PBF&`6>08K@$[<`EAU MXM[Y0TNO.@&SBA]X#MUR`T%:11GKQ?Z`L+T7(&1OEQ,=>TUAA M\#O3D3,(C$]2?DO)H[YB2TSRFM02Q*#S/)7,.P*VVW@IELPJ=`O7GP+\+CD$:4$/F2_NK+@!8X@>\ M2-IM(;"5*#L4PPZ1N0ACN7A'LWCH8%38*`B"Y\IQ`WCOZ3V-8WJ0=K'`7UWU M+BKT%`Q!IXGMTML9L%=0KEW*<6>B'"PXGQ]+(1VZ"P,W5S,(=1IR"X7?Z`L- M3_`EY?E[3J`O9P8\`ZSG(.3E9%V9\H9(Z]70%NL%PP?:F47"0";KQ`V`Y=?7 MPH=W_G.0^L?V_#4H`53(Z;@"5ZI=>Z:(LR1//V8,TR68_ M$I6"B[*%_(:1%)C^NUM@;;-N,VJ-&G0$ONDCC:NU*SQ$;;R("]QK3;,&<2B]N8.UK3)_]X)`?<8*_]-EK MJ#BK\P+>*=QZ"P/*8N`8P-3V:(:70B4XX#K0^\%= MT[I2L0J]3JR![_=LJFM,Q0"7T$%M2G5X=76\.>H:Q#APD["7U=<1W5V1#@+\ MPX_]\73((NN6FMV=R;@#\09OX(V03*-@C)>C$-R"X9,JPRM;4X11^,;9]A1] M;;X#OM5Z'"F?W3@R[PG7!ML!A.QGQO?@$F:UV^5JL5X6Z?.M$!;-!O_:1/+? M;.?93ZT1J%,3&L%V;9:48FHXZ:2[&^XMI!L"?;7K8$S3H1%>'TKN1#9#.L#M M5HL=V`\XUA1O:K4`%S*.-L<;@(X.`9!33?+8=DJTITGRC28T4]7C=7AX3U_H M,7IFL<<7^G1'8ZTQ0=ZU"GH`0^"[WK/J1CO)Z9*",*_E)Y$F?PCB:+`>6_`< MR&_:!,>%:P?;K0,4JBX<2/98MG1\V2HHQXLW-]YRO2M+BKD9C6LYT.FQE=9Y$Y6&:O+G,6WH98 MW71'EZWJJ7L!'L8$1)-_T6H)Q[L45=1%/FMQO4/[Q36/6_4B:A[`&2';JK1N M0:G(QBYH8?F*$213U<#&A8W9PNI0,2@`%Q[)]?'(1H&.B2-P MN;_99GD.I(1DA/,\,OFW^.F>HTONG4E^U4MT^S"$6+(:E*VJ0X8HW^<*[@-Z M>/O*&HXPOD[^\8N?GEA;D?=^2GEAG?9:B0-(XL"Y,Y_P]#@^B M,5'U8>&101L!''?2PA4\WVR];CH/#@*VM9OW&)/PX%"8,*8*FJ$"UX'?0P<( M0`?:N`;6$#TB@YC=-^-,?O'C?]"4.9D&N^'A'8U3/PA9Q99LY=ZUP_=DP^$X MB%%E@!\65=5(*G?"KW;F'J7B1@$L]D#.$T5U*-[8B# MF@2_&G(7NK1J1!V%$D-/Z!\GC=9/'/A+/ MC4F-H9KL^-;_+EM8/$1Q\"^>^]J2A-+Z(AHZ5-R`K6OK-29685UUJNB9)Z,* M?!Z5.Y(6!K5-/;BTFL$`VV=VD>XQ.AX^/;$JO;P=D3ACUWQEPPL6P:7G`GRB MN5KFYTPE+2(3$RDD.$@:23JO+ET@$==(:,D[?G>(X6R^U?__B01SLY:.# M$RE7ZUT393D1]`FNCS#2E+87KSL8"IX9DP83LOAN6#]\7CI_`14-75,95IO5 M4HL*E^::(?*)`IY-B*`6ZFPW.3-6T&>,+_[^,0AI_)IG@O"KCZ9-8,,+%C&C MYP)^SN.UDE:9^B0N\R+N`H\D'H=,^3XF3MK-3,9)B_@X."F2"JIT`G.( M97K#*E*T;(!OG6[FVP(J9=J)G"L[9?C5#I5QY#M/JPFJ\];$B;0:@`76,636 MBRL@^BV3O#..I)>0H51Q`M[(VA;!FAI-%45W`-532K$A$(4/;[)1G\C3A:&K M:9IM`#O3$P[&?@1/IR=CMDS]&:L(D@:&1O_K^=PK`,-?1TYVZ2^$)PF!:^P* M&ZG;]KF(HU1F_)+QMS\=_?A]X#^$49(&^T1IJ&U/VZZQJ&<%^/U7RZ4W%X44 M2UI$(C:M2:L@.:9<H.5AFW.6D@-P/N.JZ.O!Z>3W(`BGA#V/#1?,4PN&.K<9K:LVR>GE1X'% M*0SVP;-_?!NU@D+UJ$U(*,:'VHVWV^8G."45PLE@HV&H3)Y")E0@&.RI!@.= MX!@@^(VF[*[UUSAZ"0[LOO'O"2N=^3$(_7#/+NSLT^#%E+[6@8!%P,"Y@F?Y MSO+D-U93B]]/+ZBSB_^,/KM_5XY`JB%PCDDG4D%1F(KLF0I."6]M2NY+L7VC MV+:PV-VL981V5)W;N&TYDNU!R$D<=^]1N/5ZXAG]@'=BK8B#7Z:1^V/T9T(8 MM)0(1ST)[H^`?E!'/SG6L"HN/`V8JE4$\"&NX`I\O#1?[0#0+D=P=:H>JH+Z M5/UW/^J3L^C-V@5H-#,X-6Q:IUPR#>8'WSVC)UOUE M*-JY&HJY6YGT>[*_;F??(JJ;1GX&V#,I4;`8A:5#%.R<]:P__S;:YVUB5,<$ MW%A6!5XE4@5PM`JE\]&A#GJQGB\*[&0T2$6$=1/#0LH@:3@TKO?[F*;9:O/%/YYX M0X)CY(?$?X@IU=W6&RS9"XWOHDEEFWO%IR)Q2007[SJ`U`&NE!H%T2>6@75S M_XT^1W%^O^2!E[[3?3']"S81KN6BPRWO8KN5TR(W]Z2B1@IR2)`?1SQ/$B^# M?%R)EPARJ%!IM;P:9,P:P8!.N7WS+DI25J(EGZ7;-D/;W[,(I%9FP)MZLU5^ M;;?:S>0TQ3WWG"IZV#FNO&(3DTO)J@_E(2?NEB78+&5XP=2"BK+6;4G5DQA( MZKP_-M^M=^MS[*!O5`Z51[3`$DY:VM@OEF?'C-[?<+9QADJVKG^I";=C`1'T M8+/SI.VH\Z]T'\6*J`'UT-7@#Y0.;=`^KN9FZ])=*U0_:OD^J MY`)H)-OE?+$35TD%&5+20;I%.ER:N7UIS'='AXODJ41"NS%JQ$=Y650O-4J< MP38/18<>G:>5GK`95U3#@O=&EIO\FK38$KW6-DVW$$;T9%_:T<7O^:XPCMID M8_J81>[!"ZUFOH]13(.'4!3DV;_>QGZ8L`2+#'WA@?]TY)/' M]>'O)U$GY3>:WMS?^C],'W7\P6RC:G0)P)'7?.G)`*TQ(H?^).>%%,P0B1N^ MLI;X(15#;+>:[6AE/"'"'E>_8G'^F#U(^2V]7)/[0I.II#F_'.J*A)GJHGN2 MJE5GU>5,AN>&]YKF4[GF"`OFOM(XB`[9[V/6].4]%?]NV[<;3M@1!P?C%GP` MNYBM8,ZL#@''-!0&<#U MSI?;=:M;JI@A.3>$L2/#!]7AK+(1#'.$H'PW1/289&^7&ZS?Z0L.3+E?5 M](9])Z5B`WS;>+$]"W\2[A*J`X*<(*J#&"QA>=3)L)H9Z[,?LH73H2STEF$Z M?@GVN%>R`(:H`*)6.6A8ZIKZW?*2;40-392>;U?%I0T!*NNIX"!8C2-FM=.) MCIQ.>>``%:#AITJN,^[FRX_9QH@T-CSG<;>042&10$1!7T&D'?[8+(A5#"A, MIV'UYR*CV?GW+)A.\AE+GXVM?-2VO9^-#][*W2R7LLUS,D5(A9>4/5BD]7>=GP,7--EY$JFHLG6*H"LZ)XZ+I9V0-:0/?DH/)C2-+?*2R2R)R9(S M8YH&L4CU$"L8)G6BD]H6T.`V*\,.J"],$-Y&U_M_GC*-OSTE04B3A":F1E^M MKR$`4,<+.+HO6TF4\+N-2$Z35$0Q>W^-*FM5T^'9#PX\>_`N)T=\1CX)V&&A M"WAK,T\5VHPZ<@)KJBXQT`^O?!<3=2J&P.:8S0-ZZ"E;(6'/?2/*S:>_K_FT MD+#ISN5F2)VLV(A+K>:<`.?7.#J<6*47:DPS;'\/$Y3GS(#/B1:>82ZLJ$Z2 MJS@`C,/D78H)\3E@V?7\=M`A2$\9[WQNI&7S3Q:?'ME!-VOP38(G5O6,HJ?: M@RW8"$JE!E$`F7VQW_PG>OTCT&)/?L0FS*1QP1?0MD5M,?8V8:^3/Q@!I,29 MWC)X4!FLV;W"4&HF?BXIIC6_CY[\X/S:A^8A!(L6(T/M8;DL+F5+]B!((%MU M#SG.[=H@AVW+KAN-RK8E>5&L.Z-%XY@>^&;&5S^^B;^G;/+^3U:_XBN-OS_Z ML>XP%/BR332`.`(WP]J6^PH%7;%]1S+*Y"8F@C;AQ%FB$N'DD0`TONA>772^ MAW=%GC/9>7435(!ULML:\.!ZP@74K%N(*J3TERZH2H_`5D-`DNH"8V MGQ=%'C5($N3<05$/\=0("K2"8:*G;G1MR)&4X0IJ;DYIDOHA2YKM\%7EMY#Q M([$";GLQ7ZZ-())HNH.DOH*JX1291<3$E,(DVX!UKAM\=/'H$_1UQ9-H*.+# M@S-P%O.=&CG_J5M!V`9+=WG4`/E?LU]F\VIQ)(=P9'4UF\U(PDVOF)GX7K2$ M*A)&^1/NX*MFE'I,52I$PA$[!<_38<4-6EV"GOI9NUAJ,@#.N=DMJ_T(?O)? M%!G.":'A::!,GBQ34=P-&09ZFSH#@D9V'"A$>TH/R<=,&!8[^IF@-_=BROL] M/-#X4_:+D!\1A0?^Z[=^0@\L.S)CGU\P9_N22?;8\<2<$H>WJ!^C/\28ZN=#Y/O[GC:M[+:GYF#.$Z+@L>H.X` MI_Z*V(Z495UGO'_Q4Y;I\GISWR7YJS,=)(<'8@Y\ZV2WF*F<&!N$NZEB&.;- M+.2(]?%(XRO$JRF$>Y@G09W=>F>K@81?N7`]BZPO-'1>`ZYI)$_P3./TE3FI ME-7K+7*)C$G6YI?L8MS`"=1^O=FR7,8+>CR@2$7)Z3*[:L+TZK92LR/*R:O. M\M?<3QP#&><9\-KTY!3*]'?MC*^X@+`./3:\Y68-P-=DE_!ZHZNKC&5ONHM% MEN9^7JN&7$-52PTVT*N.H*QK1X'U=@N9S9B98A=)&UUL'H1^`(`/M2Q:%\.% MHA"]M!GO2IMDR]J/4?P^.MVE]Z?C]7X?G?0]@(ROV$6?E@^H_V?V5Z).4..7 M9`MZI""(AK1Q1.0(>^L?R('>I<5F-C*86NWN#$1F38Q2VK^X-77X'.Q%`Y3P M<$OWCV%TC!ZR!9^^UC_P3=O%_V%L`4UIM5NL%J(;0$F7%(1%.6*)-%*#@`DD MGCLAL;F)P`1B>T"QT1H-=$-KV7F@@ZHP9N1OK&2UX992]7>+!JT<*`VE8,+;?+:MZ_5>0/GYZ>CZE]/`IS+X03=(/]_>4WV+][X`> MR]]^\U-==EQ?:C:QT8]%\,I^M\C+#TEME-E()!^*%%1).1CAHU5_8.,AXA.'I"16LPY!0`_8`-3KG!#[Z>WK]Q):ML5D%(;Z*:*R.;W[&*0P,C8!/T-B7Z!#F^&)<(XI9% M'D](KR8D.Q`X2$(ZL'\),L8ZNMITXQRFS`LZP)NNX*OC^FFVG,%0AKTV'%EF MKZ]G<0)TAM4E4$^8``1A#0]6W:QIN=IMSQ#D!E)ZB%$#A0O&WV[GO4U:V6+` M+RC^8O>P:S3AYC7A1.F8FWM27^D@'&N-)J`'^7IH)UD0A)7G5ZTZP9G'4C$ MZ>&#'X=!^)!<[S-A_L`_V>2>N+5N>[-FXZ-*$MUVJ")BF($HDJ MR+/5C$CQH1?5]\N"F2( M-[&,OP??GL0W3MIS+[9YBO,M(TUB/?/V4%DWXCKV)/'&"5]/1YKP^WU?Z"$# M;\C[+<;/40K)C5>Y-L%G%4(#%8/QAPM=T3ZGK=STE\9TCUM<0;7 ML`!N.[`KCB7J[;D*4GA]NL80C`/G2S;C MS+/?]S3TXR"Z"=4G!YJ';,^?#0Z`UK!=;I=K,5<6),@<:4X<)L.$D-&`W.F M&R:*Z"(IZC*0A]@/V9+:O\^&S!;6>TZ/K*Y(9JP>VA2GQ44YG:EU,"HH;_^, MVD%9/80%RI(#F!5LO96WV9V!TD,&93\9ZJ#,:+@`RGZB*$'YG)&+21JYA\L& M-!JXK*L!):3,.?D]3)[I/K@/Z,'8^D'_O,VP4L<$^%1Z5W2P+($AT4+N#3&. M=)XLW158/&OQ99O=U2),HT9P8/-(#]E:\>8^;T=T^!B$04H_!R\\M2W[/L'= M4;0F>OOZQ?][%+\[^DERR[+@M-]]"$VK\!O`*+A:_')70E0,Q\X-BP&)&)'P M(4DUINCS1=Z^$CXLX>.2/_C(:'"VI2VOIJVHH:TW&FW=@;5ESSN,`*^Z!QGZ M$48*FDLVGJ(X9=5RWV5+_NOP\-$/8G[NFMS&]^,&1.=^/4`8<"FX@^[@WOJ1Q7%FO7@%;^U[LYW"=15C M\A*#O.Z\Y,#JXQ(^L%M>:GJ5-7Q2M50E]YG.2A;>9#^].==@N4&:_^Z5W&9Z MX;>'Q99I1K#XDR.>:Q`0-7ZJ_V<:>?/T'6]5PEMG?*//1=4UHU/I0P%O8Q/" M'K3DWH8M3!K;E&*$O#&.-(9P#Y9OFTTH>,-7F@5'](M3:Z+A`L]5@%=OL1^R M%3MG8*7AADEL7^\+31^C0[6=EWQFR<8I?=+=P`&_CA+VF'D";Z+,B_O==<@F M*1'$I3WEA/SQF:?6LP'08Y@1Y6\`E=%^\]1=?OMA!\RPU>$%0(,.HA:V)VUX MU1VT=MGNG.V4>RA:I+JQ'SR2V'"`NK1KVVZ^'7`Y65[$^>[&6S\)]JR^"ML@ MH8>WKV**Y\LNW8PY"DF\X+\7O]"SW-5\LSE;#2A/'*X('Y:OFTUO)QBTUH4U_.-$YF5Y;3+(-2D6 M*_T_!*+/!:29=2=W&;ZV2Z"PWFUGZ^:N2S_/@9OR-:V*1G*N#N1H3:NGT7RJ M,VE5O;W.0%?J2G+`AZ?G8_1*BRNSZF;1UT?."S_X8[OL#R'+[LK$#"*>'09< M?XXY%LJ"=40!P&?9:Z5[RADI[J#K>]!7W+#W*GZ(8(@O&IU9&6/IM^G6E/K- MF\_+S%S)"HYZ*=C^&GP"S*L7[6-_SY_"58+S#<8>[Y)=9M?C]N5V:\5MNI.^ M@*GHYJ$>=Y<*O4J:#+)@,`J3Z!@<>*7`[]E*2;1!%9N93\\Q?9-E:K/S- M$VI-K\G=P*0>=,HTB+-[:TF7!(B6=_%6Y&;&@/M0B]5BNVLNO\]O/B9H>0XC M2MGPM0TI74MM&%%XX?].3T]^S%V;Z"3"HYB7;$F:^G!@\0N#KF*E"]`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`8;10_%,'!J$@FFU55WR*@4@^$A%#E6X* M_TS=GG+RSH2U(C*9GWE/P^@I")F%\[RA1O*Y*I5?JF2$VKYS$'[4KJ2K^E'< MAEBZFSL\U)ZQ"7-Y8/!ASJQL$59L4>$V;^@MA+SIE+C1HT%E+37C;PB+:-3E M9M7U79+&_E[;%D_WN'U3;_#0X2QC7K?Z:N?VCX(8+@*&R>;UD#DX561>"O9%EKL&,A6[?J&@> M+VWXNX0T@[&:0*=3DPOXDS3=R.]J^?K*5Q$1J.('[/579;$VXUFD`TF,8TNM MF>NZ2(V%1Y/QF@"IU1D.(H\9S8=?:9@MW([7X>'ZD*UK`S9/LY*\;$L[3+0; MOK"7K:(2PA'00CUON2BG1DZ7Y(3YZ5>=-,EI8^%R=+D]2>XK\B`H7_&)TJ]+ M3O62V\-F%S.NHQ.L.7?QF2B[T/:CX1Q:DTX=C.>S]6+6%;0)4EO8Z1511_&O M,HHUJG`?QDFSL6Q_1:*`6GGPHK,-]<,V8:KD`#J9S-=ETIWFC!,)<\.E\DJI M\I/$O7SD:)@6!TOW0N.[:'+YYES`VRC-G&?20TQK;L.(IYI_T"O%'4<`2#WA M_V!9)IFS$S>NYYW,H.<0Z$ZG']_P"L3SK=E5P=/EQ#]S/HKZ#7.77)T%7>;1 MAZAZ\2QT$-V3B"=.D1>>.'5%7JD?XX8=$\"PW>L,T#^:K[IK%^+N7(@LZ`IB M_K`0P62DH]"W[:7&8!JR]&4.=.I]%"J/*>*@]P[(?HFZQKDCJG(CZ6, M$A6MN%A1&.:B'K+Q4U=K$UKU^=H>K*@'!_LV*I\V8JO(G6VXNS"7-[(JJY\84+\LH4C M:T=X?TI9P@F/P"[2O<'1/(K?`WZ8BW2(MMS@13N_OCA<>;O-^"[O9_%S@[0J M:G`)G62KR23W<\_/#4KONRG\V!2^]A?V<0VL=4VAKM`?W8N`_C< MVUNLIW-KM6[3O^IBE,OQ;X.T+`=QV?]I_,):VF>*"9+DY&>^B-`?--X'":VV M_?&WTR:$\Q1.4/F%+LH7YANMF0#W-&#!?2)NR^=[B,DGP,G`I.->@G>$"@.. M4[;SY5ANLMA)EY@K"H04[)%/#IPS.*-W=7RX9R[S>,S4F[E0<2IQ('\&61!T M2DN7ZE8^"9KAUDYPA.)J>KLBY^J]R'FGJ^L<90+J],5^RIGH[#[SASR*^1H' M>VTR/"I//],,9A(4?+DD^Q_*[-:LGE#P3[@`/^GL-]HW:_?KI8+]7,'E&N-9 MI^"?QLU#_)+5*:#UNU_B],"765.O2LX&N2`'7N<T[@&>B'KL0%S@QC:;7CM/53[S'T]$=3S2G_93[-II* M[+EP[`Q]TI41>/@+FNN@,L&+4GBCY1Q".E)(C$ZYQII\CVB2[U#;/4HC\IR) M_9@Q4)Q'BPNZO%@(K0:Z^@F6$%T]Q9A>N-.G_#G=,,(Z9"!3/Y7+'N.P;K7: MCKYJ@3KRG_*(U>)GXWY?5NB?Y^$VC[(O/6=S5'=D=P;XN<)SD`N]5HIQ*"#R(8N=@CU<':E%/:`Z&+4WB@,4D?L^DE(W"1 MKM"$P%$\FU;O3CHJ;6.CW$$7_G;2?,!QF7#)U8TJ&3BR67H=*E.T]%(K(M*2 MTXM/\,/[)F>U=@29"\_CF\2!='+$XW_/B_34]>0=##?=@8-+\M%PL<#G0(OE M?'0'?9X!^)-ZYXF^ACI]\&=VS-W]Q:A>N>-W1'/)WVAQ%O`UCC+#>+K^$1A+ MI:E?L.WPE%R`$;%<[&3_5!$C.37R!Z.'6:MLN(!>3P&M(MQH?@U`ZI7B#G[, M72=-KZ!CJ%L[Q]G*F[6A"+=)Y5A"MB#)A1Z6`%-L1U/O#I=/KP\A1\G2<8\NI]0\3".NU"XOA'KJAD#F(#KI!F7(SE(K=Z5,2A#1)BD[" MIJC5^([-2=?$"#2TVWB;XG)=08X4]$C55QDS?!U-S+->T?@1*\3Z:M-LJRI0 M0?2YK31V\T$,N'SN7()YO5B=8\2!$M3#Y/&ZR6,=$PUC4@+A,W[IYH*5F_MW M?O+X\1C]F;3U4C>]@H$(!1_@!(WUE]+"G/$!-UD-(Z M>@S&J,213C?(B/H8A'ZX#_SCURCA)8KAR-*_BH,P+3_@))/-IC$+94@KZ9*" ML$N(&T?J)O(Z2XV`P%;CU2#1K#-41'[?T]"/@PBR/*H]BX$YF0&PN6TWBW.0 M%73<6`7UEDJ`J%T6ZTA1&942&@W14;%PR])MV[Z6>`C#^OG(X!7!MJQ\7*T( M.`5L<^\NQOG"1B^&=4NOF8S2Q"MQ<6P[VO_C,3H>LL_SX9^G('W5?I[&@U9M M_'QTJ(%L-V5+88D&$42FL736`]=LZ8.$64N-=B5*?R%4*Y,]L]=94]WTE?*[ M8?ZMRPWM"ZAPZ!ID;^:[F186#BPG1I'/.Y>OP,B_NP42\RK!J(IQ3ED;8^CV M=5L?MWZRJN<%:"J+[7JUR<]455"8>M=7?Y@ZDFAZE*-M:(\J7P/E4/GLG)VV M8ZLZ-6W1B!LSY&]12M\'R?X8):>8WM(?Z=ML_'^`7;GN?=3Y4\,4O(/YSM,# MC1$G%?5L@9+1)WP`9R;8,12@F&_U<3;>=-MBP.;9UZ2GB29C-F3'";G^"OZD M7.,'F!8LYOJF=`O MJ+8D6Q]WPQ]TV>?;K)8+0Y`NS&?"WABL]A*<"N*TXA1BAN_ M>;$6\<1YX0:L^C73JD174L&I*N^]C;^Q6.^N2#2T5U@.D=Q M':>[A/[S1,/TPPOD@EG#7$M M)E<#E$D=#N!%69'#_"P>4KJ4:-C,E^OU1@<3E`H4XTFEQ(=#D&A6F&B7W0$P MM-X(UCV.!XFN=V1G6 M$2^=L^16R^U:"QC\I,!1Q'-]/FF:F@DH0Q+\)D&*\0ZBZE$\?'2ZR+?8;!>Z M"`OU6N)0F33K#P?N*!H,RP`)Y&/R,V:R\4PWTS5/(V(B9P%VS?!:4#-V!=E;&C]]COSP.LSKJE\_Q)1?O&^_P]2#@.VLRT[<`5/\O(U7 M5)EEY`FCS],LQ`BD'$*ZTV0W,W,ZJ>>=I$9-UDL;6;*PU(WD65@L^ MSNS+RI2P.H/L_RS-^L4_\OW'\'#]X@='MI;\&,7?L]_JZ[EW)V)]%N[*(=`7 MS^;;V2J?B7G!%UY^DO]#&H7/4N4X;[*!WK"1RI.I7RQ/SI,J8]Y)&20;B-24 M@3%+3ZH0KZZ0JZ9&_K?_]/Q_%`:"-X'W]0K5)-Y+I>.XM-@_T"<__H?!89T] M8MT=U<>'7M3S%IMY[FP*`DA])(8(,+M$O&_77(>Q[\'8G]I>M8;!C%4MX2@3PN]A]BQ]R).?U0,7/K_WA+0WH?I+K#1MW3%C=D-"R`\V6W1=<3F1#)*)&"%,[6S!AR>0VY MTDRN.X-I_"?4S]A+ZGXM_=/JZ&!CZ:U(R!+W%N M9K,6C!7W5XLA2#&&4^`;00T7!TFS70.`:E`:"GR_WS(&3O'K=7CX-7JA/,\A?EW\IT4!/DF8D42.<=_/$$YX#[2`XW]([E^H.'^ M5=3)P`4;Q`IKX&I5"`:8SCJTB_H:[X/C*?N=N+)^L$$]@#$2%#?H@^G7$&-_4O_<;/O[0H2$4BR9^S!*3*P=']*0[2 M('OFQ*K?I!'91T_/&3O5,]2/V2WSA#QG-L,).N<)V]U!JP=L^0P.>;X&@V_] M)-AW,SD-#7ROIV8,G-:[*;;=##Y/$>/P09SR>"/H@?N[Z23+^+V+L&2;>U!W M=^[6[MA8E^'3S$`'>#2#HIWW9RW9FOUHN>K?NN9)>NN%U]O/H:>'3J^:FG<@ M>N]P,:`W)9WV5Z>`0ZZ$SQG=[.?LI^P_,B])LQ_^/U!+`P04````"`!`:D5$ M\6^VXF(O```,$00`%0`<`&UY9VXM,C`Q,S$R,S%?<')E+GAM;%54"0`#6(#R M4EB`\E)U>`L``00E#@``!#D!``#M?>MSZ[9V[_?.]']P=V% MA?7"PO?__;:(SU8`IS!!/[S[_.'3NS.`PB2":/;#NY^>WT^>+V]OW_WW?_WC M/WS_3^_?GST]G5TE"($X!NNSOX4@!CC(P-E+\):@9+$^>\0@!2@+,C+-GRXQ*&>."%'?G9U_^OR7 M]Y_.WW_ZR\NG__CN_"_???K\/\W6R7*-X6R>G?UK^'](XT__]I[T^.;LZ$4Q1^L.[QA+? M7G'\(<&SCV2:;SYN&K[[QW\X*QM_]Y;"G0Y?O]DT__SQ;_=WS^$<+(+W$*59 M@,*=CG2PMJZ?O_WVVX_%7\O6*?PN+4:Y2\(")0D"SY@MZ'^]WS1[3W]Z__G\ M_3>?/[RET;O_HA-^CY,8/('I64'#=]EZ"7YXE\+%,@;OJM_F&$Q_>+=8SU"! M_.?SLO\_7R5AOJ!LA*)KE,%L?8NF"5X45+\[H^/^]'2[0_Z"?,D@*I@GJWCQ M(VWWD3O4Q[Z$/I&>OSX3=@=TCH?I#43D\\`@?DQ22*>XC(,TA5,((D6Z)0<] MY@H>`PQ4X5<8.9N##(9!K']-MT2@+<`DS@!&Y,.O0/=%'`ZEG=K+()W?Q,G7 M]!9%$(,PZT[MX5"]J;V":1@G:8X!%4E1'@/R90.(?P[B'-PD>+(*8!R\QH#L MLN<@!L\@S#'YW""]6-\'OY$?RQ_6+V32"8H*)GB8;GY5W=T#4S,(7/=!5A'Q M,+T"KUE-5+TC)BG]=M=_Y'!%R$992HC;+N:F7(P&K+21HA.H.9$&%U1AH$8!"`<8!FQ>:]6-=-'H,U_6GR-<#1PY(V3!_R MC&H"5$W3P`8ZJ3DB7$\@3&8(_@FB6W1)R$AB2!6_:"L!"5?3]AC,21G1"5F6A+_/DS@B:C/=LME:\\:1''\8+J"3/X%ECL,YP3[5\2'WA]1( M.&4'HO#$L("$"EA""U&"L@031B#<`T,B2J]@G!,>N0XP(MLG?02X8*[.:^LW MZR#?;4(4[V)"PO*5Q+A^"^,\`M$-3A;7C\]T5^193];L.)_.)8-9(1I1]`1B MNO,;6T+S/E2>2?\R"=,4PQ-[M!"%#ZB49W=)FEY0C8O(-Z(G@S2KM&84/1`E M'V__Z_J-BLX>\E@S'8,P_TN2!?'#DOI)R$XKYR1:$SD?R'_GY"32P<6.,B?DR2Z"N,XYKY MB<(V@^3[EX#I75FWV8ZXW,%6IG,1DP79HO#/\B!'VI8@&%;C`EX`7MPE`:)@ M%>?P9(9!H0GK93?5>30N\3)),ZI4I;=H14X8_6N3GD"G^,Y?4_!'3J:Z7FE? MD-3@>KQJ7Y(,I"_)]FRH#;$"4:(IAF&2TR-1U8I6&7GHM=2,0?Y)O3AD&]P' M^'=0'.^EE58[=JB7"Y"3'Z(7'%"+O=SVS:H;&[-!?1=L.*>SD M9[1F[9HY0W7>H7'8=W+I_^;L&8RM3?,W%^]:K4Y,PP&G/G\7H&C5_69FYAM>D*U?7L'8&9Y*A5]AP#.V[5(9< ML^*T=J&@F=$[33XT(FS?U)!LH3;KT!A08^`>9/,D:IBJ5R`-,2R(T[]^^1F' M7_MB`5=!&!F@#0"@\H%Q6D'UV=VG7X#G.?L&:JU+1NIR30S>6>1I#%` M$EOXF"V&2X.7D'\P[O#OW\LXL_#4U/L47*F%M+`@"F`:T(O/T_L&;1==#N M:/01Y2!!A9^N\.;LII.RB.5U.A;E5\DB@(A)8_7G8U%S`V.`+\F^FR68_95W M6QV+MB:J)3G"Q4=),- M%4F;`#Q+<`1P<<^/_-^[,[*"*2!J6'17+I9)84%>!G`*BI:T)TSH%8D?WIV_ M.\M3LKID68;QC>`C>\YO8-D]Q6I4/H\:E3UKHH;E?-2P,%2R&IYO/#QM-D`- MT%\\0.W&7`W1OXT:HKT3N(;EWT<-2[LJ5Z/S'QZ=0V.KAN<_1PT/VQ=7(_3M MJ!%JM>*VX'P>MXHLXRJHL7)/<6YU+6W`.;!B73:LN$CP66H#RZ=/+@+#\&7L M[J"-R^IX'/+]Q_U8UZ`1,,E2)9V].-,@?2W@R-/WLR!8EJX<$&?IYI=]GT[U M\Z]5$G[Z&*PIZU8'XIZ#1]"XN_>I/]U/(`1P1:GY`C(YZEN[&%H#S@EWP^`5 MQF5)"=$"&.T-49\O\B*3^0J0?1.6UZG)OV-0"!<4-:]1/>)D"7"V?HR#TCWW M1PZ7"^YB]0QO&)OB"EQ+20-Z]9;PW\/T)7@30R`UBI&5;N\F/0:0%G4(EC`+ M]CW$HM9&**^N"+83VKSH9X(N1@">T<@`"VN4Q=7W7'V3V$(62N2Z&AB/=OXWAWCU@RGH5%Z6^*1`IZ2 MZFIT36T771B-S-`I:15:8@XG'>Y%F+O MJ6_Q_1@S#**:"CJXRE1@.WD9TMS"5?&KK7G3T\/*)JY44NT%T6.'!U3J*W?!A M5LMQM:)B1YA4RR>Y6F2Q&WPRMVMJQ-QTC/8-4S01&CJL8V4QPL<"XCDQ?D-" MJ(G*37&2' M+-34=-<3E9.=Y0V6H>K;VCU1ZC]K991AUNE7!*C MB;3*0L432ZZ&ACI!="B37(T,=8*'\7B4XRJFSV?P^0PNY3.8"^F4X=%)3,A% M9)H5,!&[:0G8"MZZX?4PXTE/R>Q5_C^3YF8;4U32G+CJQC[+NW70S`2MFVCT M1H>\"%(8,@AN;VL-U03**QCG1"L6..5D>]NPLHHFR95L6KL2(>KS>L4F'^6& M'%*7":$'Y02JAR7`A9Q/+\`TP950(_(,I/<0%9^M^*^XM-NCW_)2?`O,M($FLPVW#6%$VX54_PDQO8IZ!#V,K4#U6!9V,K>,YB&DEX@)-]DL?K4W-O(:1@@"'M*#G%:$D3HIKL7SH M^7W,K*(`D75<;O]L)`>I\96?`5[!$*1LQF"U-D(YB&,J!(DIB(.8WD*/%A!! M>DY0YRZ?220[^\P\=UX7^86H8'/J6ER13SX#7_+%*\`/T\I=)YO+J3J*12L] M(([G9U8;P_I5"A33;F.9#/0I>M^;$4!&N*%?L3[[0Z,:$=L&!%POU"?P+X\Q M\<`G0^_QB+3/;O>I"Y83W?4JV)W@$MF@KM?'[@2:#%Z.UK%7;"3-:UT:]DH:/@'69^]:L[>`+27EN\ MID74#1#US@D;^$N1O>Z7?=TOZ#1I)7 MQ*>VOW7)S*CI=]/2%1Z2,/C]/YLG\:2SY.;= MS97M=U73%:Z1#C^Y7[%3!JZ.T5WWBWOO1DO?S6?? M8NWW:/0)R7M_Y9P/!X^GW"^AWRL_J?-1Z/Z3KD/CRDX(/-Z[K^:*)%P&Z?PF M3KZFMV31&!#D3!2XWKJITY?D"80)"F'QHGQ]7K\DE-)'G*P@6?+%^J<4D%-[ MZU&9A!E$S*K5R=:09#K MZ^2J#%W3;*>M7?E46AYC"!-K;+X6M_=('&-)O!Z^G,+U6PB(--J^1$Y==1M7 M`HBH2D[T\0*LJF)44S8Q$.\WIMTHM$CHWBBTC6D"A3KF?@739547[&%:OI+' M6"6_CY%2"HME`/&F.A/1LV:0F!`E083?8`9B8E^R"J_(]C94WF)'`-^BO7>X M66L2]K-K-74=8^4%-;I:LR;Z!O@F+%+3Q[X/ISB(5>MLO!VINKIF5SO6M'F6 MO!'FDEY46U^[5L6_,"WN9\=JZKR`\FTW<;4BV0$L61]U+]<;7IX!#SK:L9Y' M#,@!&_$OT@J[^3)'VYA,FQM!7E57&,#N]8EJ^:@/9-%ZRWR)'M^S;0"[U]?M M>_(&LFB]\D:DP@!VKZ_;][3-'WH:9>6(55?XGF\2H@`L0 M+M'1Y'I>DDGX1PXQN`_P[R"C:DU].4"P)'Y?*U9%F#_**9\#KL=%W,_,(V9) M"$!4I/K1)P?H$T6;^-E/*`*8[`E"-2421>UNL,B MT=@7!%)ZJF\;399_HN^PBR]JQ*:37L8+DQFBU_'J^(5:(%%M#).I'T/F!30S M0[B12]?OKAP+9$$(J]L]F&]+F!&8T9>Y/-"\<\_U"S3'PI>O&[G^UMFQ4):. M%;O^>MK1`%<,D':[YN,%]B'RBDJ=ZQ>&C@5[S\RB;E>///_+2)[6\'ZW2TT> MMBO.MOX,#Q("MP"^(U;%RE]I>7]*KB=4ZSVW%5#AG]K;G33 M&M7S$7K>Y:E!=K/,A29.ETBNJ9%TU8C4@Z5*^FJ-J9ME\+JG1K9Q)R>IJ-M5 M?@>8LR^4[?DWW>[OCQ!.]=0FUQ^/T0.L2LYXOZ=E3E:(*GHN6:7F'"W6JP>T M8=S*KA<#UL:PTM<,?#GAKKCW*T%F/R_V0HY[:+E>F[\7G`V&LAV*I]V>>FK!.T:66[UR23HN.WQ^;RZZT%_^742AODBCX.B M7F5%SLT^.?>`EK#@NBA<>T#'S<-5)?QR!KY`YL3\7)5HDAU<74 M&E2(MX=J(:DFZ4OP,L&$2Z_`:R8X3.3ZG'*M3H9$N0%1\1;GC+ZO1],F>*`!&V5'5?%.FG M%^OJVZ\/?"3[-]3[#'DB&'!OZ'<=3LN9\4(=E/1PWW=3H0,CC'V6J`]B-ME5 M]:S9\3MT_OJN^VS89]QNLK#X9!D74KS3==^??(B0FR&P[@BUV%ZN%Q'H#A;; MV':])$!'S/AFJ.O7^KN!UJ[G]GMQTS6L1/:[Z_?G.Z"E%&UP_IKO.AB)S"TXA M@2L5J^Y&GL;UB5+:$Z6&7AGEL9KG)E.R7V[@"KS,<9+/YB\`_1T$N.?ZN\QQ MBBAM\S('0J@>WWIT'M"&>+J.87A(.,LN`-J__%YC-(2),2SE5)PMP!CX9/'0)!L:@/F76KI19\\FF/L'3 M)WB.+<&3D2Q7F^<[AP?AQ:T`39O>C9HWJ;1M<1_-BD.R$2=S_2Z;;0=D*_1NWHBS[7!L@][1"W:FH&_+SCC>]3QS MJ:FM+_],H@B6]-VB:8(7Y;/M!B)*-:'%XSE;`I]`13,0' M-Z0^`[R"(8/WOB3%OB?[_&N`H[2\S]CX._T\7Y+L[X"^`EX]5*][=>JP>XZ);X>4KV19K\K_QBE,&1Z6[*QE! MMF1L:"K)%;S!1;[@U^+::6."2LI27X(%+\MHIXE)&EOYC]'(!)U/`9KQ@*S_ M;HPZ+C9?,=1ZC"E?%>KLQ;IN4ZFXQ6DM5].N[_A&T!'1S"*Y^)^?RX=K2C6% MI1UIG<(81J_B!;SN+^#Z;0EQ^4)O03X/("WCGQ0''7@H=/'-G=F2F5W)_I)3 M"?\PK?T,Y2/0DSR;T^0JID4WY(PGB>"Q<',*K89+\$?2E^4G&FRZD\*N>EZ= M$#\%,,OI@E!#'*>W$A)_T'E/$`0YA29BEY:"!0 MI:=W$]M?`)S-BP)S`` MN*5Z$%%P_NUS97`:(0_GGS?7'7P8W>VV09%LU[6>O>@[W#?0D1#E_/]2N3=`>A73^TJA='T$YW<'Y MFZ4G^GWX*1/.7TH=Y*L->!W.]8I5F`(J+W^]O:?:N&^QN9_J;2B65>'IQN([]GXG/73:!I(+VZ'TVG M^!6**,30#+PWR2GBU%")!KU2<3B/1TMAGE_/3QTO`U)/=G:/[$"SV\JU3)VV M6MYF$8,>V7J).$F<=\]/$R`K4&#F]E02_E[&:*YRO`U7EK&;XH][S,+4=-0' M\O>N_+VK<=^[\BG;5B/I$SG-AX0&,*AZ)7(NRV,M"W#F/T=_KXE/XNST%3IH M;3XKT_ITV0ZYF<2.>$W\I]'E`NN7I%F>#=D"5Z!\:48M=XY1]9KZ<,O1`T1(N8+!#)&?8%AEEZ;L6MBR7;54YRXG MNR?`AGDE@EW(PE-(EG(WT:]TMKH=H!U*%Q`9>SXC?2;C8)?25)E`"Y/S[89"54JQ&5'UU(%AUJZ<'S/?T5SX@Z9:S9.8+#4MZ_YK?KC=%7=J!0[? MO;_72$MPY09.LWG!S4]@N7ER`"RAG__B M+*^+GN=ZX9LZSXH[Z:'M0.)]23+`BD])=1F0KC8_M+"YL6M8A]MB6\%SLDAR M]C.)N$?I M@:>;>7"-$RN&(U)"!73=!:F$EX3ZX:KS447%.;B/(W%\N_J$@%[@ZP%32I9/T"=`'1%MF;S%?NP^FQ=@NIZ<^X"@/Z0>AR=V+18**Z;HLI<-8 M/D=U>*>JC8Y+:0>0HE-J<(>4@C/*&D<4+4E/I`O$;1?-Y7PT_"%.RBWC73+C M<,G("A2.*2/8.#5R;CT/H()<3U5B9+:T",).FN7(C&AO0,N`(F;`4=B#-,$% MA3"&5<++%2"M(***5_HPO0A2&-($31CG6;W9B)0O1+R)QQ\F84@%`3UKDAB& M$(BN4W(ZN&)PRTQU\7Z_)4O(R#E'D;5,N0!M?%-I!Z#&?"B-HK M#E!6%ZI(+#7`1B6!2?1;GF8TMY&Q3;N.9LW*B>QD4*NR8LXH%JWT@+B"0]76 MR1C#I*DL/EMJS:'/WG=5]_*F]8X2JN?8:YK?BMO1W0N!1P58YDQSV\8\&B>S MC]!^R2OT]43G`/:&OB[@]'#Y*!P&-4H3PF0%(G`%MD7YPC@G$]R0+W3]^$QO MU>19S\LAI^XJZ$$_(26J`'X&84X8@I#4Q+@!\"'7E1S)30'*7.H$1SFQN`^T-9$6&I%17K_E8 M=50K;TFOWG3#3&U_C>!508&,9#S!*@^]\_RH(*B;8/+4B>.9OJ:58F(3%'"A ML"R']8#*@F1W29I>`/(G<(O(@D":E;\3)?HAFP.\_:^J[J"F%RT.BFER'[%@ MMC;R(@0@WRPLLREI=<8%9<<_><6D>3V\#UFO"<+@N):BMQR.X[0VP7$/2T!K M?U*1M]FR#$YK:VGR90&I1P0,(OL$5@#ES!M@VS][,_*(IAB_:ME.&QL,1F_L MZHB(]KGI6954OW30<:[#X_M/JQ-1%?S9/HBQ'6(N7IK MHB]HK3X=Y\MWRIAJ+2K4\6T>"Y+O7^B-ECTVN4GP94)S-7/R4TM`PQ%G-2NIVH1CF*0SFI^^"U]3%A'(A.[RW3;> MM2]%,8T*?B&R:Y>>37B003R_DW>O>\>U)8YK[_(]6;^;=_EZ7Z5WLU@&H"9[ MV+7J%GWA8EL+WN'"8#"!WNJ\[Z4SIS$LZEY1&JL MOO_'3:KC]S%2W3^&,TAT'[I='O"/.,F7-PFN^:1@84ZNCGQ_5W)INV.]1>5B MO?WG7R$Y\'`X7]^!%8@Y0$MV-KJN>D>**KUPNQA=PRU:YEE:`/J9NY=Y/6Q9 MP;GR"LYM6,$]""A'%%&30V;G9J"JC6%TE:5L;!&@<@L4=;=@;?\_#V)(%9M5 ML)BGY,B$V)J##F$L_O8_05'U4]N6ER MRHM\UQV0:BIP*X9RRL%H@.3HW!P65#N/1@.FBN+9BFZ;]>!Z9N(@Z)T?HN>F MQUS5'&@"QU)G7$_1[X.9P&WG>@Y_+W9KU4)=S^WO@YA`!ZZA^\\Q0-?5';!3 M=(\=,W`]1JC!I3#:1!Q-V*F:,ZFEUF\2JIU/*E:N:N"?"K?65FRI++4',8+7\`$9B\:WD[;X0.LEN M`&&^(*:WM7)"R'JGL=+"U48^Y?@]H^Y4@\E9,2AV.]T4,-^E/&@SQJM;ML2A M&-_Q)T3:@AD1YG^"B)'[P&EH[/TFW@Y0S#-TR[FIA([*P>2J/U,#8(HGG:OV M/O=@&)T%+T2#PWC>9'$^'BH^?=MXY.AQ36-VW(])$GV%<5Q7#,X"5/A82D^J M-<;=)/PCAP3[&XA@!N[(V1#MT\K2T3L-84*)WA36*`A-"]PKF@$WYT_ M&(V=-6V?\ABD157Z>Q#!D`I0[&]BOBW;7($;GR]..GE!*.I^`HQU*-0UG%"_7 MBGQH6E[=VN`NZ_22[*3%!&1-PPQ9\SL8J=:0IUFR`+C(<**1N#E<"FHU<'IX MIQ5'/$S",%_D12*9Q/-K'0:R;+U-LLBYU375;5V=39\]Y@3]J1N]#L8TLS-E+#J"PCG*(F3&:M>G4I/+52^ MX"`"BP#_SB9GOXFQ;"-I2WTW@59N7]:NO\].^:NZ(R>V2YS.0=:-&=,Z[Q:" M_+9$$1'1E55M'<)1[M3I%X-4*2%[*KB)K-)^!2I<0JR/O>%JK8H^^U75ZG2U M>H6\WWYT44@U:#HY@)T-.W;#3MGMY>SE?C7\9`6AN_=<>H1?)#=ONV?+5=G7 M,T"R94I9K\(6Q\\>1U9!,EYDNL;/+7>`+CX\\!O5@+GE"^B=X2AS\K@N]3J& MWQ14F7&>)CV"1[O82D5D:C2_=0I-BY-LC:7>-5V4#^BHB749G.$P*JUEK]WR/5QR'G7B(2O7'1HN!I5]9:4UU&U MZJ@O`"_ND@#1ZR%E@=H9!L4K"-845Z&U[J7/=T9C$^H*)>46$0+RXJJT0.MB MM39/.:]P0%M++3E5VR)KCX#LG>AA6G)GFTG#:GK*1@`#E;TZR'3CII,9V;$T M@>410U2\<$`.QQQE#WF6$O%.(\9MJ'4=2F/ET&W!YDD88E`>Y5^2HI0>@"O* M2T0JT0)ZQ4E5/$+>4B96PX!6J_E'W/<4J[0&BWT'HZ6A"7IK"GZ!V?QVL$`*HSR(JZ>["V5CHV.T;65N M>Y,Z-U\/:5HGK>>GJUJUI+K3Q$>:>UTWXW1AQI-UKE?GD<"PG^[D>I4>60"9 M*KGK+[;)`L0_Z5Q->.T@R]KT3%=S6569J*=IY/JK;!S7Q.A"#Y*8"#G0W3"# M]_@>>GPODS2["%*8WJ(5$1M6N7HI;?<@FR=131S+8=K>]I2=?KHN&V_1F,1Q M5?.I_HGO/I?L[!UF)5QU`;-6;A3Y_*6[6[@VN7+"G*YF<_Y4]DA[C4T>*JYJ M'!:?IZ8K&,H)@-W'O%L/.]=]7BIR9;0JO2I(ZOPXBN*7S_EK"O[(R1S7*YOT M7/^62M^W5!C!IDO"42%AF^0")FD(`0IIY75V719N>U=L"5MT;L8WV\L[8G^L M]H8F./XQ6)=R.*FVWX:I`;?=K;&J%Z]UP2VHFLYA;0SBTUU][6`JI%?A!F;4UMH)G, MQ]N9C-:64,Z7A\SVMCV]PG^SAJ\ZN1[C]4_5>/]/)SM=H#QMMQ=#RW4].X>K MG^UZ+IA(.L]$`FVP"9/8\G#>?RC0Y':8JE5S&AD_>8^J#"A"Q=79LFC*"+6+ M=&?+GJGB(WS/ZWSL"+$//'=3D20-8X$H&JE*=&B$FS+\D- M1`$*81!O!7):Y'71U_1"FL5.L]=-%'39SOZ8Q#"$0.1LXW0P$LXZ`)$1R#IH MYP-&>@-&FD,$0C?[84.C]'(=O;N-S#XK+MKOK=JCX\:8=Y6Q/$%<_T:+\'7> MH=&ZW\=KJ#/AX'&2P^E,;'6OD=EUB^CUC@F*[@/\.\@H=-?$_,S6SR#,R6I@ M4>7X$N","!M:>)9LK?UZ02^$Q@MRL/W>76NT2X_1DD1?X7J`IG0BO6@`P^O3 MRSE"-/1.YW5XU!2EP=>Y_4ZKZ3..YPP]JJS5YV]ZGQ,U;E`7K&VM^,* M=%$\OTCHN%A?)J@X)?,@O@\RBN[ZBGR2`C4%)5)]2&]$C$01WEZ`FJP"&%,F MN$GP*/`&P7>*)`V"OH+LM$H_[+&50=% M9#3IN=Z`\@:4D@%5VS[TKOEB"5!:3%Y5+J/7S]/G.4'\@KZTN$U;[A]BZ%'6 M7);DUR;)HH+S_08U4MZ]YZ?K"01C5)\\8Z4]Y6V(86OW:9%)WJ[P=H6D/MQ; M^(_&K/`JL5>)CZD2]PT=>,78JX/'`5#$'-U\UO/8D+6B`M M7TV=53,$_R3?NJ@?7S"`O-]=]WQFT6.0CW&`9H4PN5@?2(K)UP!7C[2E/X.4 M["'J<7Y;@K"H%$Y_:KQ;H!C6.#I!WICQQHPW9KPQHRE(T&PS-)\SLD'F24R6GI8I![2MO\C1HD*5\`A,U;U&WM@;H;I\5#IE MMR]K";+]3R M6"2HX*8GL,QQ.*>F/=?)W&4$K^:ZYQ7VBJ!7!#LI@IU$D%<%O2KH5<$V5?`Z MP`BB6?H(<.&<-YJ+O4^,2.%B-3>B(C*!E"/>YSQ[O^>H%4+!WO>JH5<-)7V$ M'%'L%4&O"'I%4$D1-)>!;%X=]`K548IR$$(B&.<97#7NL5^_A7%.F/R&[&B: M+91G58J0JJ8]P$1F\?H%P-F<)J:M``YFX$M.2]M7V6ZI8HJOREA>[?9JMU>[ MO=HMS/I4$E"C4&.G-0$"S.C_?P++!-/W!!S.DG7,:-C[ M<*(7NUG-;:!=(;=3HJ=7SMU1SKT"NG^T";;]&*T41?U21OB,1A7W"J-7&'4K MC&[ERCJF-M97@O<^Y"V:)GA1,-+%NOJC0H$$I=%L4#I/2F'VZJ57+[UZ:8F2 M(.F^5!2P7N7T*J=7.=M4SIL`XI^#.&_B71*XG*2J);'DD-:E;Y0.,] M""A.T0-ZHNDUF!K\*/J2(+SYSXL@A7*)E%J&MD7U-*,^>\73*YY>\?2*IUG% ML]?1X/53KY]Z_;3]16W2&KP$;PYG6/9Y"_H`'>'CS^P>EJQ`_&(WIXM7([T: M>0P1+K'SO!;IM4CIYX1Y4M!KAUX[]-IAFW;X8Y)$7V$<$QOKELR+9I`@5EIB M7E]L.66E\!)HD&IC6+M*D9:I.(C7.[W>>8S#H=,.]IJHUT0E-5%5V>EU4Z^; M>MVTOV[J0^U5/`4BF($[N`('J$T6-"'\S^(+TO?T4`KD0NQ]AK16?[5$2[=% M>Q4^-;"/@LHC`X*^7L_V>K;7L[V>+:-G*TJET:C77*.DGU+@JUAY$\6;*&TF MR@O`B[LD0.20*Q^LGLPP*/[DL/?<%HW5ZX'#O*;*L`34>+W%'%`;P`2VV]D% MMN%A.Z\XVG1PL15'128>C?;H-9_3T'S,X,*4BW;8Z]:H@Y=)FMV#;)X0*VL% MTJSX\0JD(88%Q4:?]I(GKOW0D^_ORFL/?9)RMPA-XO@AFP/<_$F482S5V2OP M(U3@C23JJO"R'2>"5\3MT*.X3DF%`\GKX5X/MTH/MTCE7"Q@)8I1=)D@6O$- MD$9`;P)O'[U3@D*!2J0VAHE37?$[]%BF>WJVUT>]/BI_.'22)UXM]6JIM%JJ M)LF];NIU4Z^;MI;LSU]3\$=._GF]*J/E/A+N%1<[%)=CTKFW#40/`+":VT"[ M\&$&9GNO`=ET>'$U(,Y']\J.5W:L4G8,X2(0Z7:8FZV*X//I%OM2T!)M:TPYUHR69EA1GJ@'T MDE@BSXW?$2^'MX^_/"]]\LBD\@0_[0T/#GN$<4>X'I^?]CX]]$7]P!.H8 M*6,1$'!NOSB6C`>0F+FAQ0HX.AV_[AT?]P[>3PY].CMZ>'`[_:^86J[7T MYHN`O'%^@,R'[_I`<4S&!^,#PZQ_D@?!%>1>KBA?DY'ODS%2*3)FBLE'YA[$ M3)6VED`1($HW<#OAE(->;V15S#N;B<1`GEI>" M$TH)7]LVTC@5:8\*M"[SRLD@H5P:>W86Y2284D[C\4>F@G*J**V<3@4K64Z% M*4@S-&@"*NG\?4V M'8.X)AQ@OL&%<$+4DG+WD@=>L+X&SG*IY?6(YY[VK#E2'1(M7#;SN*>U'1X. M29\DY.9/8$4B7L1@]G&0YY!G'D*5?<=_UK\=ZCNAKPEOX#DFCG/8"%<2ZD@> M-*#,--M.%[]-P-@+1@^@K':EN]F5QZ'6]:A_+Y36Y-RG2L4>A6B-@>#/B@1V M\*`5(RDC@FT3=QG'1A-^*>%[V**YY(SZV`Z0AP5C@>HP?!&&]Q3JTV#!`@^* MIC:@FGH'JF^;H$K>;"CV0X?R;I2OH8^Z9",_8)*#!8^L',YB-CM^[ZKAEV91 M1,Q()$17N]AGE&P!)"`K3NC@W`WG.56+*U\\J6ON>I(Y03FU M_2HK7ZC$H8V$2EC;-68^UL#G0@7J80&]H#.,&]W3M::JYSXOE6'WD@]Y+]&L M^IH7,<5UWE';.QX"*/^%\%TF5?298]ZFU4AU;E;$AX<%Q`W&_R(1ZP[MVFA? M4LFANE;W3.IOJ!ZZVZGM:`[S:":,"'"*/N8.R_I?+IOC_S%;"8G]ML;?;`4^ M=GR/"E]KQ%(/R^(FH`N'O0CL*^K)WZD?&G5IS2;:SL$.\'$>8&1&-#=RRRB^ MU#(Z8!OT^C%.,:'/S7ON%@9V6-_F88VC*<"LZVDWP/)7(=PGS_=A>'2-LPIS M#\8Q+QN7U61IQ_M='N^$NZZH,_XD$M!Y0&T/F#"YO!&4`UQW*U1L-)=,)S5U M@'H<[?B_S^./S`ERUPX0\2>I@`[_VOCC0/>6!0OA&@&5"Z8G"K8=]=6YV MW`LA.V0!>+KT(%@R)"1T_99")-:[P:[*T`U\(KQG*%]>`OQ%CNS\48H?VV''G%CNW)Z2%B3N4W-"''GKZ MV5X).7JDGH]E"!7K`_59-O(Z6]_2_\'+Z,4:1>-@$!=+W\V2M_$.AU<68O>9 M0MPQ40)7"QKU"0@GJ29]>.JC+N98<[HF6IWDW9KH`M+"OIMA["$K_&P5_DCA^ESLR#\"/E&$,L7M*O*@[7ZW-PEVIRO$ M/$VGRW3`)]3"]+),#T)5M!;94$5[6^:F5XF;=NY6W=W22(,9%ABYKM:*^L4= M6HU([0Y2>34A)&7\-WNX'>3U:Y@M"$H)/0?=;3E;%R)1HRVO[80JQL=%YF&XJBI3%U':^I&+OK%0.N55POTX5XW+H)IV0C5>=[ M-7RO$%:MUL)5)+/[1K4H;->R[;6*P2(>LU4HG05\=\I22^1SVL$LQ%LW/G3D M10QF'7C5P[VGM<4`"N3Q.`R&A2L:E,0X,/2X\/X3Z,1\TS^/[,F9V M%RA$7S>%1<.83!P^:X%ZM!*++`W3=[Y2_T,?\<#390H-8]Q!NWQV_-!E[I44 MR\O[!VP[PZ"\?F_(QNX?A3AM6D72TBYE(HN@,`+2B"&NY`A/QZO@I->G[JOW.)UW>)NNCO`+H0-4R!'EF`[O"L MC.=HB8OP_HH"1'P7FCMRV[$L!`U-;E&OO0.R,9#;]V-6JJ7KDMNA+@0'[1LZ MNYIY#PZ`6R;TULEL5TPEY"O3V2$OQ/M*]W)V2.]C%+6Y/:]:1*\*C1WA8A`O MM[NO`Q=>XQ\\%9NK&(=#;*2KJ=!0E=7@]*+$JK*3@A0Z+M*XJQW36P3JT66 M7FXQ8'Z@4E[]C%?]TB_<+5&I$/)46!(?L/B'[U^B@G$M1DTU!/^MF2:VRT-> M``R^J8O+KMLXK.J4T24/+U.DY&Z/:IJ8A.E3/V-37Y?+"B)_ M]4@EZ2F1_O4B^<5+3"II8)#%OU^D1?Y2E$HZI$3Z5S\C-^7'UZ1H!4Y[(\<) MEZ&>@\]O:J?M:BB+D)T8<^)*Y;4X]4\:"&>[Z6E.15,`2!1CS$U%^E"%>GO8C< M`_;;S/T2>I(5-J!!N\]0*;5AY,Z\D6F14+`#IRK;9IG>\5;!JCC?5[;(#4X6 M0"F=<*K+=(MM2ZQ@SQ=X*9`[$6,<3_)LT=I(C9D*_6#;FL?([N8\S#)9"@Z4 M<>4(Y'HP8<$%&T31KMC89 ME-QU-RJY-6\4JV(85BU[B[IWE[,9+IM$,D[;F,*U8Z4O,'O6R MS#F3#1OI?=BS7/EBS=B%OK5)R.A82>Q@0)4<[0<"3X/\:!!4S`77;,J@34Z; MV*![5/=Q?PJ5G3Q!IC7\]1_95LLK4;7)W&P)G_9,G!%6H_E3G> MBOIQ-S2_KU:;WIC#-]#-NF(NDZ`\GGNZOE8J+&E0+7E:!;0W"Q9Z1T\V3+B7 M8B[ILFC2[KQM,BU:9ACO6I@(Z)Y*IA?$S/#@FS%SF/>((J`ZTOM7W63A^1@> M#+-?R.?U1EQ[[/T:2SS+XBOER2UJK&ZM65J4Z646[15L&-+>IM,2/HQ[@V,"[G2 M)PE/F+/@PA?SLA!T58(V&3EFRG-#ZL?[&/22NP04PS1[MF_@XQJ'/E-Z/]8M M-"8.5NY07\J5B,JR@&7%_&V"\@&DM5'UR9/8JKJ1UB[5T]W* MT?+AZ+!H^/33D8'".YZ3,&$66OR/%RQ*`K-8:V"8L=C"O[ZH5O88,K.-V'_6 M,W>U[KD+!7+E58UPPZV"Y/W?%Y#(],^?A9`[*N%L'1FHSV4KZ]>^F%.+NL#- M;-G^+37@TO+/I'0>U?Z![")IW:?A/5<>SE?(VZH&I7"\4>D7;JD(=8\O5SCJDH/%NF]IL3X-KYK25->G:5COJLP/P6-;=A\06:LL& MM&VJ/?&.'[:D\G/1L'Q*F]3^Q!T:L+F0V#4OF1S`Q0````(`$!J142%N*BX\Y(``,S="``1`!@```````$```"D@0````!M M>6=N+3(P,3,Q,C,Q+GAM;%54!0`#6(#R4G5X"P`!!"4.```$.0$``%!+`0(> M`Q0````(`$!J141SQ%#MHQ$``-ON```5`!@```````$```"D@3Z3``!M>6=N M+3(P,3,Q,C,Q7V-A;"YX;6Q55`4``UB`\E)U>`L``00E#@``!#D!``!02P$" M'@,4````"`!`:D5$S#HKTY&UL550%``-8@/)2=7@+``$$)0X```0Y`0``4$L! M`AX#%`````@`0&I%1%(?:#D;4P``_J@$`!4`&````````0```*2!%M(``&UY M9VXM,C`Q,S$R,S%?;&%B+GAM;%54!0`#6(#R4G5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`$!J143Q;[;B8B\```P1!``5`!@```````$```"D@8`E`0!M M>6=N+3(P,3,Q,C,Q7W!R92YX;6Q55`4``UB`\E)U>`L``00E#@``!#D!``!0 M2P$"'@,4````"`!`:D5$$SFC':0.``"?D0``$0`8```````!````I($Q50$` M;7EG;BTR,#$S,3(S,2YX`L``00E#@``!#D!``!02P4& 2``````8`!@`:`@``(&0!```` ` end XML 28 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule of Stock Repurchases (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Stockholders Equity [Line Items]

Shares purchased and retired 3,185 1,231 6,991 3,067

Common stock and additional paid-in-capital reductions $ 25,096 $ 9,372 $ 55,036 $ 23,122

Charges to retained earnings $ 52,713 $ 24,311 $ 125,088 $ 56,760

X

- Definition

Amount Charged To Retained Earnings As A Result Of Stock Repurchases.

+ References

No definition available.

+ Details

Name: mygn_AmountChargedToRetainedEarningsAsResultOfStockRepurchases

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount Of Reduction In Common Stock As A Result Of Stock Repurchases

+ References

No definition available.

+ Details

Name: mygn_AmountOfReductionInCommonStockAsResultOfStockRepurchases

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: mygn_StockholdersEquityLineItems

Namespace Prefix: mygn_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of shares that have been repurchased and retired during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30

-Article 5

+ Details

Name: us-gaap_StockRepurchasedAndRetiredDuringPeriodShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 29 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8

Goodwill and Other Intangible Assets - Additional Information (Detail) (USD $)
3 Months Ended 6 Months Ended

Dec. 31, 2013

Jun. 30, 2013

Dec. 31, 2013

Rules-Based Medicine, Inc

Dec. 31, 2013

Rules-Based Medicine, Inc

Acquired Finite-Lived Intangible Assets [Line Items]

Goodwill Acquired $ 56,850,000 $ 56,850,000 $ 56,850,000 $ 56,850,000

Impairment of goodwill $ 0 $ 0

X

- Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13854-109267

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 30 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified

Dec. 31, 2013

Jun. 30, 2013

Current assets:

Cash and cash equivalents $ 71,599 $ 104,073

Marketable investment securities 281,996 268,243

Prepaid expenses 4,237 5,963

Trade accounts receivable, less allowance for doubtful accounts of $9,200 at Dec. 31, 2013 and $7,500 at Jun. 30, 2013 84,137 94,333

Deferred taxes 9,074 8,007

Other receivables 3,463 3,373

Total current assets 454,506 483,992

Equipment and leasehold improvements:

Equipment 73,570 65,903

Leasehold improvements 18,390 18,294

Gross equipment and leasehold improvements 91,960 84,197

Less accumulated depreciation 60,647 56,595

Net equipment and leasehold improvements 31,313 27,602

Long-term marketable investment securities 135,187 158,748

Long-term deferred taxes 29,983 28,632

Note receivable 23,000 21,667

Other assets 13,000 13,000

Intangibles, net 12,842 13,330

Goodwill 56,850 56,850

Total assets 756,681 803,821

Current liabilities:

Accounts payable 17,596 18,132

Accrued liabilities 45,844 44,334

Deferred revenue 3,952 2,043

Total current liabilities 67,392 64,509

Unrecognized tax benefits 13,318 10,718

Total liabilities 80,710 75,227

Stockholders' equity:

Preferred stock, $0.01 par value, authorized 5,000 shares, issued and outstanding no shares

Common stock, $0.01 par value, authorized 150,000 shares at Dec. 31, 2013 and Jun. 30, 2013, issued and outstanding 73,974 at Dec. 31, 2013 and 80,577 at Jun. 30, 2013 740 806

Additional paid-in capital 663,122 697,346

Accumulated other comprehensive income (loss) 506 (424)

Retained earnings 11,603 30,866

Total stockholders' equity 675,971 728,594

Total liabilities and stockholders' equity $ 756,681 $ 803,821

X

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 19

-Subparagraph a

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19(a))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3-4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Subparagraph a(1)

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 20

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.20)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.14)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 14

-Article 5

+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14A

-URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669686-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 14

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e681-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.30(a)(1))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.18)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 12

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 18

-Article 5

+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.9)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 9

-Article 5

+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.A.4(a).Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 8

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section A

+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31917-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31931-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31928-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31958-109318

+ Details

Name: us-gaap_DeferredTaxAssetsNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after allocation of valuation allowances of noncurrent deferred tax asset attributable to deductible temporary differences and carryforwards. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31917-109318

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31931-109318

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31928-109318

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 45

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31958-109318

+ Details

Name: us-gaap_DeferredTaxAssetsNetNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

+ Details

Name: us-gaap_LeaseholdImprovementsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.19-26)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.32)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 25

-Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 32

-Article 5

+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.21)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 21

-Article 5

+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 4

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6812-107765

+ Details

Name: us-gaap_MachineryAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26626-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 2

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (f)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

+ Details

Name: us-gaap_MarketableSecuritiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Total debt and equity financial instruments including: (1) securities held-to-maturity and (2) securities available-for-sale that will be held for the long-term.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.12)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26626-111562

+ Details

Name: us-gaap_MarketableSecuritiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Net amount of the investment in a contractual right to receive money on demand or on fixed or determinable dates that is recognized as an asset in the creditor's statement of financial position. Examples include, but are not limited to, credit card receivables, notes receivable and receivables relating to lessor's rights to payments from leases other than operating leases that have been recorded as assets. Excludes trade accounts receivable with contractual maturity of one year or less and arose from the sale of goods or services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.3)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Article 5

+ Details

Name: us-gaap_NotesReceivableNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

The aggregate carrying amounts, as of the balance sheet date, of assets not separately disclosed in the balance sheet.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.17)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 17

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 10

-Article 7

+ Details

Name: us-gaap_OtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Carrying amounts due as of the balance sheet date from parties or arising from transactions not otherwise specified in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.8)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 8

-Article 5

+ Details

Name: us-gaap_OtherReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Current Assets

-URI http://asc.fasb.org/extlink&oid=6509628

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (g)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6787-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 340

-SubTopic 10

-Section 05

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6386993&loc=d3e5879-108316

+ Details

Name: us-gaap_PrepaidExpenseCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.13)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 13

-Subparagraph a

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 8

-Article 7

+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The cumulative amount of the reporting entity's undistributed earnings or deficit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 31

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.31(a)(3))

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Unrecognized Tax Benefit

-URI http://asc.fasb.org/extlink&oid=6527854

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 31 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8

Subsequent Event - Additional Information (Detail) (Subsequent Event, Option Agreement, Crescendo, USD $)
In Millions, unless otherwise specified
0 Months Ended

Feb. 02, 2014

Subsequent Event | Option Agreement | Crescendo

Subsequent Event [Line Items]

Cash paid for business acquisition $ 270

X

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8

Basis of Presentation
6 Months Ended

Dec. 31, 2013

Basis of Presentation

(1) Basis of Presentation

The accompanying condensed consolidated financial statements have been prepared by Myriad Genetics, Inc. (the “Company”) in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and pursuant to the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. In the opinion of management, the accompanying financial statements contain all adjustments (consisting of normal and recurring accruals) necessary to present fairly all financial statements in accordance with GAAP. The condensed consolidated financial statements herein should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2013, included in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2013. Operating results for the three and six months ended December 31, 2013 may not necessarily be indicative of results to be expected for any other interim period or for the full year.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Certain reclassifications have been made to prior period amounts to conform to the current period presentation.

X

- Definition

The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BasisOfAccounting

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8

Segment and Related Information - Additional Information (Detail)
6 Months Ended

Dec. 31, 2013

Segment

Segment Reporting Information [Line Items]

Number of reportable segment 3

X

- Definition

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

+ References

No definition available.

+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8

Earnings Per Share (Tables)
6 Months Ended

Dec. 31, 2013

Reconciliation of Denominators of Basic and Diluted Earnings Per Share Computations

The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Denominator:


Weighted-average shares outstanding used to compute basic earnings per share
 75,070 81,692 77,323 81,632

Effect of dilutive stock options
 1,755 2,548 1,989 2,459









Weighted-average shares outstanding and dilutive securities used to compute dilutive earnings per share
 76,825 84,240 79,312 84,091









Schedule of Anti-Dilutive Options Excluded from EPS Computation

These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Anti-dilutive options excluded from EPS computation
 8,500 5,605 7,136 4,585

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8

Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense (Detail) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Segment Reporting Information [Line Items]

Revenue $ 204,060 $ 149,140 $ 406,527 $ 282,577

Depreciation and amortization 2,438 2,211 4,811 4,455

Segment operating income (loss) 82,999 55,586 165,903 104,168

Research

Segment Reporting Information [Line Items]

Depreciation and amortization 482 578 992 1,210

Segment operating income (loss) (16,286) (16,334) (32,967) (30,765)

Molecular Diagnostics

Segment Reporting Information [Line Items]

Revenue 196,158 140,651 389,144 267,919

Depreciation and amortization 1,467 1,232 2,830 2,424

Segment operating income (loss) 98,233 72,970 195,981 138,030

Companion Diagnostics

Segment Reporting Information [Line Items]

Revenue 7,902 8,489 17,383 14,658

Depreciation and amortization 489 401 989 821

Segment operating income (loss) $ 1,052 $ (1,050) $ 2,889 $ (3,097)

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 36 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8

Fair Value Measurements (Tables)
6 Months Ended

Dec. 31, 2013

Schedule of Fair Value of Financial Assets

The following table sets forth the fair value of the financial assets that the Company re-measured on a regular basis:

(In thousands) Level 1 Level 2 Level 3 Total

at December 31, 2013:


Money market funds (a)
 $ 9,351 $ — $ — $ 9,351

Corporate bonds and notes
 — 89,318 — 89,318

Municipal bonds
 — 270,554 — 270,554

Federal agency issues
 — 65,635 — 65,635









Total
 $ 9,351 $ 425,507 $ — $ 434,858









(In thousands) Level 1 Level 2 Level 3 Total

at June 30, 2013:


Money market funds (a)
 $ 12,691 $ — $ — $ 12,691

Corporate bonds and notes
 — 71,624 — 71,624

Municipal bonds
 — 302,055 — 302,055

Federal agency issues
 — 104,282 — 104,282









Total
 $ 12,691 $ 477,961 $ — $ 490,652









(a) Money market funds are primarily comprised of exchange traded funds and accrued interest

X

- Definition

Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring and/or nonrecurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19190-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258

+ Details

Name: us-gaap_FairValueAssetsMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 38 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8

Marketable Investment Securities
6 Months Ended

Dec. 31, 2013

Marketable Investment Securities

(2) Marketable Investment Securities

The Company has classified its marketable investment securities as available-for-sale securities. These securities are carried at estimated fair value with unrealized holding gains and losses, net of the related tax effect, included in accumulated other comprehensive loss in stockholders’ equity until realized. Gains and losses on investment security transactions are reported on the specific-identification method. Dividend and interest income are recognized when earned. The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at December 31, 2013 and June 30, 2013 were as follows:

(In thousands) Amortized
cost Gross
unrealized
holding
gains Gross
unrealized
holding
losses Estimated
fair value

At December 31, 2013:


Cash and cash equivalents:


Cash
 $ 53,924 $ — $ — $ 53,924

Cash equivalents
 17,675 — — 17,675







Total cash and cash equivalents
 71,599 — — 71,599







Available-for-sale securities:


Corporate bonds and notes
 84,259 60 (1 ) 84,318

Municipal bonds
 268,341 300 (99 ) 268,542

Federal agency issues
 64,293 30 — 64,323







Total available-for-sale securities
 416,893 390 (100 ) 417,183







Total cash, cash equivalents and available-for-sale securities
 $ 488,492 $ 390 $ (100 ) $ 488,782







(In thousands) Amortized
cost Gross
unrealized
holding
gains Gross
unrealized
holding
losses Estimated
fair value

At June 30, 2013:


Cash and cash equivalents:


Cash
 $ 40,412 $ — $ — $ 40,412

Cash equivalents
 63,653 8 — 63,661







Total cash and cash equivalents
 104,065 8 — 104,073







Available-for-sale securities:


Corporate bonds and notes
 71,626 13 (15 ) 71,624

Municipal bonds
 251,513 109 (537 ) 251,085

Federal agency issues
 104,293 24 (35 ) 104,282







Total available-for-sale securities
 427,432 146 (587 ) 426,991







Total cash, cash equivalents and available-for-sale securities
 $ 531,497 $ 154 $ (587 ) $ 531,064







Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at December 31, 2013:

(In thousands) Amortized
cost Estimated
fair value

Cash
 $ 53,924 $ 53,924

Cash equivalents
 17,675 17,675

Available-for-sale:


Due within one year
 281,882 281,996

Due after one year through five years
 135,011 135,187

Due after five years
 — —





 $ 488,492 $ 488,782





X

- Definition

The entire disclosure for investments in certain debt and equity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-Glossary Debt Security

-URI http://asc.fasb.org/extlink&oid=6509901

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27405-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-Glossary Equity Security

-URI http://asc.fasb.org/extlink&oid=6511694

+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)
In Thousands, except Per Share data, unless otherwise specified

Dec. 31, 2013

Jun. 30, 2013

Allowance for doubtful accounts $ 9,200 $ 7,500

Preferred stock, par value $ 0.01 $ 0.01

Preferred stock, authorized 5,000 5,000

Preferred stock, issued

Preferred stock, outstanding

Common stock, par value $ 0.01 $ 0.01

Common stock, authorized 150,000 150,000

Common stock, issued 73,974 80,577

Common stock, outstanding 73,974 80,577

X

- Definition

A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=28368275&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Face amount or stated value per share of common stock.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of common shares permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition

The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.28)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29

-Article 5

+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 40 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8

Commitments and Contingencies
6 Months Ended

Dec. 31, 2013

Commitments and Contingencies

(12) Commitments and Contingencies

The Company is subject to various claims and legal proceedings covering matters that arise in the ordinary course of its business activities. As of December 31, 2013, the management of the Company believes any liability that may ultimately result from the resolution of these matters will not have a material adverse effect on the Company’s consolidated financial position, operating results, or cash flows.

X

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8

Document and Entity Information
6 Months Ended

Dec. 31, 2013

Jan. 31, 2014

Document Information [Line Items]

Document Type 10-Q

Amendment Flag false

Document Period End Date Dec. 31, 2013

Document Fiscal Year Focus 2014

Document Fiscal Period Focus Q2

Trading Symbol MYGN

Entity Registrant Name MYRIAD GENETICS INC

Entity Central Index Key 0000899923

Current Fiscal Year End Date --06-30

Entity Filer Category Large Accelerated Filer

Entity Common Stock, Shares Outstanding 72,974,449

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

XML 42 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8

Subsequent Event
6 Months Ended

Dec. 31, 2013

Subsequent Event

(13) Subsequent Event

On February 2, 2014, the Company amended and restated the Option Agreement with Crescendo by entering into an amended definitive agreement and plan of merger (the “Merger Agreement”) to purchase Crescendo for $270 million in cash, subject to adjustments for Crescendo’s cash, indebtedness, working capital and other amounts to be determined in accordance with the Merger Agreement. The Company plans to utilize its existing cash and marketable investment securities to pay the purchase price to acquire Crescendo. The Company currently anticipates that the merger will be completed by the end of fiscal year 2014, subject to regulatory clearance and the satisfaction of customary closing conditions and the other terms and conditions of the Merger Agreement.

X

- Definition

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

+ References

No definition available.

+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Statements of Income and Comprehensive Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Molecular diagnostic testing $ 196,158 $ 140,651 $ 389,144 $ 267,919

Companion diagnostic services 7,902 8,489 17,383 14,658

Total revenue 204,060 149,140 406,527 282,577

Costs and expenses:

Cost of molecular diagnostic testing 22,755 15,566 44,194 29,498

Cost of companion diagnostic services 3,376 4,318 7,418 7,713

Research and development expense 17,090 14,107 33,893 25,507

Selling, general, and administrative expense 77,840 59,563 155,119 115,691

Total costs and expenses 121,061 93,554 240,624 178,409

Operating income 82,999 55,586 165,903 104,168

Other income (expense):

Interest income 1,330 1,385 2,691 2,753

Other (185) 14 (623) (114)

Total other income 1,145 1,399 2,068 2,639

Income before income taxes 84,144 56,985 167,971 106,807

Income tax provision 33,784 21,949 62,146 41,635

Net income 50,360 35,036 105,825 65,172

Earnings per share:

Basic $ 0.67 $ 0.43 $ 1.37 $ 0.80

Diluted $ 0.66 $ 0.42 $ 1.33 $ 0.78

Weighted average shares outstanding

Basic 75,070 81,692 77,323 81,632

Diluted 76,825 84,240 79,312 84,091

Net income 50,360 35,036 105,825 65,172

Comprehensive income:

Unrealized gain (loss) on available-for-sale securities, net of tax 253 (70) 538 13

Change in foreign currency translation adjustment, net of tax (112) (280) 392 (72)

Comprehensive income $ 50,501 $ 34,686 $ 106,755 $ 65,113

X

- Definition

Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=16317811

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate cost of goods produced and sold and services rendered during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 2

-Article 5

+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Total costs of sales and operating expenses for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_EarningsPerShareBasicAndDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 18

-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 20

-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition

Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h)(1)(i))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Income Tax Expense (or Benefit)

-URI http://asc.fasb.org/extlink&oid=6515339

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7(b))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_InvestmentIncomeInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.7)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 7

-Article 5

+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_OperatingCostsAndExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The net result for the period of deducting operating expenses from operating revenues.

+ References

No definition available.

+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 30

-Section 45

-Paragraph 20

-Subparagraph (b,c)

-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 10A

-Subparagraph (e)

-URI http://asc.fasb.org/extlink&oid=28358780&loc=SL7669646-108580

+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Other costs incurred during the reporting period related to other revenue generating activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.2)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 2

-Article 5

+ Details

Name: us-gaap_OtherCostOfOperatingRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 9

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.9)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Revenues from the sale of other goods or rendering of other services, not elsewhere specified in the taxonomy; net of (reduced by) sales adjustments, returns, allowances, and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(a),(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_OtherSalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 985

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 730

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1(d))

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name: us-gaap_SalesRevenueServicesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.4)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 4

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 330

-SubTopic 10

-Section 30

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6386349&loc=d3e3636-108311

+ Details

Name: us-gaap_SellingGeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition

Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Weighted-Average Number of Common Shares Outstanding

-URI http://asc.fasb.org/extlink&oid=6528421

+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 44 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8

Fair Value Measurements
6 Months Ended

Dec. 31, 2013

Fair Value Measurements

(7) Fair Value Measurements

The fair value of the Company’s financial instruments reflects the amounts that the Company estimates it will receive in connection with the sale of an asset or pay in connection with the transfer of a liability in an orderly transaction between market participants at the measurement date (exit price). The fair value hierarchy prioritizes the use of inputs used in valuation techniques into the following three levels:

Level 1 —
quoted prices in active markets for identical assets and liabilities.

Level 2 —
observable inputs other than quoted prices in active markets for identical assets and liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Some of the Company’s marketable securities primarily utilize broker quotes in a non-active market for valuation of these securities.

Level 3 —
unobservable inputs.

The substantial majority of the Company’s financial instruments are valued using quoted prices in active markets or based on other observable inputs. For Level 2 securities, the Company uses a third party pricing service which provides documentation on an ongoing basis that includes, among other things, pricing information with respect to reference data, methodology, inputs summarized by asset class, pricing application and corroborative information. The Company reviews, tests and validates this information. The following table sets forth the fair value of the financial assets that the Company re-measured on a regular basis:

(In thousands) Level 1 Level 2 Level 3 Total

at December 31, 2013:


Money market funds (a)
 $ 9,351 $ — $ — $ 9,351

Corporate bonds and notes
 — 89,318 — 89,318

Municipal bonds
 — 270,554 — 270,554

Federal agency issues
 — 65,635 — 65,635









Total
 $ 9,351 $ 425,507 $ — $ 434,858









(In thousands) Level 1 Level 2 Level 3 Total

at June 30, 2013:


Money market funds (a)
 $ 12,691 $ — $ — $ 12,691

Corporate bonds and notes
 — 71,624 — 71,624

Municipal bonds
 — 302,055 — 302,055

Federal agency issues
 — 104,282 — 104,282









Total
 $ 12,691 $ 477,961 $ — $ 490,652









(a) Money market funds are primarily comprised of exchange traded funds and accrued interest

X

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 16

-URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13504-108611

+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8

Segment and Related Information
6 Months Ended

Dec. 31, 2013

Segment and Related Information

(6) Segment and Related Information

The Company’s business units have been aggregated into three reportable segments: (i) research, (ii) molecular diagnostics and (iii) companion diagnostics. The research segment is focused on the discovery of genes, biomarkers and proteins related to major common diseases and includes corporate services such as finance, human resources, legal, and information technology. The molecular diagnostics segment provides testing that is designed to assess an individual’s risk for developing disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression and disease recurrence. The companion diagnostics segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries. The Company evaluates segment performance based on results from operations before interest income and expense and other income and expense.

Segment revenue and operating income (loss) were as follows during the periods presented:

(In thousands) Research Molecular
diagnostics Companion
diagnostics Total

Three months ended December 31, 2013:


Revenue
 $ — $ 196,158 $ 7,902 $ 204,060

Depreciation and amortization
 482 1,467 489 2,438

Segment operating income (loss)
 (16,286 ) 98,233 1,052 82,999

Three months ended December 31, 2012:


Revenue
 $ — $ 140,651 $ 8,489 $ 149,140

Depreciation and amortization
 578 1,232 401 2,211

Segment operating income (loss)
 (16,334 ) 72,970 (1,050 ) 55,586

Six months ended December 31, 2013:


Revenue
 $ — $ 389,144 $ 17,383 $ 406,527

Depreciation and amortization
 992 2,830 989 4,811

Segment operating income (loss)
 (32,967 ) 195,981 2,889 165,903

Six months ended December 31, 2012:


Revenue
 $ — $ 267,919 $ 14,658 $ 282,577

Depreciation and amortization
 1,210 2,424 821 4,455

Segment operating income (loss)
 (30,765 ) 138,030 (3,097 ) 104,168

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Total operating income for reportable segments
 $ 82,999 $ 55,586 $ 165,903 $ 104,168

Interest income
 1,330 1,385 2,691 2,753

Other
 (185 ) 14 (623 ) (114 )

Income tax provision
 33,784 21,949 62,146 41,635





Net income
 $ 50,360 $ 35,036 $ 105,825 $ 65,172





X

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8

Segment and Related Information (Tables)
6 Months Ended

Dec. 31, 2013

Segment Revenue and Operating Income (Loss)

Segment revenue and operating income (loss) were as follows during the periods presented:

(In thousands) Research Molecular
diagnostics Companion
diagnostics Total

Three months ended December 31, 2013:


Revenue
 $ — $ 196,158 $ 7,902 $ 204,060

Depreciation and amortization
 482 1,467 489 2,438

Segment operating income (loss)
 (16,286 ) 98,233 1,052 82,999

Three months ended December 31, 2012:


Revenue
 $ — $ 140,651 $ 8,489 $ 149,140

Depreciation and amortization
 578 1,232 401 2,211

Segment operating income (loss)
 (16,334 ) 72,970 (1,050 ) 55,586

Six months ended December 31, 2013:


Revenue
 $ — $ 389,144 $ 17,383 $ 406,527

Depreciation and amortization
 992 2,830 989 4,811

Segment operating income (loss)
 (32,967 ) 195,981 2,889 165,903

Six months ended December 31, 2012:


Revenue
 $ — $ 267,919 $ 14,658 $ 282,577

Depreciation and amortization
 1,210 2,424 821 4,455

Segment operating income (loss)
 (30,765 ) 138,030 (3,097 ) 104,168

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Total operating income for reportable segments
 $ 82,999 $ 55,586 $ 165,903 $ 104,168

Interest income
 1,330 1,385 2,691 2,753

Other
 (185 ) 14 (623 ) (114 )

Income tax provision
 33,784 21,949 62,146 41,635





Net income
 $ 50,360 $ 35,036 $ 105,825 $ 65,172





X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8721-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 22

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8736-108599

+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8

Marketable Investment Securities (Tables)
6 Months Ended

Dec. 31, 2013

Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security

The amortized cost, gross unrealized holding gains, gross unrealized holding losses, and fair value for available-for-sale securities by major security type and class of security at December 31, 2013 and June 30, 2013 were as follows:

(In thousands) Amortized
cost Gross
unrealized
holding
gains Gross
unrealized
holding
losses Estimated
fair value

At December 31, 2013:


Cash and cash equivalents:


Cash
 $ 53,924 $ — $ — $ 53,924

Cash equivalents
 17,675 — — 17,675







Total cash and cash equivalents
 71,599 — — 71,599







Available-for-sale securities:


Corporate bonds and notes
 84,259 60 (1 ) 84,318

Municipal bonds
 268,341 300 (99 ) 268,542

Federal agency issues
 64,293 30 — 64,323







Total available-for-sale securities
 416,893 390 (100 ) 417,183







Total cash, cash equivalents and available-for-sale securities
 $ 488,492 $ 390 $ (100 ) $ 488,782







(In thousands) Amortized
cost Gross
unrealized
holding
gains Gross
unrealized
holding
losses Estimated
fair value

At June 30, 2013:


Cash and cash equivalents:


Cash
 $ 40,412 $ — $ — $ 40,412

Cash equivalents
 63,653 8 — 63,661







Total cash and cash equivalents
 104,065 8 — 104,073







Available-for-sale securities:


Corporate bonds and notes
 71,626 13 (15 ) 71,624

Municipal bonds
 251,513 109 (537 ) 251,085

Federal agency issues
 104,293 24 (35 ) 104,282







Total available-for-sale securities
 427,432 146 (587 ) 426,991







Total cash, cash equivalents and available-for-sale securities
 $ 531,497 $ 154 $ (587 ) $ 531,064







Schedule of Maturities of Debt Securities Classified as Cash Equivalents and Available-For-Sale

Cash, cash equivalents, and maturities of debt securities classified as available-for-sale securities are as follows at December 31, 2013:

(In thousands) Amortized
cost Estimated
fair value

Cash
 $ 53,924 $ 53,924

Cash equivalents
 17,675 17,675

Available-for-sale:


Due within one year
 281,882 281,996

Due after one year through five years
 135,011 135,187

Due after five years
 — —





 $ 488,492 $ 488,782





X

- Definition

Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.

+ References

No definition available.

+ Details

Name: us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.

+ References

No definition available.

+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8

Term Loan and Option Agreement
6 Months Ended

Dec. 31, 2013

Term Loan and Option Agreement

(10) Term Loan and Option Agreement

On September 8, 2011, the Company issued a $25,000,000 term loan to Crescendo Bioscience, Inc. (“Crescendo”) of South San Francisco, CA under a Loan and Security Agreement (“Loan Agreement”) and also secured an exclusive three-year option to acquire Crescendo pursuant to a definitive merger agreement (the “Option Agreement”). The stated interest rate on the term loan is 7%. The fair value of the Option Agreement of $8,000,000 was determined utilizing valuation models at the time of the issuance, including the market and income based approaches, which utilize various inputs including projected income, volatility, risk free rates and projected terms. The Company periodically evaluates the Option Agreement for impairment. No impairment indicators were noted at December 31, 2013.

The residual $17,000,000 value of the term loan has been classified as a note receivable at its accreted value of $23,000,000 on the condensed consolidated balance sheet as of December 31, 2013. The Company recorded interest income related to accretion of the note receivable and the stated interest rate for the three and six months ended December 31, 2013 of $1,104,000 and $2,208,000, respectively, in the condensed consolidated statement of income. The Company is utilizing the effective interest method to accrete the discount portion of the note receivable through interest income over the three-year term of the Company’s option to acquire Crescendo under the Option Agreement. The note receivable is evaluated for collectability each reporting period. If the Company determines that the note receivable and any accrued interest is not collectible, such amount will be written off in the period that determination is made. No amounts related to the note receivable or accrued interest were written off during the three or six months ended December 31, 2013.

On November 14, 2013, the Company received notice from Crescendo that Crescendo had achieved the minimum revenue milestone under the Option Agreement. If the Company exercises its option to acquire Crescendo, it expects to finance the purchase price out of the Company’s cash, cash equivalents and marketable investment securities available on hand.

X

- Definition

Term Loan And Option Agreement Disclosure

+ References

No definition available.

+ Details

Name: mygn_TermLoanAndOptionAgreementDisclosureTextBlock

Namespace Prefix: mygn_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8

Income Taxes
6 Months Ended

Dec. 31, 2013

Income Taxes

(8) Income Taxes

In order to determine the Company’s quarterly provision for income taxes, the Company used an estimated annual effective tax rate that is based on expected annual income and statutory tax rates in the various jurisdictions in which the Company operates. Certain significant or unusual items are separately recognized in the quarter during which they occur and can be a source of variability in the effective tax rates from quarter to quarter.

Income tax expense for the three months ended December 31, 2013 was $33,784,000, or approximately 40% of pre-tax income, compared to $21,949,000, for the three months ended December 31, 2012, or approximately 39% of pre-tax income. Income tax expense for the six months ended December 31, 2013 was $62,146,000, or approximately 37% of pre-tax income, compared to $41,635,000, or approximately 39% of pre-tax income. Income tax expense for the three and six months ended December 31, 2013 is based on the Company’s estimated annual effective tax rate for the full fiscal year ending June 30, 2014, adjusted by discrete items recognized during the period. For the six months ended December 31, 2013, the Company’s recognized effective tax rate differs from the U.S. federal statutory rate of 35% primarily due to the effect of state income taxes, a deduction for the write-off of stock in a wholly-owned subsidiary recently divested, as well as timing differences related to the recognition of the tax effect of equity compensation expense from incentive stock options and the deduction realized if those options are disqualified upon exercise and sale.

The Company files U.S., U.K., France and state income tax returns in jurisdictions with various statutes of limitations. Annual and interim tax provisions include amounts considered necessary to pay assessments that may result from examination of prior year tax returns; however, the amount ultimately paid upon resolution of issues may differ materially from the amount accrued. The Company’s U.S. federal tax return, U.K. and France income tax returns and all other state tax returns are not currently under examination.

X

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8

Goodwill and Intangible Assets
6 Months Ended

Dec. 31, 2013

Goodwill and Intangible Assets

(9) Goodwill and Intangible Assets

Goodwill

At December 31, 2013, the Company had recorded goodwill of $56,850,000 related to the acquisition of Myriad RBM, Inc. on May 31, 2011 (formerly Rules-Based Medicine, Inc.). There were no events or circumstances that indicated that impairment exists; therefore, the Company recorded no impairment of goodwill for the three and six months ended December 31, 2013.

Intangible Assets

Intangible assets primarily consist of amortizable assets of purchased licenses and technologies, customer relationships, and tradenames as well as non-amortizable intangible assets of in-process technologies and research and development. Certain of these intangible assets were recorded as part of the Company’s purchase of Rules-Based Medicine, Inc. on May 31, 2011. The following summarizes the amounts reported as intangible assets:

(In thousands) Gross
Carrying
Amount Accumlated
Amortization Net

December 31, 2013:


Purchased licenses and technologies
 $ 4,500 $ (2,800 ) $ 1,700

Customer relationships
 4,650 (1,208 ) 3,442

Trademarks
 3,000 (100 ) 2,900





Total amortizable intangible assets
 12,150 (4,108 ) 8,042





In-process research and development
 4,800 — 4,800





Total non-amortizable intangible assets
 4,800 — 4,800





Total intangible assets
 $ 16,950 $ (4,108 ) $ 12,842





(In thousands) Gross
Carrying
Amount Accumlated
Amortization Net

June 30, 2013:


Purchased licenses and technologies
 $ 4,500 $ (2,644 ) $ 1,856

Customer relationships
 4,650 (976 ) 3,674

Trademarks
 3,000 — 3,000





Total amortizable intangible assets
 12,150 (3,620 ) 8,530





In-process research and development
 4,800 — 4,800





Total non-amortizable intangible assets
 4,800 — 4,800





Total intangible assets
 $ 16,950 $ (3,620 ) $ 13,330





The Company recorded amortization during the respective periods for these intangible assets as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Amortization on intangible assets
 $ 244 $ 231 $ 488 $ 506

X

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13854-109267

+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8

Cost Basis Investment
6 Months Ended

Dec. 31, 2013

Cost Basis Investment

(11) Cost Basis Investment

As of December 31, 2013, the Company had a $5,000,000 investment in RainDance Technologies, Inc. which has been recorded under the cost method as an “Other Asset” on the Company’s condensed consolidated balance sheet. There were no events or circumstances that indicated that impairment exists; therefore, the Company recorded no impairment in the investment for the three or six months ended December 31, 2013.

X

- Definition

The entire disclosure for investments accounted for under the cost-method. The carrying amount of such investments may be adjusted, for example, distributions in excess of cost (return of capital) or for other-than-temporary impairments. The cost method and lower-of-cost or market, an adaptation of the cost method, is generally followed for most investments in noncontrolled corporations, in some corporate joint ventures, and to a lesser extent in unconsolidated subsidiaries in which the entity does not have the ability to exercise significant influence.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 325

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

+ Details

Name: us-gaap_CostMethodInvestmentsDescriptionTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule Of Anti-Dilutive Options Excluded From EPS Computation (Detail)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]

Anti-dilutive options excluded from EPS computation 8,500 5,605 7,136 4,585

X

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Antidilution

-URI http://asc.fasb.org/extlink&oid=6505113

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Diluted Earnings Per Share

-URI http://asc.fasb.org/extlink&oid=6510752

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Contingent Stock Agreement

-URI http://asc.fasb.org/extlink&oid=6508534

+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 53 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8

Stockholders' Equity (Tables)
6 Months Ended

Dec. 31, 2013

Schedule of Stock Repurchases

The shares retired, aggregate common stock and additional paid-in capital reductions, and related charges to retained earnings for the repurchases for the three and six months ended December 31, 2013 and 2012 were as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Shares purchased and retired
 3,185 1,231 6,991 3,067

Common stock and additional paid-in-capital reductions
 $ 25,096 $ 9,372 $ 55,036 $ 23,122

Charges to retained earnings
 $ 52,713 $ 24,311 $ 125,088 $ 56,760

X

- Definition

Schedule Of Common Stock Repurchased Table.

+ References

No definition available.

+ Details

Name: mygn_ScheduleOfCommonStockRepurchasedTableTextBlock

Namespace Prefix: mygn_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Detail) (USD $)
In Thousands, unless otherwise specified

Dec. 31, 2013

Jun. 30, 2013

Cash

Net Investment Income [Line Items]

Amortized cost $ 53,924 $ 40,412

Estimated fair value 53,924 40,412

Cash Equivalents

Net Investment Income [Line Items]

Amortized cost 17,675 63,653

Gross unrealized holding gains 8

Estimated fair value 17,675 63,661

Total Cash And Cash Equivalents

Net Investment Income [Line Items]

Amortized cost 71,599 104,065

Gross unrealized holding gains 8

Estimated fair value 71,599 104,073

Corporate Bonds And Notes

Net Investment Income [Line Items]

Amortized cost 84,259 71,626

Gross unrealized holding gains 60 13

Gross unrealized holding losses (1) (15)

Estimated fair value 84,318 71,624

Municipal Bonds

Net Investment Income [Line Items]

Amortized cost 268,341 251,513

Gross unrealized holding gains 300 109

Gross unrealized holding losses (99) (537)

Estimated fair value 268,542 251,085

Federal Agency Issues

Net Investment Income [Line Items]

Amortized cost 64,293 104,293

Gross unrealized holding gains 30 24

Gross unrealized holding losses (35)

Estimated fair value 64,323 104,282

Total Available For Sale

Net Investment Income [Line Items]

Amortized cost 416,893 427,432

Gross unrealized holding gains 390 146

Gross unrealized holding losses (100) (587)

Estimated fair value 417,183 426,991

Total Cash, Cash Equivalents & Available-For-Sale

Net Investment Income [Line Items]

Amortized cost 488,492 531,497

Gross unrealized holding gains 390 154

Gross unrealized holding losses (100) (587)

Estimated fair value $ 488,782 $ 531,064

X

- Definition

Amount of accumulated pre-tax unrealized gain before deducting pre-tax unrealized losses on investments in available-for-sale securities impacting investments.

+ References

No definition available.

+ Details

Name: mygn_AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of accumulated pre-tax unrealized loss before deducting pre-tax unrealized gain on investments in available-for-sale securities impacting investments.

+ References

No definition available.

+ Details

Name: mygn_AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 25

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-Subparagraph (aa)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562

+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8

Goodwill And Other Intangible Assets (Detail) (USD $)
In Thousands, unless otherwise specified

Dec. 31, 2013

Jun. 30, 2013

Acquired Finite And Infinite-Lived Intangible Assets [Line Items]

Gross Carrying Amount, total intangible assets $ 16,950 $ 16,950

Gross Carrying Amount, amortizable intangible assets 12,150 12,150

Accumulated Amortization (4,108) (3,620)

Net, total intangible assets 12,842 13,330

Net, amortizable intangible assets 8,042 8,530

Gross Carrying Amount, non-amortizable intangible assets 4,800 4,800

Net, non-amortizable intangible assets 4,800 4,800

In-Process Research And Development

Acquired Finite And Infinite-Lived Intangible Assets [Line Items]

Gross Carrying Amount, non-amortizable intangible assets 4,800 4,800

Net, non-amortizable intangible assets 4,800 4,800

Purchased Licenses And Technologies

Acquired Finite And Infinite-Lived Intangible Assets [Line Items]

Gross Carrying Amount, amortizable intangible assets 4,500 4,500

Accumulated Amortization (2,800) (2,644)

Net, amortizable intangible assets 1,700 1,856

Customer Relationships

Acquired Finite And Infinite-Lived Intangible Assets [Line Items]

Gross Carrying Amount, amortizable intangible assets 4,650 4,650

Accumulated Amortization (1,208) (976)

Net, amortizable intangible assets 3,442 3,674

Trademarks

Acquired Finite And Infinite-Lived Intangible Assets [Line Items]

Gross Carrying Amount, amortizable intangible assets 3,000 3,000

Accumulated Amortization (100)

Net, amortizable intangible assets $ 2,900 $ 3,000

X

- Details

Name: mygn_AcquiredIntangibleAssetsLineItems

Namespace Prefix: mygn_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Indefinite Lived Intangible Assets Gross (Excluding Goodwill)

+ References

No definition available.

+ Details

Name: mygn_IndefiniteLivedIntangibleAssetsGrossExcludingGoodwill

Namespace Prefix: mygn_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition

Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount before accumulated amortization of intangible assets, excluding goodwill.

+ References

No definition available.

+ Details

Name: us-gaap_IntangibleAssetsGrossExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 2

-Subparagraph ((a)(1),(b))

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 56 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8

Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Cash flows from operating activities:

Net income $ 105,825 $ 65,172

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization 4,811 4,455

Loss on disposition of assets 40 4

Share-based compensation expense 13,792 13,704

Bad debt expense 21,793 14,729

Impairment of intangible asset 1,490

Accreted interest on note receivable (1,333) (1,333)

Unrecognized tax benefits 2,600 130

Excess tax benefit from share-based compensation (592) (3,623)

Deferred income taxes (1,826) 5,899

Changes in operating assets and liabilities:

Prepaid expenses 1,807 501

Trade accounts receivable (11,597) (29,851)

Other receivables (172) 1,672

Accounts payable (536) 3,434

Accrued liabilities 1,510 (3,580)

Deferred revenue 1,909 667

Net cash provided by operating activities 138,031 73,470

Cash flows from investing activities:

Capital expenditures for equipment and leasehold improvements (8,098) (7,008)

Purchases of marketable investment securities (102,661) (239,264)

Proceeds from maturities and sales of marketable investment securities 113,424 207,230

Net cash provided by (used in) investing activities 2,665 (39,042)

Cash flows from financing activities:

Net proceeds from common stock issued under share-based compensation plans 6,362 23,903

Excess tax benefit from share-based compensation 592 3,623

Repurchase and retirement of common stock (180,124) (79,883)

Net cash used in financing activities (173,170) (52,357)

Net decrease in cash and cash equivalents (32,474) (17,929)

Cash and cash equivalents at beginning of period 104,073 86,352

Cash and cash equivalents at end of period $ 71,599 $ 68,423

X

- Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash

-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Cash Equivalents

-URI http://asc.fasb.org/extlink&oid=6507016

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 1

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.1)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section 45

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585

+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 830

-SubTopic 230

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906

+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907

+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 20

-Section 55

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907

+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 360

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

+ Details

Name: us-gaap_GainLossOnDispositionOfAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 30

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

+ Details

Name: us-gaap_ImpairmentOfIntangibleAssetsFinitelived

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in other amounts due to the reporting entity, which are not otherwise defined in the taxonomy.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInOtherReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 24

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 25

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585

+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 19

-Article 5

+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow to reacquire common stock during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 15

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585

+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

Cash outflow for purchase of trading, available-for-sale securities and held-to-maturity securities.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name: us-gaap_PaymentsToAcquireProductiveAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition

The total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Financing Activities

-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 14

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585

+ Details

Name: us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26853-111562

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 12

-Subparagraph (a),(b)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585

+ Details

Name: us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.5)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 5

-Article 5

+ Details

Name: us-gaap_ProvisionForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585

+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition

The net amount of all increases and decreases in unrecognized tax benefits for the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15A

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

+ Details

Name: us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

XML 57 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8

Earnings Per Share
6 Months Ended

Dec. 31, 2013

Earnings Per Share

(5) Earnings Per Share

Basic earnings per share is computed based on the weighted-average number of shares of the Company’s common stock outstanding. Diluted earnings per share is computed based on the weighted-average number of shares of the Company’s common stock, including the dilutive effect of common stock equivalents outstanding.

The following is a reconciliation of the denominators of the basic and diluted earnings per share computations:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Denominator:


Weighted-average shares outstanding used to compute basic earnings per share
 75,070 81,692 77,323 81,632

Effect of dilutive stock options
 1,755 2,548 1,989 2,459









Weighted-average shares outstanding and dilutive securities used to compute dilutive earnings per share
 76,825 84,240 79,312 84,091









Certain outstanding stock options were excluded from the computation of diluted earnings per share for the three and six months ended December 31, 2013 and 2012 because the effect would have been anti-dilutive. These potential dilutive common shares, which may be dilutive to future diluted earnings per share, are as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Anti-dilutive options excluded from EPS computation
 8,500 5,605 7,136 4,585

X

- Definition

The entire disclosure for earnings per share.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 55

-Paragraph 52

-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule of Maturities of Debt Securities Classified as Cash Equivalents and Available-For-Sale (Detail) (USD $)
In Thousands, unless otherwise specified

Dec. 31, 2013

Jun. 30, 2013

Net Investment Income [Line Items]

Due within one year, Amortized cost $ 281,882

Due after one year through five years, Amortized cost 135,011

Due after five years, Amortized cost

Total 488,492

Due within one year, Estimated fair value 281,996

Due after one year through five years, Estimated fair value 135,187

Due after five years, Estimated fair value

Total 488,782

Cash

Net Investment Income [Line Items]

Amortized cost 53,924 40,412

Estimated fair value 53,924 40,412

Cash Equivalents

Net Investment Income [Line Items]

Amortized cost 17,675 63,653

Estimated fair value $ 17,675 $ 63,661

X

- Definition

Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 25

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=28360136&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 5

-Subparagraph (aa)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6871852&loc=d3e26610-111562

+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the sixth fiscal year through the tenth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of available-for-sale debt securities at fair value maturing in the sixth fiscal year through the tenth fiscal year following the latest fiscal year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of available-for-sale debt securities at fair value maturing in the second fiscal year through the fifth fiscal year following the latest fiscal year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of available-for-sale debt securities at cost, net of adjustments, which include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (aa)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Fair value of investment in available-for-sale debt securities with a single maturity date.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the next fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings (less any cumulative-effect adjustments, as defined) and fair value hedge accounting adjustments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.2)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition

Amount of available-for-sale debt securities at fair value maturing in the next fiscal year following the latest fiscal year.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27198-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 320

-Section 50

-Paragraph 3

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62586-112803

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 320

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (d)

-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

+ Details

Name: us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_ScheduleOfInvestmentIncomeReportedAmountsByCategoryLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 59 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 99 180 1 true 36 0 false 6 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.myriad.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.myriad.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.myriad.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Parenthetical) false false R4.htm 105 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income Sheet http://www.myriad.com/taxonomy/role/StatementOfIncomeAlternative Condensed Consolidated Statements of Income and Comprehensive Income false false R5.htm 106 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.myriad.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows false false R6.htm 107 - Disclosure - Basis of Presentation Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsBasisOfAccounting Basis of Presentation false false R7.htm 108 - Disclosure - Marketable Investment Securities Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Marketable Investment Securities false false R8.htm 109 - Disclosure - Share-Based Compensation Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Share-Based Compensation false false R9.htm 110 - Disclosure - Stockholders' Equity Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Stockholders' Equity false false R10.htm 111 - Disclosure - Earnings Per Share Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Earnings Per Share false false R11.htm 112 - Disclosure - Segment and Related Information Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlock Segment and Related Information false false R12.htm 113 - Disclosure - Fair Value Measurements Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value Measurements false false R13.htm 114 - Disclosure - Income Taxes Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes false false R14.htm 115 - Disclosure - Goodwill and Intangible Assets Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock Goodwill and Intangible Assets false false R15.htm 116 - Disclosure - Term Loan and Option Agreement Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsTermLoanAndOptionAgreementDisclosureTextBlock Term Loan and Option Agreement false false R16.htm 117 - Disclosure - Cost Basis Investment Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsCostMethodInvestmentsDescriptionTextBlock Cost Basis Investment false false R17.htm 118 - Disclosure - Commitments and Contingencies Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies false false R18.htm 119 - Disclosure - Subsequent Event Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Event false false R19.htm 120 - Disclosure - Marketable Investment Securities (Tables) Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlockTables Marketable Investment Securities (Tables) false false R20.htm 121 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Share-Based Compensation (Tables) false false R21.htm 122 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables Stockholders' Equity (Tables) false false R22.htm 123 - Disclosure - Earnings Per Share (Tables) Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Earnings Per Share (Tables) false false R23.htm 124 - Disclosure - Segment and Related Information (Tables) Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsSegmentReportingDisclosureTextBlockTables Segment and Related Information (Tables) false false R24.htm 125 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value Measurements (Tables) false false R25.htm 126 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://www.myriad.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables Goodwill and Intangible Assets (Tables) false false R26.htm 127 - Disclosure - Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfFairValueForAvailableforSaleSecuritiesByMajorSecurityTypeAndClassOfSecurity Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Detail) false false R27.htm 128 - Disclosure - Schedule of Maturities of Debt Securities Classified as Cash Equivalents and Available-For-Sale (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfMaturitiesOfDebtSecuritiesClassifiedAsCashEquivalentsAndAvailableForSale Schedule of Maturities of Debt Securities Classified as Cash Equivalents and Available-For-Sale (Detail) false false R28.htm 129 - Disclosure - Share-Based Compensation - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureShareBasedCompensationAdditionalInformation Share-Based Compensation - Additional Information (Detail) false false R29.htm 130 - Disclosure - Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstanding Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding (Detail) false false R30.htm 131 - Disclosure - Schedule of Share-Based Compensation Recognized in Consolidated Statements of Comprehensive Income (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfShareBasedCompensationRecognizedInConsolidatedStatementsOfComprehensiveIncome Schedule of Share-Based Compensation Recognized in Consolidated Statements of Comprehensive Income (Detail) false false R31.htm 132 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation Stockholders' Equity - Additional Information (Detail) false false R32.htm 133 - Disclosure - Schedule of Stock Repurchases (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfStockRepurchases Schedule of Stock Repurchases (Detail) false false R33.htm 134 - Disclosure - Reconciliation of Denominators of Basic and Diluted Earnings Per Share (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureReconciliationOfDenominatorsOfBasicAndDilutedEarningsPerShare Reconciliation of Denominators of Basic and Diluted Earnings Per Share (Detail) false false R34.htm 135 - Disclosure - Schedule Of Anti-Dilutive Options Excluded From EPS Computation (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfAntiDilutiveOptionsExcludedFromEPSComputation Schedule Of Anti-Dilutive Options Excluded From EPS Computation (Detail) false false R35.htm 136 - Disclosure - Segment and Related Information - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureSegmentAndRelatedInformationAdditionalInformation Segment and Related Information - Additional Information (Detail) false false R36.htm 137 - Disclosure - Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureSegmentPerformanceBasedOnIncomeLossBeforeInterestIncomeAndOtherIncomeAndExpense Segment Performance Based on Income (Loss) before Interest Income and Other Income and Expense (Detail) false false R37.htm 138 - Disclosure - Schedule of Total Operating Income for Continuing Reportable Segments (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfTotalOperatingIncomeForContinuingReportableSegments Schedule of Total Operating Income for Continuing Reportable Segments (Detail) false false R38.htm 139 - Disclosure - Schedule of Fair Value of Financial Assets (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureScheduleOfFairValueOfFinancialAssets Schedule of Fair Value of Financial Assets (Detail) false false R39.htm 140 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) false false R40.htm 141 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsAdditionalInformation Goodwill and Other Intangible Assets - Additional Information (Detail) false false R41.htm 142 - Disclosure - Goodwill And Other Intangible Assets (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssets Goodwill And Other Intangible Assets (Detail) false false R42.htm 143 - Disclosure - Amortization on Intangible Assets (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureAmortizationOnIntangibleAssets Amortization on Intangible Assets (Detail) false false R43.htm 144 - Disclosure - Term Loan and Option Agreement - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureTermLoanAndOptionAgreementAdditionalInformation Term Loan and Option Agreement - Additional Information (Detail) false false R44.htm 145 - Disclosure - Cost Basis Investment - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureCostBasisInvestmentAdditionalInformation Cost Basis Investment - Additional Information (Detail) false false R45.htm 146 - Disclosure - Subsequent Event - Additional Information (Detail) Sheet http://www.myriad.com/taxonomy/role/DisclosureSubsequentEventAdditionalInformation Subsequent Event - Additional Information (Detail) false false All Reports Book All Reports Element us-gaap_Goodwill had a mix of decimals attribute values: -3 0. Process Flow-Through: 103 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: Removing column 'Jun. 30, 2012' Process Flow-Through: 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 105 - Statement - Condensed Consolidated Statements of Income and Comprehensive Income Process Flow-Through: 106 - Statement - Condensed Consolidated Statements of Cash Flows mygn-20131231.xml mygn-20131231.xsd mygn-20131231_cal.xml mygn-20131231_def.xml mygn-20131231_lab.xml mygn-20131231_pre.xml true true XML 60 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8

Schedule of Fair Value of Financial Assets (Detail) (USD $)
In Thousands, unless otherwise specified

Dec. 31, 2013

Jun. 30, 2013

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets $ 434,858 $ 490,652

Money Market Funds

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 9,351 ^[1] 12,691 ^[1]

Corporate Bonds And Notes

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 89,318 71,624

Municipal Bonds

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 270,554 302,055

Federal Agency Issues

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 65,635 104,282

Level 1

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 9,351 12,691

Level 1 | Money Market Funds

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 9,351 ^[1] 12,691 ^[1]

Level 2

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 425,507 477,961

Level 2 | Corporate Bonds And Notes

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 89,318 71,624

Level 2 | Municipal Bonds

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets 270,554 302,055

Level 2 | Federal Agency Issues

Fair Value, Option, Qualitative Disclosures Related to Election [Line Items]

Total fair value of financial assets $ 65,635 $ 104,282

[1] Money market funds are primarily comprised of exchange traded funds and accrued interest

X

- Definition

Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 820

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258

+ Details

Name: us-gaap_AssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueOptionQualitativeDisclosuresRelatedToElectionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 61 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

Share-Based Compensation (Tables)
6 Months Ended

Dec. 31, 2013

Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding

A summary of the stock option activity under the Company’s plans for the six months ended December 31, 2013 is as follows:

 Number of
shares Weighted
average
exercise
price

Options outstanding at June 30, 2013
 14,434,970 $ 21.75

Options granted
 3,304,553 26.48

Less:


Options exercised
 310,866 14.23

Options canceled or expired
 354,729 24.33





Options outstanding at December 31, 2013
 17,073,928 $ 22.75





Schedule of Share-Based Compensation Recognized in Consolidated Statements of Comprehensive Income

Share-based compensation expense recognized and included in the condensed consolidated statements of income was allocated as follows:

 Three months ended
December 31, Six months ended
December 31,

(In thousands) 2013 2012 2013 2012

Cost of molecular diagnostic testing
 $ 209 $ 271 $ 432 $ 560

Cost of companion diagnostic services
 74 47 137 104

Research and development expense
 846 869 1,627 1,678

Selling, general, and administrative expense
 5,728 5,918 11,596 11,362









Total share-based compensation expense
 $ 6,857 $ 7,105 $ 13,792 $ 13,704









X

- Definition

Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (b)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 14.F)

-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

-Section F

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the following for fully vested share options (or share units) and share options expected to vest at the date of the latest statement of financial position: the number, weighted-average exercise price (or conversion ratio), aggregate intrinsic value (except for nonpublic entities), and weighted-average remaining contractual term of options (or share units) outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (e)(1)

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if smaller reporting company)

Smaller reporting company

Term Loan and Option Agreement - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended	6 Months Ended
	Sep. 08, 2011 Y	Dec. 31, 2013	Dec. 31, 2013	Jun. 30, 2013
Debt Instrument [Line Items]
Loan Agreement, principal amount	$ 25,000,000
Interest rate per annum			7.00%
Fair value of Option Agreement		8,000,000	8,000,000
Effective period of option, in years	3
Residual value of loan agreement		17,000,000	17,000,000
Accreted value of loan agreement		23,000,000	23,000,000	21,667,000
Interest income related to accretion of the note receivable and the stated interest rate		$ 1,104,000	$ 2,208,000

Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding (Detail) (USD $)	6 Months Ended
	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options outstanding at beginning of year, Number of shares	14,434,970
Options granted, Number of shares	3,304,553
Options exercised, Number of shares	310,866
Options canceled or expired, Number of shares	354,729
Options outstanding at end of year, Number of shares	17,073,928
Options outstanding at beginning of year, Weighted average exercise price	$ 21.75
Options granted, Weighted average exercise price	$ 26.48
Options exercised, Weighted average exercise price	$ 14.23
Options canceled or expired, Weighted average exercise price	$ 24.33
Options outstanding at end of year, Weighted average exercise price	$ 22.75

Share-Based Compensation - Additional Information (Detail) (USD $)	6 Months Ended					6 Months Ended
	Dec. 31, 2013	Dec. 31, 2013 Options granted after December 5, 2012	Dec. 31, 2013 Options granted prior to December 5, 2012	Dec. 31, 2013 The 2010 Plan	Dec. 05, 2013 The 2010 Plan	Dec. 31, 2013 The 2010 Plan Maximum	Dec. 31, 2013 2012 Purchase Plan	Dec. 31, 2012 2012 Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares approved					3,500,000		1,856,000	2,000,000
Shares reserved for issuance exercise of options				3,733,317
Number of shares cancelled or expired without issuance	354,729			233,317
Shares available for future grant						6,999,352
Service period of option vested, years	4 years
Options expire from date of grant, years		8 years	10 years
Shares issued under the Plan							144,000
Options to purchase shares vested and exercisable, shares	9,218,423
Exercisable weighted average price of options	$ 21.39
Total unrecognized share-based compensation cost related to share-based awards granted	$ 52,276,000
Total unrecognized share-based compensation cost, weighted-average period, years	2 years 6 months 26 days

Cost Basis Investment - Additional Information (Detail) (USD $)	Dec. 31, 2013
Schedule of Cost-method Investments [Line Items]
Investment accounted under cost method	$ 5,000,000

Stockholders' Equity - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	1 Months Ended
	Dec. 31, 2013	Nov. 30, 2013
Fifth Share Repurchase Program
Stockholders Equity Note [Line Items]
Share repurchase program, authorized amount		$ 200
Sixth Share Repurchase Program
Stockholders Equity Note [Line Items]
Share repurchase program, authorized amount		300
Share repurchase program, remaining authorized repurchase amount	$ 273.3

Goodwill and Other Intangible Assets - Additional Information (Detail) (USD $)			3 Months Ended	6 Months Ended
	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2013 Rules-Based Medicine, Inc	Dec. 31, 2013 Rules-Based Medicine, Inc
Acquired Finite-Lived Intangible Assets [Line Items]
Goodwill Acquired	$ 56,850,000	$ 56,850,000	$ 56,850,000	$ 56,850,000
Impairment of goodwill			$ 0	$ 0

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Current assets:
Cash and cash equivalents	$ 71,599	$ 104,073
Marketable investment securities	281,996	268,243
Prepaid expenses	4,237	5,963
Trade accounts receivable, less allowance for doubtful accounts of $9,200 at Dec. 31, 2013 and $7,500 at Jun. 30, 2013	84,137	94,333
Deferred taxes	9,074	8,007
Other receivables	3,463	3,373
Total current assets	454,506	483,992
Equipment and leasehold improvements:
Equipment	73,570	65,903
Leasehold improvements	18,390	18,294
Gross equipment and leasehold improvements	91,960	84,197
Less accumulated depreciation	60,647	56,595
Net equipment and leasehold improvements	31,313	27,602
Long-term marketable investment securities	135,187	158,748
Long-term deferred taxes	29,983	28,632
Note receivable	23,000	21,667
Other assets	13,000	13,000
Intangibles, net	12,842	13,330
Goodwill	56,850	56,850
Total assets	756,681	803,821
Current liabilities:
Accounts payable	17,596	18,132
Accrued liabilities	45,844	44,334
Deferred revenue	3,952	2,043
Total current liabilities	67,392	64,509
Unrecognized tax benefits	13,318	10,718
Total liabilities	80,710	75,227
Stockholders' equity:
Preferred stock, $0.01 par value, authorized 5,000 shares, issued and outstanding no shares
Common stock, $0.01 par value, authorized 150,000 shares at Dec. 31, 2013 and Jun. 30, 2013, issued and outstanding 73,974 at Dec. 31, 2013 and 80,577 at Jun. 30, 2013	740	806
Additional paid-in capital	663,122	697,346
Accumulated other comprehensive income (loss)	506	(424)
Retained earnings	11,603	30,866
Total stockholders' equity	675,971	728,594
Total liabilities and stockholders' equity	$ 756,681	$ 803,821

Subsequent Event - Additional Information (Detail) (Subsequent Event, Option Agreement, Crescendo, USD $) In Millions, unless otherwise specified	0 Months Ended
	Feb. 02, 2014
Subsequent Event \| Option Agreement \| Crescendo
Subsequent Event [Line Items]
Cash paid for business acquisition	$ 270

Segment and Related Information - Additional Information (Detail)	6 Months Ended
	Dec. 31, 2013 Segment
Segment Reporting Information [Line Items]
Number of reportable segment	3

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Allowance for doubtful accounts	$ 9,200	$ 7,500
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	5,000	5,000
Preferred stock, issued
Preferred stock, outstanding
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized	150,000	150,000
Common stock, issued	73,974	80,577
Common stock, outstanding	73,974	80,577

Document and Entity Information	6 Months Ended
Document and Entity Information	Dec. 31, 2013	Jan. 31, 2014
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2013
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q2
Trading Symbol	MYGN
Entity Registrant Name	MYRIAD GENETICS INC
Entity Central Index Key	0000899923
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		72,974,449

Schedule of Fair Value for Available-for-Sale Securities by Major Security Type and Class of Security (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Cash
Net Investment Income [Line Items]
Amortized cost	$ 53,924	$ 40,412
Estimated fair value	53,924	40,412
Cash Equivalents
Net Investment Income [Line Items]
Amortized cost	17,675	63,653
Gross unrealized holding gains		8
Estimated fair value	17,675	63,661
Total Cash And Cash Equivalents
Net Investment Income [Line Items]
Amortized cost	71,599	104,065
Gross unrealized holding gains		8
Estimated fair value	71,599	104,073
Corporate Bonds And Notes
Net Investment Income [Line Items]
Amortized cost	84,259	71,626
Gross unrealized holding gains	60	13
Gross unrealized holding losses	(1)	(15)
Estimated fair value	84,318	71,624
Municipal Bonds
Net Investment Income [Line Items]
Amortized cost	268,341	251,513
Gross unrealized holding gains	300	109
Gross unrealized holding losses	(99)	(537)
Estimated fair value	268,542	251,085
Federal Agency Issues
Net Investment Income [Line Items]
Amortized cost	64,293	104,293
Gross unrealized holding gains	30	24
Gross unrealized holding losses		(35)
Estimated fair value	64,323	104,282
Total Available For Sale
Net Investment Income [Line Items]
Amortized cost	416,893	427,432
Gross unrealized holding gains	390	146
Gross unrealized holding losses	(100)	(587)
Estimated fair value	417,183	426,991
Total Cash, Cash Equivalents & Available-For-Sale
Net Investment Income [Line Items]
Amortized cost	488,492	531,497
Gross unrealized holding gains	390	154
Gross unrealized holding losses	(100)	(587)
Estimated fair value	$ 488,782	$ 531,064

Goodwill And Other Intangible Assets (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Acquired Finite And Infinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, total intangible assets	$ 16,950	$ 16,950
Gross Carrying Amount, amortizable intangible assets	12,150	12,150
Accumulated Amortization	(4,108)	(3,620)
Net, total intangible assets	12,842	13,330
Net, amortizable intangible assets	8,042	8,530
Gross Carrying Amount, non-amortizable intangible assets	4,800	4,800
Net, non-amortizable intangible assets	4,800	4,800
In-Process Research And Development
Acquired Finite And Infinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, non-amortizable intangible assets	4,800	4,800
Net, non-amortizable intangible assets	4,800	4,800
Purchased Licenses And Technologies
Acquired Finite And Infinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, amortizable intangible assets	4,500	4,500
Accumulated Amortization	(2,800)	(2,644)
Net, amortizable intangible assets	1,700	1,856
Customer Relationships
Acquired Finite And Infinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, amortizable intangible assets	4,650	4,650
Accumulated Amortization	(1,208)	(976)
Net, amortizable intangible assets	3,442	3,674
Trademarks
Acquired Finite And Infinite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, amortizable intangible assets	3,000	3,000
Accumulated Amortization	(100)
Net, amortizable intangible assets	$ 2,900	$ 3,000

Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net income	$ 105,825	$ 65,172
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,811	4,455
Loss on disposition of assets	40	4
Share-based compensation expense	13,792	13,704
Bad debt expense	21,793	14,729
Impairment of intangible asset		1,490
Accreted interest on note receivable	(1,333)	(1,333)
Unrecognized tax benefits	2,600	130
Excess tax benefit from share-based compensation	(592)	(3,623)
Deferred income taxes	(1,826)	5,899
Changes in operating assets and liabilities:
Prepaid expenses	1,807	501
Trade accounts receivable	(11,597)	(29,851)
Other receivables	(172)	1,672
Accounts payable	(536)	3,434
Accrued liabilities	1,510	(3,580)
Deferred revenue	1,909	667
Net cash provided by operating activities	138,031	73,470
Cash flows from investing activities:
Capital expenditures for equipment and leasehold improvements	(8,098)	(7,008)
Purchases of marketable investment securities	(102,661)	(239,264)
Proceeds from maturities and sales of marketable investment securities	113,424	207,230
Net cash provided by (used in) investing activities	2,665	(39,042)
Cash flows from financing activities:
Net proceeds from common stock issued under share-based compensation plans	6,362	23,903
Excess tax benefit from share-based compensation	592	3,623
Repurchase and retirement of common stock	(180,124)	(79,883)
Net cash used in financing activities	(173,170)	(52,357)
Net decrease in cash and cash equivalents	(32,474)	(17,929)
Cash and cash equivalents at beginning of period	104,073	86,352
Cash and cash equivalents at end of period	$ 71,599	$ 68,423

Schedule of Maturities of Debt Securities Classified as Cash Equivalents and Available-For-Sale (Detail) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013	Jun. 30, 2013
Net Investment Income [Line Items]
Due within one year, Amortized cost	$ 281,882
Due after one year through five years, Amortized cost	135,011
Due after five years, Amortized cost
Total	488,492
Due within one year, Estimated fair value	281,996
Due after one year through five years, Estimated fair value	135,187
Due after five years, Estimated fair value
Total	488,782
Cash
Net Investment Income [Line Items]
Amortized cost	53,924	40,412
Estimated fair value	53,924	40,412
Cash Equivalents
Net Investment Income [Line Items]
Amortized cost	17,675	63,653
Estimated fair value	$ 17,675	$ 63,661